"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Xu","Xueqiang",NA,NA
"2","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Liu","Kang",NA,NA
"3","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Cheng","Peng",NA,NA
"4","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Huang","Yaoyu",NA,NA
"5","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Huang","Chaolin",NA,NA
"6","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Wu","Wenjuan",NA,NA
"7","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Xing","Changying",NA,NA
"8","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Mao","Huijuan",NA,NA
"9","34236306","10.5414/CN110474","Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.","Continuous renal replacement therapy (CRRT) has become an important multiple organ support therapy and it is widely used in the intensive care unit (ICU). The aim of this study was to clarify the association between CRRT and 28-day mortality in critically ill coronavirus disease 2019 (-COVID-19) patients receiving mechanical ventilation. 112 respiratory decompensated critically ill adult patients with COVID-19 admitted to a COVID-19-designated ICU were included in this retrospective cohort study","2021","07","10","Clin Nephrol","Clinical nephrology",NA,"Liu","Yun",NA,NA
"10","34236305","10.5414/CP204050","Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns.","The aim of this study was to examine the development of drug purchases over the course of the coronavirus crisis in Germany in 2020. The evaluations in this retrospective cross-sectional study are based on the IMS RPM (Regional Pharmaceutical Market) weekly database, which shows weekly purchases by public pharmacies from full-service wholesalers at the time the pharmacy purchase is made in Germany. The outcome of this investigation was the development of cardiovascular drug sales by packing unit","2021","07","10","Int J Clin Pharmacol Ther","International journal of clinical pharmacology and therapeutics",NA,"Luedde","Mark",NA,NA
"11","34236305","10.5414/CP204050","Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns.","The aim of this study was to examine the development of drug purchases over the course of the coronavirus crisis in Germany in 2020. The evaluations in this retrospective cross-sectional study are based on the IMS RPM (Regional Pharmaceutical Market) weekly database, which shows weekly purchases by public pharmacies from full-service wholesalers at the time the pharmacy purchase is made in Germany. The outcome of this investigation was the development of cardiovascular drug sales by packing unit","2021","07","10","Int J Clin Pharmacol Ther","International journal of clinical pharmacology and therapeutics",NA,"Loosen","Sven",NA,NA
"12","34236305","10.5414/CP204050","Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns.","The aim of this study was to examine the development of drug purchases over the course of the coronavirus crisis in Germany in 2020. The evaluations in this retrospective cross-sectional study are based on the IMS RPM (Regional Pharmaceutical Market) weekly database, which shows weekly purchases by public pharmacies from full-service wholesalers at the time the pharmacy purchase is made in Germany. The outcome of this investigation was the development of cardiovascular drug sales by packing unit","2021","07","10","Int J Clin Pharmacol Ther","International journal of clinical pharmacology and therapeutics",NA,"Konrad","Marcel",NA,NA
"13","34236305","10.5414/CP204050","Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns.","The aim of this study was to examine the development of drug purchases over the course of the coronavirus crisis in Germany in 2020. The evaluations in this retrospective cross-sectional study are based on the IMS RPM (Regional Pharmaceutical Market) weekly database, which shows weekly purchases by public pharmacies from full-service wholesalers at the time the pharmacy purchase is made in Germany. The outcome of this investigation was the development of cardiovascular drug sales by packing unit","2021","07","10","Int J Clin Pharmacol Ther","International journal of clinical pharmacology and therapeutics",NA,"Tanislav","Christian",NA,NA
"14","34236305","10.5414/CP204050","Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns.","The aim of this study was to examine the development of drug purchases over the course of the coronavirus crisis in Germany in 2020. The evaluations in this retrospective cross-sectional study are based on the IMS RPM (Regional Pharmaceutical Market) weekly database, which shows weekly purchases by public pharmacies from full-service wholesalers at the time the pharmacy purchase is made in Germany. The outcome of this investigation was the development of cardiovascular drug sales by packing unit","2021","07","10","Int J Clin Pharmacol Ther","International journal of clinical pharmacology and therapeutics",NA,"Roderburg","Christoph",NA,NA
"15","34236305","10.5414/CP204050","Increased pharmacy purchases of cardiovascular drugs from wholesalers prior to the first and second COVID-19 lockdowns.","The aim of this study was to examine the development of drug purchases over the course of the coronavirus crisis in Germany in 2020. The evaluations in this retrospective cross-sectional study are based on the IMS RPM (Regional Pharmaceutical Market) weekly database, which shows weekly purchases by public pharmacies from full-service wholesalers at the time the pharmacy purchase is made in Germany. The outcome of this investigation was the development of cardiovascular drug sales by packing unit","2021","07","10","Int J Clin Pharmacol Ther","International journal of clinical pharmacology and therapeutics",NA,"Kostev","Karel",NA,NA
"16","34236296","10.1080/08897077.2021.1949662","Contextual challenges in police-assisted substance use referral programs: Impact of COVID-19 and Black Lives Matter movement.","Background: Police assisted referral (PAR) programs provide people with substance use disorders (SUD) with a non-arrest treatment pathway, yet systemic barriers, including stigma and access to treatment services, may limit engagement. We sought to understand how the dual contextual challenges of COVID-19 and the Black Lives Matter movement have impacted PAR programs. Methods: Participants completed semi-structured interviews between July and September 2020. Transcribed interviews w","2021","07","08","Subst Abus","Substance abuse","Black Lives Matter; COVID-19; Substance use disorder; criminal justice; police-assisted referral; substance use treatment","Liu","Jessica","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA",NA
"17","34236296","10.1080/08897077.2021.1949662","Contextual challenges in police-assisted substance use referral programs: Impact of COVID-19 and Black Lives Matter movement.","Background: Police assisted referral (PAR) programs provide people with substance use disorders (SUD) with a non-arrest treatment pathway, yet systemic barriers, including stigma and access to treatment services, may limit engagement. We sought to understand how the dual contextual challenges of COVID-19 and the Black Lives Matter movement have impacted PAR programs. Methods: Participants completed semi-structured interviews between July and September 2020. Transcribed interviews w","2021","07","08","Subst Abus","Substance abuse","Black Lives Matter; COVID-19; Substance use disorder; criminal justice; police-assisted referral; substance use treatment","Heckel","Emily","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA",NA
"18","34236296","10.1080/08897077.2021.1949662","Contextual challenges in police-assisted substance use referral programs: Impact of COVID-19 and Black Lives Matter movement.","Background: Police assisted referral (PAR) programs provide people with substance use disorders (SUD) with a non-arrest treatment pathway, yet systemic barriers, including stigma and access to treatment services, may limit engagement. We sought to understand how the dual contextual challenges of COVID-19 and the Black Lives Matter movement have impacted PAR programs. Methods: Participants completed semi-structured interviews between July and September 2020. Transcribed interviews w","2021","07","08","Subst Abus","Substance abuse","Black Lives Matter; COVID-19; Substance use disorder; criminal justice; police-assisted referral; substance use treatment","Coroiu","Adina","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA",NA
"19","34236296","10.1080/08897077.2021.1949662","Contextual challenges in police-assisted substance use referral programs: Impact of COVID-19 and Black Lives Matter movement.","Background: Police assisted referral (PAR) programs provide people with substance use disorders (SUD) with a non-arrest treatment pathway, yet systemic barriers, including stigma and access to treatment services, may limit engagement. We sought to understand how the dual contextual challenges of COVID-19 and the Black Lives Matter movement have impacted PAR programs. Methods: Participants completed semi-structured interviews between July and September 2020. Transcribed interviews w","2021","07","08","Subst Abus","Substance abuse","Black Lives Matter; COVID-19; Substance use disorder; criminal justice; police-assisted referral; substance use treatment","Rees","Vaughan W","Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA",NA
"20","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Alshahrani","Saeed Mastour","College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia",NA
"21","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Dehom","Salem","Department of Graduate Studies, Loma Linda University - School of Nursing, Loma Linda, CA, USA",NA
"22","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Almutairi","Diaa","Department of Oral Health, Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia",NA
"23","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Alnasser","Badr Saud","Department of Health Management, College of Public Health and Health Informatics, University of Ha'il, Hail, Saudi Arabia",NA
"24","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Alsaif","Bandar","Department of Public Health, University of Ha'il, Hail, Saudi Arabia",NA
"25","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Alabdrabalnabi","Ahmed A","Department of Public Health, College of Health Sciences, Saudi Electronic University, Dammam, Saudi Arabia",NA
"26","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Bin Rahmah","Abdullah","College of Dentistry, King Saud University, Riyadh, Saudi Arabia",NA
"27","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Alshahrani","Mastour Safar","Dental Department, Ministry of Health, Khamis Mushayt, Saudi Arabia",NA
"28","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","El-Metwally","Ashraf","College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia",NA
"29","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Al-Khateeb","Badr F","College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia",NA
"30","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Othman","Fatmah","College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia",NA
"31","34236290","10.1080/21645515.2021.1936869","Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.","The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters","2021","07","08","Hum Vaccin Immunother","Human vaccines &amp; immunotherapeutics","COVID-19; Saudi Arabia; acceptance; hesitancy; questionnaire; vaccine","Mahtab Alam","Mohammad","College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia",NA
"32","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Sanguedolce","Francesca","Pathology Unit, University of Foggia, Foggia, Italy",NA
"33","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Zanelli","Magda","Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Emilia, Italy",NA
"34","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Froio","Elisabetta","Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Emilia, Italy",NA
"35","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Bisagni","Alessandra","Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Emilia, Italy",NA
"36","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Zizzo","Maurizio","Surgical Oncology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Emilia, Italy",NA
"37","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Ascani","Stefano","Pathology Unit, Azienda Ospedaliera S. Maria di Terni, University of Perugia, Terni, Italy",NA
"38","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Stallone","Giovanni","Nephrology Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy",NA
"39","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Netti","Stefano","Clinical Pathology Unit, University of Foggia, Foggia, Italy",NA
"40","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Ranieri","Elena","Clinical Pathology Unit, University of Foggia, Foggia, Italy",NA
"41","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Falagario","Ugo","Urology and Renal Transplantation Unit, University of Foggia, Foggia, Italy",NA
"42","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Carrieri","Giuseppe","Urology and Renal Transplantation Unit, University of Foggia, Foggia, Italy",NA
"43","34236278","10.1080/10408363.2021.1944047","Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.","A novel coronavirus pneumonia first occurred in Wuhan, China in early December 2019; the causative agent was identified and named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO), and the resulting disease termed coronavirus disease 2019 (COVID-19), according to the WHO coronavirus disease situation reports. This condition has spread rapidly all over the world and caused more than 125 million cases globally, with more than 2 million related d","2021","07","08","Crit Rev Clin Lab Sci","Critical reviews in clinical laboratory sciences","MERS-CoV; SARS-CoV; SARS-CoV-2; ancillary techniques; nephropathy","Cormio","Luigi","Urology and Renal Transplantation Unit, University of Foggia, Foggia, Italy",NA
"44","34236275","10.1080/13691058.2021.1930173","(Re)regulating gay sex in viral times: COVID-19 and the impersonal intimacy of the glory hole.","COVID-19 has transformed the way we live our lives, and sex has been a significant element of that transformation. Gay male sex in the UK has faced the most significant (re)criminalisation and (re)regulation in living memory with intimacy outside of the heteronormative framework of domestic coupledom at best discouraged and, at worst, made into a criminal offence. This criminalisation provides a temporal praxis in which gay men experience sex in the shadows once more, an echo of a historic legal","2021","07","08","Cult Health Sex","Culture, health &amp; sexuality","COVID-19; Glory hole; desire; impersonality; intimacy","Ashford","Chris","Faculty of Business and Law, Northumbria University, Newcastle upon Tyne, UK",NA
"45","34236275","10.1080/13691058.2021.1930173","(Re)regulating gay sex in viral times: COVID-19 and the impersonal intimacy of the glory hole.","COVID-19 has transformed the way we live our lives, and sex has been a significant element of that transformation. Gay male sex in the UK has faced the most significant (re)criminalisation and (re)regulation in living memory with intimacy outside of the heteronormative framework of domestic coupledom at best discouraged and, at worst, made into a criminal offence. This criminalisation provides a temporal praxis in which gay men experience sex in the shadows once more, an echo of a historic legal","2021","07","08","Cult Health Sex","Culture, health &amp; sexuality","COVID-19; Glory hole; desire; impersonality; intimacy","Longstaff","Gareth","Media, Culture, Heritage, School of Arts and Cultures, Newcastle University, Newcastle upon Tyne, UK",NA
"46","34236274","10.1080/09273948.2021.1933077","Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2.","Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) and macular edema presumably associated with lupus anticoagulant (LA) induced by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).Method: Case report.Results: A 32-year-old male patient presented to the emergency department with a 5-day history of blurry vision. He was diagnosed with a CRVO and macular edema. The only pathological finding was positive LA which could have been induced by","2021","07","08","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; central retinal vein occlusion; lupus anticoagulant; macular edema; ozurdex; sars cov-2","Cuadros Sánchez","Carlos","Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain",NA
"47","34236274","10.1080/09273948.2021.1933077","Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2.","Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) and macular edema presumably associated with lupus anticoagulant (LA) induced by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).Method: Case report.Results: A 32-year-old male patient presented to the emergency department with a 5-day history of blurry vision. He was diagnosed with a CRVO and macular edema. The only pathological finding was positive LA which could have been induced by","2021","07","08","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; central retinal vein occlusion; lupus anticoagulant; macular edema; ozurdex; sars cov-2","Egüen","Cristina Sacristán","Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain",NA
"48","34236274","10.1080/09273948.2021.1933077","Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2.","Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) and macular edema presumably associated with lupus anticoagulant (LA) induced by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).Method: Case report.Results: A 32-year-old male patient presented to the emergency department with a 5-day history of blurry vision. He was diagnosed with a CRVO and macular edema. The only pathological finding was positive LA which could have been induced by","2021","07","08","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; central retinal vein occlusion; lupus anticoagulant; macular edema; ozurdex; sars cov-2","Gutierrez-Ezquerro","Raquel","Department of Ophthalmology, University Torrevieja Hospital, Torrevieja, Alicante, España",NA
"49","34236274","10.1080/09273948.2021.1933077","Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2.","Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) and macular edema presumably associated with lupus anticoagulant (LA) induced by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).Method: Case report.Results: A 32-year-old male patient presented to the emergency department with a 5-day history of blurry vision. He was diagnosed with a CRVO and macular edema. The only pathological finding was positive LA which could have been induced by","2021","07","08","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; central retinal vein occlusion; lupus anticoagulant; macular edema; ozurdex; sars cov-2","Giralt-Peret","Lena","Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain",NA
"50","34236274","10.1080/09273948.2021.1933077","Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2.","Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) and macular edema presumably associated with lupus anticoagulant (LA) induced by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).Method: Case report.Results: A 32-year-old male patient presented to the emergency department with a 5-day history of blurry vision. He was diagnosed with a CRVO and macular edema. The only pathological finding was positive LA which could have been induced by","2021","07","08","Ocul Immunol Inflamm","Ocular immunology and inflammation","COVID-19; central retinal vein occlusion; lupus anticoagulant; macular edema; ozurdex; sars cov-2","Fonollosa","Alex","Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain",NA
"51","34236264","10.1177/00368504211030372","Efficacy of tocilizumab in COVID-19: A review of the current evidence.","As cases of coronavirus 2019 (COVID-19) keep rising, reported deaths are increasing. Public health measures have been implemented with mixed efficacy. As vaccines are becoming more widely available and accessible globally, treating critically ill COVID-19 patients remains an issue with only dexamethasone found to be therapeutically effective to date. However, trials studying the efficacy of IL-6 inhibitors, namely tocilizumab have been underway with promising results. This paper is a narrative r","2021","07","13","Sci Prog","Science progress","COVID-19; IL-6 inhibitors; clinical outcomes; mortality; randomized clinical trial; review; tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Humans; SARS-CoV-2; Treatment Outcome","Alam","Walid","Global Health Institute, American University of Beirut, Hamra, Beirut, Lebanon",NA
"52","34236264","10.1177/00368504211030372","Efficacy of tocilizumab in COVID-19: A review of the current evidence.","As cases of coronavirus 2019 (COVID-19) keep rising, reported deaths are increasing. Public health measures have been implemented with mixed efficacy. As vaccines are becoming more widely available and accessible globally, treating critically ill COVID-19 patients remains an issue with only dexamethasone found to be therapeutically effective to date. However, trials studying the efficacy of IL-6 inhibitors, namely tocilizumab have been underway with promising results. This paper is a narrative r","2021","07","13","Sci Prog","Science progress","COVID-19; IL-6 inhibitors; clinical outcomes; mortality; randomized clinical trial; review; tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Humans; SARS-CoV-2; Treatment Outcome","Bizri","Abdul Rahman","Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Hamra, Beirut, Lebanon",NA
"53","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Huang","Yan","Department of Cardiology, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"54","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Hu","Zhenhong","Department of Respiratory Medicine, General Hospital of Central Theater Command of People's Liberation Army, China",NA
"55","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Hu","Dong","Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, China",NA
"56","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Quan","Zhou","Department of Clinical Laboratory, Renimin Hospital of Wuhan university, China",NA
"57","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Zhou","Xiaoyang","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"58","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Fan","Guohua","Department of Thoracic Surgery, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"59","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Chen","Xiu","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"60","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Liu","Xiaoxiong","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"61","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Zhang","Zhonghe","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"62","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Chen","Ganxiao","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"63","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Wu","Yanwen","Department of Respiratory Medicine, General Hospital of Central Theater Command of People's Liberation Army, China",NA
"64","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Zhang","Fangqi","Department of Respiratory Medicine, General Hospital of Central Theater Command of People's Liberation Army, China",NA
"65","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Mao","Congzheng","Department of Respiratory Medicine, General Hospital of Central Theater Command of People's Liberation Army, China",NA
"66","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Xia","Hao","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"67","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Liang","Jinjun","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"68","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Yang","Bo","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"69","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Jiang","Hong","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"70","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Huang","Congxin","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"71","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Barajas-Martínez","Hector","Pennsylvania and Jefferson Medical College, grid.280695.0Lankenau Institute for Medical Research, United States",NA
"72","34236244","10.1152/japplphysiol.00325.2021","Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19.","Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been associated with cardiovascular features, which may be deteriorated in cancer patients. However, cardiac outcomes of cancer patients with COVID-19 have not been closely examined. We retrospectively assessed 1244 patients with COVID-19 from February 1<sup>st</sup> to August 31<sup>st</sup> (140 cancer and 1104 non-cancer patients). Demographic and clinical data were obtained and compar","2021","07","08","J Appl Physiol (1985)","Journal of applied physiology (Bethesda, Md. : 1985)","Biomarker; COVID-19; Cardio-oncology; Heart failure; Risk factors","Hu","Dan","Department of Cardiology and Cardiovascular Research Institute, grid.412632.0Renmin Hospital of Wuhan University, China",NA
"73","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Matin","M Abdul","Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"74","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Nahid","Abdullah Al","Department of Biochemistry and Molecular Biology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh",NA
"75","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Sarkar","Bishajit","Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"76","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Ullah","M Asad","Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"77","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Araf","Yusha","COVID Research Cell (CRC), Wazed Miah Science Research Center (WMSRC), Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"78","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Adnan","Nihad","Department of Microbiology, Faculty of Biological Sciences, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"79","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Islam","Rashedul","X-Genomics Research Laboratory, Dhaka, Bangladesh",NA
"80","34236232","10.1128/MRA.00511-21","Genome Sequences of Two Novel Coronavirus (SARS-CoV-2) Isolates from Dhaka, Bangladesh.","This study reports the genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in the nasopharyngeal swab specimens of two coronavirus disease 2019 (COVID-19) patients from Dhaka, Bangladesh.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Rahman","Mohammad Shahedur","Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Jahangirnagar University, Savar, Dhaka, Bangladesh",NA
"81","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Sarkar","M Murshed Hasan","Bangladesh Council of Scientific &amp",NA
"82","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Rabbi","Mohammad Fazle Alam","DNA Solution Ltd., Dhaka, Bangladesh",NA
"83","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Akter","Shahina","Bangladesh Council of Scientific &amp",NA
"84","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Banu","Tanjina Akhtar","Bangladesh Council of Scientific &amp",NA
"85","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Goswami","Barna","Bangladesh Council of Scientific &amp",NA
"86","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Jahan","Iffat","Bangladesh Council of Scientific &amp",NA
"87","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Hossain","M Saddam","Bangladesh Council of Scientific &amp",NA
"88","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Osman","Eshrar","Bangladesh Council of Scientific &amp",NA
"89","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Uzzaman","Mohammad Samir","SciTech Consulting and Solutions, Dhaka, Bangladesh",NA
"90","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Habib","M Ahashan","Bangladesh Council of Scientific &amp",NA
"91","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Mahmud","Abu Sayeed Mohammad","Bangladesh Council of Scientific &amp",NA
"92","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Kabir","Firoz","DNA Solution Ltd., Dhaka, Bangladesh",NA
"93","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Hasan","Kazi Nadim","DNA Solution Ltd., Dhaka, Bangladesh",NA
"94","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Rahman","M Mizanur","DNA Solution Ltd., Dhaka, Bangladesh",NA
"95","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Khaleque","M Abdul","DNA Solution Ltd., Dhaka, Bangladesh",NA
"96","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Akhteruzzaman","Sharif","DNA Solution Ltd., Dhaka, Bangladesh",NA
"97","34236224","10.1128/MRA.00524-21","Genome Sequence of a SARS-CoV-2 P.1 Variant of Concern (20J/501Y.V3) from Bangladesh.","This study reports the coding-complete genome sequence, with variant identifications and phylogenetic analysis, of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant (20J/501Y.V3), obtained from an oropharyngeal swab specimen from a female Bangladeshi patient diagnosed with coronavirus disease 2019 (COVID-19) with no travel history.","2021","07","11","Microbiol Resour Announc","Microbiology resource announcements",NA,"Khan","M Salim","Bangladesh Council of Scientific &amp",NA
"98","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Gaigbe-Togbe","Bertille H A","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"99","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Menhaji","Kimia","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"100","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Tran","Ann D","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"101","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Bui","Anthony H","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"102","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Ascher-Walsh","Charles","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"103","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Dabney","Lisa","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"104","34236160","10.1097/SPV.0000000000001031","Virtual Interviews During COVID-19 Pandemic: A Survey of Applicants to Fellowships in Female Pelvic Medicine and Reconstructive Surgery.","The objective was to assess female pelvic medicine and reconstructive surgery (FPMRS) fellowship applicants' perspectives on the effectiveness of the virtual interview format for creating their rank lists. This was an anonymous internet-based survey study of applicants to the FPMRS fellowships in the United States, conducted from July 21, 2020, to August 5, 2020. A 34-item questionnaire queried applicants on satisfaction with interviews, comfort with creating a rank list and time, and financial ","2021","07","08","Female Pelvic Med Reconstr Surg","Female pelvic medicine &amp; reconstructive surgery",NA,"Hardart","Anne","From the *Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Mount Sinai Hospital at Icahn School of Medicine, New York City, NY Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC",NA
"105","34236141","10.1002/iid3.469","Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study.","The role of triglycerides (TG) in coronavirus disease (COVID-19) is controversial. The objective of this study was to explore the relationship between TG levels and prognosis in COVID-19 patients and investigate the factors that affect TG. COVID-19 patients were divided into normal or high TG level groups. Their demographic data, medical history, signs and symptoms, laboratory results, and final clinical results were analyzed retrospectively. A total of 174 patients were included. TG level was 1","2021","07","08","Immun Inflamm Dis","Immunity, inflammation and disease","COVID-19; IL-10; inflammation; macrophage; prognosis; serum ferritin; triglycerides","Zhong","Peng","Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing, China",NA
"106","34236141","10.1002/iid3.469","Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study.","The role of triglycerides (TG) in coronavirus disease (COVID-19) is controversial. The objective of this study was to explore the relationship between TG levels and prognosis in COVID-19 patients and investigate the factors that affect TG. COVID-19 patients were divided into normal or high TG level groups. Their demographic data, medical history, signs and symptoms, laboratory results, and final clinical results were analyzed retrospectively. A total of 174 patients were included. TG level was 1","2021","07","08","Immun Inflamm Dis","Immunity, inflammation and disease","COVID-19; IL-10; inflammation; macrophage; prognosis; serum ferritin; triglycerides","Wang","Zhenzhou","Trauma Center, National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Peking University People's Hospital, Beijing, China",NA
"107","34236141","10.1002/iid3.469","Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study.","The role of triglycerides (TG) in coronavirus disease (COVID-19) is controversial. The objective of this study was to explore the relationship between TG levels and prognosis in COVID-19 patients and investigate the factors that affect TG. COVID-19 patients were divided into normal or high TG level groups. Their demographic data, medical history, signs and symptoms, laboratory results, and final clinical results were analyzed retrospectively. A total of 174 patients were included. TG level was 1","2021","07","08","Immun Inflamm Dis","Immunity, inflammation and disease","COVID-19; IL-10; inflammation; macrophage; prognosis; serum ferritin; triglycerides","Du","Zhe","Trauma Center, National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Peking University People's Hospital, Beijing, China",NA
"108","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Nuzzi","Vincenzo","Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Valdoni 7, Trieste, 34100, Italy",NA
"109","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Merlo","Marco","Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Valdoni 7, Trieste, 34100, Italy",NA
"110","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Specchia","Claudia","Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy",NA
"111","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Lombardi","Carlo Mario","Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy",NA
"112","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Carubelli","Valentina","Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy",NA
"113","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Iorio","Annamaria","Cardiology Unit, Cardiovascular Department, Papa Giovanni XXIII Hospital-Bergamo, Bergamo, Italy",NA
"114","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Inciardi","Riccardo Maria","Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy",NA
"115","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Bellasi","Antonio","Innovation and Brand Reputation Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy",NA
"116","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Canale","Claudia","Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino-IRCCS Italian Cardiovascular Network, University of Genova, Genoa, Italy",NA
"117","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Camporotondo","Rita","Intensive Cardiac Care Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy",NA
"118","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Catagnano","Francesco","Cardiology Department, Policlinico di Monza, Monza, Italy",NA
"119","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Dalla Vecchia","Laura Adelaide","Dipartimento di Cardiologia, Istituti Clinici Scientifici Maugeri, IRCCS, Istituto Scientifico di Milano, Milan, Italy",NA
"120","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Giovinazzo","Stefano","Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino-IRCCS Italian Cardiovascular Network, University of Genova, Genoa, Italy",NA
"121","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Maccagni","Gloria","Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy",NA
"122","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Mapelli","Massimo","Centro Cardiologico Monzino, IRCCS, Milan, Italy",NA
"123","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Margonato","Davide","Cardiology Department, Policlinico di Monza, Monza, Italy",NA
"124","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Monzo","Luca","Istituto Clinico Casal Palocco, Rome, Italy",NA
"125","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Oriecuia","Chiara","Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy",NA
"126","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Peveri","Giulia","Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy",NA
"127","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Pozzi","Andrea","Cardiology Unit, Cardiovascular Department, Papa Giovanni XXIII Hospital-Bergamo, Bergamo, Italy",NA
"128","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Provenzale","Giovanni","Division of Cardiology, Ospedale San Paolo, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy",NA
"129","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Sarullo","Filippo","Cardiovascular Rehabilitation Unit, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy",NA
"130","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Tomasoni","Daniela","Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy",NA
"131","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Ameri","Pietro","Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino-IRCCS Italian Cardiovascular Network, University of Genova, Genoa, Italy",NA
"132","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Gnecchi","Massimiliano","Intensive Cardiac Care Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy",NA
"133","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Leonardi","Sergio","Intensive Cardiac Care Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy",NA
"134","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Agostoni","Piergiuseppe","Centro Cardiologico Monzino, IRCCS, Milan, Italy",NA
"135","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Carugo","Stefano","Division of Cardiology, Ospedale San Paolo, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy",NA
"136","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Danzi","Gian Battista","Division of Cardiology, Ospedale di Cremona, Cremona, Italy",NA
"137","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Guazzi","Marco","Heart Failure Unit, Cardiology Department, University of Milan, Milan, Italy",NA
"138","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","La Rovere","Maria Teresa","Dipartimento di Cardiologia, Istituti Clinici Scientifici Maugeri, IRCCS, Istituto Scientifico di Montescano, Pavia, Italy",NA
"139","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Mortara","Andrea","Cardiology Department, Policlinico di Monza, Monza, Italy",NA
"140","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Piepoli","Massimo","Heart Failure Unit, Guglielmo da Saliceto Hospital, AUSL Piacenza, Piacenza, Italy",NA
"141","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Porto","Italo","Department of Internal Medicine, IRCCS Ospedale Policlinico San Martino-IRCCS Italian Cardiovascular Network, University of Genova, Genoa, Italy",NA
"142","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Volterrani","Maurizio","Department of Cardiovascular and Respiratory Sciences, IRCCS, San Raffaele Pisana Rome, Rome, Italy",NA
"143","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Senni","Michele","Cardiology Unit, Cardiovascular Department, Papa Giovanni XXIII Hospital-Bergamo, Bergamo, Italy",NA
"144","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Metra","Marco","Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy",NA
"145","34236135","10.1002/ehf2.13462","The prognostic value of serial troponin measurements in patients admitted for COVID-19.","Myocardial injury (MI) in coronavirus disease-19 (COVID-19) is quite prevalent at admission and affects prognosis. Little is known about troponin trajectories and their prognostic role. We aimed to describe the early in-hospital evolution of MI and its prognostic impact. We performed an analysis from an Italian multicentre study enrolling COVID-19 patients, hospitalized from 1 March to 9 April 2020. MI was defined as increased troponin level. The first troponin was tested within 24 h from admiss","2021","07","08","ESC Heart Fail","ESC heart failure","COVID-19; COVID-19 outcome; Myocardial injury; Troponin trajectories","Sinagra","Gianfranco","Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Via Valdoni 7, Trieste, 34100, Italy",NA
"146","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Barssoum","Kirolos","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"147","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Victor","Varun","Department of Internal Medicine, Canton Medical Education Foundation, Canton, Ohio, USA",NA
"148","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Salem","Ahmad","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"149","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Kumar","Ashish","Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, Ohio, USA",NA
"150","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Mubasher","Mahmood","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"151","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Hassib","Mohab","St. Francis Medical Center, Trenton, New Jersey, USA",NA
"152","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Magdi","Mohamed","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"153","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Renjithlal","Sarathlal","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"154","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Abdelazeem","Mohamed","Department of Internal Medicine, St. Elizabeth Medical Center, Brighton, Massachusetts, USA",NA
"155","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Shariff","Mariam","Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA",NA
"156","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Idemudia","Osarenren","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"157","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Ibrahim","Mounir","Department of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, New Jersey, USA",NA
"158","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Mohamed","Amr","Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA",NA
"159","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Thakkar","Samarthkumar","Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA",NA
"160","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Patel","Harsh","Department of Internal Medicine, Louis A Weiss Memorial Hospital, Chicago, Illinois, USA",NA
"161","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Diab","Mohamed","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"162","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Szeles","Andras","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"163","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Ibrahim","Fadi","American University of Antigua, Antigua and Barbuda",NA
"164","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Jha","Roshan","Department of Internal Medicine, Hackensack Meridian Health Palisades Medical Center, North Bergen, New Jersey, USA",NA
"165","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Chowdhury","Medhat","Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA",NA
"166","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Akula","Navya","Department of Internal Medicine, Rochester Regional Health, Unity Hospital, Rochester, New York, USA",NA
"167","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Kalra","Ankur","Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, Ohio, USA",NA
"168","34236091","10.1111/echo.15152","Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review.","The manifestations of COVID-19 as outlined by imaging modalities such as echocardiography, lung ultrasound (LUS), and cardiac magnetic resonance (CMR) imaging are not fully described. We conducted a systematic review of the current literature and included studies that described cardiovascular manifestations of COVID-19 using echocardiography, CMR, and pulmonary manifestations using LUS. We queried PubMed, EMBASE, and Web of Science for relevant articles. Original studies and case series were inc","2021","07","08","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID19; cardiac imaging; cardiac magnetic resonance imaging; echocardiography; ultrasonography","Nanda","Navin C","Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA",NA
"169","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Santhi","Veerasamy Pushparaj","Department of Fruit Science, Horticultural College and Research Institute for Women, Tamil Nadu Agricultural University, Tiruchirappalli, India",NA
"170","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Masilamani","Poomaruthai","Department of Fruit Science, Horticultural College and Research Institute for Women, Tamil Nadu Agricultural University, Tiruchirappalli, India",NA
"171","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Sriramavaratharajan","Venkatraman","Virchow Biotech Private Limited, Hyderabad, India",NA
"172","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Murugan","Ramar","Centre for Research and Postgraduate Studies in Botany, Ayya Nadar Janaki Ammal College (Autonomous), Sivakasi, India",NA
"173","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Gurav","Shailendra S","Department of Pharmacognosy and Phytochemistry, Goa College of Pharmacy, Goa University, Panaji, India",NA
"174","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Sarasu","Veerasamy Pushparaj","Department of Clinical Microbiology, Government Medical College, Pudukkottai, India",NA
"175","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Parthiban","Subbaiyan","Department of Fruit Science, Horticultural College and Research Institute for Women, Tamil Nadu Agricultural University, Tiruchirappalli, India",NA
"176","34236082","10.1111/jfbc.13851","Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.","Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, a-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiti","2021","07","08","J Food Biochem","Journal of food biochemistry","COVID-19; immune-modulators; phytochemicals; therapeutics; viral replication","Ayyanar","Muniappan","Department of Botany, A.V.V.M. Sri Pushpam College (Autonomous), Bharathidasan University, Thanjavur, India",NA
"177","34236025","10.1017/ice.2021.277","COVID-19 outbreaks in prisons.",NA,"2021","07","08","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Irshaidat","Sara","Jordan University Hospital, Amman, Jordan",NA
"178","34236025","10.1017/ice.2021.277","COVID-19 outbreaks in prisons.",NA,"2021","07","08","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Serhan","Hashem Abu","Jordan University Hospital, Amman, Jordan",NA
"179","34236025","10.1017/ice.2021.277","COVID-19 outbreaks in prisons.",NA,"2021","07","08","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Tahir","Muhammad Junaid","Lahore General Hospital, Lahore, Pakistan",NA
"180","34236025","10.1017/ice.2021.277","COVID-19 outbreaks in prisons.",NA,"2021","07","08","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Jabbar","Abdul","Department of Clinical Medicine, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, Lahore, Pakistan",NA
"181","34236025","10.1017/ice.2021.277","COVID-19 outbreaks in prisons.",NA,"2021","07","08","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Ullah","Irfan","Kabir Medical College, Gandhara University, Peshawar, Pakistan",NA
"182","34235993","10.1177/21501327211031760","Double Jeopardy: Maintaining Livelihoods or Preserving Health? The Tough Choices Sex Workers Faced during the COVID-19 Pandemic.","The COVID-19 pandemic and associated public health preventive measures such as lockdown and home confinement have posed unique challenges to female sex workers (FSW) globally, including in Canada where the sex trade is not formally recognized. In this commentary, we discuss the unintended consequences the pandemic has had on various social determinants of health among FSW. We draw on a review of scholarly and grey literature, complemented by our experience with the Exit Doors Here program, a sex","2021","07","13","J Prim Care Community Health","Journal of primary care &amp; community health","access to care; health promotion; program evaluation; risky sexual behavior; underserved communities; COVID-19; Canada; Communicable Disease Control; Female; Humans; Pandemics; SARS-CoV-2; Sex Workers","Shareck","Martine","Université de Sherbrooke, Sherbrooke, QC, Canada",NA
"183","34235993","10.1177/21501327211031760","Double Jeopardy: Maintaining Livelihoods or Preserving Health? The Tough Choices Sex Workers Faced during the COVID-19 Pandemic.","The COVID-19 pandemic and associated public health preventive measures such as lockdown and home confinement have posed unique challenges to female sex workers (FSW) globally, including in Canada where the sex trade is not formally recognized. In this commentary, we discuss the unintended consequences the pandemic has had on various social determinants of health among FSW. We draw on a review of scholarly and grey literature, complemented by our experience with the Exit Doors Here program, a sex","2021","07","13","J Prim Care Community Health","Journal of primary care &amp; community health","access to care; health promotion; program evaluation; risky sexual behavior; underserved communities; COVID-19; Canada; Communicable Disease Control; Female; Humans; Pandemics; SARS-CoV-2; Sex Workers","Hassan","Maha","MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada",NA
"184","34235993","10.1177/21501327211031760","Double Jeopardy: Maintaining Livelihoods or Preserving Health? The Tough Choices Sex Workers Faced during the COVID-19 Pandemic.","The COVID-19 pandemic and associated public health preventive measures such as lockdown and home confinement have posed unique challenges to female sex workers (FSW) globally, including in Canada where the sex trade is not formally recognized. In this commentary, we discuss the unintended consequences the pandemic has had on various social determinants of health among FSW. We draw on a review of scholarly and grey literature, complemented by our experience with the Exit Doors Here program, a sex","2021","07","13","J Prim Care Community Health","Journal of primary care &amp; community health","access to care; health promotion; program evaluation; risky sexual behavior; underserved communities; COVID-19; Canada; Communicable Disease Control; Female; Humans; Pandemics; SARS-CoV-2; Sex Workers","Buhariwala","Pearl","MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada",NA
"185","34235993","10.1177/21501327211031760","Double Jeopardy: Maintaining Livelihoods or Preserving Health? The Tough Choices Sex Workers Faced during the COVID-19 Pandemic.","The COVID-19 pandemic and associated public health preventive measures such as lockdown and home confinement have posed unique challenges to female sex workers (FSW) globally, including in Canada where the sex trade is not formally recognized. In this commentary, we discuss the unintended consequences the pandemic has had on various social determinants of health among FSW. We draw on a review of scholarly and grey literature, complemented by our experience with the Exit Doors Here program, a sex","2021","07","13","J Prim Care Community Health","Journal of primary care &amp; community health","access to care; health promotion; program evaluation; risky sexual behavior; underserved communities; COVID-19; Canada; Communicable Disease Control; Female; Humans; Pandemics; SARS-CoV-2; Sex Workers","Perri","Melissa","MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada",NA
"186","34235993","10.1177/21501327211031760","Double Jeopardy: Maintaining Livelihoods or Preserving Health? The Tough Choices Sex Workers Faced during the COVID-19 Pandemic.","The COVID-19 pandemic and associated public health preventive measures such as lockdown and home confinement have posed unique challenges to female sex workers (FSW) globally, including in Canada where the sex trade is not formally recognized. In this commentary, we discuss the unintended consequences the pandemic has had on various social determinants of health among FSW. We draw on a review of scholarly and grey literature, complemented by our experience with the Exit Doors Here program, a sex","2021","07","13","J Prim Care Community Health","Journal of primary care &amp; community health","access to care; health promotion; program evaluation; risky sexual behavior; underserved communities; COVID-19; Canada; Communicable Disease Control; Female; Humans; Pandemics; SARS-CoV-2; Sex Workers","Balla","Ermelina","Elizabeth Fry Toronto, Toronto, ON, Canada",NA
"187","34235993","10.1177/21501327211031760","Double Jeopardy: Maintaining Livelihoods or Preserving Health? The Tough Choices Sex Workers Faced during the COVID-19 Pandemic.","The COVID-19 pandemic and associated public health preventive measures such as lockdown and home confinement have posed unique challenges to female sex workers (FSW) globally, including in Canada where the sex trade is not formally recognized. In this commentary, we discuss the unintended consequences the pandemic has had on various social determinants of health among FSW. We draw on a review of scholarly and grey literature, complemented by our experience with the Exit Doors Here program, a sex","2021","07","13","J Prim Care Community Health","Journal of primary care &amp; community health","access to care; health promotion; program evaluation; risky sexual behavior; underserved communities; COVID-19; Canada; Communicable Disease Control; Female; Humans; Pandemics; SARS-CoV-2; Sex Workers","O'Campo","Patricia","MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada",NA
"188","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Adiukwu","Frances","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"189","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","de Filippis","Renato","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"190","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Orsolini","Laura","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"191","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Gashi Bytyçi","Drita","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"192","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Shoib","Sheikh","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"193","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Ransing","Ramdas","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"194","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Slaih","Mohammad","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"195","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Jaguga","Florence","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"196","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Handuleh","Jibril I M","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"197","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Ojeahere","Margaret Isioma","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"198","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Ullah","Irfan","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"199","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Karaliuniene","Ruta","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"200","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Nagendrappa","Sachin","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"201","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Vahdani","Bita","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"202","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Ashrafi","Agaah","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"203","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Ori","Dorottya","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"204","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Noël","Camille","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"205","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Abbass","Zargham","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"206","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Jatchavala","Chonnakarn","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"207","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Pinto da Costa","Mariana","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"208","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Essam","Lamiaà","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"209","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Vadivel","Ramyadarshni","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"210","34235945","10.1176/appi.ps.202000774","Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond.","Every health care system requires an adequate health care workforce, service delivery, financial support, and information technology. During the COVID-19 pandemic, global health systems were ill prepared to address the rising prevalence of mental health problems, especially in low- and middle-income countries (LMICs), thereby increasing treatment gaps. To close these gaps globally, task shifting and telepsychiatry should be made available and maximized, particularly in LMICs. Task shifting to no","2021","07","08","Psychiatr Serv","Psychiatric services (Washington, D.C.)","Task shifting; mental health care equity; mental health gap; telepsychiatry","Shalbafan","Mohammadreza","Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (Adiukwu)",NA
"211","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Hahn","Britta",NA,NA
"212","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Hollenberger","Laura",NA,NA
"213","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Schlagenhauf","Ulrich",NA,NA
"214","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Böhm","Hartmut",NA,NA
"215","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Haubitz","Imme Renate",NA,NA
"216","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Soliman","Sebastian",NA,NA
"217","34235907","10.3290/j.qi.b1702163","The utilization of dental emergency servic<U+FEFF>es during COVID-19 pandemic in a German university center: Do we lose vulnerable patients?","The COVID-19 pandemic poses a major challenge <U+FEFF>to health care worldwide. As a part of the virus containment strategy, health care services were limited to the treatment of essential emergencies. The aim was to evaluate the influence of COVID-19 pandemic on patients' utilization of dental emergency services, focusing on patients vulnerable to severe courses of COVID-19. Files of 1,299 patients of the Dental School of the University Hospital Wuerzburg between 3 February and 7 June 2020 were retros","2021","07","16","Quintessence Int","Quintessence international (Berlin, Germany : 1985)","COVID-19; SARS-CoV-2; dental emergency care; dental public health; dentistry; pandemic","Jockel-Schneider","Yvonne",NA,NA
"218","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Deng","Junhua","Luoyang Putai Biotechnology Co., Ltd, Luoyang, China",NA
"219","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Huo","Ningning","National Research Center for Veterinary Medicine, Luoyang, China",NA
"220","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Chen","Yalei","National Research Center for Veterinary Medicine, Luoyang, China",NA
"221","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Wu","Hongchao","National Research Center for Veterinary Medicine, Luoyang, China",NA
"222","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Bai","Jingjing","Luoyang Putai Biotechnology Co., Ltd, Luoyang, China",NA
"223","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Li","Xiangdong","Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China",NA
"224","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Liu","Yuxiu","National Research Center for Veterinary Medicine, Luoyang, China",NA
"225","34235893","10.1111/tbed.14229","SARS-CoV-2 infection in farmed fur animals.",NA,"2021","07","16","Transbound Emerg Dis","Transboundary and emerging diseases",NA,"Tian","Kegong","National Research Center for Veterinary Medicine, Luoyang, China",NA
"226","34235835","10.1111/ans.17071","The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: A Binational Colorectal Cancer Audit study.","The COVID-19 pandemic has resulted in global disruptions to the delivery of healthcare. The national responses of Australia and New Zealand has resulted in unprecedented changes to the care of colorectal cancer patients, amongst others. This paper aims to determine the impact of COVID-19 on colorectal cancer diagnosis and management in Australia and New Zealand. This is a multicentre retrospective cohort study using the prospectively maintained Binational Colorectal Cancer Audit (BCCA) registry.","2021","07","16","ANZ J Surg","ANZ journal of surgery","COVID-19; cancer outcomes; colorectal cancer; coronavirus","Williams","Evan","Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia",NA
"227","34235835","10.1111/ans.17071","The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: A Binational Colorectal Cancer Audit study.","The COVID-19 pandemic has resulted in global disruptions to the delivery of healthcare. The national responses of Australia and New Zealand has resulted in unprecedented changes to the care of colorectal cancer patients, amongst others. This paper aims to determine the impact of COVID-19 on colorectal cancer diagnosis and management in Australia and New Zealand. This is a multicentre retrospective cohort study using the prospectively maintained Binational Colorectal Cancer Audit (BCCA) registry.","2021","07","16","ANZ J Surg","ANZ journal of surgery","COVID-19; cancer outcomes; colorectal cancer; coronavirus","Kong","Joseph C","Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia",NA
"228","34235835","10.1111/ans.17071","The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: A Binational Colorectal Cancer Audit study.","The COVID-19 pandemic has resulted in global disruptions to the delivery of healthcare. The national responses of Australia and New Zealand has resulted in unprecedented changes to the care of colorectal cancer patients, amongst others. This paper aims to determine the impact of COVID-19 on colorectal cancer diagnosis and management in Australia and New Zealand. This is a multicentre retrospective cohort study using the prospectively maintained Binational Colorectal Cancer Audit (BCCA) registry.","2021","07","16","ANZ J Surg","ANZ journal of surgery","COVID-19; cancer outcomes; colorectal cancer; coronavirus","Singh","Parry","Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia",NA
"229","34235835","10.1111/ans.17071","The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: A Binational Colorectal Cancer Audit study.","The COVID-19 pandemic has resulted in global disruptions to the delivery of healthcare. The national responses of Australia and New Zealand has resulted in unprecedented changes to the care of colorectal cancer patients, amongst others. This paper aims to determine the impact of COVID-19 on colorectal cancer diagnosis and management in Australia and New Zealand. This is a multicentre retrospective cohort study using the prospectively maintained Binational Colorectal Cancer Audit (BCCA) registry.","2021","07","16","ANZ J Surg","ANZ journal of surgery","COVID-19; cancer outcomes; colorectal cancer; coronavirus","Prabhakaran","Swetha","Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia",NA
"230","34235835","10.1111/ans.17071","The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: A Binational Colorectal Cancer Audit study.","The COVID-19 pandemic has resulted in global disruptions to the delivery of healthcare. The national responses of Australia and New Zealand has resulted in unprecedented changes to the care of colorectal cancer patients, amongst others. This paper aims to determine the impact of COVID-19 on colorectal cancer diagnosis and management in Australia and New Zealand. This is a multicentre retrospective cohort study using the prospectively maintained Binational Colorectal Cancer Audit (BCCA) registry.","2021","07","16","ANZ J Surg","ANZ journal of surgery","COVID-19; cancer outcomes; colorectal cancer; coronavirus","Warrier","Satish K","Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia",NA
"231","34235835","10.1111/ans.17071","The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: A Binational Colorectal Cancer Audit study.","The COVID-19 pandemic has resulted in global disruptions to the delivery of healthcare. The national responses of Australia and New Zealand has resulted in unprecedented changes to the care of colorectal cancer patients, amongst others. This paper aims to determine the impact of COVID-19 on colorectal cancer diagnosis and management in Australia and New Zealand. This is a multicentre retrospective cohort study using the prospectively maintained Binational Colorectal Cancer Audit (BCCA) registry.","2021","07","16","ANZ J Surg","ANZ journal of surgery","COVID-19; cancer outcomes; colorectal cancer; coronavirus","Bell","Stephen","Department of Colorectal Surgery, Alfred Hospital, Melbourne, Victoria, Australia",NA
"232","34235817","10.1002/1348-9585.12243","Physical relaxation for occupational stress in healthcare workers: A systematic review and network meta-analysis of randomized controlled trials.","Work related stress is a major occupational health problem that is associated with adverse effects on physical and mental health. Healthcare workers are particularly vulnerable in the era of COVID-19. Physical methods of stress relief such as yoga and massage therapy may reduce occupational stress. The objective of this systematic review and network meta-analysis is to determine the effects of yoga, massage therapy, progressive muscle relaxation, and stretching on alleviating stress and improvin","2021","07","15","J Occup Health","Journal of occupational health","burnout; healthcare workers; occupational medicine; stress; COVID-19; Health Personnel; Humans; Network Meta-Analysis; Occupational Health; Occupational Stress; Randomized Controlled Trials as Topic; Relaxation Therapy; Workplace; Yoga","Zhang","Michael","Administration Division, Southern Nevada Health District, Las Vegas, NV, USA",NA
"233","34235817","10.1002/1348-9585.12243","Physical relaxation for occupational stress in healthcare workers: A systematic review and network meta-analysis of randomized controlled trials.","Work related stress is a major occupational health problem that is associated with adverse effects on physical and mental health. Healthcare workers are particularly vulnerable in the era of COVID-19. Physical methods of stress relief such as yoga and massage therapy may reduce occupational stress. The objective of this systematic review and network meta-analysis is to determine the effects of yoga, massage therapy, progressive muscle relaxation, and stretching on alleviating stress and improvin","2021","07","15","J Occup Health","Journal of occupational health","burnout; healthcare workers; occupational medicine; stress; COVID-19; Health Personnel; Humans; Network Meta-Analysis; Occupational Health; Occupational Stress; Randomized Controlled Trials as Topic; Relaxation Therapy; Workplace; Yoga","Murphy","Brittany","Department of Exercise Science, Florida Atlantic University, Boca Raton, FL, USA",NA
"234","34235817","10.1002/1348-9585.12243","Physical relaxation for occupational stress in healthcare workers: A systematic review and network meta-analysis of randomized controlled trials.","Work related stress is a major occupational health problem that is associated with adverse effects on physical and mental health. Healthcare workers are particularly vulnerable in the era of COVID-19. Physical methods of stress relief such as yoga and massage therapy may reduce occupational stress. The objective of this systematic review and network meta-analysis is to determine the effects of yoga, massage therapy, progressive muscle relaxation, and stretching on alleviating stress and improvin","2021","07","15","J Occup Health","Journal of occupational health","burnout; healthcare workers; occupational medicine; stress; COVID-19; Health Personnel; Humans; Network Meta-Analysis; Occupational Health; Occupational Stress; Randomized Controlled Trials as Topic; Relaxation Therapy; Workplace; Yoga","Cabanilla","Abegail","School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA",NA
"235","34235817","10.1002/1348-9585.12243","Physical relaxation for occupational stress in healthcare workers: A systematic review and network meta-analysis of randomized controlled trials.","Work related stress is a major occupational health problem that is associated with adverse effects on physical and mental health. Healthcare workers are particularly vulnerable in the era of COVID-19. Physical methods of stress relief such as yoga and massage therapy may reduce occupational stress. The objective of this systematic review and network meta-analysis is to determine the effects of yoga, massage therapy, progressive muscle relaxation, and stretching on alleviating stress and improvin","2021","07","15","J Occup Health","Journal of occupational health","burnout; healthcare workers; occupational medicine; stress; COVID-19; Health Personnel; Humans; Network Meta-Analysis; Occupational Health; Occupational Stress; Randomized Controlled Trials as Topic; Relaxation Therapy; Workplace; Yoga","Yidi","Christina","Department of Veterans Affairs, Orlando VA Healthcare System, Orlando, FL, USA",NA
"236","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Anschau","Fernando","Grupo Hospitalar Conceição, Porto Alegre, Brazil",NA
"237","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Worm","Paulo Valdeci","Grupo Hospitalar Conceição, Porto Alegre, Brazil",NA
"238","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Kopittke","Luciane","Grupo Hospitalar Conceição, Porto Alegre, Brazil",NA
"239","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"de Mello Villwock","Luis Humberto","Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"240","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Lemos Sartori","Marcos Luiggi","Tecnopuc-Toth Lifecare, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"241","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Cardoso do Rosário","Jéferson","Tecnopuc-Toth Lifecare, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"242","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Secorun Inácio","José Francisco","Tecnopuc-Toth Lifecare, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"243","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Much","Maicon Diogo","Tecnopuc-Toth Lifecare, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"244","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Marckmann","Eduardo","Tecnopuc-Toth Lifecare, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"245","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Pinheiro","Sandro","Tecnopuc-Toth Lifecare, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"246","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Nickenig Vissoci","João Ricardo","Duke Univestiy, Duke Global Health Institute, Durham, NC, USA",NA
"247","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"de Lara Machado","Wagner","Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"248","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Costa","Dalton Breno","Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"249","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Klug","Daniel","Grupo Hospitalar Conceição, Porto Alegre, Brazil",NA
"250","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Martin Prestes","Juliane","Grupo Hospitalar Conceição, Porto Alegre, Brazil",NA
"251","34235816","10.1111/ijcp.14610","Smart Check - COVID-19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service.","Most patients with COVID-19 have mild or moderate manifestations; however, there is a wide spectrum of clinical presentations and even more severe repercussions that require high diagnostic suspicion. Vital sign acquisition and monitoring are crucial for detecting and responding to patients with COVID-19. Thus, we conducted this study to demonstrate the impact of using a tool called Smart Check on the triage time of patients with suspected COVID-19 and to identify the main initial clinical manif","2021","07","16","Int J Clin Pract","International journal of clinical practice",NA,"Hessel","Fabiano","Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil",NA
"252","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Rathore","Sawai Singh","Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur, India",NA
"253","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Rojas","Gianpier Alonzo","Internal Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru",NA
"254","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Sondhi","Manush","Internal Medicine, Kasturba Medical College, Manipal, India",NA
"255","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Pothuru","Suveenkrishna","Internal Medicine, Ascension Via Christi Hospital, Manhattan, KS, USA",NA
"256","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Pydi","Reshma","Internal Medicine, Andhra Medical College, Visakhapatnam, India",NA
"257","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Kancherla","Neeraj","Internal Medicine, Andhra Medical College, Visakhapatnam, India",NA
"258","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Singh","Romil","Department of Critical Care, Mayo Clinic, Rochester, MN, USA",NA
"259","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Ahmed","Noman Khurshid","Internal Medicine, Dow Medical College, Karachi, Pakistan",NA
"260","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Shah","Jill","Internal Medicine, Tambov State University named after G.R. Derzhavin, Tambov, Russia",NA
"261","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Tousif","Sohaib","Internal Medicine, Ziauddin Medical University, Karachi, Pakistan",NA
"262","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Baloch","Unaiza Tariq","Internal Medicine, Aga Khan University Hospital, Karachi, Pakistan",NA
"263","34235815","10.1111/ijcp.14470","Myocarditis associated with Covid-19 disease: A systematic review of published case reports and case series.","Covid-19 is an extremely contagious illness caused by the severe acute respiratory syndrome (SARS-CoV-2) virus. The cardiac involvement in such a public health emergency disease has not been well studied and a conflicting evidence exists on this issue. This systematic review article aimed to compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19. A literature search was accomplished for published eligible art","2021","07","08","Int J Clin Pract","International journal of clinical practice",NA,"Wen","Qingqing","Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA",NA
"264","34235781","10.1002/hpm.3276","Kanban system applications in healthcare services: A literature review.","Lean Management method has been applied in several fields before its implementation in healthcare area. Among the different techniques associated with Lean, in this paper, we are focused on Kanban system, which is a method that presents several benefits such as inventory holding reduction or improvement of the employees' satisfaction. Our main objective is to carry out a literature review focused on Kanban methodology applied to health care. In this sense, this study can serve as a script to imp","2021","07","08","Int J Health Plann Manage","The International journal of health planning and management","Kanban system; barriers; health; hospital; positive effects","Lanza-León","Paloma","Health Economics and Health Services Management Research Group, Santander, Spain",NA
"265","34235781","10.1002/hpm.3276","Kanban system applications in healthcare services: A literature review.","Lean Management method has been applied in several fields before its implementation in healthcare area. Among the different techniques associated with Lean, in this paper, we are focused on Kanban system, which is a method that presents several benefits such as inventory holding reduction or improvement of the employees' satisfaction. Our main objective is to carry out a literature review focused on Kanban methodology applied to health care. In this sense, this study can serve as a script to imp","2021","07","08","Int J Health Plann Manage","The International journal of health planning and management","Kanban system; barriers; health; hospital; positive effects","Sanchez-Ruiz","Lidia","Health Economics and Health Services Management Research Group, Santander, Spain",NA
"266","34235781","10.1002/hpm.3276","Kanban system applications in healthcare services: A literature review.","Lean Management method has been applied in several fields before its implementation in healthcare area. Among the different techniques associated with Lean, in this paper, we are focused on Kanban system, which is a method that presents several benefits such as inventory holding reduction or improvement of the employees' satisfaction. Our main objective is to carry out a literature review focused on Kanban methodology applied to health care. In this sense, this study can serve as a script to imp","2021","07","08","Int J Health Plann Manage","The International journal of health planning and management","Kanban system; barriers; health; hospital; positive effects","Cantarero-Prieto","David","Health Economics and Health Services Management Research Group, Santander, Spain",NA
"267","34235773","10.1002/ab.21986","School bullying before and during COVID-19: Results from a population-based randomized design.","We examined the impact of COVID-19 on bullying prevalence rates in a sample of 6578 Canadian students in Grades 4 to 12. To account for school changes associated with the pandemic, students were randomized at the school level into two conditions: (1) the pre-COVID-19 condition, assessing bullying prevalence rates retrospectively before the pandemic, and (2) the current condition, assessing rates during the pandemic. Results indicated that students reported far higher rates of bullying involvemen","2021","07","08","Aggress Behav","Aggressive behavior","COVID-19; bullying; pandemic; prevalence; students","Vaillancourt","Tracy","Counselling Psychology, Faculty of Education, University of Ottawa, Ottawa, Canada",NA
"268","34235773","10.1002/ab.21986","School bullying before and during COVID-19: Results from a population-based randomized design.","We examined the impact of COVID-19 on bullying prevalence rates in a sample of 6578 Canadian students in Grades 4 to 12. To account for school changes associated with the pandemic, students were randomized at the school level into two conditions: (1) the pre-COVID-19 condition, assessing bullying prevalence rates retrospectively before the pandemic, and (2) the current condition, assessing rates during the pandemic. Results indicated that students reported far higher rates of bullying involvemen","2021","07","08","Aggress Behav","Aggressive behavior","COVID-19; bullying; pandemic; prevalence; students","Brittain","Heather","Counselling Psychology, Faculty of Education, University of Ottawa, Ottawa, Canada",NA
"269","34235773","10.1002/ab.21986","School bullying before and during COVID-19: Results from a population-based randomized design.","We examined the impact of COVID-19 on bullying prevalence rates in a sample of 6578 Canadian students in Grades 4 to 12. To account for school changes associated with the pandemic, students were randomized at the school level into two conditions: (1) the pre-COVID-19 condition, assessing bullying prevalence rates retrospectively before the pandemic, and (2) the current condition, assessing rates during the pandemic. Results indicated that students reported far higher rates of bullying involvemen","2021","07","08","Aggress Behav","Aggressive behavior","COVID-19; bullying; pandemic; prevalence; students","Krygsman","Amanda","Counselling Psychology, Faculty of Education, University of Ottawa, Ottawa, Canada",NA
"270","34235773","10.1002/ab.21986","School bullying before and during COVID-19: Results from a population-based randomized design.","We examined the impact of COVID-19 on bullying prevalence rates in a sample of 6578 Canadian students in Grades 4 to 12. To account for school changes associated with the pandemic, students were randomized at the school level into two conditions: (1) the pre-COVID-19 condition, assessing bullying prevalence rates retrospectively before the pandemic, and (2) the current condition, assessing rates during the pandemic. Results indicated that students reported far higher rates of bullying involvemen","2021","07","08","Aggress Behav","Aggressive behavior","COVID-19; bullying; pandemic; prevalence; students","Farrell","Ann H","Counselling Psychology, Faculty of Education, University of Ottawa, Ottawa, Canada",NA
"271","34235773","10.1002/ab.21986","School bullying before and during COVID-19: Results from a population-based randomized design.","We examined the impact of COVID-19 on bullying prevalence rates in a sample of 6578 Canadian students in Grades 4 to 12. To account for school changes associated with the pandemic, students were randomized at the school level into two conditions: (1) the pre-COVID-19 condition, assessing bullying prevalence rates retrospectively before the pandemic, and (2) the current condition, assessing rates during the pandemic. Results indicated that students reported far higher rates of bullying involvemen","2021","07","08","Aggress Behav","Aggressive behavior","COVID-19; bullying; pandemic; prevalence; students","Landon","Sally","Hamilton-Wentworth District School Board, Hamilton, Ontario, Canada",NA
"272","34235773","10.1002/ab.21986","School bullying before and during COVID-19: Results from a population-based randomized design.","We examined the impact of COVID-19 on bullying prevalence rates in a sample of 6578 Canadian students in Grades 4 to 12. To account for school changes associated with the pandemic, students were randomized at the school level into two conditions: (1) the pre-COVID-19 condition, assessing bullying prevalence rates retrospectively before the pandemic, and (2) the current condition, assessing rates during the pandemic. Results indicated that students reported far higher rates of bullying involvemen","2021","07","08","Aggress Behav","Aggressive behavior","COVID-19; bullying; pandemic; prevalence; students","Pepler","Debra","Department of Psychology, York University, Toronto, Ontario, Canada",NA
"273","34235757","10.1111/cen.14548","Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage.",NA,"2021","07","08","Clin Endocrinol (Oxf)","Clinical endocrinology","COVID-19; VITT; adrenal; vaccine","Taylor","Peter","Department of Endocrinology, University Hospital Wales, Heath Park, Cardiff, Wales, UK",NA
"274","34235757","10.1111/cen.14548","Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage.",NA,"2021","07","08","Clin Endocrinol (Oxf)","Clinical endocrinology","COVID-19; VITT; adrenal; vaccine","Allen","Lowri","Department of Endocrinology, University Hospital Wales, Heath Park, Cardiff, Wales, UK",NA
"275","34235757","10.1111/cen.14548","Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage.",NA,"2021","07","08","Clin Endocrinol (Oxf)","Clinical endocrinology","COVID-19; VITT; adrenal; vaccine","Shrikrishnapalasuriyar","Natasha","Department of Endocrinology, University Hospital Wales, Heath Park, Cardiff, Wales, UK",NA
"276","34235757","10.1111/cen.14548","Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage.",NA,"2021","07","08","Clin Endocrinol (Oxf)","Clinical endocrinology","COVID-19; VITT; adrenal; vaccine","Stechman","Michael","Department of Endocrine Surgery, University Hospital Wales, Heath Park, Cardiff, Wales, UK",NA
"277","34235757","10.1111/cen.14548","Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage.",NA,"2021","07","08","Clin Endocrinol (Oxf)","Clinical endocrinology","COVID-19; VITT; adrenal; vaccine","Rees","Aled","Department of Endocrinology, University Hospital Wales, Heath Park, Cardiff, Wales, UK",NA
"278","34235747","10.1002/jcop.22651","What makes Dutch youth comply with preventive COVID-19 measures? An explorative study.","The measures to contain the spread of COVID-19 are challenging for youth, especially the social isolation measures. These measures are antagonistic to healthy youth development, which requires sufficient social contact with peers and adults. This explorative study examined what factors are associated with adherence to COVID-19 measures in a sample of Dutch youth (N = 263; 79.8% female) with ages ranging between 16 and 24 years (M = 21.1 years; SD = 2.44 years), who completed an online questionna","2021","07","08","J Community Psychol","Journal of community psychology","Covid-19; coping; mental health; natural mentoring; resilience","Koning","Naomi","Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands",NA
"279","34235747","10.1002/jcop.22651","What makes Dutch youth comply with preventive COVID-19 measures? An explorative study.","The measures to contain the spread of COVID-19 are challenging for youth, especially the social isolation measures. These measures are antagonistic to healthy youth development, which requires sufficient social contact with peers and adults. This explorative study examined what factors are associated with adherence to COVID-19 measures in a sample of Dutch youth (N = 263; 79.8% female) with ages ranging between 16 and 24 years (M = 21.1 years; SD = 2.44 years), who completed an online questionna","2021","07","08","J Community Psychol","Journal of community psychology","Covid-19; coping; mental health; natural mentoring; resilience","Hagedoorn","Nikki","Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands",NA
"280","34235747","10.1002/jcop.22651","What makes Dutch youth comply with preventive COVID-19 measures? An explorative study.","The measures to contain the spread of COVID-19 are challenging for youth, especially the social isolation measures. These measures are antagonistic to healthy youth development, which requires sufficient social contact with peers and adults. This explorative study examined what factors are associated with adherence to COVID-19 measures in a sample of Dutch youth (N = 263; 79.8% female) with ages ranging between 16 and 24 years (M = 21.1 years; SD = 2.44 years), who completed an online questionna","2021","07","08","J Community Psychol","Journal of community psychology","Covid-19; coping; mental health; natural mentoring; resilience","Stams","Geert-Jan J M","Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands",NA
"281","34235747","10.1002/jcop.22651","What makes Dutch youth comply with preventive COVID-19 measures? An explorative study.","The measures to contain the spread of COVID-19 are challenging for youth, especially the social isolation measures. These measures are antagonistic to healthy youth development, which requires sufficient social contact with peers and adults. This explorative study examined what factors are associated with adherence to COVID-19 measures in a sample of Dutch youth (N = 263; 79.8% female) with ages ranging between 16 and 24 years (M = 21.1 years; SD = 2.44 years), who completed an online questionna","2021","07","08","J Community Psychol","Journal of community psychology","Covid-19; coping; mental health; natural mentoring; resilience","Assink","Mark","Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands",NA
"282","34235747","10.1002/jcop.22651","What makes Dutch youth comply with preventive COVID-19 measures? An explorative study.","The measures to contain the spread of COVID-19 are challenging for youth, especially the social isolation measures. These measures are antagonistic to healthy youth development, which requires sufficient social contact with peers and adults. This explorative study examined what factors are associated with adherence to COVID-19 measures in a sample of Dutch youth (N = 263; 79.8% female) with ages ranging between 16 and 24 years (M = 21.1 years; SD = 2.44 years), who completed an online questionna","2021","07","08","J Community Psychol","Journal of community psychology","Covid-19; coping; mental health; natural mentoring; resilience","van Dam","Levi","Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands",NA
"283","34235743","10.1111/jgs.17358","Application of the Haddon matrix to COVID-19 prevention and containment in nursing homes.","COVID-19 has exacted a disproportionate toll on the health of persons living in nursing homes. Healthcare providers and other decision-makers in those settings must refer to multiple evolving sources of guidance to coordinate care delivery in such a way as to minimize the introduction and spread of the causal virus, SARS-CoV-2. It is essential that guidance be presented in an accessible and usable format to facilitate its translation into evidence-based best practice. In this article, we propose","2021","07","12","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; Haddon matrix; long-term care; nursing home","Fritch","William M","Infectious Disease Epidemiology Program, Health Surveillance Division, Vermont Department of Health, Burlington, Vermont, USA",NA
"284","34235743","10.1111/jgs.17358","Application of the Haddon matrix to COVID-19 prevention and containment in nursing homes.","COVID-19 has exacted a disproportionate toll on the health of persons living in nursing homes. Healthcare providers and other decision-makers in those settings must refer to multiple evolving sources of guidance to coordinate care delivery in such a way as to minimize the introduction and spread of the causal virus, SARS-CoV-2. It is essential that guidance be presented in an accessible and usable format to facilitate its translation into evidence-based best practice. In this article, we propose","2021","07","12","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; Haddon matrix; long-term care; nursing home","Agnew","Jacqueline","Department of Environmental Health &amp",NA
"285","34235743","10.1111/jgs.17358","Application of the Haddon matrix to COVID-19 prevention and containment in nursing homes.","COVID-19 has exacted a disproportionate toll on the health of persons living in nursing homes. Healthcare providers and other decision-makers in those settings must refer to multiple evolving sources of guidance to coordinate care delivery in such a way as to minimize the introduction and spread of the causal virus, SARS-CoV-2. It is essential that guidance be presented in an accessible and usable format to facilitate its translation into evidence-based best practice. In this article, we propose","2021","07","12","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; Haddon matrix; long-term care; nursing home","Rosman","Lori","Welch Medical Library, Johns Hopkins University, Baltimore, Maryland, USA",NA
"286","34235743","10.1111/jgs.17358","Application of the Haddon matrix to COVID-19 prevention and containment in nursing homes.","COVID-19 has exacted a disproportionate toll on the health of persons living in nursing homes. Healthcare providers and other decision-makers in those settings must refer to multiple evolving sources of guidance to coordinate care delivery in such a way as to minimize the introduction and spread of the causal virus, SARS-CoV-2. It is essential that guidance be presented in an accessible and usable format to facilitate its translation into evidence-based best practice. In this article, we propose","2021","07","12","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; Haddon matrix; long-term care; nursing home","Cadorette","Maureen A","Department of Environmental Health &amp",NA
"287","34235743","10.1111/jgs.17358","Application of the Haddon matrix to COVID-19 prevention and containment in nursing homes.","COVID-19 has exacted a disproportionate toll on the health of persons living in nursing homes. Healthcare providers and other decision-makers in those settings must refer to multiple evolving sources of guidance to coordinate care delivery in such a way as to minimize the introduction and spread of the causal virus, SARS-CoV-2. It is essential that guidance be presented in an accessible and usable format to facilitate its translation into evidence-based best practice. In this article, we propose","2021","07","12","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; Haddon matrix; long-term care; nursing home","Barnett","Daniel J","Department of Environmental Health &amp",NA
"288","34235728","10.1111/bph.15587","Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.","Identifying drug targets mitigating vascular dysfunction, thrombo-inflammation and thromboembolic complications in COVID-19 is essential. COVID-19 coagulopathy differs from sepsis coagulopathy. Factors that drive severe lung pathology and coagulation abnormalities in COVID-19 are not understood. Protein-protein interaction studies indicate that the tagged viral bait protein ORF9c directly interacts with PAR2, which modulates host cell IFN and inflammatory cytokines. In addition to direct interac","2021","07","08","Br J Pharmacol","British journal of pharmacology","COVID-19-associated coagulopathy; PAR1; PAR2; acute respiratory distress syndrome; sepsis","Subramaniam","Saravanan","Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA",NA
"289","34235728","10.1111/bph.15587","Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.","Identifying drug targets mitigating vascular dysfunction, thrombo-inflammation and thromboembolic complications in COVID-19 is essential. COVID-19 coagulopathy differs from sepsis coagulopathy. Factors that drive severe lung pathology and coagulation abnormalities in COVID-19 are not understood. Protein-protein interaction studies indicate that the tagged viral bait protein ORF9c directly interacts with PAR2, which modulates host cell IFN and inflammatory cytokines. In addition to direct interac","2021","07","08","Br J Pharmacol","British journal of pharmacology","COVID-19-associated coagulopathy; PAR1; PAR2; acute respiratory distress syndrome; sepsis","Ruf","Wolfram","Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany",NA
"290","34235728","10.1111/bph.15587","Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.","Identifying drug targets mitigating vascular dysfunction, thrombo-inflammation and thromboembolic complications in COVID-19 is essential. COVID-19 coagulopathy differs from sepsis coagulopathy. Factors that drive severe lung pathology and coagulation abnormalities in COVID-19 are not understood. Protein-protein interaction studies indicate that the tagged viral bait protein ORF9c directly interacts with PAR2, which modulates host cell IFN and inflammatory cytokines. In addition to direct interac","2021","07","08","Br J Pharmacol","British journal of pharmacology","COVID-19-associated coagulopathy; PAR1; PAR2; acute respiratory distress syndrome; sepsis","Bosmann","Markus","Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA",NA
"291","34235722","10.1111/josh.13067","US School-Based Physical Fitness Assessments and Data Dissemination.","Low physical fitness (PF) levels during childhood affect healthy growth and development, and increase the risk of cardiovascular diseases. Physical education standards exist for nearly all states in the United States, but evaluation of PF in youth has yet to be systematic, reproducible, and harmonized. The purpose of this project was to describe publicly available data of school-based PF testing (SB-PFT). A list of state-mandated SB-PFT programs published by SHAPE 2016 was confirmed by contactin","2021","07","08","J Sch Health","The Journal of school health","fitness testing; physical fitness; school-aged children","Krochmal","Patrick","Albany Medical College, 174 Siesta Avenue, Thousand Oaks, CA, 91360",NA
"292","34235722","10.1111/josh.13067","US School-Based Physical Fitness Assessments and Data Dissemination.","Low physical fitness (PF) levels during childhood affect healthy growth and development, and increase the risk of cardiovascular diseases. Physical education standards exist for nearly all states in the United States, but evaluation of PF in youth has yet to be systematic, reproducible, and harmonized. The purpose of this project was to describe publicly available data of school-based PF testing (SB-PFT). A list of state-mandated SB-PFT programs published by SHAPE 2016 was confirmed by contactin","2021","07","08","J Sch Health","The Journal of school health","fitness testing; physical fitness; school-aged children","Cooper","Dan M","Principal Investigator, UC Irvine CTSA",NA
"293","34235722","10.1111/josh.13067","US School-Based Physical Fitness Assessments and Data Dissemination.","Low physical fitness (PF) levels during childhood affect healthy growth and development, and increase the risk of cardiovascular diseases. Physical education standards exist for nearly all states in the United States, but evaluation of PF in youth has yet to be systematic, reproducible, and harmonized. The purpose of this project was to describe publicly available data of school-based PF testing (SB-PFT). A list of state-mandated SB-PFT programs published by SHAPE 2016 was confirmed by contactin","2021","07","08","J Sch Health","The Journal of school health","fitness testing; physical fitness; school-aged children","Radom-Aizik","Shlomit","Pediatric Exercise and Genomics Research Center, Associate Professor, Department of Pediatrics, University of California, Irvine School of Medicine, 101 Academy Way, Suite 150, Irvine, CA, 92617",NA
"294","34235722","10.1111/josh.13067","US School-Based Physical Fitness Assessments and Data Dissemination.","Low physical fitness (PF) levels during childhood affect healthy growth and development, and increase the risk of cardiovascular diseases. Physical education standards exist for nearly all states in the United States, but evaluation of PF in youth has yet to be systematic, reproducible, and harmonized. The purpose of this project was to describe publicly available data of school-based PF testing (SB-PFT). A list of state-mandated SB-PFT programs published by SHAPE 2016 was confirmed by contactin","2021","07","08","J Sch Health","The Journal of school health","fitness testing; physical fitness; school-aged children","Lu","Kim D","University of California, Irvine School of Medicine Pediatric Exercise and Genomics Research Center, 101 Academy Way, Suite 150, Irvine, CA, 92617",NA
"295","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Abizanda","Pedro","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"296","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Calbo Mayo","Juan María","Department of Internal Medicine, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"297","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Mas Romero","Marta","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"298","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Cortés Zamora","Elisa Belén","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"299","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Tabernero Sahuquillo","María Teresa","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"300","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Romero Rizos","Luis","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"301","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Sánchez-Jurado","Pedro Manuel","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"302","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Sánchez-Nievas","Ginés","Department of Rheumatology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"303","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Campayo Escolano","Carlos","Department of Internal Medicine, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"304","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Ochoa Serrano","Alba","Department of Internal Medicine, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"305","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Sánchez-Flor Alfaro","Victoria","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"306","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","López Bru","Rita","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"307","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Gómez Ballesteros","Cristina","Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain",NA
"308","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Caldevilla Bernardo","David","Department of Radiology, Complejo Hospitalario Universitario of Albacete, Albacete, Spain",NA
"309","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Callejas González","Francisco Javier","Department of Neumology, Complejo Hospitalario Universitario of Albacete, Albacete, Spain",NA
"310","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Andrés-Pretel","Fernando","Department of Statistics, Foundation of the National Paraplegics Hospital of Toledo, Toledo, Spain",NA
"311","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Lauschke","Volker Martin","Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden",NA
"312","34235720","10.1111/jgs.17357","Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.","Older adults are at the highest risk of severe disease and death due to COVID-19. Randomized data have shown that baricitinib improves outcomes in these patients, but focused stratified analyses of geriatric cohorts are lacking. Our objective was to analyze the efficacy of baricitinib in older adults with COVID-19 moderate-to-severe pneumonia. This is a propensity score [PS]-matched retrospective cohort study. Patients from the COVID-AGE and Alba-Score cohorts, hospitalized for moderate-to-sever","2021","07","09","J Am Geriatr Soc","Journal of the American Geriatrics Society","COVID-19; baricitinib; mortality; older adults","Stebbing","Justin","Department of Surgery and Cancer, Imperial College, Hammersmith Hospital, ICTEM Building, London, UK",NA
"313","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Kerr","Colm","Department of Infectious Diseases, St. James's Hospital, Dublin, Ireland. colmkerr@gmail","colmkerr@gmail.com"
"314","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Allen","Niamh","Department of Infectious Diseases, St. James's Hospital, Dublin, Ireland",NA
"315","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Hughes","Gerry","Department of Infectious Diseases, St. James's Hospital, Dublin, Ireland",NA
"316","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Kelly","Martina","Department of Clinical Microbiology, St. James's Hospital, Dublin, Ireland",NA
"317","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","O'Rourke","Fiona","Department of Clinical Microbiology, St. James's Hospital, Dublin, Ireland",NA
"318","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Lynagh","Yvonne","Department of Clinical Microbiology, St. James's Hospital, Dublin, Ireland",NA
"319","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Dunne","Jean","Department of Immunology, St. James's Hospital, Dublin, Ireland",NA
"320","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Crowley","Brendan","Department of Clinical Microbiology, St. James's Hospital, Dublin, Ireland",NA
"321","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Conlon","Niall","Department of Immunology, St. James's Hospital, Dublin, Ireland",NA
"322","34235708","10.1007/s11845-021-02700-5","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","Serological SARS-CoV-2 assays have an important role in guiding the pandemic response. This research aimed to compare the performance of 2 antinucleocapsid assays. Serum from 49 HCWs was analysed at baseline and 6 months using the Abbott diagnostics SARS-CoV-2 IgG assay and the Roche Diagnostics Elecsys Anti-SARS-CoV-2 total antibody assay. At baseline, 14/49 participants (29%) demonstrated antibody reactivity using the Abbott assay. At 6 months, 4/14 participants (29%) continued to demonstrate ","2021","07","10","Ir J Med Sci","Irish journal of medical science","Anti-nucleocapsid; Antibody; Assay; COVID-19; SARS-CoV-2","Bergin","Colm","Department of Infectious Diseases, St. James's Hospital, Dublin, Ireland",NA
"323","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Painter","Chris","Health Intervention and Technology Assessment Program, Nonthaburi, Thailand. chris.painter@me",NA
"324","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Isaranuwatchai","Wanrudee","Health Intervention and Technology Assessment Program, Nonthaburi, Thailand",NA
"325","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Prawjaeng","Juthamas","Health Intervention and Technology Assessment Program, Nonthaburi, Thailand",NA
"326","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Wee","Hwee Lin","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"327","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Chua","Brandon Wen Bing","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"328","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Huynh","Vinh Anh","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"329","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Lou","Jing","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"330","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Goh","Fang Ting","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"331","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Luangasanatip","Nantasit","Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand",NA
"332","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Pan-Ngum","Wirichada","Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand",NA
"333","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Yi","Wang","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"334","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Clapham","Hannah","Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore",NA
"335","34235643","10.1007/s40258-021-00661-5","Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.","With vaccines for coronavirus disease 2019 (COVID-19) being introduced in countries across the world, policy makers are facing many practical considerations about how best to implement a vaccination programme. The supply of vaccines is insufficient for the global population, so decisions must be made as to which groups are prioritised for any vaccination and when. Furthermore, the aims of vaccination programmes will differ between countries, with some prioritising economic benefits that could st","2021","07","22","Appl Health Econ Health Policy","Applied health economics and health policy","COVID-19; COVID-19 Vaccines; Cost-Benefit Analysis; Health Policy; Humans; Immunization Programs; SARS-CoV-2; Singapore; Thailand; Vaccination","Teerawattananon","Yot","Health Intervention and Technology Assessment Program, Nonthaburi, Thailand",NA
"336","34235630","10.1007/s10578-021-01216-4","Depressive Symptoms Among Adolescents: Testing Vulnerability-Stress and Protective Models in the Context of COVID-19.","Adolescents who experience negative life events may be at risk for depression, particularly those with psychosocial vulnerabilities. We investigate longitudinally the impact of vulnerability/protective factors on the relation between a large-scale negative life event, the COVID-19 pandemic, and depressive symptoms. Adolescents (N = 228, Mage = 14.5 years, 53% female, 73% white) self-reported depressive symptoms 2-4 months before the pandemic (Time 1), and again 2 months following stay","2021","07","10","Child Psychiatry Hum Dev","Child psychiatry and human development","Adolescent; COVID-19; Cognitive styles; Depression; Resilience","Gladstone","Tracy R G","The Robert S. and Grace W. Stone Primary Prevention Initiatives, Wellesley Centers for Women, Wellesley College, 106 Central Street, Wellesley, MA, 02481, USA. tgladsto@wellesley","tgladsto@wellesley.edu"
"337","34235630","10.1007/s10578-021-01216-4","Depressive Symptoms Among Adolescents: Testing Vulnerability-Stress and Protective Models in the Context of COVID-19.","Adolescents who experience negative life events may be at risk for depression, particularly those with psychosocial vulnerabilities. We investigate longitudinally the impact of vulnerability/protective factors on the relation between a large-scale negative life event, the COVID-19 pandemic, and depressive symptoms. Adolescents (N = 228, Mage = 14.5 years, 53% female, 73% white) self-reported depressive symptoms 2-4 months before the pandemic (Time 1), and again 2 months following stay","2021","07","10","Child Psychiatry Hum Dev","Child psychiatry and human development","Adolescent; COVID-19; Cognitive styles; Depression; Resilience","Schwartz","Jennifer A J","University of Colorado, Boulder, CO, USA",NA
"338","34235630","10.1007/s10578-021-01216-4","Depressive Symptoms Among Adolescents: Testing Vulnerability-Stress and Protective Models in the Context of COVID-19.","Adolescents who experience negative life events may be at risk for depression, particularly those with psychosocial vulnerabilities. We investigate longitudinally the impact of vulnerability/protective factors on the relation between a large-scale negative life event, the COVID-19 pandemic, and depressive symptoms. Adolescents (N = 228, Mage = 14.5 years, 53% female, 73% white) self-reported depressive symptoms 2-4 months before the pandemic (Time 1), and again 2 months following stay","2021","07","10","Child Psychiatry Hum Dev","Child psychiatry and human development","Adolescent; COVID-19; Cognitive styles; Depression; Resilience","Pössel","Patrick","Department of Counseling and Human Development, University of Louisville, Louisville, KY, USA",NA
"339","34235630","10.1007/s10578-021-01216-4","Depressive Symptoms Among Adolescents: Testing Vulnerability-Stress and Protective Models in the Context of COVID-19.","Adolescents who experience negative life events may be at risk for depression, particularly those with psychosocial vulnerabilities. We investigate longitudinally the impact of vulnerability/protective factors on the relation between a large-scale negative life event, the COVID-19 pandemic, and depressive symptoms. Adolescents (N = 228, Mage = 14.5 years, 53% female, 73% white) self-reported depressive symptoms 2-4 months before the pandemic (Time 1), and again 2 months following stay","2021","07","10","Child Psychiatry Hum Dev","Child psychiatry and human development","Adolescent; COVID-19; Cognitive styles; Depression; Resilience","Richer","Amanda M","The Robert S. and Grace W. Stone Primary Prevention Initiatives, Wellesley Centers for Women, Wellesley College, 106 Central Street, Wellesley, MA, 02481, USA",NA
"340","34235630","10.1007/s10578-021-01216-4","Depressive Symptoms Among Adolescents: Testing Vulnerability-Stress and Protective Models in the Context of COVID-19.","Adolescents who experience negative life events may be at risk for depression, particularly those with psychosocial vulnerabilities. We investigate longitudinally the impact of vulnerability/protective factors on the relation between a large-scale negative life event, the COVID-19 pandemic, and depressive symptoms. Adolescents (N = 228, Mage = 14.5 years, 53% female, 73% white) self-reported depressive symptoms 2-4 months before the pandemic (Time 1), and again 2 months following stay","2021","07","10","Child Psychiatry Hum Dev","Child psychiatry and human development","Adolescent; COVID-19; Cognitive styles; Depression; Resilience","Buchholz","Katherine R","The Robert S. and Grace W. Stone Primary Prevention Initiatives, Wellesley Centers for Women, Wellesley College, 106 Central Street, Wellesley, MA, 02481, USA",NA
"341","34235630","10.1007/s10578-021-01216-4","Depressive Symptoms Among Adolescents: Testing Vulnerability-Stress and Protective Models in the Context of COVID-19.","Adolescents who experience negative life events may be at risk for depression, particularly those with psychosocial vulnerabilities. We investigate longitudinally the impact of vulnerability/protective factors on the relation between a large-scale negative life event, the COVID-19 pandemic, and depressive symptoms. Adolescents (N = 228, Mage = 14.5 years, 53% female, 73% white) self-reported depressive symptoms 2-4 months before the pandemic (Time 1), and again 2 months following stay","2021","07","10","Child Psychiatry Hum Dev","Child psychiatry and human development","Adolescent; COVID-19; Cognitive styles; Depression; Resilience","Rintell","L Sophia","The Robert S. and Grace W. Stone Primary Prevention Initiatives, Wellesley Centers for Women, Wellesley College, 106 Central Street, Wellesley, MA, 02481, USA",NA
"342","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Honey","Anne","Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. anne.honey@sydney.edu","anne.honey@sydney.edu.au"
"343","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Waks","Shifra","Faculty of Medicine and Health, The University of Sydney, Sydney, Australia",NA
"344","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Hines","Monique","Faculty of Medicine and Health, The University of Sydney, Sydney, Australia",NA
"345","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Glover","Helen","Enlightened Consultants, Brisbane, QLD, Australia",NA
"346","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Hancock","Nicola","Faculty of Medicine and Health, The University of Sydney, Sydney, Australia",NA
"347","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Hamilton","Debra","Faculty of Medicine and Health, The University of Sydney, Sydney, Australia",NA
"348","34235615","10.1007/s10597-021-00871-0","COVID-19 and Psychosocial Support Services: Experiences of People Living with Enduring Mental Health Conditions.","This paper uses secondary analysis to understand how COVID-19 shaped people's experiences with psychosocial support services in Australia. Data are drawn from questionnaires (n = 66) and semi-structured interviews (n = 62), conducted for a national service evaluation, with 121 people living with enduring mental health conditions and using psychosocial support services. Data relating to COVID-19 were inductively coded and analysed using constant comparative analysis. Most people's experiences inc","2021","07","10","Community Ment Health J","Community mental health journal","COVID-19; Community mental health support; Lived experience perspectives; Mental health; Psychosocial support program","Smith-Merry","Jennifer","Faculty of Medicine and Health, The University of Sydney, Sydney, Australia",NA
"349","34235610","10.1007/s11695-021-05551-2","Bariatric Surgeries and COVID-19 Outcomes: More and More Benefits.",NA,"2021","07","10","Obes Surg","Obesity surgery",NA,"Toubasi","Ahmad A","Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan. tubasi_ahmad@yahoo","ahmad@yahoo.com"
"350","34235606","10.1007/s10943-021-01332-4","""Everything is Either Sent by God or Used by God"": An Exploratory Study on the Impact of COVID-19 Upon the Religious Lives of Black Families Living with Dementia.","The purpose of this research study was to explore the impact of COVID-19 on church engagement for Black families affected by dementia in the USA. Semi-structured interviews were conducted with current caregivers, church leaders, and persons with dementia (n = 16). The following themes emerged: (a) Ability to continue religious practices, (b) Increased church engagement, (c) Importance of fellowship, (d) Role of technology, and (e) New normal. As the Internet becomes the new church building, onli","2021","07","11","J Relig Health","Journal of religion and health","African American; Alzheimers disease; Coronavirus; Faith practices; Religion","Ge","Yiran","Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Road, Office 238, Atlanta, GA, 30322, USA",NA
"351","34235606","10.1007/s10943-021-01332-4","""Everything is Either Sent by God or Used by God"": An Exploratory Study on the Impact of COVID-19 Upon the Religious Lives of Black Families Living with Dementia.","The purpose of this research study was to explore the impact of COVID-19 on church engagement for Black families affected by dementia in the USA. Semi-structured interviews were conducted with current caregivers, church leaders, and persons with dementia (n = 16). The following themes emerged: (a) Ability to continue religious practices, (b) Increased church engagement, (c) Importance of fellowship, (d) Role of technology, and (e) New normal. As the Internet becomes the new church building, onli","2021","07","11","J Relig Health","Journal of religion and health","African American; Alzheimers disease; Coronavirus; Faith practices; Religion","Sainz","Mayra","Rollins School of Public Health, Emory University, Atlanta, GA, USA",NA
"352","34235606","10.1007/s10943-021-01332-4","""Everything is Either Sent by God or Used by God"": An Exploratory Study on the Impact of COVID-19 Upon the Religious Lives of Black Families Living with Dementia.","The purpose of this research study was to explore the impact of COVID-19 on church engagement for Black families affected by dementia in the USA. Semi-structured interviews were conducted with current caregivers, church leaders, and persons with dementia (n = 16). The following themes emerged: (a) Ability to continue religious practices, (b) Increased church engagement, (c) Importance of fellowship, (d) Role of technology, and (e) New normal. As the Internet becomes the new church building, onli","2021","07","11","J Relig Health","Journal of religion and health","African American; Alzheimers disease; Coronavirus; Faith practices; Religion","Gore","Janelle","Rollins School of Public Health, Emory University, Atlanta, GA, USA",NA
"353","34235606","10.1007/s10943-021-01332-4","""Everything is Either Sent by God or Used by God"": An Exploratory Study on the Impact of COVID-19 Upon the Religious Lives of Black Families Living with Dementia.","The purpose of this research study was to explore the impact of COVID-19 on church engagement for Black families affected by dementia in the USA. Semi-structured interviews were conducted with current caregivers, church leaders, and persons with dementia (n = 16). The following themes emerged: (a) Ability to continue religious practices, (b) Increased church engagement, (c) Importance of fellowship, (d) Role of technology, and (e) New normal. As the Internet becomes the new church building, onli","2021","07","11","J Relig Health","Journal of religion and health","African American; Alzheimers disease; Coronavirus; Faith practices; Religion","Epps","Fayron","Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Road, Office 238, Atlanta, GA, 30322, USA. fepps@emory","fepps@emory.edu"
"354","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Mandal","Avik","Department of Radiation Oncology, All India Institute of Medical Sciences, Aurangabad Road, Phulwari Sharif, Patna, Bihar, 801507, India. dravikmandal@gmail","dravikmandal@gmail.com"
"355","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Singh","Pritanjali","Department of Radiation Oncology, All India Institute of Medical Sciences, Aurangabad Road, Phulwari Sharif, Patna, Bihar, 801507, India",NA
"356","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Samaddar","Arghadip","Depratment of Neuromicrobiology, National Institute of Mental Health &amp",NA
"357","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Singh","Dharmendra","Department of Radiation Oncology, All India Institute of Medical Sciences, Aurangabad Road, Phulwari Sharif, Patna, Bihar, 801507, India",NA
"358","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Verma","Manika","Department of Radiation Oncology, All India Institute of Medical Sciences, Aurangabad Road, Phulwari Sharif, Patna, Bihar, 801507, India",NA
"359","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Rakesh","Amrita","Department of Radiation Oncology, All India Institute of Medical Sciences, Aurangabad Road, Phulwari Sharif, Patna, Bihar, 801507, India",NA
"360","34235592","10.1007/s12032-021-01540-8","Vaccination of cancer patients against COVID-19: towards the end of a dilemma.","With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such","2021","07","16","Med Oncol","Medical oncology (Northwood, London, England)","Anticancer treatment; COVID-19; COVID-19 vaccines; Cancer patients; SARS-CoV-2; COVID-19; COVID-19 Vaccines; Humans; Neoplasms; SARS-CoV-2; Vaccination","Ranjan","Rakesh","Department of Radiation Oncology, All India Institute of Medical Sciences, Aurangabad Road, Phulwari Sharif, Patna, Bihar, 801507, India",NA
"361","34235578","10.1007/s00405-021-06951-x","COVID-19 caused hearing loss.","The objective of this cross-sectional study was to determine if there is a potential link between COVID-19 infection and hearing loss. The prospective study was conducted in the COVID Hospital Clinical Centre Ni, Serbia. We performed tonal audiometry and used a custom questionnaire and medical histories to determine the incidence of hearing loss in COVID-19 positive patients. There were 74 patients with COVID-19 that met the inclusion criteria of this study and they composed our experimental gr","2021","07","10","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","Audiometry; Covid-19; Hearing loss","Dusan","Milisavljevic","Department of Otolaryngology, University Clinic Centre Nis, Bul. Zorana Ðindica 48, Nis, Serbia. dusanorldusan@gmail","dusanorldusan@gmail.com"
"362","34235578","10.1007/s00405-021-06951-x","COVID-19 caused hearing loss.","The objective of this cross-sectional study was to determine if there is a potential link between COVID-19 infection and hearing loss. The prospective study was conducted in the COVID Hospital Clinical Centre Ni, Serbia. We performed tonal audiometry and used a custom questionnaire and medical histories to determine the incidence of hearing loss in COVID-19 positive patients. There were 74 patients with COVID-19 that met the inclusion criteria of this study and they composed our experimental gr","2021","07","10","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","Audiometry; Covid-19; Hearing loss","Milan","Stankovic","Department of Otolaryngology, University Clinic Centre Nis, Bul. Zorana Ðindica 48, Nis, Serbia",NA
"363","34235578","10.1007/s00405-021-06951-x","COVID-19 caused hearing loss.","The objective of this cross-sectional study was to determine if there is a potential link between COVID-19 infection and hearing loss. The prospective study was conducted in the COVID Hospital Clinical Centre Ni, Serbia. We performed tonal audiometry and used a custom questionnaire and medical histories to determine the incidence of hearing loss in COVID-19 positive patients. There were 74 patients with COVID-19 that met the inclusion criteria of this study and they composed our experimental gr","2021","07","10","Eur Arch Otorhinolaryngol","European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","Audiometry; Covid-19; Hearing loss","Nikola","Dordevic","Department of Otolaryngology, University Clinic Centre Nis, Bul. Zorana Ðindica 48, Nis, Serbia",NA
"364","34235568","10.1007/s00216-021-03499-x","Glycosylation of SARS-CoV-2: structural and functional insights.","The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. S, E, and M proteins are glycosylated, and the N protein is phosphorylated. The S protein is involved in the interaction with the host receptor human angiotensin-converting enzyme 2 (hACE2), which is also heavily glycosylated. Recent studies","2021","07","11","Anal Bioanal Chem","Analytical and bioanalytical chemistry","Envelope protein glycosylation; Glycosaminoglycan SARS-CoV-2; Human ACE2 SARS-CoV-2; Membrane protein glycosylation; SARS-CoV-2 glycosylation; Spike protein glycosylation","Shajahan","Asif","Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA",NA
"365","34235568","10.1007/s00216-021-03499-x","Glycosylation of SARS-CoV-2: structural and functional insights.","The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. S, E, and M proteins are glycosylated, and the N protein is phosphorylated. The S protein is involved in the interaction with the host receptor human angiotensin-converting enzyme 2 (hACE2), which is also heavily glycosylated. Recent studies","2021","07","11","Anal Bioanal Chem","Analytical and bioanalytical chemistry","Envelope protein glycosylation; Glycosaminoglycan SARS-CoV-2; Human ACE2 SARS-CoV-2; Membrane protein glycosylation; SARS-CoV-2 glycosylation; Spike protein glycosylation","Pepi","Lauren E","Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA",NA
"366","34235568","10.1007/s00216-021-03499-x","Glycosylation of SARS-CoV-2: structural and functional insights.","The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. S, E, and M proteins are glycosylated, and the N protein is phosphorylated. The S protein is involved in the interaction with the host receptor human angiotensin-converting enzyme 2 (hACE2), which is also heavily glycosylated. Recent studies","2021","07","11","Anal Bioanal Chem","Analytical and bioanalytical chemistry","Envelope protein glycosylation; Glycosaminoglycan SARS-CoV-2; Human ACE2 SARS-CoV-2; Membrane protein glycosylation; SARS-CoV-2 glycosylation; Spike protein glycosylation","Rouhani","Daniel S","Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA",NA
"367","34235568","10.1007/s00216-021-03499-x","Glycosylation of SARS-CoV-2: structural and functional insights.","The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. S, E, and M proteins are glycosylated, and the N protein is phosphorylated. The S protein is involved in the interaction with the host receptor human angiotensin-converting enzyme 2 (hACE2), which is also heavily glycosylated. Recent studies","2021","07","11","Anal Bioanal Chem","Analytical and bioanalytical chemistry","Envelope protein glycosylation; Glycosaminoglycan SARS-CoV-2; Human ACE2 SARS-CoV-2; Membrane protein glycosylation; SARS-CoV-2 glycosylation; Spike protein glycosylation","Heiss","Christian","Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA",NA
"368","34235568","10.1007/s00216-021-03499-x","Glycosylation of SARS-CoV-2: structural and functional insights.","The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Similar to other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. S, E, and M proteins are glycosylated, and the N protein is phosphorylated. The S protein is involved in the interaction with the host receptor human angiotensin-converting enzyme 2 (hACE2), which is also heavily glycosylated. Recent studies","2021","07","11","Anal Bioanal Chem","Analytical and bioanalytical chemistry","Envelope protein glycosylation; Glycosaminoglycan SARS-CoV-2; Human ACE2 SARS-CoV-2; Membrane protein glycosylation; SARS-CoV-2 glycosylation; Spike protein glycosylation","Azadi","Parastoo","Complex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA. azadi@ccrc.uga","azadi@ccrc.uga.edu"
"369","34235512","10.1002/ski2.30","Dermatology services: The new normal post COVID-19.","The article discusses the impact of COVID-19 on the future of dermatology services. It will explore the changes dermatology services may need to follow to minimise disease transmission. This will include an integration of teledermatology into everyday practice, a shift in dermatology training, and change in dermoscopy technique.","2021","07","08","Skin Health Dis","Skin health and disease",NA,"Yuen","S","Blizzard Institute Barts and The London School of Medicine and Dentistry London UK",NA
"370","34235511","10.1002/ski2.20","A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.","Infection with COVID-19 is characterized by respiratory, gastrointestinal and neurologic symptoms. However, limited evidence exists of the involvement of the integumentary system among COVID-19 patients and evidence suggests that these symptoms may even be the first presenting sign. To systematically evaluate the literature published on dermatologic signs of COVID-19 in order to educate doctors about the dermatologic signs of COVID-19 infection. Lit COVID, World Health Organization COVID-19 data","2021","07","08","Skin Health Dis","Skin health and disease","evidence-based dermatology; infection; virology","Schwartzberg","L N","New York Institute of Technology College of Osteopathic Medicine New York USA",NA
"371","34235511","10.1002/ski2.20","A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.","Infection with COVID-19 is characterized by respiratory, gastrointestinal and neurologic symptoms. However, limited evidence exists of the involvement of the integumentary system among COVID-19 patients and evidence suggests that these symptoms may even be the first presenting sign. To systematically evaluate the literature published on dermatologic signs of COVID-19 in order to educate doctors about the dermatologic signs of COVID-19 infection. Lit COVID, World Health Organization COVID-19 data","2021","07","08","Skin Health Dis","Skin health and disease","evidence-based dermatology; infection; virology","Advani","S","Terasaki Institute of Biomedical Innovation Los Angeles California USA",NA
"372","34235511","10.1002/ski2.20","A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.","Infection with COVID-19 is characterized by respiratory, gastrointestinal and neurologic symptoms. However, limited evidence exists of the involvement of the integumentary system among COVID-19 patients and evidence suggests that these symptoms may even be the first presenting sign. To systematically evaluate the literature published on dermatologic signs of COVID-19 in order to educate doctors about the dermatologic signs of COVID-19 infection. Lit COVID, World Health Organization COVID-19 data","2021","07","08","Skin Health Dis","Skin health and disease","evidence-based dermatology; infection; virology","Clancy","D C","New York Institute of Technology College of Osteopathic Medicine New York USA",NA
"373","34235511","10.1002/ski2.20","A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.","Infection with COVID-19 is characterized by respiratory, gastrointestinal and neurologic symptoms. However, limited evidence exists of the involvement of the integumentary system among COVID-19 patients and evidence suggests that these symptoms may even be the first presenting sign. To systematically evaluate the literature published on dermatologic signs of COVID-19 in order to educate doctors about the dermatologic signs of COVID-19 infection. Lit COVID, World Health Organization COVID-19 data","2021","07","08","Skin Health Dis","Skin health and disease","evidence-based dermatology; infection; virology","Lin","A","Department of Dermatology St. John's Episcopal Hospital New York USA",NA
"374","34235511","10.1002/ski2.20","A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.","Infection with COVID-19 is characterized by respiratory, gastrointestinal and neurologic symptoms. However, limited evidence exists of the involvement of the integumentary system among COVID-19 patients and evidence suggests that these symptoms may even be the first presenting sign. To systematically evaluate the literature published on dermatologic signs of COVID-19 in order to educate doctors about the dermatologic signs of COVID-19 infection. Lit COVID, World Health Organization COVID-19 data","2021","07","08","Skin Health Dis","Skin health and disease","evidence-based dermatology; infection; virology","Jorizzo","J L","Department of Dermatology Wake Forest Baptist Health Winston-Salem North Carolina USA",NA
"375","34235510","10.1002/ski2.54","Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience.",NA,"2021","07","08","Skin Health Dis","Skin health and disease","Hidradenitis suppurativa; medical dermatology; psoriasis; virology","Khan","S","Department of Dermatology Oxford University Hospitals NHS Foundation Trust Oxford UK",NA
"376","34235510","10.1002/ski2.54","Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience.",NA,"2021","07","08","Skin Health Dis","Skin health and disease","Hidradenitis suppurativa; medical dermatology; psoriasis; virology","Karponis","D","Department of Dermatology Oxford University Hospitals NHS Foundation Trust Oxford UK",NA
"377","34235510","10.1002/ski2.54","Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience.",NA,"2021","07","08","Skin Health Dis","Skin health and disease","Hidradenitis suppurativa; medical dermatology; psoriasis; virology","Wali","G","Department of Dermatology Oxford University Hospitals NHS Foundation Trust Oxford UK",NA
"378","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Shultz","James M","Center for Disaster &amp",NA
"379","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Berg","Ryan C","Senior Fellow, Americas Program, Center for Strategic and International Studies (CSIS), Washington, DC 20036, USA",NA
"380","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Kossin","James P","Climate Science and Services Division, NOAA's National Centers for Environmental Information (NCEI), Madison, WI 53706, USA. Current affiliation: The Climate Service, Durham, NC 27701, USA",NA
"381","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Burkle","Frederick","Harvard Humanitarian Initiative, Harvard University &amp",NA
"382","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Maggioni","Alessandra","Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA",NA
"383","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Pinilla Escobar","Victoria A","Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA",NA
"384","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Castillo","Melissa Nicole","Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA",NA
"385","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Espinel","Zelde","Sylvester Comprehensive Cancer Center, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA",NA
"386","34235501","10.1016/j.joclim.2021.100019","Convergence of climate-driven hurricanes and COVID-19: The impact of 2020 hurricanes Eta and Iota on Nicaragua.","The 2020 Atlantic hurricane season was notable for a record-setting 30 named storms while, contemporaneously, the COVID-19 pandemic was circumnavigating the globe. The active spread of COVID-19 complicated disaster preparedness and response actions to safeguard coastal and island populations from hurricane hazards. Major hurricanes Eta and Iota, the most powerful storms of the 2020 Atlantic season, made November landfalls just two weeks apart, both coming ashore along the Miskito Coast in Nicara","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID-19; Climate change; Climate driver; Humanitarian emergency; Hurricane; Mitigation; Tropical cyclone","Galea","Sandro","Robert A Knox Professor, School of Public Health, Boston University, 715 Albany Street - Talbot 301, Boston, MA 02118, USA",NA
"387","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Tsagkaris","Christos","University of Crete, Faculty of Medicine, Heraklion, Greece",NA
"388","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Moysidis","Dimitrios V","Aristotle University of Thessaloniki, Faculty of Medicine, Thessaloniki, Greece",NA
"389","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Papazoglou","Andreas S","Aristotle University of Thessaloniki, Faculty of Medicine, Thessaloniki, Greece",NA
"390","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Louka","Anna Maria","University of Thessaly, Faculty of Medicine, Larissa, Greece",NA
"391","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Kalaitzidis","Konstantinos","University of Thessaly, Department of Digital Systems, Larissa, Greece",NA
"392","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Ahmad","Shoaib","Punjab Medical College, Faisalabad, Pakistan",NA
"393","34235500","10.1016/j.joclim.2021.100018","Detection of SARS-CoV-2 in wastewater raises public awareness of the effects of climate change on human health: The experience from Thessaloniki, Greece.",NA,"2021","07","08","J Clim Chang Health","The journal of climate change and health","Climate adaptation; Climate change; Covid-19; SSARS-CoV-2; Viral load; Wastewater","Essar","Mohammad Yasir","Medical Research Center, Kateb University, Kabul, Afghanistan",NA
"394","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Phadke","Rachana","Indira Gandhi Government Medical College, Nagpur, India",NA
"395","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Dos Santos Costa","Ana Carla","Federal University of Bahia, Salvador, Bahia, Brazil",NA
"396","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Dapke","Kartik","Indira Gandhi Government Medical College, Nagpur, India",NA
"397","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Ghosh","Shayon","GMERS, Medical College and Hospital, Sola, Gujarat, India",NA
"398","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Ahmad","Shoaib","Punjab Medical College, Faisalabad, Pakistan",NA
"399","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Tsagkaris","Christos","University of Crete, Faculty of Medicine, Heraklion, Greece",NA
"400","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Raiya","Sunidhi","Amity Institute of Biotechnology, Amity University Noida, India",NA
"401","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Maheswari","M Subha","Amity Institute of Biotechnology, Amity University Noida, India",NA
"402","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Essar","Mohammad Yasir","Kabul University of Medical Sciences, Kabul, Afghanistan",NA
"403","34235499","10.1016/j.joclim.2021.100005","Eco-friendly vaccination: Tackling an unforeseen adverse effect.","The beginning of 2021 was marked by COVID-19 vaccination campaigns worldwide. The pace of production has been accelerated, in order to meet global needs and achieve the desired levels of immunization of the general population against COVID-19 within the year. Several debatable aspects of this endeavor, from logistics to health promotion have been addressed so far. However, the environmental repercussions of plastic syringes used for massive COVID-19 vaccinations are yet to be discussed. This art","2021","07","08","J Clim Chang Health","The journal of climate change and health","COVID 19; Climate change; Plastic waste; Sustainable solutions; Vaccination","Ahmad","Shahzaib","FMH College of Medicine &amp",NA
"404","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Esmail","Sally","Departments of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6G 2V4, Canada",NA
"405","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Knauer","Michael J","Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"406","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Abdoh","Husam","Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"407","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Voss","Courtney","Departments of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6G 2V4, Canada",NA
"408","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Chin-Yee","Benjamin","Divison of Hematology, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"409","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Stogios","Peter","Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, ON M5S 3E5, Canada",NA
"410","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Seitova","Almagul","Structural Genomics Consortium, University of Toronto, 101 College Street, MaRS South Tower, Suite 700, Toronto, ON M5G 1L7, Canada",NA
"411","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Hutchinson","Ashley","Structural Genomics Consortium, University of Toronto, 101 College Street, MaRS South Tower, Suite 700, Toronto, ON M5G 1L7, Canada",NA
"412","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Yusifov","Farhad","Structural Genomics Consortium, University of Toronto, 101 College Street, MaRS South Tower, Suite 700, Toronto, ON M5G 1L7, Canada",NA
"413","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Skarina","Tatiana","Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, ON M5S 3E5, Canada",NA
"414","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Evdokimova","Elena","Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, ON M5S 3E5, Canada",NA
"415","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Ackloo","Suzanne","Structural Genomics Consortium, University of Toronto, 101 College Street, MaRS South Tower, Suite 700, Toronto, ON M5G 1L7, Canada",NA
"416","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Lowes","Lori","Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"417","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Hedley","Benjamin D","Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"418","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Bhayana","Vipin","Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"419","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Chin-Yee","Ian","Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Road East, London, ON N6A 5W9, Canada",NA
"420","34235498","10.1016/j.crmeth.2021.100011","Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.","We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and ~98% sensitivity. Furthermore, we fo","2021","07","08","Cell Rep Methods","Cell reports methods","COVID-19; SARS-CoV-2; agglutination assay; antibody test; neutralizing antibody; nucleocapsid; rapid testing; serology; spike","Li","Shawn S-C","Departments of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6G 2V4, Canada",NA
"421","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Davidi","Dan","Department of Genetics, Harvard Medical School, Boston, MA, USA",NA
"422","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Fitzgerald","Susan","Harvard University Health Services, Harvard University, Cambridge, MA, USA",NA
"423","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Glaspell","Hannah L","Biological Safety, Environment, Health and Safety, Cornell University, Ithaca, NY USA",NA
"424","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Jalbert","Samantha","Department of Systems Biology, Harvard Medical School, Boston, MA, USA",NA
"425","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Klapperich","Catherine M","Department of Biomedical Engineering and Precision Diagnostics Center, Boston University, Boston, MA 02215",NA
"426","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Landaverde","Lena","Department of Biomedical Engineering and Precision Diagnostics Center, Boston University, Boston, MA 02215",NA
"427","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Maheras","Stylianos","Harvard University Health Services, Harvard University, Cambridge, MA, USA",NA
"428","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Mattoon","Stephanie E","Biological Safety, Environment, Health and Safety, Cornell University, Ithaca, NY USA",NA
"429","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Britto","Vanessa M","Department of Medicine/University Health Services, Brown University, Providence, RI, USA",NA
"430","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Nguyen","Giang T","Harvard University Health Services, Harvard University, Cambridge, MA, USA",NA
"431","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Platt","Judy T","Student Health Services, Boston University, Boston, MA, USA",NA
"432","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Kuhfeldt","Kayla","Student Health Services, Boston University, Boston, MA, USA",NA
"433","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Landsberg","Hannah","Student Health Services, Boston University, Boston, MA, USA",NA
"434","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Stuopis","Cecilia W","MIT Medical, Massachusetts Institute of Technology, Cambridge, MA, USA",NA
"435","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Turse","Joshua E","Biological Safety, Environment, Health and Safety, Cornell University, Ithaca, NY USA",NA
"436","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Hamer","Davidson H","Department of Global Health, Boston University School of Public Health, Boston, MA, USA",NA
"437","34235497","10.1016/j.crmeth.2021.100005","Amplicon residues in research laboratories masquerade as COVID-19 in surveillance tests.","Asymptomatic surveillance testing together with COVID-19-related research can lead to positive SARS-CoV-2 tests resulting not from true infections, but non-infectious, non-hazardous by-products of research (amplicons). Amplicons can be widespread and persistent in lab environments and can be difficult to distinguish for true infections. We discuss prevention and mitigation strategies.","2021","07","08","Cell Rep Methods","Cell reports methods",NA,"Springer","Michael","Department of Systems Biology, Harvard Medical School, Boston, MA, USA",NA
"438","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Hatoum","Alexander S","Washington University School of Medicine, Department of Psychiatry",NA
"439","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Morrison","Claire L","Institute for Behavioral Genetics, University of Colorado Boulder",NA
"440","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Colbert","Sarah M C","Washington University School of Medicine, Department of Psychiatry",NA
"441","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Winiger","Evan A","Institute for Behavioral Genetics, University of Colorado Boulder",NA
"442","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Johnson","Emma C","Washington University School of Medicine, Department of Psychiatry",NA
"443","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Agrawal","Arpana","Washington University School of Medicine, Department of Psychiatry",NA
"444","34235496","10.1016/j.bpsgos.2021.06.005","Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.","Vulnerability to COVID-19 hospitalization has been linked to behavioral risk factors, including combustible psychoactive substance use (e.g., tobacco smoking). Paralleling the COVID-19 crisis have been increasingly permissive laws for recreational cannabis use. Cannabis Use Disorder (CUD) is a psychiatric disorder that is heritable and genetically correlated with respiratory disease, independent of tobacco smoking. We examined the genetic relationship between CUD and COVID-19 hospitalization. We","2021","07","09","Biol Psychiatry Glob Open Sci","Biological psychiatry global open science","COVID-19; Cannabis use disorder; genetic correlations; genome-wide association statistics; tobacco use","Bogdan","Ryan","Washington University in St. Louis, Department of Psychological &amp",NA
"445","34235495","10.1016/j.bbadva.2021.100016","Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely spread around the world. It is necessary to examine the viral proteins that play a notorious role in the invasion of our body. The main protease (3CL<sup>pro</sup>) facilitates the maturation of the coronavirus. It is thought that the dimerization of 3CL<sup>pro</sup> leads to its catalytic activity; the detailed mechanism has, however, not been suggested. Furthermore, the structural differences between the predecessor ","2021","07","12","BBA Adv","BBA advances","Atomistic molecular dynamics simulation; Catalysis; Cysteine protease; Dimerization; SARS-CoV-2; Water molecule","Iida","Shinji","Technology Research Association for Next-Generation Natural Products Chemistry, 2-3-26, Aomi, Koto-ku, Tokyo, Japan 135-0064",NA
"446","34235495","10.1016/j.bbadva.2021.100016","Asymmetric dynamics of dimeric SARS-CoV-2 and SARS-CoV main proteases in an apo form: Molecular dynamics study on fluctuations of active site, catalytic dyad, and hydration water.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely spread around the world. It is necessary to examine the viral proteins that play a notorious role in the invasion of our body. The main protease (3CL<sup>pro</sup>) facilitates the maturation of the coronavirus. It is thought that the dimerization of 3CL<sup>pro</sup> leads to its catalytic activity; the detailed mechanism has, however, not been suggested. Furthermore, the structural differences between the predecessor ","2021","07","12","BBA Adv","BBA advances","Atomistic molecular dynamics simulation; Catalysis; Cysteine protease; Dimerization; SARS-CoV-2; Water molecule","Fukunishi","Yoshifumi","Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2-3-26 Aomi, Koto-ku, Tokyo, Japan 135-0064",NA
"447","34235460","10.1097/CCE.0000000000000482","Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.","The pulmonary vascular endothelialitis together with the high rate of distal pulmonary embolism or thrombosis extensively reported in critically ill coronavirus disease 2019 patients may impair antibiotic diffusion in the lung parenchyma of coronavirus disease 2019 patients with ventilator-associated pneumonia leading to insufficient antibiotic concentration, thus promoting lung abscess formation. We report that 17 of 119 coronavirus disease 2019 patients (14%) with ventilator-associated pneumon","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; antibiotics therapy; coronavirus disease 2019; intensive care unit; lung abscess; ventilator-associated pneumonia","Beaucoté","Victor","Service de réanimation polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France",NA
"448","34235460","10.1097/CCE.0000000000000482","Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.","The pulmonary vascular endothelialitis together with the high rate of distal pulmonary embolism or thrombosis extensively reported in critically ill coronavirus disease 2019 patients may impair antibiotic diffusion in the lung parenchyma of coronavirus disease 2019 patients with ventilator-associated pneumonia leading to insufficient antibiotic concentration, thus promoting lung abscess formation. We report that 17 of 119 coronavirus disease 2019 patients (14%) with ventilator-associated pneumon","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; antibiotics therapy; coronavirus disease 2019; intensive care unit; lung abscess; ventilator-associated pneumonia","Plantefève","Gaëtan","Service de réanimation polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France",NA
"449","34235460","10.1097/CCE.0000000000000482","Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.","The pulmonary vascular endothelialitis together with the high rate of distal pulmonary embolism or thrombosis extensively reported in critically ill coronavirus disease 2019 patients may impair antibiotic diffusion in the lung parenchyma of coronavirus disease 2019 patients with ventilator-associated pneumonia leading to insufficient antibiotic concentration, thus promoting lung abscess formation. We report that 17 of 119 coronavirus disease 2019 patients (14%) with ventilator-associated pneumon","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; antibiotics therapy; coronavirus disease 2019; intensive care unit; lung abscess; ventilator-associated pneumonia","Tirolien","Jo-Anna","Service de réanimation polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France",NA
"450","34235460","10.1097/CCE.0000000000000482","Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.","The pulmonary vascular endothelialitis together with the high rate of distal pulmonary embolism or thrombosis extensively reported in critically ill coronavirus disease 2019 patients may impair antibiotic diffusion in the lung parenchyma of coronavirus disease 2019 patients with ventilator-associated pneumonia leading to insufficient antibiotic concentration, thus promoting lung abscess formation. We report that 17 of 119 coronavirus disease 2019 patients (14%) with ventilator-associated pneumon","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; antibiotics therapy; coronavirus disease 2019; intensive care unit; lung abscess; ventilator-associated pneumonia","Desaint","Paul","Service de réanimation polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France",NA
"451","34235460","10.1097/CCE.0000000000000482","Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.","The pulmonary vascular endothelialitis together with the high rate of distal pulmonary embolism or thrombosis extensively reported in critically ill coronavirus disease 2019 patients may impair antibiotic diffusion in the lung parenchyma of coronavirus disease 2019 patients with ventilator-associated pneumonia leading to insufficient antibiotic concentration, thus promoting lung abscess formation. We report that 17 of 119 coronavirus disease 2019 patients (14%) with ventilator-associated pneumon","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; antibiotics therapy; coronavirus disease 2019; intensive care unit; lung abscess; ventilator-associated pneumonia","Fraissé","Megan","Service de réanimation polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France",NA
"452","34235460","10.1097/CCE.0000000000000482","Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.","The pulmonary vascular endothelialitis together with the high rate of distal pulmonary embolism or thrombosis extensively reported in critically ill coronavirus disease 2019 patients may impair antibiotic diffusion in the lung parenchyma of coronavirus disease 2019 patients with ventilator-associated pneumonia leading to insufficient antibiotic concentration, thus promoting lung abscess formation. We report that 17 of 119 coronavirus disease 2019 patients (14%) with ventilator-associated pneumon","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; antibiotics therapy; coronavirus disease 2019; intensive care unit; lung abscess; ventilator-associated pneumonia","Contou","Damien","Service de réanimation polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France",NA
"453","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Alladina","Jehan W","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"454","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Giacona","Francesca L","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"455","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","White","Emma B","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"456","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Brait","Kelsey L","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"457","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Abe","Elizabeth A","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"458","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Michelhaugh","Sam A","Division of Cardiology, Massachusetts General Hospital, Boston, MA",NA
"459","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Hibbert","Kathryn A","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"460","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Januzzi","James L","Division of Cardiology, Massachusetts General Hospital, Boston, MA",NA
"461","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Thompson","B Taylor","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"462","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Cho","Josalyn L","Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa Carver College of Medicine, Iowa City, IA",NA
"463","34235459","10.1097/CCE.0000000000000480","Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.","We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate with continued ventilator dependence. We associated serial plasma soluble suppression of tumorigenicity-2 levels and markers of systemic inflammation including d-dimer, C-reactive protein, and erythrocyte sedimentation rate with 30-day mortality and ventilator ","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; biomarkers; coronavirus disease 2019 virus disease; ventilator weaning","Medoff","Benjamin D","Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA",NA
"464","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Zadek","Francesco","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"465","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Rubin","Jonah","Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"466","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Grassi","Luigi","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"467","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Van Den Kroonenberg","Daniel","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"468","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Larson","Grant","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"469","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Capriles","Martin","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"470","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","De Santis Santiago","Roberta","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"471","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Florio","Gaetano","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"472","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Imber","David A","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"473","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Bittner","Edward A","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"474","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Hibbert","Kathryn A","Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"475","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Legassey","Alex","Department of Respiratory Care, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"476","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","LaRocque","Jeliene","Department of Respiratory Care, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"477","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Cudemus-Deseda","Gaston","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"478","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Bagchi","Aranya","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"479","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Crowley","Jerome","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"480","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Shelton","Kenneth","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"481","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Kacmarek","Robert","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"482","34235455","10.1097/CCE.0000000000000461","Individualized Multimodal Physiologic Approach to Mechanical Ventilation in Patients With Obesity and Severe Acute Respiratory Distress Syndrome Reduced Venovenous Extracorporeal Membrane Oxygenation Utilization.","To investigate whether individualized optimization of mechanical ventilation through the implementation of a lung rescue team could reduce the need for venovenous extracorporeal membrane oxygenation in patients with obesity and acute respiratory distress syndrome and decrease ICU and hospital length of stay and mortality. Single-center, retrospective study at the Massachusetts General Hospital from June 2015 to June 2019. All patients with obesity and acute respiratory distress syndrome who were","2021","07","09","Crit Care Explor","Critical care explorations","acute respiratory distress syndrome; mechanical power; mechanical ventilation; obesity; recruitment maneuver; venovenous extracorporeal membrane oxygenation","Berra","Lorenzo","Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA",NA
"483","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Almond","Jeffrey","The Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK",NA
"484","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Hacker","Jörg","German National Academy of Science Leopoldina, Jägerberg 1, 06108 Halle, Germany",NA
"485","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Harwood","Colin","Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Baddiley-Clark Building, Newcastle upon Tyne NE2 4AX, UK",NA
"486","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Pizza","Mariagrazia","GSK Vaccines, Via Fiorentina, 1, 53100 Siena SI, Italy",NA
"487","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Rappuoli","Rino","GSK Vaccines, Via Fiorentina, 1, 53100 Siena SI, Italy",NA
"488","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Ron","Eliora Z","The Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, PO Box 39040, Tel Aviv 6997801, Israel",NA
"489","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Sansonetti","Philippe","Institut Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France",NA
"490","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Vanderslott","Samantha","Oxford Vaccine Group and Oxford Martin School, 34 Broad St, Oxford OX1 3BD, UK",NA
"491","34235437","10.1093/femsml/uqaa003","Development of vaccines at the time of COVID-19.","In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Followi","2021","07","08","Microlife","microLife","COVID-19; pandemics; pathogens; vaccination; vaccines; vaccinology","Wieler","Lothar H","Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany",NA
"492","34235433","10.1093/nargab/lqab062","RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion.","Relation extraction (RE) is a fundamental task for extracting gene-disease associations from biomedical text. Many state-of-the-art tools have limited capacity, as they can extract gene-disease associations only from single sentences or abstract texts. A few studies have explored extracting gene-disease associations from full-text articles, but there exists a large room for improvements. In this work, we propose RENET2, a deep learning-based RE method, which implements Section Filtering and ambi","2021","07","09","NAR Genom Bioinform","NAR genomics and bioinformatics",NA,"Su","Junhao","Department of Computer Science, The University of Hong Kong, Hong Kong, 999077, China",NA
"493","34235433","10.1093/nargab/lqab062","RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion.","Relation extraction (RE) is a fundamental task for extracting gene-disease associations from biomedical text. Many state-of-the-art tools have limited capacity, as they can extract gene-disease associations only from single sentences or abstract texts. A few studies have explored extracting gene-disease associations from full-text articles, but there exists a large room for improvements. In this work, we propose RENET2, a deep learning-based RE method, which implements Section Filtering and ambi","2021","07","09","NAR Genom Bioinform","NAR genomics and bioinformatics",NA,"Wu","Ye","Department of Computer Science, The University of Hong Kong, Hong Kong, 999077, China",NA
"494","34235433","10.1093/nargab/lqab062","RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion.","Relation extraction (RE) is a fundamental task for extracting gene-disease associations from biomedical text. Many state-of-the-art tools have limited capacity, as they can extract gene-disease associations only from single sentences or abstract texts. A few studies have explored extracting gene-disease associations from full-text articles, but there exists a large room for improvements. In this work, we propose RENET2, a deep learning-based RE method, which implements Section Filtering and ambi","2021","07","09","NAR Genom Bioinform","NAR genomics and bioinformatics",NA,"Ting","Hing-Fung","Department of Computer Science, The University of Hong Kong, Hong Kong, 999077, China",NA
"495","34235433","10.1093/nargab/lqab062","RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion.","Relation extraction (RE) is a fundamental task for extracting gene-disease associations from biomedical text. Many state-of-the-art tools have limited capacity, as they can extract gene-disease associations only from single sentences or abstract texts. A few studies have explored extracting gene-disease associations from full-text articles, but there exists a large room for improvements. In this work, we propose RENET2, a deep learning-based RE method, which implements Section Filtering and ambi","2021","07","09","NAR Genom Bioinform","NAR genomics and bioinformatics",NA,"Lam","Tak-Wah","Department of Computer Science, The University of Hong Kong, Hong Kong, 999077, China",NA
"496","34235433","10.1093/nargab/lqab062","RENET2: high-performance full-text gene-disease relation extraction with iterative training data expansion.","Relation extraction (RE) is a fundamental task for extracting gene-disease associations from biomedical text. Many state-of-the-art tools have limited capacity, as they can extract gene-disease associations only from single sentences or abstract texts. A few studies have explored extracting gene-disease associations from full-text articles, but there exists a large room for improvements. In this work, we propose RENET2, a deep learning-based RE method, which implements Section Filtering and ambi","2021","07","09","NAR Genom Bioinform","NAR genomics and bioinformatics",NA,"Luo","Ruibang","Department of Computer Science, The University of Hong Kong, Hong Kong, 999077, China",NA
"497","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Nicksic","Peter J","Department of Surgery, Division of Plastic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA",NA
"498","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Karczewski","Alison M","University of Wisconsin School of Medicine and Public Health, Madison, WI, USA",NA
"499","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Zhao","Qianqian","Department of Biostatistics and Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA",NA
"500","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Garcia","Nicholas A","Department of Surgery, Division of Plastic Surgery, University of Minnesota Medical School, Minneapolis, MN, USA",NA
"501","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Michelotti","Brett F","Department of Surgery, Division of Plastic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA",NA
"502","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Mahajan","Ashish Y","Department of Plastic and Hand Surgery HealthPartners/Regions Hospital, St. Paul, MN, USA",NA
"503","34235429","10.1093/asjof/ojab017","The Contribution of the Lower Third of the Face to Perceived Age: Do Masks Make You Appear Younger?","There is evidence that changes to the midface and lower third of the face in isolation contribute significantly to one's perception of the overall facial age. Since the spread of the coronavirus disease 2019 (COVID-19), mask wearing has become commonplace. To date, there have been no studies that explore how covering the lower third of the face impacts the perception of age. The authors hypothesized that covering the lower third of the face with a mask will make a person appear younger. One hund","2021","07","09","Aesthet Surg J Open Forum","Aesthetic surgery journal. Open forum",NA,"Poore","Samuel O","Department of Surgery, Division of Plastic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA",NA
"504","34235427","10.7196/AJTCCM.2020.v26i4.119","Observational study of therapeutic bronchoscopy in critical hypoxaemic ventilated patients with COVID-19 at Mediclinic Midstream Private Hospital in Pretoria, South Africa.","Flexible fibreoptic bronchoscopy (FFB) has been used for years as a diagnostic and therapeutic adjunct for the diagnosis of potential airway obstruction as a cause of acute respiratory failure or in the management of hypoxaemia ventilated patients. In these circumstances, it is useful to evaluate airway patency or airway damage and for the management of atelectasis. To evaluate the use of FFB as a rescue therapy in mechanically ventilated patients with severe hypoxaemic respiratory failure cause","2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; Respiratory Tract Diseases; Therapeutic bronchoscopy; Viral; Lung Diseases. Parasitic; Viral; Pneumonia; hypoxaemic; ventilated","Taban","E M","Critical Care Unit, Mediclinic Midstream Critical Care Unit, Private Hospital Pretoria, South Africa",NA
"505","34235427","10.7196/AJTCCM.2020.v26i4.119","Observational study of therapeutic bronchoscopy in critical hypoxaemic ventilated patients with COVID-19 at Mediclinic Midstream Private Hospital in Pretoria, South Africa.","Flexible fibreoptic bronchoscopy (FFB) has been used for years as a diagnostic and therapeutic adjunct for the diagnosis of potential airway obstruction as a cause of acute respiratory failure or in the management of hypoxaemia ventilated patients. In these circumstances, it is useful to evaluate airway patency or airway damage and for the management of atelectasis. To evaluate the use of FFB as a rescue therapy in mechanically ventilated patients with severe hypoxaemic respiratory failure cause","2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; Respiratory Tract Diseases; Therapeutic bronchoscopy; Viral; Lung Diseases. Parasitic; Viral; Pneumonia; hypoxaemic; ventilated","Richards","G A","Department of Critical Care and Pulmonology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"506","34235426","10.7196/AJTCCM.2020.v26i3.114","Controversies and challenges with COVID-19 in children: Why are they less susceptible and should they be at home rather than in school?",NA,"2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; Children; Economy; Low middle income country; SARS-cov2; South Africa challenges","Masekela","R","Department of Paediatrics and Child Health, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"507","34235426","10.7196/AJTCCM.2020.v26i3.114","Controversies and challenges with COVID-19 in children: Why are they less susceptible and should they be at home rather than in school?",NA,"2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; Children; Economy; Low middle income country; SARS-cov2; South Africa challenges","Wessels","A J","Department of Paediatrics and Child Health, Queen Nandi Regional Hospital, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"508","34235425","10.7196/AJTCCM.2020.v26i3.107","Brief review: Cardiac complications and platelet activation in COVID-19 infection.","COVID-19 pneumonia, much like that of bacterial and viral community-acquired pneumonia before it, is accompanied by a high rate of cardio- and cerebrovascular events that are associated with an increased risk of complications and a greater mortality. Although the mechanisms underlying the pathogenesis of these adverse events are not entirely clear and may be multifactorial, platelets appear to have a prominent aetiologic role and this, together with an overview of the clinical evidence, forms th","2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; Cardiovascular events; Pathogenesis; Platelets","Feldman","C","Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"509","34235425","10.7196/AJTCCM.2020.v26i3.107","Brief review: Cardiac complications and platelet activation in COVID-19 infection.","COVID-19 pneumonia, much like that of bacterial and viral community-acquired pneumonia before it, is accompanied by a high rate of cardio- and cerebrovascular events that are associated with an increased risk of complications and a greater mortality. Although the mechanisms underlying the pathogenesis of these adverse events are not entirely clear and may be multifactorial, platelets appear to have a prominent aetiologic role and this, together with an overview of the clinical evidence, forms th","2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; Cardiovascular events; Pathogenesis; Platelets","Anderson","R","Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"510","34235424","10.7196/AJTCCM.2020.v26i3.106","The use of corticosteroids for COVID-19 infection.","The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detriment","2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; SARS-CoV-2; coronavirus; corticosteroids; therapy","Richards","G A","Department of Critical Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"511","34235424","10.7196/AJTCCM.2020.v26i3.106","The use of corticosteroids for COVID-19 infection.","The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detriment","2021","07","09","Afr J Thorac Crit Care Med","African journal of thoracic and critical care medicine","COVID-19; SARS-CoV-2; coronavirus; corticosteroids; therapy","Feldman","C","Department of Critical Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"512","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Feldman","Peter R","Arbor Life Labs, Toronto, Ontario, Canada",NA
"513","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Fiebig","Klaus M","Arbor Life Labs, Toronto, Ontario, Canada",NA
"514","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Piwko","Charles","CHP Pharma Inc, Thornhill, Ontario, Canada",NA
"515","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Mints","Boris M","B&amp",NA
"516","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Brown","Dennis","Valent Technologies, Menlo Park, California, USA",NA
"517","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Cahan","Deborah J","Arbor Life Labs, Toronto, Ontario, Canada",NA
"518","34235415","10.1016/j.eclinm.2021.100978","Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.","Scalp hair loss (alopecia) in women is a common ageing and senescing condition. It usually presents as androgenetic alopecia (AGA) or telogen effluvium (TE) and often has pronounced psychological consequences. ALRV5XR is a novel treatment aiming to regenerate a normal hair phenotype by targeting multiple molecular pathways linked to hair growth promotion and hair follicle stem cell activation. The primary objectives of this 24-week trial were to evaluate the safety and efficacy of ALRV5XR in ter","2021","07","09","EClinicalMedicine","EClinicalMedicine","Aging; Androgenetic alopecia; Botanical; COVID-19; Female pattern hair loss; Finasteride; Hair regeneration; Hair restoration; Menopause; Minoxidil; Multi-targeting; PRP; Regenerative medicine; Senescence; Stem cell; Telogen effluvium; Wnt/beta-catenin; Women's health","Guevara-Aguirre","Jaime","Universidad San Francisco de Quito (USFQ), Quito, Ecuador",NA
"519","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Salmanton-García","Jon","Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany",NA
"520","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Busca","Alessandro","Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy",NA
"521","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Cornely","Oliver A","Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany",NA
"522","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Corradini","Paolo","University of Milan &amp",NA
"523","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Hoenigl","Martin","Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, CA, USA",NA
"524","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Klimko","Nikolai","Department of Clinical Mycology, Allergy and Immunology, North Western State Medical University, St Petersburg, Russia",NA
"525","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Marchesi","Francesco","Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy",NA
"526","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Pagliuca","Antonio","Department of Hematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom",NA
"527","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Passamonti","Francesco","Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Italy",NA
"528","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Koehler","Philipp","Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, Germany",NA
"529","34235404","10.1097/HS9.0000000000000612","EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19.",NA,"2021","07","09","Hemasphere","HemaSphere",NA,"Pagano","Livio","Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy",NA
"530","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Gaitzsch","Erik","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"531","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Passerini","Verena","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"532","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Khatamzas","Elham","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"533","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Strobl","Carolin D","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"534","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Muenchhoff","Maximilian","Max von Pettenkofer Institute &amp",NA
"535","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Scherer","Clemens","COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU Munich, Germany",NA
"536","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Osterman","Andreas","Max von Pettenkofer Institute &amp",NA
"537","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Heide","Michael","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"538","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Reischer","Anna","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"539","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Subklewe","Marion","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"540","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Leutbecher","Alexandra","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"541","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Tast","Benjamin","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"542","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Ruhle","Adrian","German Center for Infection Research (DZIF), partner site Munich, Germany",NA
"543","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Weiglein","Tobias","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"544","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Stecher","Stephanie-Susanne","Department of Medicine II, University Hospital, LMU Munich, Germany",NA
"545","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Stemmler","Hans J","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"546","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Dreyling","Martin","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"547","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Girl","Philipp","Bundeswehr Institute of Microbiology, Munich, Germany",NA
"548","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Georgi","Enrico","Bundeswehr Institute of Microbiology, Munich, Germany",NA
"549","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Wölfel","Roman","Bundeswehr Institute of Microbiology, Munich, Germany",NA
"550","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Mateyka","Laura","Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Germany",NA
"551","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"D'Ippolito","Elvira","Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Germany",NA
"552","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Schober","Kilian","Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Germany",NA
"553","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Busch","Dirk H","Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Germany",NA
"554","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Kager","Juliane","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"555","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Spinner","Christoph D","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Munich, Germany",NA
"556","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Treiber","Matthias","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Munich, Germany",NA
"557","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Rasch","Sebastian","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"558","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Lahmer","Tobias","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"559","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Iakoubov","Roman","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"560","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Schneider","Jochen","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"561","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Protzer","Ulrike","German Center for Infection Research (DZIF), partner site Munich, Germany",NA
"562","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Winter","Christof","German Cancer Consortium (DKTK), Munich, Germany",NA
"563","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Ruland","Jürgen","German Cancer Consortium (DKTK), Munich, Germany",NA
"564","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Quante","Michael","Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany",NA
"565","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Keppler","Oliver T","Max von Pettenkofer Institute &amp",NA
"566","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"von Bergwelt-Baildon","Michael","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"567","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Hellmuth","Johannes","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"568","34235400","10.1097/HS9.0000000000000603","COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.","The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and chemotherapy for B-cell lymphomas. The control cohort consisted of age- and sex-matched patients without lymphoma who were hospitalized because of COVID-19. We performed detailed clinical analyses, in-depth cellular and molecular immune profiling, and","2021","07","09","Hemasphere","HemaSphere",NA,"Weigert","Oliver","Department of Medicine III, University Hospital, LMU Munich, Germany",NA
"569","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Marchetti","Marina","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"570","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Gomez-Rosas","Patricia","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"571","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Sanga","Eleonora","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"572","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Gamba","Sara","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"573","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Verzeroli","Cristina","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"574","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Russo","Laura","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"575","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Restuccia","Francesco","Department of Anesthesiology and Critical Care Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"576","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Schieppati","Francesca","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"577","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Bonanomi","Ezio","Department of Anesthesiology and Critical Care Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"578","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Rizzi","Marco","Unit of Infectious Diseases, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"579","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Fagiuoli","Stefano","Department of Internal Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"580","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","D'Alessio","Andrea","Department of Medical Oncology and Internal Medicine, Policlinico San Marco, Zingonia, Bergamo, Italy",NA
"581","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Lorini","Luca","Department of Anesthesiology and Critical Care Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"582","34235394","10.1055/s-0041-1731711","Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.","Introduction  Endothelial damage and hypercoagulability are major players behind the hemostatic derangement of SARS-CoV-2 infection. Aim  In this prospective study we assessed endothelial and inflammatory biomarkers in a cohort of COVID-19 patients, aiming to identify predictive factors of in-hospital mortality. Methods  COVID-19 patients hospitalized in intensive care (ICU) and non-ICU units at 2 Bergamo (Italy) hospitals from March 23 to May 30, 2020, were enrolled. Marker","2021","07","09","TH Open","TH open : companion journal to thrombosis and haemostasis","COVID-19; endothelium; hypercoagulation; von willebrand factor","Falanga","Anna","Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy",NA
"583","34235363","10.1089/heq.2021.0011","American Indians and Alaska Natives in the COVID-19 Pandemic: The Grave Burden We Stand to Bear.","The United States is bearing witness as a crisis-within-a-crisis unfolds across Indian Country, where a persistently underfunded system with inadequate resources and outdated facilities set the stage for coronavirus disease 2019 (COVID-19) to overwhelm Tribes. Now is the time to reimagine our way forward as a country beyond the pandemic. To address these issues, we recommend that (1) the federal government appropriately fund the Indian Health Service and work more closely with tribal governments","2021","07","09","Health Equity","Health equity","American Indian health; COVID-19; Indigenous health; Native American health; health inequities","Brodt","Erik","Department of Family Medicine and Oregon Health and Science University, Portland, Oregon, USA",NA
"584","34235363","10.1089/heq.2021.0011","American Indians and Alaska Natives in the COVID-19 Pandemic: The Grave Burden We Stand to Bear.","The United States is bearing witness as a crisis-within-a-crisis unfolds across Indian Country, where a persistently underfunded system with inadequate resources and outdated facilities set the stage for coronavirus disease 2019 (COVID-19) to overwhelm Tribes. Now is the time to reimagine our way forward as a country beyond the pandemic. To address these issues, we recommend that (1) the federal government appropriately fund the Indian Health Service and work more closely with tribal governments","2021","07","09","Health Equity","Health equity","American Indian health; COVID-19; Indigenous health; Native American health; health inequities","Empey","Allison","Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA",NA
"585","34235348","10.1097/pq9.0000000000000418","Quality Improvement Education in the Era of COVID-19: A Pivot Toward Virtual Education.",NA,"2021","07","09","Pediatr Qual Saf","Pediatric quality &amp; safety",NA,"Cronin","Jessica A","Division of Quality and Safety, Children's National Hospital, Washington, D",NA
"586","34235348","10.1097/pq9.0000000000000418","Quality Improvement Education in the Era of COVID-19: A Pivot Toward Virtual Education.",NA,"2021","07","09","Pediatr Qual Saf","Pediatric quality &amp; safety",NA,"Saha","Anit","Division of Quality and Safety, Children's National Hospital, Washington, D",NA
"587","34235348","10.1097/pq9.0000000000000418","Quality Improvement Education in the Era of COVID-19: A Pivot Toward Virtual Education.",NA,"2021","07","09","Pediatr Qual Saf","Pediatric quality &amp; safety",NA,"Bhattarai","Sopnil","Division of Quality and Safety, Children's National Hospital, Washington, D",NA
"588","34235348","10.1097/pq9.0000000000000418","Quality Improvement Education in the Era of COVID-19: A Pivot Toward Virtual Education.",NA,"2021","07","09","Pediatr Qual Saf","Pediatric quality &amp; safety",NA,"Fink","Alia","Division of Quality and Safety, Children's National Hospital, Washington, D",NA
"589","34235348","10.1097/pq9.0000000000000418","Quality Improvement Education in the Era of COVID-19: A Pivot Toward Virtual Education.",NA,"2021","07","09","Pediatr Qual Saf","Pediatric quality &amp; safety",NA,"Fahey","Lisbeth","Division of Quality and Safety, Children's National Hospital, Washington, D",NA
"590","34235348","10.1097/pq9.0000000000000418","Quality Improvement Education in the Era of COVID-19: A Pivot Toward Virtual Education.",NA,"2021","07","09","Pediatr Qual Saf","Pediatric quality &amp; safety",NA,"Shah","Rahul","Division of Quality and Safety, Children's National Hospital, Washington, D",NA
"591","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Niesor","Eric J","DalCor Pharmaceuticals, Montreal H3A 2R7, Canada",NA
"592","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Boivin","Guy","Centre Hospitalier Universitaire de Québec, Université Laval, Québec City G1V 0A6, Canada",NA
"593","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Rhéaume","Eric","Montreal Heart Institute, Université de Montréal, Montreal H1T 1C8, Canada",NA
"594","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Shi","Rong","Department of Biochemistry, Microbiology and Bioinformatics, Université Laval, Quebec G1V 0A6, Canada",NA
"595","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Lavoie","Véronique","Montreal Heart Institute, Université de Montréal, Montreal H1T 1C8, Canada",NA
"596","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Goyette","Nathalie","Centre Hospitalier Universitaire de Québec, Université Laval, Québec City G1V 0A6, Canada",NA
"597","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Picard","Marie-Eve","Department of Biochemistry, Microbiology and Bioinformatics, Université Laval, Quebec G1V 0A6, Canada",NA
"598","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Perez","Anne","Hartis-Pharma, Nyon 1260, Switzerland",NA
"599","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Laghrissi-Thode","Fouzia","DalCor Pharmaceuticals, Montreal H3A 2R7, Canada",NA
"600","34235330","10.1021/acsomega.1c01797","Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 3CL protease is a promising target for inhibition of viral replication by interaction with a cysteine residue (Cys145) at its catalytic site. Dalcetrapib exerts its lipid-modulating effect by binding covalently to cysteine 13 of a cholesteryl ester transfer protein. Because 12 free cysteine residues are present in the 3CL protease, we investigated the potential of dalcetrapib to inhibit 3CL protease activity and SARS-CoV-2 replicat","2021","07","09","ACS Omega","ACS omega",NA,"Tardif","Jean-Claude","Montreal Heart Institute, Université de Montréal, Montreal H1T 1C8, Canada",NA
"601","34235292","10.1016/j.chbr.2020.100029","Has the COVID-19 pandemic affected the susceptibility to cyberbullying in India?","Owing to the COVID-19 induced lockdown in India, most people's internet activity surged, leading to an expected increase in the rate of cybercrimes. This research focuses on analyzing whether the factors significant in cyberbullying susceptibility changed with the lockdown. The study was conducted by surveying 256 students before the pandemic, in October 2019, and 118 students during the lockdown, in June 2020. This included questions about the respondents' demographics, online presence, experie","2021","07","08","Comput Hum Behav Rep","Computers in human behavior reports","Coronavirus; Cyberbullying Susceptibility; Data Analysis; Statistical Inferences","Jain","Ojasvi","Narsee Monjee Institute of Management Studies, V. L, Pherozeshah Mehta Rd, Vile Parle, Mumbai, Maharashtra, 400056, India",NA
"602","34235292","10.1016/j.chbr.2020.100029","Has the COVID-19 pandemic affected the susceptibility to cyberbullying in India?","Owing to the COVID-19 induced lockdown in India, most people's internet activity surged, leading to an expected increase in the rate of cybercrimes. This research focuses on analyzing whether the factors significant in cyberbullying susceptibility changed with the lockdown. The study was conducted by surveying 256 students before the pandemic, in October 2019, and 118 students during the lockdown, in June 2020. This included questions about the respondents' demographics, online presence, experie","2021","07","08","Comput Hum Behav Rep","Computers in human behavior reports","Coronavirus; Cyberbullying Susceptibility; Data Analysis; Statistical Inferences","Gupta","Muskan","Narsee Monjee Institute of Management Studies, V. L, Pherozeshah Mehta Rd, Vile Parle, Mumbai, Maharashtra, 400056, India",NA
"603","34235292","10.1016/j.chbr.2020.100029","Has the COVID-19 pandemic affected the susceptibility to cyberbullying in India?","Owing to the COVID-19 induced lockdown in India, most people's internet activity surged, leading to an expected increase in the rate of cybercrimes. This research focuses on analyzing whether the factors significant in cyberbullying susceptibility changed with the lockdown. The study was conducted by surveying 256 students before the pandemic, in October 2019, and 118 students during the lockdown, in June 2020. This included questions about the respondents' demographics, online presence, experie","2021","07","08","Comput Hum Behav Rep","Computers in human behavior reports","Coronavirus; Cyberbullying Susceptibility; Data Analysis; Statistical Inferences","Satam","Sidh","Narsee Monjee Institute of Management Studies, V. L, Pherozeshah Mehta Rd, Vile Parle, Mumbai, Maharashtra, 400056, India",NA
"604","34235292","10.1016/j.chbr.2020.100029","Has the COVID-19 pandemic affected the susceptibility to cyberbullying in India?","Owing to the COVID-19 induced lockdown in India, most people's internet activity surged, leading to an expected increase in the rate of cybercrimes. This research focuses on analyzing whether the factors significant in cyberbullying susceptibility changed with the lockdown. The study was conducted by surveying 256 students before the pandemic, in October 2019, and 118 students during the lockdown, in June 2020. This included questions about the respondents' demographics, online presence, experie","2021","07","08","Comput Hum Behav Rep","Computers in human behavior reports","Coronavirus; Cyberbullying Susceptibility; Data Analysis; Statistical Inferences","Panda","Siba","Narsee Monjee Institute of Management Studies, V. L, Pherozeshah Mehta Rd, Vile Parle, Mumbai, Maharashtra, 400056, India",NA
"605","34235277","10.1016/j.jctube.2021.100259","Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).","The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.","2021","07","09","J Clin Tuberc Other Mycobact Dis","Journal of clinical tuberculosis and other mycobacterial diseases","Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis","Starshinova","A","Almazov National Medical Research Centre, Saint Petersburg, Russia",NA
"606","34235277","10.1016/j.jctube.2021.100259","Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).","The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.","2021","07","09","J Clin Tuberc Other Mycobact Dis","Journal of clinical tuberculosis and other mycobacterial diseases","Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis","Guglielmetti","L","APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, F-75013 Paris, France",NA
"607","34235277","10.1016/j.jctube.2021.100259","Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).","The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.","2021","07","09","J Clin Tuberc Other Mycobact Dis","Journal of clinical tuberculosis and other mycobacterial diseases","Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis","Rzhepishevska","O","Umeå University, Umeå, Sweden",NA
"608","34235277","10.1016/j.jctube.2021.100259","Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).","The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.","2021","07","09","J Clin Tuberc Other Mycobact Dis","Journal of clinical tuberculosis and other mycobacterial diseases","Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis","Ekaterincheva","O","St. Petersburg Tuberculosis Hospital No. 2, Saint Petersburg, Russia",NA
"609","34235277","10.1016/j.jctube.2021.100259","Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).","The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.","2021","07","09","J Clin Tuberc Other Mycobact Dis","Journal of clinical tuberculosis and other mycobacterial diseases","Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis","Zinchenko","Yu","St. Petersburg Research Institute of Phthisiopulmonology, Russia",NA
"610","34235277","10.1016/j.jctube.2021.100259","Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).","The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.","2021","07","09","J Clin Tuberc Other Mycobact Dis","Journal of clinical tuberculosis and other mycobacterial diseases","Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis","Kudlay","D","I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"611","34235275","10.12688/wellcomeopenres.16849.1","Vaccine-enhanced disease: case studies and ethical implications for research and public health.","Vaccination is a cornerstone of global public health. Although licensed vaccines are generally extremely safe, both experimental and licensed vaccines are sometimes associated with rare serious adverse events. Vaccine-enhanced disease (VED) is a type of adverse event in which disease severity is increased when a person who has received the vaccine is later infected with the relevant pathogen. VED can occur during research with experimental vaccines and/or after vaccine licensure, sometimes month","2021","07","09","Wellcome Open Res","Wellcome open research","Staphylococcus aureus.; Vaccine; dengue; ethics; measles; respiratory syncytial virus; risk; uncertainty","Jamrozik","Euzebiusz","The Ethox Centre &amp",NA
"612","34235275","10.12688/wellcomeopenres.16849.1","Vaccine-enhanced disease: case studies and ethical implications for research and public health.","Vaccination is a cornerstone of global public health. Although licensed vaccines are generally extremely safe, both experimental and licensed vaccines are sometimes associated with rare serious adverse events. Vaccine-enhanced disease (VED) is a type of adverse event in which disease severity is increased when a person who has received the vaccine is later infected with the relevant pathogen. VED can occur during research with experimental vaccines and/or after vaccine licensure, sometimes month","2021","07","09","Wellcome Open Res","Wellcome open research","Staphylococcus aureus.; Vaccine; dengue; ethics; measles; respiratory syncytial virus; risk; uncertainty","Heriot","George","Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia",NA
"613","34235275","10.12688/wellcomeopenres.16849.1","Vaccine-enhanced disease: case studies and ethical implications for research and public health.","Vaccination is a cornerstone of global public health. Although licensed vaccines are generally extremely safe, both experimental and licensed vaccines are sometimes associated with rare serious adverse events. Vaccine-enhanced disease (VED) is a type of adverse event in which disease severity is increased when a person who has received the vaccine is later infected with the relevant pathogen. VED can occur during research with experimental vaccines and/or after vaccine licensure, sometimes month","2021","07","09","Wellcome Open Res","Wellcome open research","Staphylococcus aureus.; Vaccine; dengue; ethics; measles; respiratory syncytial virus; risk; uncertainty","Bull","Susan","The Ethox Centre &amp",NA
"614","34235275","10.12688/wellcomeopenres.16849.1","Vaccine-enhanced disease: case studies and ethical implications for research and public health.","Vaccination is a cornerstone of global public health. Although licensed vaccines are generally extremely safe, both experimental and licensed vaccines are sometimes associated with rare serious adverse events. Vaccine-enhanced disease (VED) is a type of adverse event in which disease severity is increased when a person who has received the vaccine is later infected with the relevant pathogen. VED can occur during research with experimental vaccines and/or after vaccine licensure, sometimes month","2021","07","09","Wellcome Open Res","Wellcome open research","Staphylococcus aureus.; Vaccine; dengue; ethics; measles; respiratory syncytial virus; risk; uncertainty","Parker","Michael","The Ethox Centre &amp",NA
"615","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Liu","Lin","Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, 30602 Athens, Georgia, United States",NA
"616","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Chopra","Pradeep","Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, 30602 Athens, Georgia, United States",NA
"617","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Li","Xiuru","Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, 30602 Athens, Georgia, United States",NA
"618","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Bouwman","Kim M","Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands",NA
"619","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Tompkins","S Mark","Center for Vaccines and Immunology, University of Georgia, 30602 Athens, Georgia, United States",NA
"620","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Wolfert","Margreet A","Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, 30602 Athens, Georgia, United States",NA
"621","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"de Vries","Robert P","Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands",NA
"622","34235261","10.1021/acscentsci.1c00010","Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.","Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is causing an unprecedented global pandemic demanding the urgent development of therapeutic strategies. Microarray binding experiments, using an extensive heparan sulfate (HS) oligosaccharide library, showed that the receptor binding domain (RBD) of the spike of SARS-CoV-2 can bind HS in a length- and sequence-dependent manner. A hexasaccharide composed of IdoA2S-GlcNS6S repeating units was identified as the minimal binding epi","2021","07","13","ACS Cent Sci","ACS central science",NA,"Boons","Geert-Jan","Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, 30602 Athens, Georgia, United States",NA
"623","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Ibrahim","Wadah","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"624","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Cordell","Rebecca L","School of Chemistry, University of Leicester, Leicester, UK",NA
"625","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Wilde","Michael J","School of Chemistry, University of Leicester, Leicester, UK",NA
"626","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Richardson","Matthew","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"627","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Carr","Liesl","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"628","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Sundari Devi Dasi","Ananga","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"629","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Hargadon","Beverley","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"630","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Free","Robert C","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"631","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Monks","Paul S","School of Chemistry, University of Leicester, Leicester, UK",NA
"632","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Brightling","Christopher E","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"633","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Greening","Neil J","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"634","34235208","10.1183/23120541.00139-2021","Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.","The ongoing coronavirus disease 2019 (COVID-19) pandemic has claimed over two and a half million lives worldwide so far. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is perceived to be seasonally recurrent, and a rapid noninvasive biomarker to accurately diagnose patients early on in their disease course will be necessary to meet the operational demands for COVID-19 control in the coming years. The aim of this study was to evaluate the role of exhaled breath volatile bi","2021","07","09","ERJ Open Res","ERJ open research",NA,"Siddiqui","Salman","Dept of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"635","34235201","10.3389/fvets.2021.669712","COVID Sniffer Dogs: Technical and Ethical Concerns.",NA,"2021","07","09","Front Vet Sci","Frontiers in veterinary science","COVID-19; SARS-CoV-2; detection dogs; dogs; volatile organic compounds","D'Aniello","Biagio","Department of Biology, University of Naples Federico II, Naples, Italy",NA
"636","34235201","10.3389/fvets.2021.669712","COVID Sniffer Dogs: Technical and Ethical Concerns.",NA,"2021","07","09","Front Vet Sci","Frontiers in veterinary science","COVID-19; SARS-CoV-2; detection dogs; dogs; volatile organic compounds","Pinelli","Claudia","Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania ""L. Vanvitelli"", Caserta, Italy",NA
"637","34235201","10.3389/fvets.2021.669712","COVID Sniffer Dogs: Technical and Ethical Concerns.",NA,"2021","07","09","Front Vet Sci","Frontiers in veterinary science","COVID-19; SARS-CoV-2; detection dogs; dogs; volatile organic compounds","Varcamonti","Mario","Department of Biology, University of Naples Federico II, Naples, Italy",NA
"638","34235201","10.3389/fvets.2021.669712","COVID Sniffer Dogs: Technical and Ethical Concerns.",NA,"2021","07","09","Front Vet Sci","Frontiers in veterinary science","COVID-19; SARS-CoV-2; detection dogs; dogs; volatile organic compounds","Rendine","Marcello","Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy",NA
"639","34235201","10.3389/fvets.2021.669712","COVID Sniffer Dogs: Technical and Ethical Concerns.",NA,"2021","07","09","Front Vet Sci","Frontiers in veterinary science","COVID-19; SARS-CoV-2; detection dogs; dogs; volatile organic compounds","Lombardi","Pietro","Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy",NA
"640","34235201","10.3389/fvets.2021.669712","COVID Sniffer Dogs: Technical and Ethical Concerns.",NA,"2021","07","09","Front Vet Sci","Frontiers in veterinary science","COVID-19; SARS-CoV-2; detection dogs; dogs; volatile organic compounds","Scandurra","Anna","Department of Biology, University of Naples Federico II, Naples, Italy",NA
"641","34235176","10.3389/fmolb.2021.620806","Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2.","Human-derived antimicrobial peptides (AMPs), such as defensins and cathelicidin LL-37, are members of the innate immune system and play a crucial role in early pulmonary defense against viruses. These AMPs achieve viral inhibition through a variety of mechanisms including, but not limited to, direct binding to virions, binding to and modulating host cell-surface receptors, blocking viral replication, and aggregation of viral particles and indirectly by functioning as chemokines to enhance or cur","2021","07","09","Front Mol Biosci","Frontiers in molecular biosciences","COVID-19; LL-37; MSCs; antimicrobial peptides (AMPs); coronavirus; defensins; vitamin D3","Ghosh","Santosh K","Department of Biological Sciences, Case Western Reserve University, Cleveland, OH, United States",NA
"642","34235176","10.3389/fmolb.2021.620806","Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2.","Human-derived antimicrobial peptides (AMPs), such as defensins and cathelicidin LL-37, are members of the innate immune system and play a crucial role in early pulmonary defense against viruses. These AMPs achieve viral inhibition through a variety of mechanisms including, but not limited to, direct binding to virions, binding to and modulating host cell-surface receptors, blocking viral replication, and aggregation of viral particles and indirectly by functioning as chemokines to enhance or cur","2021","07","09","Front Mol Biosci","Frontiers in molecular biosciences","COVID-19; LL-37; MSCs; antimicrobial peptides (AMPs); coronavirus; defensins; vitamin D3","Weinberg","Aaron","Department of Biological Sciences, Case Western Reserve University, Cleveland, OH, United States",NA
"643","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Belkora","Jeffrey","Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, United States",NA
"644","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Weinberg","Tia","Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, United States",NA
"645","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Murphy","Jasper","University of California, Berkeley, Berkeley, CA, United States",NA
"646","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Karthikeyan","Sneha","University of California, Berkeley, Berkeley, CA, United States",NA
"647","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Tran","Henrietta","Office of Population Health and Accountable Care, University of California, San Francisco, San Francisco, CA, United States",NA
"648","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Toliver","Tasha","Office of Population Health and Accountable Care, University of California, San Francisco, San Francisco, CA, United States",NA
"649","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Lopez","Freddie","Office of Population Health and Accountable Care, University of California, San Francisco, San Francisco, CA, United States",NA
"650","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Tominaga","Grant","Office of Population Health and Accountable Care, University of California, San Francisco, San Francisco, CA, United States",NA
"651","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Helle","Michael","Office of Population Health and Accountable Care, University of California, San Francisco, San Francisco, CA, United States",NA
"652","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Intinarelli","Gina","Office of Population Health and Accountable Care, University of California, San Francisco, San Francisco, CA, United States",NA
"653","34235134","10.3389/fpubh.2021.697515","Extending the Population Health Workforce Through Service Learning Internships During COVID: A Community Case Study.","This report arises from the intersection of service learning and population health at an academic medical center. At the University of California, San Francisco (UCSF), the Office of Population Health and Accountable Care (OPHAC) employs health care navigators to help patients access and benefit from high-value care. In early 2020, facing COVID-19, UCSF leaders asked OPHAC to help patients and employees navigate testing, treatment, tracing, and returning to work protocols. OPHAC established a CO","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; internship; navigation; population health; service learning; telehealth; undergraduate; workforce innovation; COVID-19; Humans; Internship and Residency; Population Health; SARS-CoV-2; San Francisco; Workforce","Adler","Joshua","UCSF Health, University of California, San Francisco, San Francisco, CA, United States",NA
"654","34235131","10.3389/fpubh.2021.675766","Identification of Variable Importance for Predictions of Mortality From COVID-19 Using AI Models for Ontario, Canada.","The Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has challenged medical systems to the brink of collapse around the globe. In this paper, logistic regression and three other artificial intelligence models (XGBoost, Artificial Neural Network and Random Forest) are described and used to predict mortality risk of individual patients. The database is based on census data for the designated area and co-morbidities obtained using data from the Ontario Health Data Platform. The dataset cons","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; SHapley; XGBoost; artificial intelligence; mortality; Artificial Intelligence; COVID-19; Humans; Ontario; Pandemics; SARS-CoV-2","Snider","Brett","School of Engineering, University of Guelph, Guelph, ON, Canada",NA
"655","34235131","10.3389/fpubh.2021.675766","Identification of Variable Importance for Predictions of Mortality From COVID-19 Using AI Models for Ontario, Canada.","The Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has challenged medical systems to the brink of collapse around the globe. In this paper, logistic regression and three other artificial intelligence models (XGBoost, Artificial Neural Network and Random Forest) are described and used to predict mortality risk of individual patients. The database is based on census data for the designated area and co-morbidities obtained using data from the Ontario Health Data Platform. The dataset cons","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; SHapley; XGBoost; artificial intelligence; mortality; Artificial Intelligence; COVID-19; Humans; Ontario; Pandemics; SARS-CoV-2","McBean","Edward A","School of Engineering, University of Guelph, Guelph, ON, Canada",NA
"656","34235131","10.3389/fpubh.2021.675766","Identification of Variable Importance for Predictions of Mortality From COVID-19 Using AI Models for Ontario, Canada.","The Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has challenged medical systems to the brink of collapse around the globe. In this paper, logistic regression and three other artificial intelligence models (XGBoost, Artificial Neural Network and Random Forest) are described and used to predict mortality risk of individual patients. The database is based on census data for the designated area and co-morbidities obtained using data from the Ontario Health Data Platform. The dataset cons","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; SHapley; XGBoost; artificial intelligence; mortality; Artificial Intelligence; COVID-19; Humans; Ontario; Pandemics; SARS-CoV-2","Yawney","John","Adastra Corporation, Toronto, ON, Canada",NA
"657","34235131","10.3389/fpubh.2021.675766","Identification of Variable Importance for Predictions of Mortality From COVID-19 Using AI Models for Ontario, Canada.","The Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has challenged medical systems to the brink of collapse around the globe. In this paper, logistic regression and three other artificial intelligence models (XGBoost, Artificial Neural Network and Random Forest) are described and used to predict mortality risk of individual patients. The database is based on census data for the designated area and co-morbidities obtained using data from the Ontario Health Data Platform. The dataset cons","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; SHapley; XGBoost; artificial intelligence; mortality; Artificial Intelligence; COVID-19; Humans; Ontario; Pandemics; SARS-CoV-2","Gadsden","S Andrew","School of Engineering, University of Guelph, Guelph, ON, Canada",NA
"658","34235131","10.3389/fpubh.2021.675766","Identification of Variable Importance for Predictions of Mortality From COVID-19 Using AI Models for Ontario, Canada.","The Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has challenged medical systems to the brink of collapse around the globe. In this paper, logistic regression and three other artificial intelligence models (XGBoost, Artificial Neural Network and Random Forest) are described and used to predict mortality risk of individual patients. The database is based on census data for the designated area and co-morbidities obtained using data from the Ontario Health Data Platform. The dataset cons","2021","07","13","Front Public Health","Frontiers in public health","COVID-19; SHapley; XGBoost; artificial intelligence; mortality; Artificial Intelligence; COVID-19; Humans; Ontario; Pandemics; SARS-CoV-2","Patel","Bhumi","School of Engineering, University of Guelph, Guelph, ON, Canada",NA
"659","34235043","10.1097/GOX.0000000000003710","Perception of Cosmetic Procedures among Saudis during COVID-19 Pandemic.","A novel coronavirus disease (COVID-19) was first reported in December 2019 in Wuhan, China. The fast spread of the virus has led to a significant reduction in the numbers of elective procedures especially cosmetic interventions. Although many measures have been carried out to offload the health care system, it is unclear whether these changes had an effect on general population perception toward undergoing cosmetic procedures. The aim of this study was to assess the perception of Saudis toward u","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Alhujayri","Abdulaziz K","Plastic Surgery Division, Department of Surgery, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia",NA
"660","34235043","10.1097/GOX.0000000000003710","Perception of Cosmetic Procedures among Saudis during COVID-19 Pandemic.","A novel coronavirus disease (COVID-19) was first reported in December 2019 in Wuhan, China. The fast spread of the virus has led to a significant reduction in the numbers of elective procedures especially cosmetic interventions. Although many measures have been carried out to offload the health care system, it is unclear whether these changes had an effect on general population perception toward undergoing cosmetic procedures. The aim of this study was to assess the perception of Saudis toward u","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Alyousef","Loujain A","King Abdullah International Medical Research Center, Riyadh, Saudi Arabia",NA
"661","34235043","10.1097/GOX.0000000000003710","Perception of Cosmetic Procedures among Saudis during COVID-19 Pandemic.","A novel coronavirus disease (COVID-19) was first reported in December 2019 in Wuhan, China. The fast spread of the virus has led to a significant reduction in the numbers of elective procedures especially cosmetic interventions. Although many measures have been carried out to offload the health care system, it is unclear whether these changes had an effect on general population perception toward undergoing cosmetic procedures. The aim of this study was to assess the perception of Saudis toward u","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Alharthi","Sawsan A","King Abdullah International Medical Research Center, Riyadh, Saudi Arabia",NA
"662","34235043","10.1097/GOX.0000000000003710","Perception of Cosmetic Procedures among Saudis during COVID-19 Pandemic.","A novel coronavirus disease (COVID-19) was first reported in December 2019 in Wuhan, China. The fast spread of the virus has led to a significant reduction in the numbers of elective procedures especially cosmetic interventions. Although many measures have been carried out to offload the health care system, it is unclear whether these changes had an effect on general population perception toward undergoing cosmetic procedures. The aim of this study was to assess the perception of Saudis toward u","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Aldekhayel","Salah","Plastic Surgery Division, Department of Surgery, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia",NA
"663","34235042","10.1097/GOX.0000000000003692","Cleft Lip and Palate Surgery during COVID-19 Pandemic.","The COVID-19 pandemic has caused a negative impact in every sector of life, especially in the health sector. Patients with different medical conditions are suffering delays in their surgical treatments. Cleft lip and palate is a common congenital disease that requires early interdisciplinary attention, and there is uncertainty about the safety of performing its surgical treatment during the COVID-19 pandemic. The objective of this study was to evaluate the safety of a surgical cleft protocol for","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Rossell-Perry","Percy","Post Graduate Studies, Faculty of Medicine, San Martin de Porres University, Lima, Peru",NA
"664","34235042","10.1097/GOX.0000000000003692","Cleft Lip and Palate Surgery during COVID-19 Pandemic.","The COVID-19 pandemic has caused a negative impact in every sector of life, especially in the health sector. Patients with different medical conditions are suffering delays in their surgical treatments. Cleft lip and palate is a common congenital disease that requires early interdisciplinary attention, and there is uncertainty about the safety of performing its surgical treatment during the COVID-19 pandemic. The objective of this study was to evaluate the safety of a surgical cleft protocol for","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Gavino-Gutierrez","Arquimedes","Post Graduate Studies, Faculty of Medicine, San Martin de Porres University, Lima, Peru",NA
"665","34235041","10.1097/GOX.0000000000003691","Reconstructive Microsurgery in the COVID-19 Environment.","The COVID-19 pandemic has presented unique challenges to the plastic surgery field. Substantial changes have been incorporated in hospital and practice protocols in all branches of medicine. Organic medical teams were placed on scheduled shifts to prevent cross-infection, and some working teams were discontinued. Remote technology consultations and deliberations were instituted in hospitals and community medical services to maintain the flow of information on patient status. Several mitigation s","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Shachar","Tal","Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel",NA
"666","34235041","10.1097/GOX.0000000000003691","Reconstructive Microsurgery in the COVID-19 Environment.","The COVID-19 pandemic has presented unique challenges to the plastic surgery field. Substantial changes have been incorporated in hospital and practice protocols in all branches of medicine. Organic medical teams were placed on scheduled shifts to prevent cross-infection, and some working teams were discontinued. Remote technology consultations and deliberations were instituted in hospitals and community medical services to maintain the flow of information on patient status. Several mitigation s","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Yaacobi","Dafna Shilo","Department of Plastic Surgery and Burns, Rabin Medical Center - Beilinson Hospital, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"667","34235041","10.1097/GOX.0000000000003691","Reconstructive Microsurgery in the COVID-19 Environment.","The COVID-19 pandemic has presented unique challenges to the plastic surgery field. Substantial changes have been incorporated in hospital and practice protocols in all branches of medicine. Organic medical teams were placed on scheduled shifts to prevent cross-infection, and some working teams were discontinued. Remote technology consultations and deliberations were instituted in hospitals and community medical services to maintain the flow of information on patient status. Several mitigation s","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Cohen","Keren","Department of Plastic Surgery and Burns, Rabin Medical Center - Beilinson Hospital, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"668","34235041","10.1097/GOX.0000000000003691","Reconstructive Microsurgery in the COVID-19 Environment.","The COVID-19 pandemic has presented unique challenges to the plastic surgery field. Substantial changes have been incorporated in hospital and practice protocols in all branches of medicine. Organic medical teams were placed on scheduled shifts to prevent cross-infection, and some working teams were discontinued. Remote technology consultations and deliberations were instituted in hospitals and community medical services to maintain the flow of information on patient status. Several mitigation s","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Olshinka","Asaf","Department of Plastic Surgery and Burns, Rabin Medical Center - Beilinson Hospital, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"669","34235041","10.1097/GOX.0000000000003691","Reconstructive Microsurgery in the COVID-19 Environment.","The COVID-19 pandemic has presented unique challenges to the plastic surgery field. Substantial changes have been incorporated in hospital and practice protocols in all branches of medicine. Organic medical teams were placed on scheduled shifts to prevent cross-infection, and some working teams were discontinued. Remote technology consultations and deliberations were instituted in hospitals and community medical services to maintain the flow of information on patient status. Several mitigation s","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Ad-El","Dean D","Department of Plastic Surgery and Burns, Rabin Medical Center - Beilinson Hospital, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"670","34235040","10.1097/GOX.0000000000003676","Effect of COVID-19 on Geographic Distribution of the Integrated Plastic Surgery Match.","COVID-19 had significant impact on the 2021 integrated plastic surgery match, most notably through cancellation of away rotations and virtual interviews. While previous studies have analyzed geographic outcomes of the match in prior years, the effects of COVID-19 have not been determined. This study aims to contribute 2021 match data to determine the effects of COVID-19 on the geographic distribution of the integrated plastic surgery match. Official match results for each program were populated ","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Om","Anjali","Emory University School of Medicine. Division of Plastic and Reconstructive Surgery, Atlanta, Ga",NA
"671","34235040","10.1097/GOX.0000000000003676","Effect of COVID-19 on Geographic Distribution of the Integrated Plastic Surgery Match.","COVID-19 had significant impact on the 2021 integrated plastic surgery match, most notably through cancellation of away rotations and virtual interviews. While previous studies have analyzed geographic outcomes of the match in prior years, the effects of COVID-19 have not been determined. This study aims to contribute 2021 match data to determine the effects of COVID-19 on the geographic distribution of the integrated plastic surgery match. Official match results for each program were populated ","2021","07","09","Plast Reconstr Surg Glob Open","Plastic and reconstructive surgery. Global open",NA,"Losken","Albert","Emory University School of Medicine. Division of Plastic and Reconstructive Surgery, Atlanta, Ga",NA
"672","34235030","10.7759/cureus.16045","Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19).","Since the emergence of the coronavirus disease pandemic, several effective vaccines have been introduced. These vaccines work through several different immunogenic pathways to produce effective immunity. There have been a number of reports of patients developing subacute thyroiditis and thyroid dysfunction after receiving the coronavirus (COVID-19) vaccine. This paper presents a case of a female patient who developed subacute thyroiditis soon after receiving the adenovirus-vectored COVID-19 vacc","2021","07","09","Cureus","Cureus","adenovirus-vector; coronavirus vaccine; covid 19; overt hypothyroidism; subacute thyroiditis","Oyibo","Samson O","Diabetes and Endocrinology, Peterborough City Hospital, Peterborough, GBR",NA
"673","34235025","10.7759/cureus.15348","Can We Routinely Employ the Use of Low-Pressure Gynaecological Laparoscopy? A Systematic Review.","Clinicians have learnt valuable lessons throughout the COV-SARS-2 pandemic, many of which have produced solutions that we aim to continue to implement within the foreseeable future. Optimising patients' surgical pathways to reduce the length of stay and complications is an area of particular importance, both for maximal utilisation of available resources and for reduction of the exposure of inpatient and elective patients to an increased risk of infection within healthcare facilities. The aim of","2021","07","09","Cureus","Cureus","gynae; low-pressure; minimally invasive laparoscopy; pneumoperitoneum; postoperative pain","Hamer","Jack","Obstetrics and Gynaecology, Russells Hall Hospital, The Dudley Group National Health Service (NHS) Foundation Trust, Dudley, GBR",NA
"674","34235025","10.7759/cureus.15348","Can We Routinely Employ the Use of Low-Pressure Gynaecological Laparoscopy? A Systematic Review.","Clinicians have learnt valuable lessons throughout the COV-SARS-2 pandemic, many of which have produced solutions that we aim to continue to implement within the foreseeable future. Optimising patients' surgical pathways to reduce the length of stay and complications is an area of particular importance, both for maximal utilisation of available resources and for reduction of the exposure of inpatient and elective patients to an increased risk of infection within healthcare facilities. The aim of","2021","07","09","Cureus","Cureus","gynae; low-pressure; minimally invasive laparoscopy; pneumoperitoneum; postoperative pain","Jones","Edward","Anaesthesiology, Russells Hall Hospital, The Dudley Group National Health Service (NHS) Foundation Trust, Dudley, GBR",NA
"675","34235025","10.7759/cureus.15348","Can We Routinely Employ the Use of Low-Pressure Gynaecological Laparoscopy? A Systematic Review.","Clinicians have learnt valuable lessons throughout the COV-SARS-2 pandemic, many of which have produced solutions that we aim to continue to implement within the foreseeable future. Optimising patients' surgical pathways to reduce the length of stay and complications is an area of particular importance, both for maximal utilisation of available resources and for reduction of the exposure of inpatient and elective patients to an increased risk of infection within healthcare facilities. The aim of","2021","07","09","Cureus","Cureus","gynae; low-pressure; minimally invasive laparoscopy; pneumoperitoneum; postoperative pain","Chan","Amy","Obstetrics and Gynaecology, Russells Hall Hospital, The Dudley Group National Health Service (NHS) Foundation Trust, Dudley, GBR",NA
"676","34235025","10.7759/cureus.15348","Can We Routinely Employ the Use of Low-Pressure Gynaecological Laparoscopy? A Systematic Review.","Clinicians have learnt valuable lessons throughout the COV-SARS-2 pandemic, many of which have produced solutions that we aim to continue to implement within the foreseeable future. Optimising patients' surgical pathways to reduce the length of stay and complications is an area of particular importance, both for maximal utilisation of available resources and for reduction of the exposure of inpatient and elective patients to an increased risk of infection within healthcare facilities. The aim of","2021","07","09","Cureus","Cureus","gynae; low-pressure; minimally invasive laparoscopy; pneumoperitoneum; postoperative pain","Tahmasebi","Farshad","Obstetrics and Gynaecology, Russells Hall Hospital, The Dudley Group National Health Service (NHS) Foundation Trust, Dudley, GBR",NA
"677","34235005","10.1109/JTEHM.2021.3077142","Automated Diagnosis of COVID-19 Using Deep Features and Parameter Free BAT Optimization.","Background: Accurate and fast diagnosis of COVID-19 is very important to manage the medical conditions of affected persons. The task is challenging owing to shortage and ineffectiveness of clinical testing kits. However, the existing problems can be improved by employing computational intelligent techniques on radiological images like CT-Scans (Computed Tomography) of lungs. Extensive research has been reported using deep learning models to diagnose the severity of COVID-19 from CT images","2021","07","16","IEEE J Transl Eng Health Med","IEEE journal of translational engineering in health and medicine","COVID-19; deep features; diagnosis; parameter free BAT optimization; Algorithms; COVID-19; Deep Learning; Female; Humans; Image Interpretation, Computer-Assisted; Lung; Male; SARS-CoV-2; Tomography, X-Ray Computed","Kaur","Taranjit","Department of Electrical EngineeringIndian Institute of Technology Delhi (IIT Delhi)New Delhi110016India",NA
"678","34235005","10.1109/JTEHM.2021.3077142","Automated Diagnosis of COVID-19 Using Deep Features and Parameter Free BAT Optimization.","Background: Accurate and fast diagnosis of COVID-19 is very important to manage the medical conditions of affected persons. The task is challenging owing to shortage and ineffectiveness of clinical testing kits. However, the existing problems can be improved by employing computational intelligent techniques on radiological images like CT-Scans (Computed Tomography) of lungs. Extensive research has been reported using deep learning models to diagnose the severity of COVID-19 from CT images","2021","07","16","IEEE J Transl Eng Health Med","IEEE journal of translational engineering in health and medicine","COVID-19; deep features; diagnosis; parameter free BAT optimization; Algorithms; COVID-19; Deep Learning; Female; Humans; Image Interpretation, Computer-Assisted; Lung; Male; SARS-CoV-2; Tomography, X-Ray Computed","Gandhi","Tapan K","Department of Electrical EngineeringIndian Institute of Technology Delhi (IIT Delhi)New Delhi110016India",NA
"679","34235005","10.1109/JTEHM.2021.3077142","Automated Diagnosis of COVID-19 Using Deep Features and Parameter Free BAT Optimization.","Background: Accurate and fast diagnosis of COVID-19 is very important to manage the medical conditions of affected persons. The task is challenging owing to shortage and ineffectiveness of clinical testing kits. However, the existing problems can be improved by employing computational intelligent techniques on radiological images like CT-Scans (Computed Tomography) of lungs. Extensive research has been reported using deep learning models to diagnose the severity of COVID-19 from CT images","2021","07","16","IEEE J Transl Eng Health Med","IEEE journal of translational engineering in health and medicine","COVID-19; deep features; diagnosis; parameter free BAT optimization; Algorithms; COVID-19; Deep Learning; Female; Humans; Image Interpretation, Computer-Assisted; Lung; Male; SARS-CoV-2; Tomography, X-Ray Computed","Panigrahi","Bijaya K","Department of Electrical EngineeringIndian Institute of Technology Delhi (IIT Delhi)New Delhi110016India",NA
"680","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Beaudoin","Christopher A","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"681","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Jamasb","Arian R","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"682","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Alsulami","Ali F","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"683","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Copoiu","Liviu","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"684","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","van Tonder","Andries J","Department of Veterinary Medicine, University of Cambridge, Madingley Rd, Cambridge CB3 0ES, United Kingdom",NA
"685","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Hala","Sharif","King Abdullah International Medical Research Centre - Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia",NA
"686","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Bannerman","Bridget P","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"687","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Thomas","Sherine E","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"688","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Vedithi","Sundeep Chaitanya","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"689","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Torres","Pedro H M","Laboratório de Modelagem e Dinâmica Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil",NA
"690","34234921","10.1016/j.csbj.2021.06.041","Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses.","Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs, which could be important in determining tropism and druggability of the virus. Peptide and epitope motifs have been detected on coronavirus spike proteins using sequence homology approaches; however, comparing the three-dimensional shape of the prot","2021","07","17","Comput Struct Biotechnol J","Computational and structural biotechnology journal","COVID-19; Coronavirus spike protein; Infectious disease; MERS-CoV; SARS-CoV; SARS-CoV-2; Structural bioinformatics; Viral host mimicry","Blundell","Tom L","Department of Biochemistry, Sanger Building, University of Cambridge, Tennis Court Rd, Cambridge CB2 1GA, United Kingdom",NA
"691","34234900","10.1080/20009666.2021.1893506","Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association.","Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is associated with a hypercoagulable state leading to increased incidence of thromboembolism. However, it is exceedingly rare to see presence of both arterial and venous thromboembolism simultaneously. Herein, we report an unusual presentation of a 39-year-old male with recently diagnosed COVID -19 who initially had acute myocardial infarction secondary to thrombotic occlusion of right coronary artery f","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus disease-2019; acute myocardial infarction; acute pulmonary embolism; thromboembolism","Randhawa","Preet","Department of Cardiology, St Michael's Medical Center, Newark, NJ, USA",NA
"692","34234900","10.1080/20009666.2021.1893506","Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association.","Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is associated with a hypercoagulable state leading to increased incidence of thromboembolism. However, it is exceedingly rare to see presence of both arterial and venous thromboembolism simultaneously. Herein, we report an unusual presentation of a 39-year-old male with recently diagnosed COVID -19 who initially had acute myocardial infarction secondary to thrombotic occlusion of right coronary artery f","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus disease-2019; acute myocardial infarction; acute pulmonary embolism; thromboembolism","Singh","Parminder P","Department of Cardiology, The University of Arizona Scholl of Medicine, Phoenix, AZ, USA",NA
"693","34234900","10.1080/20009666.2021.1893506","Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association.","Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is associated with a hypercoagulable state leading to increased incidence of thromboembolism. However, it is exceedingly rare to see presence of both arterial and venous thromboembolism simultaneously. Herein, we report an unusual presentation of a 39-year-old male with recently diagnosed COVID -19 who initially had acute myocardial infarction secondary to thrombotic occlusion of right coronary artery f","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus disease-2019; acute myocardial infarction; acute pulmonary embolism; thromboembolism","Guragai","Nirmal","Department of Cardiology, St Joseph Regional Medical Center, Paterson, NJ, USA",NA
"694","34234900","10.1080/20009666.2021.1893506","Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association.","Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is associated with a hypercoagulable state leading to increased incidence of thromboembolism. However, it is exceedingly rare to see presence of both arterial and venous thromboembolism simultaneously. Herein, we report an unusual presentation of a 39-year-old male with recently diagnosed COVID -19 who initially had acute myocardial infarction secondary to thrombotic occlusion of right coronary artery f","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus disease-2019; acute myocardial infarction; acute pulmonary embolism; thromboembolism","Kaur","Parminder","Department of Cardiology, St Joseph Regional Medical Center, Paterson, NJ, USA",NA
"695","34234900","10.1080/20009666.2021.1893506","Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association.","Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is associated with a hypercoagulable state leading to increased incidence of thromboembolism. However, it is exceedingly rare to see presence of both arterial and venous thromboembolism simultaneously. Herein, we report an unusual presentation of a 39-year-old male with recently diagnosed COVID -19 who initially had acute myocardial infarction secondary to thrombotic occlusion of right coronary artery f","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus disease-2019; acute myocardial infarction; acute pulmonary embolism; thromboembolism","Singh","Balraj","Department of Cardiology, St Joseph Regional Medical Center, Paterson, NJ, USA",NA
"696","34234900","10.1080/20009666.2021.1893506","Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association.","Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is associated with a hypercoagulable state leading to increased incidence of thromboembolism. However, it is exceedingly rare to see presence of both arterial and venous thromboembolism simultaneously. Herein, we report an unusual presentation of a 39-year-old male with recently diagnosed COVID -19 who initially had acute myocardial infarction secondary to thrombotic occlusion of right coronary artery f","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Coronavirus disease-2019; acute myocardial infarction; acute pulmonary embolism; thromboembolism","Walia","Jasjit S","Department of Cardiology, St Michael's Medical Center, Newark, NJ, USA",NA
"697","34234899","10.1080/20009666.2021.1896831","Ventilator-induced barotrauma in critically ill patients with COVID-19: a retrospective observational study.","Background: Ventilator-induced Barotrauma is a complication of intubation that is associated with high driving pressures and positive end-expiratory pressure use. We attempt to determine the incidence of barotrauma in intubated patients with SARS-CoV-2 infection. Methods: Retrospective observation case series of patients with SARS-CoV-2 infection who were intubated in the ICU. Data were collected for a total of 3 months from electronic health records on patient's age, sex, BMI, inc","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; barotrauma; intubation; obesity","Sah","Anuraag","Department of Internal Medicine, Trintas Regional Medical Center, NJ, USA",NA
"698","34234899","10.1080/20009666.2021.1896831","Ventilator-induced barotrauma in critically ill patients with COVID-19: a retrospective observational study.","Background: Ventilator-induced Barotrauma is a complication of intubation that is associated with high driving pressures and positive end-expiratory pressure use. We attempt to determine the incidence of barotrauma in intubated patients with SARS-CoV-2 infection. Methods: Retrospective observation case series of patients with SARS-CoV-2 infection who were intubated in the ICU. Data were collected for a total of 3 months from electronic health records on patient's age, sex, BMI, inc","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; barotrauma; intubation; obesity","Fabian","Emilio J","Department of Internal Medicine, Trintas Regional Medical Center, NJ, USA",NA
"699","34234899","10.1080/20009666.2021.1896831","Ventilator-induced barotrauma in critically ill patients with COVID-19: a retrospective observational study.","Background: Ventilator-induced Barotrauma is a complication of intubation that is associated with high driving pressures and positive end-expiratory pressure use. We attempt to determine the incidence of barotrauma in intubated patients with SARS-CoV-2 infection. Methods: Retrospective observation case series of patients with SARS-CoV-2 infection who were intubated in the ICU. Data were collected for a total of 3 months from electronic health records on patient's age, sex, BMI, inc","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; barotrauma; intubation; obesity","Remolina","Carlos","Department of Pulmonology, Trinitas Regional Medical Center, Elizabeth, NJ, USA",NA
"700","34234898","10.1080/20009666.2021.1899581","Telemedicine in the COVID-19 era: a tricky transition.",NA,"2021","07","08","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives",NA,"Palabindala","Venkataraman","Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA palabindala@gmail","palabindala@gmail.com"
"701","34234898","10.1080/20009666.2021.1899581","Telemedicine in the COVID-19 era: a tricky transition.",NA,"2021","07","08","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives",NA,"Bharathidasan","Kavya","Department of Medicine, Vydehi Institute of Medical Sciences and Research Center, Bangalore, India",NA
"702","34234897","10.1080/20009666.2021.1918440","Deaths due to delayed presentation to the hospital from fear of contracting COVID-19 during lockdown period: a tertiary care center experience.","Background: Sudden rise in COVID-19 cases in March 2020 due to spread of pandemic led to immediate lockdown order in many states and cities across the USA. Everyone had to stay home to stop the spread of the virus. We investigated all deaths in our hospital during lockdown period and assessed how many presented and died from non-COVID-19-related illness. Among those deaths, we assessed how many presented late due to excessive fear of catching coronavirus in the hospital and succumbed to t","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; lockdown; non-COVID mortality; stay-home","Bansal","Saurabh","Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA",NA
"703","34234897","10.1080/20009666.2021.1918440","Deaths due to delayed presentation to the hospital from fear of contracting COVID-19 during lockdown period: a tertiary care center experience.","Background: Sudden rise in COVID-19 cases in March 2020 due to spread of pandemic led to immediate lockdown order in many states and cities across the USA. Everyone had to stay home to stop the spread of the virus. We investigated all deaths in our hospital during lockdown period and assessed how many presented and died from non-COVID-19-related illness. Among those deaths, we assessed how many presented late due to excessive fear of catching coronavirus in the hospital and succumbed to t","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; lockdown; non-COVID mortality; stay-home","Roy","Moni","Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA",NA
"704","34234897","10.1080/20009666.2021.1918440","Deaths due to delayed presentation to the hospital from fear of contracting COVID-19 during lockdown period: a tertiary care center experience.","Background: Sudden rise in COVID-19 cases in March 2020 due to spread of pandemic led to immediate lockdown order in many states and cities across the USA. Everyone had to stay home to stop the spread of the virus. We investigated all deaths in our hospital during lockdown period and assessed how many presented and died from non-COVID-19-related illness. Among those deaths, we assessed how many presented late due to excessive fear of catching coronavirus in the hospital and succumbed to t","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; lockdown; non-COVID mortality; stay-home","Chatterjee","Tulika","Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL, USA",NA
"705","34234897","10.1080/20009666.2021.1918440","Deaths due to delayed presentation to the hospital from fear of contracting COVID-19 during lockdown period: a tertiary care center experience.","Background: Sudden rise in COVID-19 cases in March 2020 due to spread of pandemic led to immediate lockdown order in many states and cities across the USA. Everyone had to stay home to stop the spread of the virus. We investigated all deaths in our hospital during lockdown period and assessed how many presented and died from non-COVID-19-related illness. Among those deaths, we assessed how many presented late due to excessive fear of catching coronavirus in the hospital and succumbed to t","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; lockdown; non-COVID mortality; stay-home","Roy","Ashish Kumar","Department of Internal Medicine, OSF Saint Francis Medical Center, Peoria, IL, USA",NA
"706","34234896","10.1080/20009666.2021.1918475","COVID-19 mental health consequences on medical students worldwide.","Background: The COVID-19 epidemic has impacted medical education for medical students worldwide. As medical students are already vulnerable to poor psychological well-being, the mental health of medical students may be significantly affected by the changes caused by COVID-19. Objective: In this article, we discuss the curriculum and mental health ramifications of the COVID-19 epidemic on the international medical school population Methods: In this review, we analyzed 13 stud","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Medical school; education, COVID-19; medical education; medical student; mental health","Mittal","Rea","Department of Internal Medicine, Penn State College of Medicine, Hershey, USA",NA
"707","34234896","10.1080/20009666.2021.1918475","COVID-19 mental health consequences on medical students worldwide.","Background: The COVID-19 epidemic has impacted medical education for medical students worldwide. As medical students are already vulnerable to poor psychological well-being, the mental health of medical students may be significantly affected by the changes caused by COVID-19. Objective: In this article, we discuss the curriculum and mental health ramifications of the COVID-19 epidemic on the international medical school population Methods: In this review, we analyzed 13 stud","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Medical school; education, COVID-19; medical education; medical student; mental health","Su","Lilly","Department of Internal Medicine, Penn State College of Medicine, Hershey, USA",NA
"708","34234896","10.1080/20009666.2021.1918475","COVID-19 mental health consequences on medical students worldwide.","Background: The COVID-19 epidemic has impacted medical education for medical students worldwide. As medical students are already vulnerable to poor psychological well-being, the mental health of medical students may be significantly affected by the changes caused by COVID-19. Objective: In this article, we discuss the curriculum and mental health ramifications of the COVID-19 epidemic on the international medical school population Methods: In this review, we analyzed 13 stud","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","Medical school; education, COVID-19; medical education; medical student; mental health","Jain","Rohit","Rea Mittal, 130A University Manor East Hershey PA 17033, Hershey, USA",NA
"709","34234895","10.1080/20009666.2021.1890340","Physicians at the crossroad of prognosis and faith: practical help communicating with patients and families during the COVID-19 pandemic.","Physicians will ultimately face the necessary but unpleasant task of caring for a dying patient at some point in their careers. Communicating with patients or their families during such dire times is very important especially when the patient or family members have unrealistic expectations. Herein, we have highlighted practical suggestions which if applied can prevent unnecessary draining encounters with patients and families; for example, incorporating ancillary staff such as palliative and pas","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; SARS-CoV-2; death; palliative; pandemic; prognosis","Salabei","Joshua K","School of Medicine/North Florida Regional Medical Center, University of Central Florida, Gainesville, FL, USA",NA
"710","34234895","10.1080/20009666.2021.1890340","Physicians at the crossroad of prognosis and faith: practical help communicating with patients and families during the COVID-19 pandemic.","Physicians will ultimately face the necessary but unpleasant task of caring for a dying patient at some point in their careers. Communicating with patients or their families during such dire times is very important especially when the patient or family members have unrealistic expectations. Herein, we have highlighted practical suggestions which if applied can prevent unnecessary draining encounters with patients and families; for example, incorporating ancillary staff such as palliative and pas","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; SARS-CoV-2; death; palliative; pandemic; prognosis","Fishman","Troy J","School of Medicine/North Florida Regional Medical Center, University of Central Florida, Gainesville, FL, USA",NA
"711","34234895","10.1080/20009666.2021.1890340","Physicians at the crossroad of prognosis and faith: practical help communicating with patients and families during the COVID-19 pandemic.","Physicians will ultimately face the necessary but unpleasant task of caring for a dying patient at some point in their careers. Communicating with patients or their families during such dire times is very important especially when the patient or family members have unrealistic expectations. Herein, we have highlighted practical suggestions which if applied can prevent unnecessary draining encounters with patients and families; for example, incorporating ancillary staff such as palliative and pas","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; SARS-CoV-2; death; palliative; pandemic; prognosis","Schwartz","Steven J","School of Medicine/North Florida Regional Medical Center, University of Central Florida, Gainesville, FL, USA",NA
"712","34234895","10.1080/20009666.2021.1890340","Physicians at the crossroad of prognosis and faith: practical help communicating with patients and families during the COVID-19 pandemic.","Physicians will ultimately face the necessary but unpleasant task of caring for a dying patient at some point in their careers. Communicating with patients or their families during such dire times is very important especially when the patient or family members have unrealistic expectations. Herein, we have highlighted practical suggestions which if applied can prevent unnecessary draining encounters with patients and families; for example, incorporating ancillary staff such as palliative and pas","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; SARS-CoV-2; death; palliative; pandemic; prognosis","Okonoboh","Peters","School of Medicine/North Florida Regional Medical Center, University of Central Florida, Gainesville, FL, USA",NA
"713","34234895","10.1080/20009666.2021.1890340","Physicians at the crossroad of prognosis and faith: practical help communicating with patients and families during the COVID-19 pandemic.","Physicians will ultimately face the necessary but unpleasant task of caring for a dying patient at some point in their careers. Communicating with patients or their families during such dire times is very important especially when the patient or family members have unrealistic expectations. Herein, we have highlighted practical suggestions which if applied can prevent unnecessary draining encounters with patients and families; for example, incorporating ancillary staff such as palliative and pas","2021","07","09","J Community Hosp Intern Med Perspect","Journal of community hospital internal medicine perspectives","COVID-19; SARS-CoV-2; death; palliative; pandemic; prognosis","Iyer","Uma G","School of Medicine/North Florida Regional Medical Center, University of Central Florida, Gainesville, FL, USA",NA
"714","34234882","10.1002/cl2.1107","Editorial: Fifty Campbell systematic reviews relevant to the policy response to COVID-19.",NA,"2021","07","08","Campbell Syst Rev","Campbell systematic reviews",NA,"Board","Campbell Editorial","Editor in Chief Vivian Welch, Bruyère Research Institute, Canada Business and Management Denise Rousseau Carnegie Mellon University Pittsburgh USA Eric Barends, Centre for Evidence Based Management (CEBMa), Leiden The Netherlands",NA
"715","34234832","10.7573/dic.2021-5-2","Corrigendum: The effect of azoximer bromide (Polyoxidonium<sup>®</sup>) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study.","[This corrects the article DOI: 10.7573/dic.2020-11-1.].","2021","07","08","Drugs Context","Drugs in context",NA,NA,NA,NA,NA
"716","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"García-Saisó","Sebastián","Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America",NA
"717","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Marti","Myrna","Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America",NA
"718","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Brooks","Ian","University of Illinois Urbana-Champaign United States of America University of Illinois, Urbana-Champaign, United States of America",NA
"719","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Curioso","Walter","Universidad Continental Lima Peru Universidad Continental, Lima, Peru",NA
"720","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"González","Diego","Pan American Health Organization São Paulo Brazil Pan American Health Organization, São Paulo, Brazil",NA
"721","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Malek","Victoria","Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America",NA
"722","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Medina","Felipe Mejía","Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America",NA
"723","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Radix","Carlene","Organization of Eastern Caribbean States Castries Saint Lucia Organization of Eastern Caribbean States, Castries, Saint Lucia",NA
"724","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Otzoy","Daniel","Central American Health Informatics Network Guatemala Guatemala Central American Health Informatics Network, Guatemala City, Guatemala",NA
"725","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Zacarías","Soraya","Ministry of Health of Brazil Brasilia Brazil Ministry of Health of Brazil, Brasilia, Brazil",NA
"726","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"Dos Santos","Eliane Pereira","Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America",NA
"727","34234820","10.26633/RPSP.2021.56","The COVID-19 Infodemic.",NA,"2021","07","16","Rev Panam Salud Publica","Revista panamericana de salud publica = Pan American journal of public health",NA,"D'Agostino","Marcelo","Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America",NA
"728","34234787","10.3389/fimmu.2021.701752","Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis.","For more than a year now, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been causing the coronavirus disease (COVID-19) pandemic with high mortality and detrimental effects on society, economy, and individual lives. Great hopes are being placed on vaccination as one of the most potent escape strategies from the pandemic and multiple vaccines are already in clinical use. However, there is still a lot of insecurity about the safety and efficacy of vaccines in patients with autoi","2021","07","19","Front Immunol","Frontiers in immunology","CD20; coronavirus disease (COVID-19); immune response; immunomodulation; immunotherapy; multiple sclerosis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); vaccination; COVID-19; COVID-19 Vaccines; Humans; Immunocompromised Host; Monitoring, Immunologic; Multiple Sclerosis; SARS-CoV-2; Vaccination","Woopen","Christina","Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany",NA
"729","34234787","10.3389/fimmu.2021.701752","Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis.","For more than a year now, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been causing the coronavirus disease (COVID-19) pandemic with high mortality and detrimental effects on society, economy, and individual lives. Great hopes are being placed on vaccination as one of the most potent escape strategies from the pandemic and multiple vaccines are already in clinical use. However, there is still a lot of insecurity about the safety and efficacy of vaccines in patients with autoi","2021","07","19","Front Immunol","Frontiers in immunology","CD20; coronavirus disease (COVID-19); immune response; immunomodulation; immunotherapy; multiple sclerosis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); vaccination; COVID-19; COVID-19 Vaccines; Humans; Immunocompromised Host; Monitoring, Immunologic; Multiple Sclerosis; SARS-CoV-2; Vaccination","Schleußner","Katharina","Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany",NA
"730","34234787","10.3389/fimmu.2021.701752","Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis.","For more than a year now, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been causing the coronavirus disease (COVID-19) pandemic with high mortality and detrimental effects on society, economy, and individual lives. Great hopes are being placed on vaccination as one of the most potent escape strategies from the pandemic and multiple vaccines are already in clinical use. However, there is still a lot of insecurity about the safety and efficacy of vaccines in patients with autoi","2021","07","19","Front Immunol","Frontiers in immunology","CD20; coronavirus disease (COVID-19); immune response; immunomodulation; immunotherapy; multiple sclerosis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); vaccination; COVID-19; COVID-19 Vaccines; Humans; Immunocompromised Host; Monitoring, Immunologic; Multiple Sclerosis; SARS-CoV-2; Vaccination","Akgün","Katja","Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany",NA
"731","34234787","10.3389/fimmu.2021.701752","Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis.","For more than a year now, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been causing the coronavirus disease (COVID-19) pandemic with high mortality and detrimental effects on society, economy, and individual lives. Great hopes are being placed on vaccination as one of the most potent escape strategies from the pandemic and multiple vaccines are already in clinical use. However, there is still a lot of insecurity about the safety and efficacy of vaccines in patients with autoi","2021","07","19","Front Immunol","Frontiers in immunology","CD20; coronavirus disease (COVID-19); immune response; immunomodulation; immunotherapy; multiple sclerosis; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); vaccination; COVID-19; COVID-19 Vaccines; Humans; Immunocompromised Host; Monitoring, Immunologic; Multiple Sclerosis; SARS-CoV-2; Vaccination","Ziemssen","Tjalf","Center of Clinical Neuroscience, Department of Neurology, University Hospital Carl Gustav Carus Dresden, Technical University of Dresden, Dresden, Germany",NA
"732","34234779","10.3389/fimmu.2021.677008","Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?",NA,"2021","07","19","Front Immunol","Frontiers in immunology","SARS  CoV  2; cytokine storm; diabetes; immunometabolism; inflammation; Animals; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Humans; Inflammation; Inflammation Mediators; Interleukin-10; SARS-CoV-2; Up-Regulation","Islam","Hashim","School of Health and Exercise Sciences, University of British Columbia Okanagan, Kelowna, BC, Canada",NA
"733","34234779","10.3389/fimmu.2021.677008","Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?",NA,"2021","07","19","Front Immunol","Frontiers in immunology","SARS  CoV  2; cytokine storm; diabetes; immunometabolism; inflammation; Animals; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Humans; Inflammation; Inflammation Mediators; Interleukin-10; SARS-CoV-2; Up-Regulation","Chamberlain","Thomas C","Department of Surgery, University of British Columbia, Vancouver, BC, Canada",NA
"734","34234779","10.3389/fimmu.2021.677008","Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?",NA,"2021","07","19","Front Immunol","Frontiers in immunology","SARS  CoV  2; cytokine storm; diabetes; immunometabolism; inflammation; Animals; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Humans; Inflammation; Inflammation Mediators; Interleukin-10; SARS-CoV-2; Up-Regulation","Mui","Alice L","Department of Surgery, University of British Columbia, Vancouver, BC, Canada",NA
"735","34234779","10.3389/fimmu.2021.677008","Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?",NA,"2021","07","19","Front Immunol","Frontiers in immunology","SARS  CoV  2; cytokine storm; diabetes; immunometabolism; inflammation; Animals; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Humans; Inflammation; Inflammation Mediators; Interleukin-10; SARS-CoV-2; Up-Regulation","Little","Jonathan P","School of Health and Exercise Sciences, University of British Columbia Okanagan, Kelowna, BC, Canada",NA
"736","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Leung","Leslie Y T","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"737","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Khan","Srijit","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"738","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Budylowski","Patrick","Department of Medicine, University of Toronto, Toronto, ON, Canada",NA
"739","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Li","Zhijie","Department of Biochemistry, University of Toronto, Toronto, ON, Canada",NA
"740","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Goroshko","Sofiya","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"741","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Liu","Yanling","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"742","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Dong","Shilan","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"743","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Carlyle","James R","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"744","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Rini","James M","Department of Biochemistry, University of Toronto, Toronto, ON, Canada",NA
"745","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Ostrowski","Mario","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"746","34234774","10.3389/fimmu.2021.659071","Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.","SARS-CoV-2 is a newly emerged betacoronavirus and the causative agent for the COVID-19 pandemic. Antibodies recognizing the viral spike protein are instrumental in natural and vaccine-induced immune responses to the pathogen and in clinical diagnostic and therapeutic applications. Unlike conventional immunoglobulins, the variable lymphocyte receptor antibodies of jawless vertebrates are structurally distinct, indicating that they may recognize different epitopes. Here we report the isolation of ","2021","07","19","Front Immunol","Frontiers in immunology","SARS-CoV-2; monoclonal antibody; neutralization; sea lamprey (Petromyzon marinus); variable lymphocyte receptor; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Biological Evolution; COVID-19; Cross Reactions; Epitopes, B-Lymphocyte; Fish Proteins; Humans; Petromyzon; SARS-CoV-2","Ehrhardt","Götz R A","Department of Immunology, University of Toronto, Toronto, ON, Canada",NA
"747","34234758","10.3389/fmicb.2021.665041","A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.","An unprecedented amount of SARS-CoV-2 sequencing has been performed, however, novel bioinformatic tools to cope with and process these large datasets is needed. Here, we have devised a bioinformatic pipeline that inputs SARS-CoV-2 genome sequencing in FASTA/FASTQ format and outputs a single Variant Calling Format file that can be processed to obtain variant annotations and perform downstream population genetic testing. As proof of concept, we have analyzed over 229,000 SARS-CoV-2 viral sequences","2021","07","09","Front Microbiol","Frontiers in microbiology","3cpsdummy'UTR; SARS-CoV-2 variants; Tajimas D-statistic; VCF; nucleotide diversity (p); viral evolution","Farkas","Carlos","Research Institute in Oncology and Hematology (RIOH), CancerCare Manitoba, Winnipeg, MB, Canada",NA
"748","34234758","10.3389/fmicb.2021.665041","A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.","An unprecedented amount of SARS-CoV-2 sequencing has been performed, however, novel bioinformatic tools to cope with and process these large datasets is needed. Here, we have devised a bioinformatic pipeline that inputs SARS-CoV-2 genome sequencing in FASTA/FASTQ format and outputs a single Variant Calling Format file that can be processed to obtain variant annotations and perform downstream population genetic testing. As proof of concept, we have analyzed over 229,000 SARS-CoV-2 viral sequences","2021","07","09","Front Microbiol","Frontiers in microbiology","3cpsdummy'UTR; SARS-CoV-2 variants; Tajimas D-statistic; VCF; nucleotide diversity (p); viral evolution","Mella","Andy","Departamento de Física, Facultad de Ciencias Físicas y Matemáticas, Universidad de Chile, Santiago, Chile",NA
"749","34234758","10.3389/fmicb.2021.665041","A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.","An unprecedented amount of SARS-CoV-2 sequencing has been performed, however, novel bioinformatic tools to cope with and process these large datasets is needed. Here, we have devised a bioinformatic pipeline that inputs SARS-CoV-2 genome sequencing in FASTA/FASTQ format and outputs a single Variant Calling Format file that can be processed to obtain variant annotations and perform downstream population genetic testing. As proof of concept, we have analyzed over 229,000 SARS-CoV-2 viral sequences","2021","07","09","Front Microbiol","Frontiers in microbiology","3cpsdummy'UTR; SARS-CoV-2 variants; Tajimas D-statistic; VCF; nucleotide diversity (p); viral evolution","Turgeon","Maxime","Department of Statistics, University of Manitoba, Winnipeg, MB, Canada",NA
"750","34234758","10.3389/fmicb.2021.665041","A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity.","An unprecedented amount of SARS-CoV-2 sequencing has been performed, however, novel bioinformatic tools to cope with and process these large datasets is needed. Here, we have devised a bioinformatic pipeline that inputs SARS-CoV-2 genome sequencing in FASTA/FASTQ format and outputs a single Variant Calling Format file that can be processed to obtain variant annotations and perform downstream population genetic testing. As proof of concept, we have analyzed over 229,000 SARS-CoV-2 viral sequences","2021","07","09","Front Microbiol","Frontiers in microbiology","3cpsdummy'UTR; SARS-CoV-2 variants; Tajimas D-statistic; VCF; nucleotide diversity (p); viral evolution","Haigh","Jody J","Research Institute in Oncology and Hematology (RIOH), CancerCare Manitoba, Winnipeg, MB, Canada",NA
"751","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Yang","Lei","Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China",NA
"752","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Xu","Dou","School of Software Engineering, Xi'an Jiaotong University, Xi'an, China",NA
"753","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Tan","Yiqing","Department of Radiology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China",NA
"754","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Li","Bolin","Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China",NA
"755","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Zhu","Dan","Department of Radiology, Shanghai Ninth People's Hospital Affiliated to JiaoTong University School of Medicine, Shanghai, China",NA
"756","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Wang","Jingbo","Department of Radiology, Shanghai Ninth People's Hospital Affiliated to JiaoTong University School of Medicine, Shanghai, China",NA
"757","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Sun","Hui","SenseTime Research, Beijing, China",NA
"758","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Liu","Xinglong","SenseTime Research, Beijing, China",NA
"759","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Zheng","Xiaopu","Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China",NA
"760","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Zhu","Ling","Department of Radiology, Shanghai Ninth People's Hospital Affiliated to JiaoTong University School of Medicine, Shanghai, China",NA
"761","34234738","10.3389/fendo.2021.642452","Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.","We investigated if the concentration and ""rangeability"" of cystatin C (CysC) influenced the prognosis of coronavirus disease 2019 (COVID-19) in patients suffering from, or not suffering from, type 2 diabetes mellitus (T2DM). A total of 675 T2DM patients and 572 non-T2DM patients were divided into ""low"" and ""high"" CysC groups and low and high CysC-rangeability groups according to serum CysC level and range of change of CysC level, respectively. Demographic characteristics, clinical data, and labo","2021","07","16","Front Endocrinol (Lausanne)","Frontiers in endocrinology","COVID-19; all-cause death; cystatin C; renal function; type 2 diabetes mellitus; Aged; Biomarkers; COVID-19; Case-Control Studies; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; SARS-CoV-2","Li","Zhongyu","School of Software Engineering, Xi'an Jiaotong University, Xi'an, China",NA
"762","34234723","10.3389/fpsyg.2021.688463","The Combined Effect of Safety Specific Transformational Leadership and Safety Consciousness on Psychological Well-Being of Healthcare Workers.","Occupational health researchers have begun to realize that the psychological well-being of healthcare workers who are providing treatment against COVID-19 is deteriorating. However, there is minimal research conducted on it, particularly in the context of leadership. The current study aims to fill this important gap by identifying critical factors that can enhance the psychological well-being of healthcare workers. We proposed that safety specific transformational leadership enhances psychologic","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19 perceived risk; healthcare worker; occupational hazard; psychological well-being; safety consciousness; safety specific transformational leadership","Irshad","Muhammad","Faculty of Management Sciences, National University of Modern Languages Islamabad Campus, Islamabad, Pakistan",NA
"763","34234723","10.3389/fpsyg.2021.688463","The Combined Effect of Safety Specific Transformational Leadership and Safety Consciousness on Psychological Well-Being of Healthcare Workers.","Occupational health researchers have begun to realize that the psychological well-being of healthcare workers who are providing treatment against COVID-19 is deteriorating. However, there is minimal research conducted on it, particularly in the context of leadership. The current study aims to fill this important gap by identifying critical factors that can enhance the psychological well-being of healthcare workers. We proposed that safety specific transformational leadership enhances psychologic","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19 perceived risk; healthcare worker; occupational hazard; psychological well-being; safety consciousness; safety specific transformational leadership","Majeed","Mehwish","Faculty of Management Sciences, International Islamic University, Islamabad, Pakistan",NA
"764","34234723","10.3389/fpsyg.2021.688463","The Combined Effect of Safety Specific Transformational Leadership and Safety Consciousness on Psychological Well-Being of Healthcare Workers.","Occupational health researchers have begun to realize that the psychological well-being of healthcare workers who are providing treatment against COVID-19 is deteriorating. However, there is minimal research conducted on it, particularly in the context of leadership. The current study aims to fill this important gap by identifying critical factors that can enhance the psychological well-being of healthcare workers. We proposed that safety specific transformational leadership enhances psychologic","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19 perceived risk; healthcare worker; occupational hazard; psychological well-being; safety consciousness; safety specific transformational leadership","Khattak","Sana Aroos","Faculty of Management Sciences, Bahria University Islamabad, Islamabad, Pakistan",NA
"765","34234720","10.3389/fpsyg.2021.681091","The Influence of COVID-19 on the Well-Being of People: Big Data Methods for Capturing the Well-Being of Working Adults and Protective Factors Nationwide.","The COVID-19 outbreak has affected the lives of people across the globe. To investigate the mental impact of COVID-19 and to respond to the call of researchers for the use of unobtrusive and intensive measurement in capturing time-sensitive psychological concepts (e.g., affect), we used big data methods to investigate the impact of COVID-19 by analyzing 348,933 tweets that people posted from April 1, 2020 to April 24, 2020. The dataset covers 2,231 working adults, who are from 454 counties acros","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big data; personality; positive affect and negative affect; social connectedness","Zhang","Xiyang","Department of Psychology, University of Akron, Akron, OH, United States",NA
"766","34234720","10.3389/fpsyg.2021.681091","The Influence of COVID-19 on the Well-Being of People: Big Data Methods for Capturing the Well-Being of Working Adults and Protective Factors Nationwide.","The COVID-19 outbreak has affected the lives of people across the globe. To investigate the mental impact of COVID-19 and to respond to the call of researchers for the use of unobtrusive and intensive measurement in capturing time-sensitive psychological concepts (e.g., affect), we used big data methods to investigate the impact of COVID-19 by analyzing 348,933 tweets that people posted from April 1, 2020 to April 24, 2020. The dataset covers 2,231 working adults, who are from 454 counties acros","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big data; personality; positive affect and negative affect; social connectedness","Wang","Yu","Department of Political Science, University of Rochester, Rochester, NY, United States",NA
"767","34234720","10.3389/fpsyg.2021.681091","The Influence of COVID-19 on the Well-Being of People: Big Data Methods for Capturing the Well-Being of Working Adults and Protective Factors Nationwide.","The COVID-19 outbreak has affected the lives of people across the globe. To investigate the mental impact of COVID-19 and to respond to the call of researchers for the use of unobtrusive and intensive measurement in capturing time-sensitive psychological concepts (e.g., affect), we used big data methods to investigate the impact of COVID-19 by analyzing 348,933 tweets that people posted from April 1, 2020 to April 24, 2020. The dataset covers 2,231 working adults, who are from 454 counties acros","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big data; personality; positive affect and negative affect; social connectedness","Lyu","Hanjia","Goergen Institute for Data Science, University of Rochester, Rochester, NY, United States",NA
"768","34234720","10.3389/fpsyg.2021.681091","The Influence of COVID-19 on the Well-Being of People: Big Data Methods for Capturing the Well-Being of Working Adults and Protective Factors Nationwide.","The COVID-19 outbreak has affected the lives of people across the globe. To investigate the mental impact of COVID-19 and to respond to the call of researchers for the use of unobtrusive and intensive measurement in capturing time-sensitive psychological concepts (e.g., affect), we used big data methods to investigate the impact of COVID-19 by analyzing 348,933 tweets that people posted from April 1, 2020 to April 24, 2020. The dataset covers 2,231 working adults, who are from 454 counties acros","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big data; personality; positive affect and negative affect; social connectedness","Zhang","Yipeng","Department of Computer Science, University of Rochester, Rochester, NY, United States",NA
"769","34234720","10.3389/fpsyg.2021.681091","The Influence of COVID-19 on the Well-Being of People: Big Data Methods for Capturing the Well-Being of Working Adults and Protective Factors Nationwide.","The COVID-19 outbreak has affected the lives of people across the globe. To investigate the mental impact of COVID-19 and to respond to the call of researchers for the use of unobtrusive and intensive measurement in capturing time-sensitive psychological concepts (e.g., affect), we used big data methods to investigate the impact of COVID-19 by analyzing 348,933 tweets that people posted from April 1, 2020 to April 24, 2020. The dataset covers 2,231 working adults, who are from 454 counties acros","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big data; personality; positive affect and negative affect; social connectedness","Liu","Yubao","Department of Computer Science, University of Rochester, Rochester, NY, United States",NA
"770","34234720","10.3389/fpsyg.2021.681091","The Influence of COVID-19 on the Well-Being of People: Big Data Methods for Capturing the Well-Being of Working Adults and Protective Factors Nationwide.","The COVID-19 outbreak has affected the lives of people across the globe. To investigate the mental impact of COVID-19 and to respond to the call of researchers for the use of unobtrusive and intensive measurement in capturing time-sensitive psychological concepts (e.g., affect), we used big data methods to investigate the impact of COVID-19 by analyzing 348,933 tweets that people posted from April 1, 2020 to April 24, 2020. The dataset covers 2,231 working adults, who are from 454 counties acros","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big data; personality; positive affect and negative affect; social connectedness","Luo","Jiebo","Department of Computer Science, University of Rochester, Rochester, NY, United States",NA
"771","34234714","10.3389/fpsyg.2021.666655","Alone Together: Computer-Mediated Communication in Leisure Time During and After the COVID-19 Pandemic.","In spring 2020, the COVID-19 outbreak was declared a global pandemic and several lockdowns were followed in Germany. To weaken the spread of the virus, SARS-CoV-2, people were required to reduce their face-to-face contact with others. Computer-mediated communication (CMC) offers opportunities to stay in touch with important people and still meets social needs. During the first lockdown in spring 2020, we collected data from 679 participants to explore the role of CMC for social interaction in th","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big five; computer-mediated communication; inter-individual differences; leisure activities; perceived social closeness; personality; uses and gratification approach","Meier","Jennifer V","Department of Psychology, University of Cologne, Cologne, Germany",NA
"772","34234714","10.3389/fpsyg.2021.666655","Alone Together: Computer-Mediated Communication in Leisure Time During and After the COVID-19 Pandemic.","In spring 2020, the COVID-19 outbreak was declared a global pandemic and several lockdowns were followed in Germany. To weaken the spread of the virus, SARS-CoV-2, people were required to reduce their face-to-face contact with others. Computer-mediated communication (CMC) offers opportunities to stay in touch with important people and still meets social needs. During the first lockdown in spring 2020, we collected data from 679 participants to explore the role of CMC for social interaction in th","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big five; computer-mediated communication; inter-individual differences; leisure activities; perceived social closeness; personality; uses and gratification approach","Noel","Josephine A","Department of Psychology, University of Cologne, Cologne, Germany",NA
"773","34234714","10.3389/fpsyg.2021.666655","Alone Together: Computer-Mediated Communication in Leisure Time During and After the COVID-19 Pandemic.","In spring 2020, the COVID-19 outbreak was declared a global pandemic and several lockdowns were followed in Germany. To weaken the spread of the virus, SARS-CoV-2, people were required to reduce their face-to-face contact with others. Computer-mediated communication (CMC) offers opportunities to stay in touch with important people and still meets social needs. During the first lockdown in spring 2020, we collected data from 679 participants to explore the role of CMC for social interaction in th","2021","07","09","Front Psychol","Frontiers in psychology","COVID-19; big five; computer-mediated communication; inter-individual differences; leisure activities; perceived social closeness; personality; uses and gratification approach","Kaspar","Kai","Department of Psychology, University of Cologne, Cologne, Germany",NA
"774","34234704","10.3389/fpsyt.2021.702807","Did the UK COVID-19 Lockdown Modify the Influence of Neighbourhood Disorder on Psychological Distress? Evidence From a Prospective Cohort Study.","Background: National lockdown in the UK during the COVID-19 pandemic severely restricted the mobility of residents and increased time spent in their residential neighbourhoods. This is a unique opportunity to understand how an exogenous factor that reduces mobility may influence the association between neighbourhood social environment and mental health. This study investigates whether the COVID-19 lockdown may modify the effect of neighbourhood disorder on psychological distress. Metho","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; exogeneity; longitudinal study; mental health; mobility; neighbourhood disorder; public health; residential environment","Teo","Celine","Department of Applied Health Sciences, Brock University, St. Catharines, ON, Canada",NA
"775","34234704","10.3389/fpsyt.2021.702807","Did the UK COVID-19 Lockdown Modify the Influence of Neighbourhood Disorder on Psychological Distress? Evidence From a Prospective Cohort Study.","Background: National lockdown in the UK during the COVID-19 pandemic severely restricted the mobility of residents and increased time spent in their residential neighbourhoods. This is a unique opportunity to understand how an exogenous factor that reduces mobility may influence the association between neighbourhood social environment and mental health. This study investigates whether the COVID-19 lockdown may modify the effect of neighbourhood disorder on psychological distress. Metho","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; exogeneity; longitudinal study; mental health; mobility; neighbourhood disorder; public health; residential environment","Kim","Chungah","Department of Applied Health Sciences, Brock University, St. Catharines, ON, Canada",NA
"776","34234704","10.3389/fpsyt.2021.702807","Did the UK COVID-19 Lockdown Modify the Influence of Neighbourhood Disorder on Psychological Distress? Evidence From a Prospective Cohort Study.","Background: National lockdown in the UK during the COVID-19 pandemic severely restricted the mobility of residents and increased time spent in their residential neighbourhoods. This is a unique opportunity to understand how an exogenous factor that reduces mobility may influence the association between neighbourhood social environment and mental health. This study investigates whether the COVID-19 lockdown may modify the effect of neighbourhood disorder on psychological distress. Metho","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; exogeneity; longitudinal study; mental health; mobility; neighbourhood disorder; public health; residential environment","Nielsen","Andrew","Department of Applied Health Sciences, Brock University, St. Catharines, ON, Canada",NA
"777","34234704","10.3389/fpsyt.2021.702807","Did the UK COVID-19 Lockdown Modify the Influence of Neighbourhood Disorder on Psychological Distress? Evidence From a Prospective Cohort Study.","Background: National lockdown in the UK during the COVID-19 pandemic severely restricted the mobility of residents and increased time spent in their residential neighbourhoods. This is a unique opportunity to understand how an exogenous factor that reduces mobility may influence the association between neighbourhood social environment and mental health. This study investigates whether the COVID-19 lockdown may modify the effect of neighbourhood disorder on psychological distress. Metho","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; exogeneity; longitudinal study; mental health; mobility; neighbourhood disorder; public health; residential environment","Young","Thomas","Department of Applied Health Sciences, Brock University, St. Catharines, ON, Canada",NA
"778","34234704","10.3389/fpsyt.2021.702807","Did the UK COVID-19 Lockdown Modify the Influence of Neighbourhood Disorder on Psychological Distress? Evidence From a Prospective Cohort Study.","Background: National lockdown in the UK during the COVID-19 pandemic severely restricted the mobility of residents and increased time spent in their residential neighbourhoods. This is a unique opportunity to understand how an exogenous factor that reduces mobility may influence the association between neighbourhood social environment and mental health. This study investigates whether the COVID-19 lockdown may modify the effect of neighbourhood disorder on psychological distress. Metho","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; exogeneity; longitudinal study; mental health; mobility; neighbourhood disorder; public health; residential environment","O'Campo","Patricia","MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, ON, Canada",NA
"779","34234704","10.3389/fpsyt.2021.702807","Did the UK COVID-19 Lockdown Modify the Influence of Neighbourhood Disorder on Psychological Distress? Evidence From a Prospective Cohort Study.","Background: National lockdown in the UK during the COVID-19 pandemic severely restricted the mobility of residents and increased time spent in their residential neighbourhoods. This is a unique opportunity to understand how an exogenous factor that reduces mobility may influence the association between neighbourhood social environment and mental health. This study investigates whether the COVID-19 lockdown may modify the effect of neighbourhood disorder on psychological distress. Metho","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; exogeneity; longitudinal study; mental health; mobility; neighbourhood disorder; public health; residential environment","Chum","Antony","Department of Applied Health Sciences, Brock University, St. Catharines, ON, Canada",NA
"780","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Qiu","Xiuli","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"781","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Lan","Yan","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"782","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Miao","Jinfeng","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"783","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Wang","Hui","Nursing Department, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"784","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Wang","He","Department of Medical Affair, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"785","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Wu","Jianhong","Department of Gastrointestinal Surgery, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"786","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Li","Guo","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"787","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Zhao","Xin","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"788","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Cao","Ziqin","Department of Chemistry, Emory University, Atlanta, GA, United States",NA
"789","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Mei","Junhua","Department of Neurology, Wuhan First Hospital, Wuhan, China",NA
"790","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Sun","Wenzhe","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"791","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Zhu","Zhou","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"792","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Zhu","Suiqiang","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"793","34234703","10.3389/fpsyt.2021.701032","A Comparative Study on the Psychological Health of Frontline Health Workers in Wuhan Under and After the Lockdown.","Background: The coronavirus disease-2019 (COVID-19) outbreak and a 3-month lockdown of Wuhan may have had a long-term impact on the mental health of frontline healthcare workers (HWs). However, there is still a lack of comparative studies on the mental health of front-line HWs in the initial phase of the lockdown and 1 month after the lifting of the lockdown. Methods: We recruited 1717 HWs during the initial phase of the lockdown and 2214 HWs 1 month after the lifting of the lockdo","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety symptoms; depressive symptoms; front-line healthcare workers; stress","Wang","Wei","Department of Neurology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China",NA
"794","34234700","10.3389/fpsyt.2021.663758","Psychosocial Aspects During the First Wave of COVID-19 Infection in South Africa.","Background: In South Africa, as in many countries, the nationwide spread of COVID-19 caused a public health emergency that resulted in the government implementing necessary restrictive measures such as the nationwide lockdown as a way of containing the pandemic. Such restrictive measure, while necessary, can disrupt many aspects of people's lives resulting in unprecedented psychosocial distress. Aim: The present study aims to describe the psychosocial health and situational factors","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety; depression; lockdown 2020; mental health; psychosocial; stress; threat","Lentoor","Antonio G","Department of Clinical Psychology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa",NA
"795","34234700","10.3389/fpsyt.2021.663758","Psychosocial Aspects During the First Wave of COVID-19 Infection in South Africa.","Background: In South Africa, as in many countries, the nationwide spread of COVID-19 caused a public health emergency that resulted in the government implementing necessary restrictive measures such as the nationwide lockdown as a way of containing the pandemic. Such restrictive measure, while necessary, can disrupt many aspects of people's lives resulting in unprecedented psychosocial distress. Aim: The present study aims to describe the psychosocial health and situational factors","2021","07","09","Front Psychiatry","Frontiers in psychiatry","COVID-19; anxiety; depression; lockdown 2020; mental health; psychosocial; stress; threat","Maepa","Mokoena Patronella","Department of Clinical Psychology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa",NA
"796","34234698","10.3389/fpsyt.2021.655079","Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report.","The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-injury behavior, and obesity are predisposed to aggravation of their symptoms at this time, requiring new therapeutic approaches to balance their disrupted neuro-hormonal stress axis. Here we present our observations of an off-label treatment with lamotrigine in an adolescent girl with PTSD, self-injur","2021","07","09","Front Psychiatry","Frontiers in psychiatry","Post-traumatic stress disorder; inflammation; lamotrigine; obesity; self-harm behavior","Pham","Thuylinh L","Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University of Leipzig, Leipzig, Germany",NA
"797","34234698","10.3389/fpsyt.2021.655079","Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report.","The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-injury behavior, and obesity are predisposed to aggravation of their symptoms at this time, requiring new therapeutic approaches to balance their disrupted neuro-hormonal stress axis. Here we present our observations of an off-label treatment with lamotrigine in an adolescent girl with PTSD, self-injur","2021","07","09","Front Psychiatry","Frontiers in psychiatry","Post-traumatic stress disorder; inflammation; lamotrigine; obesity; self-harm behavior","Chrousos","George P","University Research Institute of Maternal and Child Health and Precision Medicine, National and Kapodistrian University of Athens, Athens, Greece",NA
"798","34234698","10.3389/fpsyt.2021.655079","Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report.","The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-injury behavior, and obesity are predisposed to aggravation of their symptoms at this time, requiring new therapeutic approaches to balance their disrupted neuro-hormonal stress axis. Here we present our observations of an off-label treatment with lamotrigine in an adolescent girl with PTSD, self-injur","2021","07","09","Front Psychiatry","Frontiers in psychiatry","Post-traumatic stress disorder; inflammation; lamotrigine; obesity; self-harm behavior","Merkenschlager","Andreas","Department of Neuropediatrics, University of Leipzig, Leipzig, Germany",NA
"799","34234698","10.3389/fpsyt.2021.655079","Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report.","The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-injury behavior, and obesity are predisposed to aggravation of their symptoms at this time, requiring new therapeutic approaches to balance their disrupted neuro-hormonal stress axis. Here we present our observations of an off-label treatment with lamotrigine in an adolescent girl with PTSD, self-injur","2021","07","09","Front Psychiatry","Frontiers in psychiatry","Post-traumatic stress disorder; inflammation; lamotrigine; obesity; self-harm behavior","Petrowski","Katja","Department of Medical Psychology and Medical Sociology, Clinic and Policlinic for Psychosomatic Medicine and Psychotherapy, University Medicine Mainz, Mainz, Germany",NA
"800","34234698","10.3389/fpsyt.2021.655079","Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report.","The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-injury behavior, and obesity are predisposed to aggravation of their symptoms at this time, requiring new therapeutic approaches to balance their disrupted neuro-hormonal stress axis. Here we present our observations of an off-label treatment with lamotrigine in an adolescent girl with PTSD, self-injur","2021","07","09","Front Psychiatry","Frontiers in psychiatry","Post-traumatic stress disorder; inflammation; lamotrigine; obesity; self-harm behavior","Ullmann","Enrico","Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University of Leipzig, Leipzig, Germany",NA
"801","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Hu","Ziwei","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"802","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Lin","Jinhong","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"803","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Chen","Jintao","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"804","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Cai","Tengxi","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"805","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Xia","Lixin","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"806","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Liu","Ying","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"807","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","Song","Xun","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"808","34234668","10.3389/fphar.2021.630834","Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.","Viral pneumonia has been a serious threat to global health, especially now we have dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of community-acquired pneumonia occur every year, and over 20% of which need hospital admission. Influenza virus, respiratory virus, and coronavirus are the noteworthy causative agents to be investigated based on recent clinical research. Currently, anaphylactic reaction and inflammation induced by antiviral immunity can be incrimin","2021","07","09","Front Pharmacol","Frontiers in pharmacology","coronavirus; influenza virus; medicinal plants; natural compounds; respiratory syncytial virus; viral pneumonia","He","Zhendan","School of Basic Medicine, School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China",NA
"809","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Milovanovic","Branislav","Neurocardiology Lab, Department of Cardiology, University Hospital Medical Center Bezanijska kosa, Belgrade, Serbia",NA
"810","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Djajic","Vlado","Neurology Clinic, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina",NA
"811","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Bajic","Dragana","Faculty of Technical Sciences, University of Novi Sad, Novi Sad, Serbia",NA
"812","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Djokovic","Aleksandra","Faculty of Medicine, University of Belgrade, Belgrade, Serbia",NA
"813","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Krajnovic","Tatjana","Community Health Care Center ""Dr J. J. Zmaj"", Stara Pazova, Serbia",NA
"814","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Jovanovic","Sladjana","Telekom Srbija a.d., Belgrade, Serbia",NA
"815","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Verhaz","Antonija","Neurology Clinic, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina",NA
"816","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Kovacevic","Pedja","Neurology Clinic, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina",NA
"817","34234638","10.3389/fnins.2021.640835","Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.","We are facing the outburst of coronavirus disease 2019 (COVID-19) defined as a serious, multisystem, disorder, including various neurological manifestations in its presentation. So far, autonomic dysfunction (AD) has not been reported in patients with COVID-19 infection. Assessment of AD in the early phase of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus). We analyzed 116 PCR positive COVID-19 patients. After the exclusion of 41 patients with associate diseases","2021","07","09","Front Neurosci","Frontiers in neuroscience","COVID-19; autonomic nervous system; autonomic neuropathy; cardiovascular reflex test; heart rate variability","Ostojic","Miodrag","Neurology Clinic, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina",NA
"818","34234624","10.1016/j.rser.2021.111294","Changes in energy consumption according to building use type under COVID-19 pandemic in South Korea.","An unprecedented global lockdown has been implemented for controlling the spread of COVID-19 in many countries. These actions are reducing the number of coronics, but with the prolonged COVID-19 outbreak, the restrictions on the activities of people are having a significant impact on all industries. Accordingly, this study aimed to statistically analyze changes in building energy consumption under the COVID-19 pandemic in South Korea, as well as identify the relationship between COVID-19 and bui","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Building energy consumption; Building use type; COVID-19; Global lockdown; Social distancing","Kang","Hyuna","Department of Architecture and Architectural Engineering, Yonsei University, Seoul, Republic of Korea",NA
"819","34234624","10.1016/j.rser.2021.111294","Changes in energy consumption according to building use type under COVID-19 pandemic in South Korea.","An unprecedented global lockdown has been implemented for controlling the spread of COVID-19 in many countries. These actions are reducing the number of coronics, but with the prolonged COVID-19 outbreak, the restrictions on the activities of people are having a significant impact on all industries. Accordingly, this study aimed to statistically analyze changes in building energy consumption under the COVID-19 pandemic in South Korea, as well as identify the relationship between COVID-19 and bui","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Building energy consumption; Building use type; COVID-19; Global lockdown; Social distancing","An","Jongbaek","Department of Architecture and Architectural Engineering, Yonsei University, Seoul, Republic of Korea",NA
"820","34234624","10.1016/j.rser.2021.111294","Changes in energy consumption according to building use type under COVID-19 pandemic in South Korea.","An unprecedented global lockdown has been implemented for controlling the spread of COVID-19 in many countries. These actions are reducing the number of coronics, but with the prolonged COVID-19 outbreak, the restrictions on the activities of people are having a significant impact on all industries. Accordingly, this study aimed to statistically analyze changes in building energy consumption under the COVID-19 pandemic in South Korea, as well as identify the relationship between COVID-19 and bui","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Building energy consumption; Building use type; COVID-19; Global lockdown; Social distancing","Kim","Hakpyeong","Department of Architecture and Architectural Engineering, Yonsei University, Seoul, Republic of Korea",NA
"821","34234624","10.1016/j.rser.2021.111294","Changes in energy consumption according to building use type under COVID-19 pandemic in South Korea.","An unprecedented global lockdown has been implemented for controlling the spread of COVID-19 in many countries. These actions are reducing the number of coronics, but with the prolonged COVID-19 outbreak, the restrictions on the activities of people are having a significant impact on all industries. Accordingly, this study aimed to statistically analyze changes in building energy consumption under the COVID-19 pandemic in South Korea, as well as identify the relationship between COVID-19 and bui","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Building energy consumption; Building use type; COVID-19; Global lockdown; Social distancing","Ji","Changyoon","Green Building Research Institute, Korea Appraisal Board, Seoul, 06225, Republic of Korea",NA
"822","34234624","10.1016/j.rser.2021.111294","Changes in energy consumption according to building use type under COVID-19 pandemic in South Korea.","An unprecedented global lockdown has been implemented for controlling the spread of COVID-19 in many countries. These actions are reducing the number of coronics, but with the prolonged COVID-19 outbreak, the restrictions on the activities of people are having a significant impact on all industries. Accordingly, this study aimed to statistically analyze changes in building energy consumption under the COVID-19 pandemic in South Korea, as well as identify the relationship between COVID-19 and bui","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Building energy consumption; Building use type; COVID-19; Global lockdown; Social distancing","Hong","Taehoon","Department of Architecture and Architectural Engineering, Yonsei University, Seoul, Republic of Korea",NA
"823","34234624","10.1016/j.rser.2021.111294","Changes in energy consumption according to building use type under COVID-19 pandemic in South Korea.","An unprecedented global lockdown has been implemented for controlling the spread of COVID-19 in many countries. These actions are reducing the number of coronics, but with the prolonged COVID-19 outbreak, the restrictions on the activities of people are having a significant impact on all industries. Accordingly, this study aimed to statistically analyze changes in building energy consumption under the COVID-19 pandemic in South Korea, as well as identify the relationship between COVID-19 and bui","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Building energy consumption; Building use type; COVID-19; Global lockdown; Social distancing","Lee","Seunghye","Department of Architectural Engineering, Sejong University, Seoul, Republic of Korea",NA
"824","34234623","10.1016/j.rser.2021.111239","COVID-19 and environmental concerns: A rapid review.","COVID-19 has slowed global economic growth and consequently impacted the environment as well. Parallelly, the environment also influences the transmission of this novel coronavirus through various factors. Every nation deals with varied population density and size; air quality and pollutants; the nature of land and water, which significantly impact the transmission of coronavirus. The WHO (Ziaeepour et al., 2008) [1] has recommended rapid reviews to provide timely evidence to the policymakers to","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Air pollutants; Air quality; COVID-19; Environment; Meteorological factors; Pandemic; Rapid review","Sharma","Gagan Deep","University School of Management Studies, Guru Gobind Singh Indraprastha University, Sector 16 C, Dwarka, New Delhi, India",NA
"825","34234623","10.1016/j.rser.2021.111239","COVID-19 and environmental concerns: A rapid review.","COVID-19 has slowed global economic growth and consequently impacted the environment as well. Parallelly, the environment also influences the transmission of this novel coronavirus through various factors. Every nation deals with varied population density and size; air quality and pollutants; the nature of land and water, which significantly impact the transmission of coronavirus. The WHO (Ziaeepour et al., 2008) [1] has recommended rapid reviews to provide timely evidence to the policymakers to","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Air pollutants; Air quality; COVID-19; Environment; Meteorological factors; Pandemic; Rapid review","Tiwari","Aviral Kumar","Rajagiri Business School, Rajagiri Valley, Kochi, India",NA
"826","34234623","10.1016/j.rser.2021.111239","COVID-19 and environmental concerns: A rapid review.","COVID-19 has slowed global economic growth and consequently impacted the environment as well. Parallelly, the environment also influences the transmission of this novel coronavirus through various factors. Every nation deals with varied population density and size; air quality and pollutants; the nature of land and water, which significantly impact the transmission of coronavirus. The WHO (Ziaeepour et al., 2008) [1] has recommended rapid reviews to provide timely evidence to the policymakers to","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Air pollutants; Air quality; COVID-19; Environment; Meteorological factors; Pandemic; Rapid review","Jain","Mansi","University School of Management Studies, Guru Gobind Singh Indraprastha University, Sector 16 C, Dwarka, New Delhi, India",NA
"827","34234623","10.1016/j.rser.2021.111239","COVID-19 and environmental concerns: A rapid review.","COVID-19 has slowed global economic growth and consequently impacted the environment as well. Parallelly, the environment also influences the transmission of this novel coronavirus through various factors. Every nation deals with varied population density and size; air quality and pollutants; the nature of land and water, which significantly impact the transmission of coronavirus. The WHO (Ziaeepour et al., 2008) [1] has recommended rapid reviews to provide timely evidence to the policymakers to","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Air pollutants; Air quality; COVID-19; Environment; Meteorological factors; Pandemic; Rapid review","Yadav","Anshita","University School of Management Studies, Guru Gobind Singh Indraprastha University, Sector 16 C, Dwarka, New Delhi, India",NA
"828","34234623","10.1016/j.rser.2021.111239","COVID-19 and environmental concerns: A rapid review.","COVID-19 has slowed global economic growth and consequently impacted the environment as well. Parallelly, the environment also influences the transmission of this novel coronavirus through various factors. Every nation deals with varied population density and size; air quality and pollutants; the nature of land and water, which significantly impact the transmission of coronavirus. The WHO (Ziaeepour et al., 2008) [1] has recommended rapid reviews to provide timely evidence to the policymakers to","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","Air pollutants; Air quality; COVID-19; Environment; Meteorological factors; Pandemic; Rapid review","Srivastava","Mrinalini","University School of Management Studies, Guru Gobind Singh Indraprastha University, Sector 16 C, Dwarka, New Delhi, India",NA
"829","34234622","10.1016/j.rser.2020.110578","Exploring the effects of California's COVID-19 shelter-in-place order on household energy practices and intention to adopt smart home technologies.","To contain the spread of the novel coronavirus (COVID-19), local and state governments in the U.S. have imposed restrictions on daily life, resulting in dramatic changes to how and where people interact, travel, socialize, and work. Using a social practice perspective, we explore how California's Shelter-in-Place (SIP) order impacted household energy activities. To do so, we conducted an online survey of California residents (n = 804) during active SIP restrictions (May 5-18, 2020). We asked res","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Coronavirus; Residential energy use; Shelter in place; Smart home technology; Social practice theory; Stay at home","Zanocco","C","Civil and Environmental Engineering, Stanford University, Y2E2, 473 Via Ortega, Room 311, Stanford, CA, 94305, USA",NA
"830","34234622","10.1016/j.rser.2020.110578","Exploring the effects of California's COVID-19 shelter-in-place order on household energy practices and intention to adopt smart home technologies.","To contain the spread of the novel coronavirus (COVID-19), local and state governments in the U.S. have imposed restrictions on daily life, resulting in dramatic changes to how and where people interact, travel, socialize, and work. Using a social practice perspective, we explore how California's Shelter-in-Place (SIP) order impacted household energy activities. To do so, we conducted an online survey of California residents (n = 804) during active SIP restrictions (May 5-18, 2020). We asked res","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Coronavirus; Residential energy use; Shelter in place; Smart home technology; Social practice theory; Stay at home","Flora","J","Civil and Environmental Engineering, Stanford University, Y2E2, 473 Via Ortega, Room 311, Stanford, CA, 94305, USA",NA
"831","34234622","10.1016/j.rser.2020.110578","Exploring the effects of California's COVID-19 shelter-in-place order on household energy practices and intention to adopt smart home technologies.","To contain the spread of the novel coronavirus (COVID-19), local and state governments in the U.S. have imposed restrictions on daily life, resulting in dramatic changes to how and where people interact, travel, socialize, and work. Using a social practice perspective, we explore how California's Shelter-in-Place (SIP) order impacted household energy activities. To do so, we conducted an online survey of California residents (n = 804) during active SIP restrictions (May 5-18, 2020). We asked res","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Coronavirus; Residential energy use; Shelter in place; Smart home technology; Social practice theory; Stay at home","Rajagopal","R","Civil and Environmental Engineering, Stanford University, Y2E2, 473 Via Ortega, Room 311, Stanford, CA, 94305, USA",NA
"832","34234622","10.1016/j.rser.2020.110578","Exploring the effects of California's COVID-19 shelter-in-place order on household energy practices and intention to adopt smart home technologies.","To contain the spread of the novel coronavirus (COVID-19), local and state governments in the U.S. have imposed restrictions on daily life, resulting in dramatic changes to how and where people interact, travel, socialize, and work. Using a social practice perspective, we explore how California's Shelter-in-Place (SIP) order impacted household energy activities. To do so, we conducted an online survey of California residents (n = 804) during active SIP restrictions (May 5-18, 2020). We asked res","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Coronavirus; Residential energy use; Shelter in place; Smart home technology; Social practice theory; Stay at home","Boudet","H","School of Public Policy, Oregon State University, 300 Bexell Hall, Corvallis, OR, 97331, USA",NA
"833","34234619","10.1016/j.rser.2020.110349","Herding behaviour in energy stock markets during the Global Financial Crisis, SARS, and ongoing COVID-19.","Environmental change created worldwide interest in investing in renewable energy. Less reliance on fossil fuels would have a substantial influence on investors for alternative energy, especially renewable energy. The literature has concentrated on empirical studies of herding behaviour in finance, but not in renewable energy. This paper fills the gap by investigating herding in renewable energy, using daily closing prices in renewable and fossil fuel energy stock returns in the USA, Europe, and ","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Cross-area effects; Cross-sector effects; Crude oil market; Extreme market movements; Global financial crisis; Herding behaviour; Renewable energy; SARS","Chang","Chia-Lin","Department of Applied Economics and Department of FinanceNational Chung Hsing University, Taiwan",NA
"834","34234619","10.1016/j.rser.2020.110349","Herding behaviour in energy stock markets during the Global Financial Crisis, SARS, and ongoing COVID-19.","Environmental change created worldwide interest in investing in renewable energy. Less reliance on fossil fuels would have a substantial influence on investors for alternative energy, especially renewable energy. The literature has concentrated on empirical studies of herding behaviour in finance, but not in renewable energy. This paper fills the gap by investigating herding in renewable energy, using daily closing prices in renewable and fossil fuel energy stock returns in the USA, Europe, and ","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Cross-area effects; Cross-sector effects; Crude oil market; Extreme market movements; Global financial crisis; Herding behaviour; Renewable energy; SARS","McAleer","Michael","Department of Finance, Asia University, Taiwan",NA
"835","34234619","10.1016/j.rser.2020.110349","Herding behaviour in energy stock markets during the Global Financial Crisis, SARS, and ongoing COVID-19.","Environmental change created worldwide interest in investing in renewable energy. Less reliance on fossil fuels would have a substantial influence on investors for alternative energy, especially renewable energy. The literature has concentrated on empirical studies of herding behaviour in finance, but not in renewable energy. This paper fills the gap by investigating herding in renewable energy, using daily closing prices in renewable and fossil fuel energy stock returns in the USA, Europe, and ","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19; Cross-area effects; Cross-sector effects; Crude oil market; Extreme market movements; Global financial crisis; Herding behaviour; Renewable energy; SARS","Wang","Yu-Ann","Department of Applied Economics and Department of FinanceNational Chung Hsing University, Taiwan",NA
"836","34234614","10.1016/j.rser.2020.109883","Minimising the present and future plastic waste, energy and environmental footprints related to COVID-19.","The COVID-19 pandemic has had growing environmental consequences related to plastic use and follow-up waste, but more urgent health issues have far overshadowed the potential impacts. This paper gives a prospective outlook on how the disruption caused by COVID-19 can act as a catalyst for short-term and long-term changes in plastic waste management practices throughout the world. The impact of the pandemic and epidemic following through the life cycles of various plastic products, particularly t","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 pandemic; Dynamic waste management; Environmental footprints reduction; Plastic waste footprint","Kleme","Jirí Jaromír","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology - VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"837","34234614","10.1016/j.rser.2020.109883","Minimising the present and future plastic waste, energy and environmental footprints related to COVID-19.","The COVID-19 pandemic has had growing environmental consequences related to plastic use and follow-up waste, but more urgent health issues have far overshadowed the potential impacts. This paper gives a prospective outlook on how the disruption caused by COVID-19 can act as a catalyst for short-term and long-term changes in plastic waste management practices throughout the world. The impact of the pandemic and epidemic following through the life cycles of various plastic products, particularly t","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 pandemic; Dynamic waste management; Environmental footprints reduction; Plastic waste footprint","Fan","Yee Van","Sustainable Process Integration Laboratory - SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology - VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic",NA
"838","34234614","10.1016/j.rser.2020.109883","Minimising the present and future plastic waste, energy and environmental footprints related to COVID-19.","The COVID-19 pandemic has had growing environmental consequences related to plastic use and follow-up waste, but more urgent health issues have far overshadowed the potential impacts. This paper gives a prospective outlook on how the disruption caused by COVID-19 can act as a catalyst for short-term and long-term changes in plastic waste management practices throughout the world. The impact of the pandemic and epidemic following through the life cycles of various plastic products, particularly t","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 pandemic; Dynamic waste management; Environmental footprints reduction; Plastic waste footprint","Tan","Raymond R","Chemical Engineering Department, De La Salle University, 2401 Taft Avenue, 0922, Manila, Philippines",NA
"839","34234614","10.1016/j.rser.2020.109883","Minimising the present and future plastic waste, energy and environmental footprints related to COVID-19.","The COVID-19 pandemic has had growing environmental consequences related to plastic use and follow-up waste, but more urgent health issues have far overshadowed the potential impacts. This paper gives a prospective outlook on how the disruption caused by COVID-19 can act as a catalyst for short-term and long-term changes in plastic waste management practices throughout the world. The impact of the pandemic and epidemic following through the life cycles of various plastic products, particularly t","2021","07","08","Renew Sustain Energy Rev","Renewable &amp; sustainable energy reviews","COVID-19 pandemic; Dynamic waste management; Environmental footprints reduction; Plastic waste footprint","Jiang","Peng","Department of Systems Science, Institute of High Performance Computing, ASTAR, Singapore, 138632, Singapore",NA
"840","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Aly","Mai M","Clinical Hematology Unit, Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"841","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Meshref","Taghreed S","Critical Care Unit, Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"842","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Abdelhameid","Marwa A","Department of Internal Medicine, Faculty of Medicine, Aswan University, Aswan, Egypt",NA
"843","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Ahmed","Shimaa A","Department of Internal Medicine, Faculty of Medicine, Qena University, Qena, Egypt",NA
"844","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Shaltout","Asmaa S","Department of Medical Microbiology &amp",NA
"845","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Abdel-Moniem","Alaa Eldin","Critical Care Unit, Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"846","34234607","10.2147/JBM.S316681","Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.","Coronaviruses belong to a large family that leads to respiratory infection of various severity. Hematological ratios are indicators of inflammatory response widely used in viral pneumonia with affordability in developing countries. Study the role of the neutrophil lymphocyte ratio (NLR), derived NLR ratio (d-NLR), platelet lymphocyte ratio (PLR), and lymphocyte monocyte ratio (LMR) in predicting the outcome of COVID-19 Egyptian patients. A retrospective study on 496 COVID-19 Egyptian patients, m","2021","07","09","J Blood Med","Journal of blood medicine","COVID-19; Egypt; LMR; NLR; PLR; d-NLR","Hamad","Dina A","Critical Care Unit, Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt",NA
"847","34234600","10.2147/NSS.S325962","Erratum: Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled [Corrigendum].","[This corrects the article DOI: 10.2147/NSS.S307996.].","2021","07","08","Nat Sci Sleep","Nature and science of sleep",NA,NA,NA,NA,NA
"848","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Lin","Ying Ni","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"849","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Liu","Zhuo Ran","Department of Thyroid and Vascular Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"850","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Li","Shi Qi","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"851","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Li","Chuan Xiang","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"852","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Zhang","Liu","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"853","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Li","Ning","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"854","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Sun","Xian Wen","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"855","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Li","Hong Peng","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"856","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Zhou","Jian Ping","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"857","34234598","10.2147/NSS.S312037","Burden of Sleep Disturbance During COVID-19 Pandemic: A Systematic Review.","Coronavirus disease 2019 (COVID-19) pandemic may exert adverse impacts on sleep among populations, which may raise awareness of the burden of sleep disturbance, and the demand of intervention strategies for different populations. We aimed to summarize the current evidence for the impacts of COVID-19 on sleep in patients with COVID-19, healthcare workers (HWs), and the general population. We searched PubMed and Embase for studies on the prevalence of sleep disturbance. Totally, 86 studies were in","2021","07","09","Nat Sci Sleep","Nature and science of sleep","COVID-19 pandemic; SARS-CoV2; sleep disturbance","Li","Qing Yun","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"858","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Seboka","Binyam Tariku","School of public health, Dilla University, Dilla, Ethiopia",NA
"859","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Yehualashet","Delelegn Emwodew","School of public health, Dilla University, Dilla, Ethiopia",NA
"860","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Belay","Moges Mareg","School of public health, Dilla University, Dilla, Ethiopia",NA
"861","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Kabthymer","Robel Hussen","School of public health, Dilla University, Dilla, Ethiopia",NA
"862","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Ali","Helen","School of public health, Dilla University, Dilla, Ethiopia",NA
"863","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Hailegebreal","Samuel","Department of Health Informatics, Arbaminch University, Arbaminch, Ethiopia",NA
"864","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Demeke","Abel Desalegn","Department of Nursing, Dilla University, Dilla, Ethiopia",NA
"865","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Amede","Endris Seid","Department of Psychiatry, Dilla University, Dilla, Ethiopia",NA
"866","34234590","10.2147/RMHP.S315043","Factors Influencing COVID-19 Vaccination Demand and Intent in Resource-Limited Settings: Based on Health Belief Model.","Vaccination is, without doubt, one of the most outstanding health interventions in reducing unprecedented damages of coronavirus disease (COVID-19). Globally, several vaccines have been produced to be effective against COVID-19. This survey aimed to assess the demand and intent towards the COVID-19 vaccine among the general population in Ethiopia. Also, factors influencing their demand, intention, and willingness to pay for the COVID-19 vaccine were described, which is poorly understood in resou","2021","07","09","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; Ethiopia; demand; health belief model; intention; willingness-to-pay","Tesfa","Getanew Aschalew","School of public health, Dilla University, Dilla, Ethiopia",NA
"867","34234587","10.2147/PRBM.S316664","The Effect of Emotional Intelligence and Academic Social Networking Sites on Academic Performance During the COVID-19 Pandemic.","During the COVID-19 pandemic, there has been an increase in the use of digital platforms for educational purposes, and increased use of smartphones and social media has affected the academic performance of students. In this study, we explored how emotional intelligence can, directly and indirectly, influence academic performance, with academic social networking sites (ASNS) as a mediator. A survey questionnaire comprising 42 items was used to collect data on emotional intelligence, ASNS, and aca","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","academic social networking sites; higher education; motivation; self-awareness; self-regulation; social skills","Iqbal","Javed","School of Education, Guangzhou University, Guangzhou, People's Republic of China",NA
"868","34234587","10.2147/PRBM.S316664","The Effect of Emotional Intelligence and Academic Social Networking Sites on Academic Performance During the COVID-19 Pandemic.","During the COVID-19 pandemic, there has been an increase in the use of digital platforms for educational purposes, and increased use of smartphones and social media has affected the academic performance of students. In this study, we explored how emotional intelligence can, directly and indirectly, influence academic performance, with academic social networking sites (ASNS) as a mediator. A survey questionnaire comprising 42 items was used to collect data on emotional intelligence, ASNS, and aca","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","academic social networking sites; higher education; motivation; self-awareness; self-regulation; social skills","Qureshi","Naima","Division of Education, University of Education, Lahore, Pakistan",NA
"869","34234587","10.2147/PRBM.S316664","The Effect of Emotional Intelligence and Academic Social Networking Sites on Academic Performance During the COVID-19 Pandemic.","During the COVID-19 pandemic, there has been an increase in the use of digital platforms for educational purposes, and increased use of smartphones and social media has affected the academic performance of students. In this study, we explored how emotional intelligence can, directly and indirectly, influence academic performance, with academic social networking sites (ASNS) as a mediator. A survey questionnaire comprising 42 items was used to collect data on emotional intelligence, ASNS, and aca","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","academic social networking sites; higher education; motivation; self-awareness; self-regulation; social skills","Ashraf","Muhammad Azeem","Research Institute of Education Science, Hunan University, Changsha, Hunan, People's Republic of China",NA
"870","34234587","10.2147/PRBM.S316664","The Effect of Emotional Intelligence and Academic Social Networking Sites on Academic Performance During the COVID-19 Pandemic.","During the COVID-19 pandemic, there has been an increase in the use of digital platforms for educational purposes, and increased use of smartphones and social media has affected the academic performance of students. In this study, we explored how emotional intelligence can, directly and indirectly, influence academic performance, with academic social networking sites (ASNS) as a mediator. A survey questionnaire comprising 42 items was used to collect data on emotional intelligence, ASNS, and aca","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","academic social networking sites; higher education; motivation; self-awareness; self-regulation; social skills","Rasool","Samma Faiz","School of Innovation and Entrepreneurship, Entrepreneurship Institute, Guangzhou University, Guangzhou, People's Republic of China",NA
"871","34234587","10.2147/PRBM.S316664","The Effect of Emotional Intelligence and Academic Social Networking Sites on Academic Performance During the COVID-19 Pandemic.","During the COVID-19 pandemic, there has been an increase in the use of digital platforms for educational purposes, and increased use of smartphones and social media has affected the academic performance of students. In this study, we explored how emotional intelligence can, directly and indirectly, influence academic performance, with academic social networking sites (ASNS) as a mediator. A survey questionnaire comprising 42 items was used to collect data on emotional intelligence, ASNS, and aca","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","academic social networking sites; higher education; motivation; self-awareness; self-regulation; social skills","Asghar","Muhammad Zaheer","Education &amp",NA
"872","34234585","10.2147/PRBM.S310266","The Experience of Patients with COVID-19 in China: An Interpretative Phenomenological Analysis.","The present study examined the experiences of patients diagnosed with COVID-19 to better understand their concerns and inspiration and provide better care. Semistructured interviews were performed with 10 COVID-19 patients from the Optical Valley Branch of Maternity and Child Healthcare Hospital of Hubei Province. Interviews were recorded on audiotape and transcribed verbatim. Transcripts were analysed using an interpretative phenomenological analysis. Four superordinate themes emerged: psycholo","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","COVID-19; adaptation and growth; interpretative phenomenological analysis; patients experience","Wang","Yanbo","Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine, Shanghai, 200122, People's Republic of China",NA
"873","34234585","10.2147/PRBM.S310266","The Experience of Patients with COVID-19 in China: An Interpretative Phenomenological Analysis.","The present study examined the experiences of patients diagnosed with COVID-19 to better understand their concerns and inspiration and provide better care. Semistructured interviews were performed with 10 COVID-19 patients from the Optical Valley Branch of Maternity and Child Healthcare Hospital of Hubei Province. Interviews were recorded on audiotape and transcribed verbatim. Transcripts were analysed using an interpretative phenomenological analysis. Four superordinate themes emerged: psycholo","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","COVID-19; adaptation and growth; interpretative phenomenological analysis; patients experience","Pan","Xiao","Department of Medical Psychology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, People's Republic of China",NA
"874","34234585","10.2147/PRBM.S310266","The Experience of Patients with COVID-19 in China: An Interpretative Phenomenological Analysis.","The present study examined the experiences of patients diagnosed with COVID-19 to better understand their concerns and inspiration and provide better care. Semistructured interviews were performed with 10 COVID-19 patients from the Optical Valley Branch of Maternity and Child Healthcare Hospital of Hubei Province. Interviews were recorded on audiotape and transcribed verbatim. Transcripts were analysed using an interpretative phenomenological analysis. Four superordinate themes emerged: psycholo","2021","07","09","Psychol Res Behav Manag","Psychology research and behavior management","COVID-19; adaptation and growth; interpretative phenomenological analysis; patients experience","Bai","Yonghai","Department of Medical Psychology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, People's Republic of China",NA
"875","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Santos","Caique","Bauru School of Dentistry, University of São Paulo, Periodontics, Bauru, Brazil",NA
"876","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","da Fonseca Orcina","Bernardo","Bauru School of Dentistry, University of São Paulo, Department of Surgery, Stomatology, Pathology and Radiology, Bauru, Brazil",NA
"877","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Brito Reia","Verônica Caroline","Bauru School of Dentistry, University of São Paulo, Department of Surgery, Stomatology, Pathology and Radiology, Bauru, Brazil",NA
"878","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Ribeiro","Lucas Gabriel","Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil",NA
"879","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Grotto","Rejane M T","Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil",NA
"880","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Prudenciatti","Aruã","Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil",NA
"881","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","de Moraes","Leonardo Nazario","Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil",NA
"882","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Ragghianti Zangrando","Mariana","Bauru School of Dentistry, University of São Paulo, Periodontics, Bauru, Brazil",NA
"883","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","Vilhena","Fabiano Vieira","TRIALS - Oral Health &amp",NA
"884","34234570","10.2147/CCIDE.S315419","Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.","This research suggested an in vitro virucidal action of a dental gel and a mouthwash with phthalocyanine derivative. The aim of this study was to report an in vitro study evaluating the virucidal capacity of mouthwash and dental gel containing anionic phthalocyanine derivate (APD). The research followed the recommendations of the National Health Surveillance Agency (ANVISA) and adapted methodology, described in the standards EN14776: 2015; ASTM E1053-11 and the Robert Koch Institute - RKI, in ad","2021","07","09","Clin Cosmet Investig Dent","Clinical, cosmetic and investigational dentistry","coronavirus infections; dentifrices; in vitro techniques; mouthwash","da Silva Santos","Paulo Sérgio","Bauru School of Dentistry, University of São Paulo, Department of Surgery, Stomatology, Pathology and Radiology, Bauru, Brazil",NA
"885","34234532","10.2147/IJGM.S313860","SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.","Since December 2019, corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, posing a huge threat to human health, and the current epidemic prevention situation is still severe. Hematological parameters directly reflect the damage of SARS-CoV-2 to human blood cells, which can better assess the severity and prognosis of patients infected with COVID-19, but hematological parameters have some differences between adult","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; adults; blood parameters; child; hematology","Liu","Lanqin","Department of Pediatric Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China",NA
"886","34234532","10.2147/IJGM.S313860","SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.","Since December 2019, corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, posing a huge threat to human health, and the current epidemic prevention situation is still severe. Hematological parameters directly reflect the damage of SARS-CoV-2 to human blood cells, which can better assess the severity and prognosis of patients infected with COVID-19, but hematological parameters have some differences between adult","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; adults; blood parameters; child; hematology","She","Jiatong","Department of Pediatrics, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China",NA
"887","34234532","10.2147/IJGM.S313860","SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.","Since December 2019, corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, posing a huge threat to human health, and the current epidemic prevention situation is still severe. Hematological parameters directly reflect the damage of SARS-CoV-2 to human blood cells, which can better assess the severity and prognosis of patients infected with COVID-19, but hematological parameters have some differences between adult","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; adults; blood parameters; child; hematology","Bai","Yongqi","Department of Pediatric Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China",NA
"888","34234532","10.2147/IJGM.S313860","SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.","Since December 2019, corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, posing a huge threat to human health, and the current epidemic prevention situation is still severe. Hematological parameters directly reflect the damage of SARS-CoV-2 to human blood cells, which can better assess the severity and prognosis of patients infected with COVID-19, but hematological parameters have some differences between adult","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; adults; blood parameters; child; hematology","Liu","Wenjun","Department of Pediatric Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China",NA
"889","34234528","10.2147/IJGM.S317350","Impacts of Demographic and Clinical Characteristics on Disease Severity and Mortality in Patients with Confirmed COVID-19.","We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with confirmed COVID-19 who were consecutively admitted to our tertiary hospital. In this retrospective, single-center, observational study, we enrolled consecutive 540 adult patients who had COVID-19 confirmed by a molecular method. Patients were categorized into three groups based on disease severity. Patients' demographic and cl","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; clinical characteristics; demographic characteristics; disease severity; mortality","Az","Adem","University of Health Sciences, Haseki Training and Research Hospital, Department of Emergency Medicine, Istanbul, Turkey",NA
"890","34234528","10.2147/IJGM.S317350","Impacts of Demographic and Clinical Characteristics on Disease Severity and Mortality in Patients with Confirmed COVID-19.","We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with confirmed COVID-19 who were consecutively admitted to our tertiary hospital. In this retrospective, single-center, observational study, we enrolled consecutive 540 adult patients who had COVID-19 confirmed by a molecular method. Patients were categorized into three groups based on disease severity. Patients' demographic and cl","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; clinical characteristics; demographic characteristics; disease severity; mortality","Sogut","Ozgur","University of Health Sciences, Haseki Training and Research Hospital, Department of Emergency Medicine, Istanbul, Turkey",NA
"891","34234528","10.2147/IJGM.S317350","Impacts of Demographic and Clinical Characteristics on Disease Severity and Mortality in Patients with Confirmed COVID-19.","We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with confirmed COVID-19 who were consecutively admitted to our tertiary hospital. In this retrospective, single-center, observational study, we enrolled consecutive 540 adult patients who had COVID-19 confirmed by a molecular method. Patients were categorized into three groups based on disease severity. Patients' demographic and cl","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; clinical characteristics; demographic characteristics; disease severity; mortality","Akdemir","Tarik","University of Health Sciences, Haseki Training and Research Hospital, Department of Emergency Medicine, Istanbul, Turkey",NA
"892","34234528","10.2147/IJGM.S317350","Impacts of Demographic and Clinical Characteristics on Disease Severity and Mortality in Patients with Confirmed COVID-19.","We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with confirmed COVID-19 who were consecutively admitted to our tertiary hospital. In this retrospective, single-center, observational study, we enrolled consecutive 540 adult patients who had COVID-19 confirmed by a molecular method. Patients were categorized into three groups based on disease severity. Patients' demographic and cl","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; clinical characteristics; demographic characteristics; disease severity; mortality","Ergenc","Huseyin","University of Health Sciences, Haseki Training and Research Hospital, Department of Emergency Medicine, Istanbul, Turkey",NA
"893","34234528","10.2147/IJGM.S317350","Impacts of Demographic and Clinical Characteristics on Disease Severity and Mortality in Patients with Confirmed COVID-19.","We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with confirmed COVID-19 who were consecutively admitted to our tertiary hospital. In this retrospective, single-center, observational study, we enrolled consecutive 540 adult patients who had COVID-19 confirmed by a molecular method. Patients were categorized into three groups based on disease severity. Patients' demographic and cl","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; clinical characteristics; demographic characteristics; disease severity; mortality","Dogan","Yunus","University of Health Sciences, Haseki Training and Research Hospital, Department of Emergency Medicine, Istanbul, Turkey",NA
"894","34234528","10.2147/IJGM.S317350","Impacts of Demographic and Clinical Characteristics on Disease Severity and Mortality in Patients with Confirmed COVID-19.","We investigated potential predictive factors for mortality and disease severity from demographic and clinical data, comorbidities, and laboratory findings in patients with confirmed COVID-19 who were consecutively admitted to our tertiary hospital. In this retrospective, single-center, observational study, we enrolled consecutive 540 adult patients who had COVID-19 confirmed by a molecular method. Patients were categorized into three groups based on disease severity. Patients' demographic and cl","2021","07","09","Int J Gen Med","International journal of general medicine","COVID-19; clinical characteristics; demographic characteristics; disease severity; mortality","Cakirca","Mustafa","Bezmialem Vakif University, Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey",NA
"895","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Kazmi","Samia","Department of Internal Medicine, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"896","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Alam","Ashar","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"897","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Salman","Beena","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"898","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Saeed","Faiza","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"899","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Memon","Shoukat","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"900","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Chughtai","Javeria","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"901","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Ahmed","Shahzad","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"902","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Tariq","Sobia","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"903","34234514","10.2147/IJNRD.S310035","Clinical Course and Outcome of ESRD Patients on Maintenance Hemodialysis Infected with COVID-19: A Single-Center Study.","In an ESRD subset of patients, COVID-19 infection is associated with increased disease burden and higher mortality rates. We conducted a retrospective single-center cohort study in which 43 ESRD patients had a diagnosis of COVID-19. Association of risk factors with mortality was assessed by chi-square test and logistic regression analysis. Data were collected on a structured performa which included variables like age, gender, comorbid conditions, drug history, clinical presentation, hemodynamic ","2021","07","09","Int J Nephrol Renovasc Dis","International journal of nephrology and renovascular disease","CKD; COVID-19; CRRT; ESRD; Pakistan; hemodialysis","Imtiaz","Salman","Department of Nephrology, The Indus Hospital and Health Network, Karachi, Sindh, Pakistan",NA
"904","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Rochmah","Nur","Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia",NA
"905","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Faizi","Muhammad","Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia",NA
"906","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Hisbiyah","Yuni","Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia",NA
"907","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Triastuti","Ike Wahyu","Department of Child Health, Dr. Soetomo General Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia",NA
"908","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Wicaksono","Garindra","Department of Child Health, Dr. Soetomo General Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia",NA
"909","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Endaryanto","Anang","Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia",NA
"910","34234488","10.2147/DMSO.S313575","Quality of Life Differences in Pre- and Post-Educational Treatment in Type 1 Diabetes Mellitus During COVID-19.","The coronavirus-19 (COVID-19) pandemic requires the use of online media to ensure monitoring of type 1 diabetes mellitus (T1DM) in children. Thus, this study aims to determine whether online education effectively improves the quality of life (QoL) in children with T1DM during the coronavirus-19 pandemic. The study, conducted from March to October 2020, utilized the paired t-test before and after online education. Moreover, it adopts the recommended Pediatric Quality of Life Inventory (PedsQL) 3.","2021","07","09","Diabetes Metab Syndr Obes","Diabetes, metabolic syndrome and obesity : targets and therapy","COVID-19; PedsQL; T1DM; children; online education","Soetjipto","Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia","Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia","34234488"
"911","34234455","10.2147/JMDH.S319872","A Survey on the Health and Financial Status of Private Educational Institutions in Afghanistan During COVID-19 Pandemic.","The worldwide spread of the coronavirus named SARS-CoV-2 has disrupted the world economy and the economy of Afghanistan as part of it. In addition, it has affected health and education in the country. The aim of this study is to highlight the damage the pandemic has done to private educational institutes in Afghanistan, in terms of finances, health and educational aspects. This is to draw attention to the setbacks the COVID-19 pandemic has caused to post-war (ie, post 2001) Afghan private educat","2021","07","09","J Multidiscip Healthc","Journal of multidisciplinary healthcare","coronavirus; education crisis; learning center; school; student; survey","Nemat","Arash","Department of Microbiology, Kabul University of Medical Sciences, Kabul, Afghanistan",NA
"912","34234455","10.2147/JMDH.S319872","A Survey on the Health and Financial Status of Private Educational Institutions in Afghanistan During COVID-19 Pandemic.","The worldwide spread of the coronavirus named SARS-CoV-2 has disrupted the world economy and the economy of Afghanistan as part of it. In addition, it has affected health and education in the country. The aim of this study is to highlight the damage the pandemic has done to private educational institutes in Afghanistan, in terms of finances, health and educational aspects. This is to draw attention to the setbacks the COVID-19 pandemic has caused to post-war (ie, post 2001) Afghan private educat","2021","07","09","J Multidiscip Healthc","Journal of multidisciplinary healthcare","coronavirus; education crisis; learning center; school; student; survey","Raufi","Nahid","Department of Dermatology, Kabul University of Medical Sciences, Kabul, Afghanistan",NA
"913","34234455","10.2147/JMDH.S319872","A Survey on the Health and Financial Status of Private Educational Institutions in Afghanistan During COVID-19 Pandemic.","The worldwide spread of the coronavirus named SARS-CoV-2 has disrupted the world economy and the economy of Afghanistan as part of it. In addition, it has affected health and education in the country. The aim of this study is to highlight the damage the pandemic has done to private educational institutes in Afghanistan, in terms of finances, health and educational aspects. This is to draw attention to the setbacks the COVID-19 pandemic has caused to post-war (ie, post 2001) Afghan private educat","2021","07","09","J Multidiscip Healthc","Journal of multidisciplinary healthcare","coronavirus; education crisis; learning center; school; student; survey","Essar","Mohammad Yasir","Medical Research Center, Kateb University, Kabul, Afghanistan",NA
"914","34234455","10.2147/JMDH.S319872","A Survey on the Health and Financial Status of Private Educational Institutions in Afghanistan During COVID-19 Pandemic.","The worldwide spread of the coronavirus named SARS-CoV-2 has disrupted the world economy and the economy of Afghanistan as part of it. In addition, it has affected health and education in the country. The aim of this study is to highlight the damage the pandemic has done to private educational institutes in Afghanistan, in terms of finances, health and educational aspects. This is to draw attention to the setbacks the COVID-19 pandemic has caused to post-war (ie, post 2001) Afghan private educat","2021","07","09","J Multidiscip Healthc","Journal of multidisciplinary healthcare","coronavirus; education crisis; learning center; school; student; survey","Zeng","Qingchun","Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China",NA
"915","34234446","10.2147/JMDH.S306253","Knowledge and Practice of Health Care Providers Towards Proper Face Mask Utilization to Minimize the Extent of COVID-19 Infection in Amhara Region Referral Hospitals, Ethiopia.","The novel coronavirus disease (COVID-19) pandemic began in early 2020, causing tens of thousands of deaths, over a million cases, and widespread socioeconomic disruption. The aim of the study was to assess health care workers' knowledge and practice of proper face mask utilization to prevent the spread of COVID-19 infection in Amhara region referral hospitals, Ethiopia. A cross-sectional institutional-based quantitative study design was conducted from May 15 to 30/2020 using pre-tested self-admi","2021","07","09","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; health care workers; knowledge; practice; proper face mask utilization","Seid Yimer","Tigist","Department of Midwifery, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"916","34234446","10.2147/JMDH.S306253","Knowledge and Practice of Health Care Providers Towards Proper Face Mask Utilization to Minimize the Extent of COVID-19 Infection in Amhara Region Referral Hospitals, Ethiopia.","The novel coronavirus disease (COVID-19) pandemic began in early 2020, causing tens of thousands of deaths, over a million cases, and widespread socioeconomic disruption. The aim of the study was to assess health care workers' knowledge and practice of proper face mask utilization to prevent the spread of COVID-19 infection in Amhara region referral hospitals, Ethiopia. A cross-sectional institutional-based quantitative study design was conducted from May 15 to 30/2020 using pre-tested self-admi","2021","07","09","J Multidiscip Healthc","Journal of multidisciplinary healthcare","COVID-19; health care workers; knowledge; practice; proper face mask utilization","Gebrehana Belay","Habtamu","Department of Midwifery, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia",NA
"917","34234442","10.2147/TCRM.S313003","Therapeutic Agents Rounding Up the Immunopathology of COVID-19.","COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause ""cytokine storm"", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 ther","2021","07","09","Ther Clin Risk Manag","Therapeutics and clinical risk management","COVID-19; corticosteroids; cytokines; immunotherapy; inflammation; monoclonal antibodies","Li","Hong Peng","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"918","34234442","10.2147/TCRM.S313003","Therapeutic Agents Rounding Up the Immunopathology of COVID-19.","COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause ""cytokine storm"", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 ther","2021","07","09","Ther Clin Risk Manag","Therapeutics and clinical risk management","COVID-19; corticosteroids; cytokines; immunotherapy; inflammation; monoclonal antibodies","He","Xuan","Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"919","34234442","10.2147/TCRM.S313003","Therapeutic Agents Rounding Up the Immunopathology of COVID-19.","COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause ""cytokine storm"", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 ther","2021","07","09","Ther Clin Risk Manag","Therapeutics and clinical risk management","COVID-19; corticosteroids; cytokines; immunotherapy; inflammation; monoclonal antibodies","Zhang","Liu","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"920","34234442","10.2147/TCRM.S313003","Therapeutic Agents Rounding Up the Immunopathology of COVID-19.","COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause ""cytokine storm"", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 ther","2021","07","09","Ther Clin Risk Manag","Therapeutics and clinical risk management","COVID-19; corticosteroids; cytokines; immunotherapy; inflammation; monoclonal antibodies","Li","Chuan Xiang","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"921","34234442","10.2147/TCRM.S313003","Therapeutic Agents Rounding Up the Immunopathology of COVID-19.","COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause ""cytokine storm"", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 ther","2021","07","09","Ther Clin Risk Manag","Therapeutics and clinical risk management","COVID-19; corticosteroids; cytokines; immunotherapy; inflammation; monoclonal antibodies","Li","Shi Qi","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"922","34234442","10.2147/TCRM.S313003","Therapeutic Agents Rounding Up the Immunopathology of COVID-19.","COVID-19 pandemic has caused more than 3 million deaths globally during the past year. The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the progress and deterioration of COVID-19. After the virus invades, the activation and release of cytokines/chemokines cause ""cytokine storm"", leading to acute respiratory distress syndrome (ARDS) and multiple organs dysfunction syndrome (MODS). Eliminating virus and blocking cytokines are important checkpoints of COVID-19 ther","2021","07","09","Ther Clin Risk Manag","Therapeutics and clinical risk management","COVID-19; corticosteroids; cytokines; immunotherapy; inflammation; monoclonal antibodies","Li","Qing Yun","Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China",NA
"923","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Forget","Marie-France","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"924","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Del Degan","Sophie","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"925","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Leblanc","Julie","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"926","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Tannous","Rita","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"927","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Desjardins","Michaël","Department of Medicine, Division of Infectious Disease, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"928","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Durand","Madeleine","Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"929","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Vu","Thien Tuong Minh","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"930","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Nguyen","Quoc Dinh","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"931","34234422","10.2147/CIA.S315405","Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.","The occurrence and predictors of delirium in older adults hospitalized for coronavirus disease 2019 (COVID-19) have not been well described. Highlighting the association with inflammatory markers may be useful for identifying delirium. This study aimed to determine the prevalence and incidence of delirium and explore its association with the C-reactive protein (CRP). This cohort study of adults aged 65 and older with a COVID-19 diagnosis took place at an academic healthcare institution between A","2021","07","21","Clin Interv Aging","Clinical interventions in aging","COVID-19; SARS-CoV-2; delirium; older adults; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; COVID-19; Cohort Studies; Delirium; Female; Hospitalization; Humans; Incidence; Inflammation Mediators; Length of Stay; Male; Prevalence; Retrospective Studies; SARS-CoV-2","Desmarais","Philippe","Department of Medicine, Division of Geriatrics, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada",NA
"932","34234394","10.6026/97320630017337","Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.","The current emergence of novel coronavirus, SARS-CoV-2 and its ceaseless expansion worldwide has posed a global health emergency that has adversely affected the humans. With the entire world striving to understand the newly emerged virus, differences in morbidity and infection rate of SARS-CoV-2 have been observed across varied geographic areas, which have been ascribed to viral mutation and evolution over time. The homotrimeric Spike (S) glycoprotein on the viral envelope surface is responsible","2021","07","09","Bioinformation","Bioinformation","RBD; SARS-CoV-2; Spike protein; binding affinity; hACE2; molecular docking; molecular modeling","Baig","Mirza Sarwar","Department of Molecular Medicine, School of Interdisciplinary Sciences &amp",NA
"933","34234394","10.6026/97320630017337","Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.","The current emergence of novel coronavirus, SARS-CoV-2 and its ceaseless expansion worldwide has posed a global health emergency that has adversely affected the humans. With the entire world striving to understand the newly emerged virus, differences in morbidity and infection rate of SARS-CoV-2 have been observed across varied geographic areas, which have been ascribed to viral mutation and evolution over time. The homotrimeric Spike (S) glycoprotein on the viral envelope surface is responsible","2021","07","09","Bioinformation","Bioinformation","RBD; SARS-CoV-2; Spike protein; binding affinity; hACE2; molecular docking; molecular modeling","Reyaz","Enam","Department of Molecular Medicine, School of Interdisciplinary Sciences &amp",NA
"934","34234394","10.6026/97320630017337","Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.","The current emergence of novel coronavirus, SARS-CoV-2 and its ceaseless expansion worldwide has posed a global health emergency that has adversely affected the humans. With the entire world striving to understand the newly emerged virus, differences in morbidity and infection rate of SARS-CoV-2 have been observed across varied geographic areas, which have been ascribed to viral mutation and evolution over time. The homotrimeric Spike (S) glycoprotein on the viral envelope surface is responsible","2021","07","09","Bioinformation","Bioinformation","RBD; SARS-CoV-2; Spike protein; binding affinity; hACE2; molecular docking; molecular modeling","Selvapandiyan","Angamuthu","Department of Molecular Medicine, School of Interdisciplinary Sciences &amp",NA
"935","34234394","10.6026/97320630017337","Differential binding of SARS-CoV-2 Spike protein variants to its cognate receptor hACE2 using molecular modeling based binding analysis.","The current emergence of novel coronavirus, SARS-CoV-2 and its ceaseless expansion worldwide has posed a global health emergency that has adversely affected the humans. With the entire world striving to understand the newly emerged virus, differences in morbidity and infection rate of SARS-CoV-2 have been observed across varied geographic areas, which have been ascribed to viral mutation and evolution over time. The homotrimeric Spike (S) glycoprotein on the viral envelope surface is responsible","2021","07","09","Bioinformation","Bioinformation","RBD; SARS-CoV-2; Spike protein; binding affinity; hACE2; molecular docking; molecular modeling","Krishnan","Anuja","Department of Molecular Medicine, School of Interdisciplinary Sciences &amp",NA
"936","34234340","10.1038/d41586-021-01826-x","COVID and schools: the evidence for reopening safely.",NA,"2021","07","13","Nature","Nature","Diseases; Epidemiology; SARS-CoV-2; Adolescent; Adult; Anxiety; COVID-19; COVID-19 Vaccines; Centers for Disease Control and Prevention, U.S.; Child; Child, Preschool; Dissent and Disputes; Education; Education, Distance; Educational Status; Humans; Masks; Parents; Politics; Risk Assessment; SARS-CoV-2; Safety; School Teachers; Schools; Student Dropouts; Students; UNESCO; Uncertainty; United States; Vaccination; Ventilation; Young Adult","Willyard","Cassandra",NA,NA
"937","34234324","10.1038/s41582-021-00536-2","Single-cell transcriptomics reveals neuroinflammation in severe COVID-19.",NA,"2021","07","10","Nat Rev Neurol","Nature reviews. Neurology",NA,"Lemprière","Sarah","Nature Reviews Neurology, . nrneuro@nature","nrneuro@nature.com"
"938","34234323","10.1038/d41586-021-01693-6","COVID and the brain: researchers zero in on how damage occurs.",NA,"2021","07","22","Nature","Nature","Diseases; Neuroscience; SARS-CoV-2","Marshall","Michael",NA,NA
"939","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Guo","Wenjing","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"940","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Pan","Bohu","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"941","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Sakkiah","Sugunadevi","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"942","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Ji","Zuowei","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"943","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Yavas","Gokhan","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"944","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Lu","Yanhui","Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA",NA
"945","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Komatsu","Takashi E","Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA",NA
"946","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Lal-Nag","Madhu","Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA",NA
"947","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Tong","Weida","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"948","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Patterson","Tucker A","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA",NA
"949","34234253","10.1038/s41598-021-93500-5","Informing selection of drugs for COVID-19 treatment through adverse events analysis.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. Therefore, selection of safe drugs for COVID-19 patients is vital for combating this pandemic. Our goal was to evaluate the safety concerns of drugs by analyzing adverse events reported in post-market surveilla","2021","07","15","Sci Rep","Scientific reports","Adverse Drug Reaction Reporting Systems; COVID-19; Clinical Trials as Topic; Databases, Factual; Humans; Product Surveillance, Postmarketing; Safety","Hong","Huixiao","National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR, 72079, USA. huixiao.hong@fda.hhs","huixiao.hong@fda.hhs.gov"
"950","34234251","10.1038/s41598-021-93546-5","Clinical characterization of dysautonomia in long COVID-19 patients.","Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in second","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Primary Dysautonomias","Barizien","Nicolas","Department of Physical Medicine and Rehabilitation, Foch Hospital, Suresnes, France",NA
"951","34234251","10.1038/s41598-021-93546-5","Clinical characterization of dysautonomia in long COVID-19 patients.","Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in second","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Primary Dysautonomias","Le Guen","Morgan","Department of Anesthesiology, Foch Hospital, Suresnes, France",NA
"952","34234251","10.1038/s41598-021-93546-5","Clinical characterization of dysautonomia in long COVID-19 patients.","Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in second","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Primary Dysautonomias","Russel","Stéphanie","Department of Cardiology, Foch Hospital, Suresnes, France",NA
"953","34234251","10.1038/s41598-021-93546-5","Clinical characterization of dysautonomia in long COVID-19 patients.","Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in second","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Primary Dysautonomias","Touche","Pauline","Department of Clinical Research and Innovation, Foch Hospital, 40 rue Worth, 92150, Suresnes, France",NA
"954","34234251","10.1038/s41598-021-93546-5","Clinical characterization of dysautonomia in long COVID-19 patients.","Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in second","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Primary Dysautonomias","Huang","Florent","Department of Cardiology, Foch Hospital, Suresnes, France",NA
"955","34234251","10.1038/s41598-021-93546-5","Clinical characterization of dysautonomia in long COVID-19 patients.","Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in second","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Fatigue; Female; Heart Rate; Humans; Male; Middle Aged; Primary Dysautonomias","Vallée","Alexandre","Department of Clinical Research and Innovation, Foch Hospital, 40 rue Worth, 92150, Suresnes, France. alexandre.g.vallee@gmail","alexandre.g.vallee@gmail.com"
"956","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Razzaq","Misbah","INSERM, BPH, U1219, Université Bordeaux, 33000, Bordeaux, France. misbah.razzaq@inserm","misbah.razzaq@inserm.fr"
"957","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Iglesias","Maria Jesus","Science for Life Laboratory, Department of Protein Science, CBH, KTH Royal Institute of Technology, Stockholm, Sweden",NA
"958","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Ibrahim-Kosta","Manal","INSERM, INRAE, C2VN, Aix Marseille University, Marseille, France",NA
"959","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Goumidi","Louisa","INSERM, INRAE, C2VN, Aix Marseille University, Marseille, France",NA
"960","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Soukarieh","Omar","INSERM, BPH, U1219, Université Bordeaux, 33000, Bordeaux, France",NA
"961","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Proust","Carole","INSERM, BPH, U1219, Université Bordeaux, 33000, Bordeaux, France",NA
"962","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Roux","Maguelonne","Laboratory of Excellence GENMED (Medical Genomics), Strasbourg, France",NA
"963","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Suchon","Pierre","INSERM, INRAE, C2VN, Aix Marseille University, Marseille, France",NA
"964","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Boland","Anne","Laboratory of Excellence GENMED (Medical Genomics), Strasbourg, France",NA
"965","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Daiain","Delphine","Laboratory of Excellence GENMED (Medical Genomics), Strasbourg, France",NA
"966","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Olaso","Robert","Laboratory of Excellence GENMED (Medical Genomics), Strasbourg, France",NA
"967","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Havervall","Sebastian","Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden",NA
"968","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Thalin","Charlotte","Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden",NA
"969","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Butler","Lynn","Science for Life Laboratory, Department of Protein Science, CBH, KTH Royal Institute of Technology, Stockholm, Sweden",NA
"970","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Deleuze","Jean-François","Laboratory of Excellence GENMED (Medical Genomics), Strasbourg, France",NA
"971","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Odeberg","Jacob","Science for Life Laboratory, Department of Protein Science, CBH, KTH Royal Institute of Technology, Stockholm, Sweden",NA
"972","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Morange","Pierre-Emmanuel","INSERM, INRAE, C2VN, Aix Marseille University, Marseille, France",NA
"973","34234248","10.1038/s41598-021-93390-7","An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism.","Venous thromboembolism is the third common cardiovascular disease and is composed of two entities, deep vein thrombosis (DVT) and its potential fatal form, pulmonary embolism (PE). While PE is observed in ~ 40% of patients with documented DVT, there is limited biomarkers that can help identifying patients at high PE risk. To fill this need, we implemented a two hidden-layers artificial neural networks (ANN) on 376 antibodies and 19 biological traits measured in the plasma of 1388 DVT patients, w","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Neural Networks, Computer; Phenotype; Polymorphism, Single Nucleotide; Proteomics; Pulmonary Embolism; Receptors, Cell Surface","Trégouët","David-Alexandre","INSERM, BPH, U1219, Université Bordeaux, 33000, Bordeaux, France. david-alexandre.tregouet@u-bordeaux",NA
"974","34234190","10.1038/s41598-021-93148-1","Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.","During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called ""immunity passports"") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some con","2021","07","12","Sci Rep","Scientific reports",NA,"Aranzales","Iván","School of Economics and Finance, Queensland University of Technology, Brisbane, QLD, Australia",NA
"975","34234190","10.1038/s41598-021-93148-1","Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.","During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called ""immunity passports"") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some con","2021","07","12","Sci Rep","Scientific reports",NA,"Chan","Ho Fai","School of Economics and Finance, Queensland University of Technology, Brisbane, QLD, Australia",NA
"976","34234190","10.1038/s41598-021-93148-1","Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.","During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called ""immunity passports"") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some con","2021","07","12","Sci Rep","Scientific reports",NA,"Eichenberger","Reiner","University of Fribourg, Fribourg, Switzerland",NA
"977","34234190","10.1038/s41598-021-93148-1","Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.","During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called ""immunity passports"") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some con","2021","07","12","Sci Rep","Scientific reports",NA,"Hegselmann","Rainer","Frankfurt School of Finance &amp",NA
"978","34234190","10.1038/s41598-021-93148-1","Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.","During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called ""immunity passports"") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some con","2021","07","12","Sci Rep","Scientific reports",NA,"Stadelmann","David","Centre for Behavioural Economics, Society and Technology (BEST), Brisbane, QLD, Australia. david.stadelmann@uni-bayreuth",NA
"979","34234190","10.1038/s41598-021-93148-1","Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.","During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called ""immunity passports"") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some con","2021","07","12","Sci Rep","Scientific reports",NA,"Torgler","Benno","School of Economics and Finance, Queensland University of Technology, Brisbane, QLD, Australia",NA
"980","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Jing","Min","Faculty of Computing, Engineering and the Built Environment, Ulster University, Jordanstown , UK",NA
"981","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Bond","Raymond","Faculty of Computing, Engineering and the Built Environment, Ulster University, Jordanstown , UK",NA
"982","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Robertson","Louise J","Biomedical Sciences Research Institute, Ulster University, Coleraine, UK",NA
"983","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Moore","Julie","Biomedical Sciences Research Institute, Ulster University, Coleraine, UK",NA
"984","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Kowalczyk","Amanda","Biomedical Sciences Research Institute, Ulster University, Coleraine, UK",NA
"985","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Price","Ruth","Biomedical Sciences Research Institute, Ulster University, Coleraine, UK",NA
"986","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Burns","William","Faculty of Computing, Engineering and the Built Environment, Ulster University, Jordanstown , UK",NA
"987","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Nesbit","M Andrew","Biomedical Sciences Research Institute, Ulster University, Coleraine, UK",NA
"988","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","McLaughlin","James","Faculty of Computing, Engineering and the Built Environment, Ulster University, Jordanstown , UK. jad.mclaughlin@ulster.ac","jad.mclaughlin@ulster.ac.uk"
"989","34234188","10.1038/s41598-021-93262-0","User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing.","Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of ","2021","07","15","Sci Rep","Scientific reports","Adolescent; Adult; Antibodies, Viral; COVID-19 Testing; Child; Educational Status; Female; Humans; Immunoassay; Male; Middle Aged; Patient Satisfaction; Point-of-Care Systems; Self Administration; Sensitivity and Specificity; Young Adult","Moore","Tara","Biomedical Sciences Research Institute, Ulster University, Coleraine, UK. tara.moore@ulster.ac","tara.moore@ulster.ac.uk"
"990","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Liu","Rong","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"991","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Wu","Pei","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"992","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Ogrodzki","Pauline","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"993","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Mahmoud","Sally","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"994","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Liang","Ke","MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"995","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Liu","Pengjuan","MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"996","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Francis","Stephen S","Department of Neurological Surgery, University of California, San Francisco, USA",NA
"997","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Khalak","Hanif","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"998","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Liu","Denghui","Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China",NA
"999","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Li","Junhua","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1000","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Ma","Tao","MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1001","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Chen","Fang","MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1002","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Liu","Weibin","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1003","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Huang","Xinyu","MGI, BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1004","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","He","Wenjun","Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China",NA
"1005","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Yuan","Zhaorong","Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China",NA
"1006","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Qiao","Nan","Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China",NA
"1007","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Meng","Xin","Laboratory of Health Intelligence, Huawei Technologies Co., Ltd., Shenzhen, 518100, China",NA
"1008","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Alqarni","Budoor","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"1009","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Quilez","Javier","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"1010","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Kusuma","Vinay","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"1011","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Lin","Long","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1012","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Jin","Xin","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1013","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Yang","Chongguang","Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA",NA
"1014","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Anton","Xavier","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"1015","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Koshy","Ashish","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"1016","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Yang","Huanming","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1017","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Xu","Xun","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1018","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Wang","Jian","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China",NA
"1019","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Xiao","Peng","Group42 Healthcare, Abu Dhabi, United Arab Emirates",NA
"1020","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Al Kaabi","Nawal","SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates",NA
"1021","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Fasihuddin","Mohammed Saifuddin","SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates",NA
"1022","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Selvaraj","Francis Amirtharaj","SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates",NA
"1023","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Weber","Stefan","SEHA, Abu Dhabi Health Services Co., Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates",NA
"1024","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Al Hosani","Farida Ismail","Department of Health, Abu Dhabi, United Arab Emirates",NA
"1025","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Liu","Siyang","BGI-Shenzhen, Shenzhen, 518083, Guangdong, China. liusiyang@bgi","liusiyang@bgi.com"
"1026","34234167","10.1038/s41598-021-92851-3","Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response.","To unravel the source of SARS-CoV-2 introduction and the pattern of its spreading and evolution in the United Arab Emirates, we conducted meta-transcriptome sequencing of 1067 nasopharyngeal swab samples collected between May 9th and Jun 29th, 2020 during the first peak of the local COVID-19 epidemic. We identified global clade distribution and eleven novel genetic variants that were almost absent in the rest of the world and that defined five subclades specific to the UAE viral population. Cros","2021","07","15","Sci Rep","Scientific reports","Adult; COVID-19; Coinfection; Cytidine Deaminase; Female; Gene Expression Profiling; Genome, Viral; Genomics; Humans; Immunity, Innate; Male; Middle Aged; Mutation; Nasopharynx; Organ Specificity; SARS-CoV-2","Zaher","Walid Abbas","Group42 Healthcare, Abu Dhabi, United Arab Emirates. Walid.Zaher@g42","Walid.Zaher@g42.ai"
"1027","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Greaney","Allison J","Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA",NA
"1028","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Starr","Tyler N","Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA",NA
"1029","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Barnes","Christopher O","Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA",NA
"1030","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Weisblum","Yiska","Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA",NA
"1031","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Schmidt","Fabian","Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA",NA
"1032","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Caskey","Marina","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1033","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Gaebler","Christian","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1034","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Cho","Alice","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1035","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Agudelo","Marianna","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1036","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Finkin","Shlomo","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1037","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Wang","Zijun","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1038","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Poston","Daniel","Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA",NA
"1039","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Muecksch","Frauke","Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA",NA
"1040","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Hatziioannou","Theodora","Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA",NA
"1041","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bieniasz","Paul D","Howard Hughes Medical Institute, Chevy Chase, MD, USA",NA
"1042","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Robbiani","Davide F","Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA",NA
"1043","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Nussenzweig","Michel C","Howard Hughes Medical Institute, Chevy Chase, MD, USA",NA
"1044","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bjorkman","Pamela J","Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA",NA
"1045","34234131","10.1038/s41467-021-24435-8","Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.","Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear. Here we use a yeast-display system to map all mutations to the viral spike receptor-binding domain (RBD) that escape binding by representatives of three potently neutralizing classes of anti-RBD antibodies with high-resolution structures. We compare the antibody","2021","07","14","Nat Commun","Nature communications","Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Binding Sites; COVID-19; Epitopes; HLA Antigens; Humans; Immune Evasion; Models, Molecular; Mutation; Neutralization Tests; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Bloom","Jesse D","Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. jbloom@fredhutch","jbloom@fredhutch.org"
"1046","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Zengyuan","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1047","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Yanfang","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1048","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Liu","Kefang","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1049","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Li","Yan","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1050","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Lu","Qiong","Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), Beijing, China",NA
"1051","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Wang","Qingling","Shanxi Natural Carbohydrate Resource Engineering Research Center, College of Food Science and Technology, Northwest University, Xi'an, China",NA
"1052","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhang","Yuqin","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1053","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Wang","Liang","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1054","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Liao","Hanyi","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1055","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zheng","Anqi","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1056","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Ma","Sufang","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1057","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Fan","Zheng","Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1058","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Li","Huifang","The Northern Medical District of the PLA General Hospital, Beijing, China",NA
"1059","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Huang","Weijin","Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), Beijing, China",NA
"1060","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Bi","Yuhai","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1061","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Zhao","Xin","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1062","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Wang","Qihui","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China",NA
"1063","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Gao","George F","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. gaof@im.ac","gaof@im.ac.cn"
"1064","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Xiao","Haixia","Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China. xiao_hx@tib.cas",NA
"1065","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Tong","Zhou","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. tongz@im.ac","tongz@im.ac.cn"
"1066","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Qi","Jianxun","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. jxqi@im.ac","jxqi@im.ac.cn"
"1067","34234119","10.1038/s41467-021-24326-y","The molecular basis for SARS-CoV-2 binding to dog ACE2.","SARS-CoV-2 can infect many domestic animals, including dogs. Herein, we show that dog angiotensin-converting enzyme 2 (dACE2) can bind to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD), and that both pseudotyped and authentic SARS-CoV-2 can infect dACE2-expressing cells. We solved the crystal structure of RBD in complex with dACE2 and found that the total number of contact residues, contact atoms, hydrogen bonds and salt bridges at the binding interface in this complex are slight","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Cell Line; Cricetinae; Crystallography, X-Ray; Dogs; HeLa Cells; Humans; Mutation; Protein Binding; Protein Domains; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Sun","Yeping","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. sunyeping@im.ac","sunyeping@im.ac.cn"
"1068","34234112","10.1038/s41392-021-00679-0","The signal pathways and treatment of cytokine storm in COVID-19.","The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; Signal Transduction","Yang","Lan","Institute of Pediatrics, Children's Hospital of Fudan University, National Children's Medical Center, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China",NA
"1069","34234112","10.1038/s41392-021-00679-0","The signal pathways and treatment of cytokine storm in COVID-19.","The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; Signal Transduction","Xie","Xueru","Institute of Pediatrics, Children's Hospital of Fudan University, National Children's Medical Center, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China",NA
"1070","34234112","10.1038/s41392-021-00679-0","The signal pathways and treatment of cytokine storm in COVID-19.","The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; Signal Transduction","Tu","Zikun","Institute of Pediatrics, Children's Hospital of Fudan University, National Children's Medical Center, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China",NA
"1071","34234112","10.1038/s41392-021-00679-0","The signal pathways and treatment of cytokine storm in COVID-19.","The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; Signal Transduction","Fu","Jinrong","General Department, Children's Hospital of Fudan University, Shanghai, China",NA
"1072","34234112","10.1038/s41392-021-00679-0","The signal pathways and treatment of cytokine storm in COVID-19.","The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; Signal Transduction","Xu","Damo","State Key Laboratory of Respiratory Disease for Allergy at Shenzhen University, Shenzhen Key Laboratory of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen, China. xdm@szu.edu","xdm@szu.edu.cn"
"1073","34234112","10.1038/s41392-021-00679-0","The signal pathways and treatment of cytokine storm in COVID-19.","The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis and is more devastating than any other previous infectious disease. It has affected a significant proportion of the global population both physically and mentally, and destroyed businesses and societies. Current evidence suggested that immunopathology may be responsible for COVID-19 pathogenesis, including lymphopenia, neutrophilia, dysregulation of monocytes and macrophages, reduced or delayed type I interferon (IFN-I) ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Respiratory Distress Syndrome; Signal Transduction","Zhou","Yufeng","Institute of Pediatrics, Children's Hospital of Fudan University, National Children's Medical Center, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. yfzhou1@fudan.edu","yfzhou1@fudan.edu.cn"
"1074","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Pan","Yunbao","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China",NA
"1075","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Jiang","Xianghu","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China",NA
"1076","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Yang","Liu","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China",NA
"1077","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Chen","Liangjun","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China",NA
"1078","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Zeng","Xiaojiao","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China",NA
"1079","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Liu","Guohong","Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China",NA
"1080","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Tang","Yueting","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China",NA
"1081","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Qian","Chungen","The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics &amp",NA
"1082","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Wang","Xinming","Reagent R&amp",NA
"1083","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Cheng","Fangming","Reagent R&amp",NA
"1084","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Lin","Jun","Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China. linjun2021@126","linjun2021@126.com"
"1085","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Wang","Xinghuan","Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China. wangxinghuan@whu.edu","wangxinghuan@whu.edu.cn"
"1086","34234102","10.1038/s41392-021-00686-1","SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.","We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged patients. Follow-up analysis in a cohort of 171 patients at 4-11 months after the onset revealed high levels of IgG antibodies. A total of 78.1% (164/210) of the specimens tested positive for neutralizing antibody (NAb). SARS-CoV-2 antigen peptide pools-stimulated-IL-2 and -IFN-<U+03B3> response can distinguish COVID-19 convalescent ","2021","07","15","Signal Transduct Target Ther","Signal transduction and targeted therapy","Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Convalescence; Cytokines; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Lymphocyte Subsets; Male; Middle Aged; Young Adult","Li","Yirong","Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China. liyirong838@163","liyirong838@163.com"
"1087","34234098","10.1038/s41392-021-00681-6","Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants.",NA,"2021","07","12","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Humans; Immunity; RNA, Messenger; SARS-CoV-2; Vaccination","Pawelec","Graham","Department of Immunology, University of Tübingen, Tübingen, Germany. graham.pawelec@uni-tuebingen",NA
"1088","34234098","10.1038/s41392-021-00681-6","Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants.",NA,"2021","07","12","Signal Transduct Target Ther","Signal transduction and targeted therapy","COVID-19; Humans; Immunity; RNA, Messenger; SARS-CoV-2; Vaccination","Picard","Emilie","Health Sciences North Research Institute, Sudbury, ON, Canada. epicard@hsnri","epicard@hsnri.ca"
"1089","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Chopra","Neha","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1090","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Chowdhury","Mohit","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1091","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Singh","Anupam K","Department of Medicine, Santosh Medical College, Delhi NCR, India",NA
"1092","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Ma","Khan","Department of Bio-statistics, All India Institute of Medical Sciences, New Delhi, India",NA
"1093","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Kumar","Arvind","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1094","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Ranjan","Piyush","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1095","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Desai","Devashish","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1096","34234065","10.5582/ddt.2021.01014","Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India.","A variable proportion of patients develop persistent/prolonged symptoms of Coronavirus Disease 2019 (COVID-19) infection (long COVID). We aimed to study the clinical predictors of persistent symptoms in patients with mild COVID-19 at 30 days post discharge (long COVID-19). We also tried to identify symptom clusters among mild COVID-19 patients. Fifty-seven patients admitted at a tertiary care centre after a positive RT-PCR report over a period of 2 months, were enrolled in the study. Details of ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; long COVID; phenotypes; predictors; Adult; COVID-19; Female; Follow-Up Studies; Humans; India; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Tertiary Care Centers; Time and Motion Studies; Young Adult","Wig","Naveet","Department of Medicine, All India Institute of Medical Sciences, New Delhi, India",NA
"1097","34234060","10.5582/ddt.2021.01052","Antimicrobial resistance and COVID-19 syndemic: Impact on public health.","The COVID -19 pandemic has had a catastrophic impact on the global economy and the healthcare industry. Unfortunately, the scientific community still hasn't discovered a definite cure for this virus. Also, owing to the unscrupulous use of antibiotics in wake of the current situation, another ongoing pandemic of antimicrobial resistance (AMR) has been entirely eclipsed. However, increased compliance to infection control measures like hand hygiene (both at hospital and community level), and restri","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; MDR; antimicrobial resistance (AMR); pandemic; COVID-19; Drug Resistance, Microbial; Humans; Public Health Practice; SARS-CoV-2; Syndemic","Vidyarthi","Ashima Jain","Department of Microbiology, All India Institute of Medical Sciences, New Delh, India",NA
"1098","34234060","10.5582/ddt.2021.01052","Antimicrobial resistance and COVID-19 syndemic: Impact on public health.","The COVID -19 pandemic has had a catastrophic impact on the global economy and the healthcare industry. Unfortunately, the scientific community still hasn't discovered a definite cure for this virus. Also, owing to the unscrupulous use of antibiotics in wake of the current situation, another ongoing pandemic of antimicrobial resistance (AMR) has been entirely eclipsed. However, increased compliance to infection control measures like hand hygiene (both at hospital and community level), and restri","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; MDR; antimicrobial resistance (AMR); pandemic; COVID-19; Drug Resistance, Microbial; Humans; Public Health Practice; SARS-CoV-2; Syndemic","Das","Arghya","Department of Microbiology, All India Institute of Medical Sciences, New Delh, India",NA
"1099","34234060","10.5582/ddt.2021.01052","Antimicrobial resistance and COVID-19 syndemic: Impact on public health.","The COVID -19 pandemic has had a catastrophic impact on the global economy and the healthcare industry. Unfortunately, the scientific community still hasn't discovered a definite cure for this virus. Also, owing to the unscrupulous use of antibiotics in wake of the current situation, another ongoing pandemic of antimicrobial resistance (AMR) has been entirely eclipsed. However, increased compliance to infection control measures like hand hygiene (both at hospital and community level), and restri","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; MDR; antimicrobial resistance (AMR); pandemic; COVID-19; Drug Resistance, Microbial; Humans; Public Health Practice; SARS-CoV-2; Syndemic","Chaudhry","Rama","Department of Microbiology, All India Institute of Medical Sciences, New Delh, India",NA
"1100","34234059","10.5582/ddt.2021.01058","Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.","The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharmaceutical interventions have been rigorously and widely implemented, living conditions caused by the pandemic will last until highly effective vaccines are successfully improved and globally administered. Several first-generation COVID-19 vaccines were approved at the end of 2020. However, the COVID-19 pandemic is persisting worldwide. To be clear, ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; NVX-CoV2373; SARS-CoV-2; distribution; vaccination; vaccines; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Humans; SARS-CoV-2","Li","Qian","Department of Infectious Diseases, Shanghai Public Health Clinical Center, Shanghai, China",NA
"1101","34234059","10.5582/ddt.2021.01058","Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.","The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharmaceutical interventions have been rigorously and widely implemented, living conditions caused by the pandemic will last until highly effective vaccines are successfully improved and globally administered. Several first-generation COVID-19 vaccines were approved at the end of 2020. However, the COVID-19 pandemic is persisting worldwide. To be clear, ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; NVX-CoV2373; SARS-CoV-2; distribution; vaccination; vaccines; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Humans; SARS-CoV-2","Wang","Jun","Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Jiangnan University, Wuxi, China",NA
"1102","34234059","10.5582/ddt.2021.01058","Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.","The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharmaceutical interventions have been rigorously and widely implemented, living conditions caused by the pandemic will last until highly effective vaccines are successfully improved and globally administered. Several first-generation COVID-19 vaccines were approved at the end of 2020. However, the COVID-19 pandemic is persisting worldwide. To be clear, ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; NVX-CoV2373; SARS-CoV-2; distribution; vaccination; vaccines; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Humans; SARS-CoV-2","Tang","Yang","Department of Infectious Diseases, Shanghai Public Health Clinical Center, Shanghai, China",NA
"1103","34234059","10.5582/ddt.2021.01058","Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.","The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharmaceutical interventions have been rigorously and widely implemented, living conditions caused by the pandemic will last until highly effective vaccines are successfully improved and globally administered. Several first-generation COVID-19 vaccines were approved at the end of 2020. However, the COVID-19 pandemic is persisting worldwide. To be clear, ","2021","07","19","Drug Discov Ther","Drug discoveries &amp; therapeutics","COVID-19; NVX-CoV2373; SARS-CoV-2; distribution; vaccination; vaccines; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Humans; SARS-CoV-2","Lu","Hongzhou","Department of Infectious Diseases, Shanghai Public Health Clinical Center, Shanghai, China",NA
"1104","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Pavlov","Ivan","Department of Emergency Medicine, Hôpital de Verdun, Montréal, Québec, Canada",NA
"1105","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","He","Hangyong","Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, China",NA
"1106","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","McNicholas","Bairbre","Anaesthesia and Intensive Care Medicine, School of Medicine, National University of Ireland Galway",NA
"1107","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Perez","Yonatan","CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSEP research network, Tours, France",NA
"1108","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Tavernier","Elsa","Universities of Tours and Nantes, INSERM 1246-SPHERE, Tours, France",NA
"1109","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Trump","Matthew W","Department Pulmonary and Critical Care Medicine, The Iowa Clinic, West Des Moines, Iowa, United States of America",NA
"1110","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Jackson","Julie A","Department of Respiratory Therapy, UnityPoint Health, Des Moines, Iowa, United States of America",NA
"1111","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Zhang","Wei","Department of Respiratory and Critical Care Medicine, First affiliated hospital, the Second Military Medical University, Shanghai, China",NA
"1112","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Rubin","Daniel S","Department of Anesthesia and Critical Care, University of Chicago, Illinois, United States of America",NA
"1113","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Spiegel","Thomas","Section of Emergency Medicine, Department of Medicine, University of Chicago, Illinois, United States of America",NA
"1114","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Hung","Anthony","Pritzker School of Medicine, University of Chicago, Illinois, United States of America",NA
"1115","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Estrada","Miguel Ángel Ibarra","Intensive Care Unit, Hospital Civil Fray Antonio Alcalde, Universidad de Guadalajara. Guadalajara, Jalisco, Mexico",NA
"1116","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Roca","Oriol","Servei de Medicina Intensiva, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, Spain",NA
"1117","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Vines","David L","Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University Medical Center, Chicago, Illinois, United States of America",NA
"1118","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Cosgrave","David","Anaesthesia and Intensive Care Medicine, School of Medicine, National University of Ireland Galway",NA
"1119","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Mirza","Sara","Division of Pulmonary and Critical care, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, United States of America",NA
"1120","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Laffey","John G","Anaesthesia and Intensive Care Medicine, School of Medicine, National University of Ireland Galway",NA
"1121","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Rice","Todd W","Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America",NA
"1122","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Ehrmann","Stephan","CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSEP research network, Tours, France","stephanehrmann@gmail.com"
"1123","34234032","10.4187/respcare.09191","Awake prone positioning in non-intubated patients with acute hypoxemic respiratory failure due to COVID-19: A systematic review of proportional outcomes comparing observational studies with and without awake prone positioning in the setting of COVID-19.","Background Awake prone positioning (APP) has been advocated to improve oxygenation and prevent intubations of patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). This paper aims to synthesize the available evidence on the efficacy of APP.Methods: We performed a systematic review of proportional outcomes from observational studies to compare intubation rate in patients treated with APP or with standard care.Results: A total of 46 publ","2021","07","08","Respir Care","Respiratory care","Acute hypoxemic respiratory failure (AHRF); Acute respiratory distress syndrome (ARDS); Acute respiratory failure (ARF); Awake prone positioning (APP); Continuous positive airway pressure (CPAP); Coronavirus disease 2019 (COVID-19); High-flow nasal cannula (HFNC); Non-invasive ventilation (NIV); Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)","Li","Jie","Department of Cardiopulmonary Sciences, Division of Respiratory Care, Rush University Medical Center, Chicago, Illinois, United States of America. stephanehrmann@gmail.com Jie_Li@rush","stephanehrmann@gmail.com"
"1124","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Babu","Giridhara R","Indian Institute of Public Health, Public Health Foundation of India, Bengaluru, India",NA
"1125","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Ray","Debashree","Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"1126","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Bhaduri","Ritwik","Indian Statistical Institute, Kolkata, India",NA
"1127","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Halder","Aritra","Social and Decision Analytics Division, Biocomplexity Institute, University of Virginia, USA",NA
"1128","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Kundu","Ritoban","Indian Statistical Institute, Kolkata, India",NA
"1129","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Menon","Gautam I","Ashoka University, Sonepat, India",NA
"1130","34234020","10.9745/GHSP-D-21-00233","COVID-19 Pandemic in India: Through the Lens of Modeling.",NA,"2021","07","21","Glob Health Sci Pract","Global health, science and practice","COVID-19; Humans; India; Pandemics; Public Health; SARS-CoV-2","Mukherjee","Bhramar","University of Michigan School of Public Health, Ann Arbor, MI, USA. bhramar@umich","bhramar@umich.edu"
"1131","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Staquicini","Daniela I","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1132","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Tang","Fenny H F","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1133","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Markosian","Christopher","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1134","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Yao","Virginia J","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1135","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Staquicini","Fernanda I","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1136","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Dodero-Rojas","Esteban","Center for Theoretical Biological Physics, Rice University, Houston, TX 77005",NA
"1137","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Contessoto","Vinícius G","Center for Theoretical Biological Physics, Rice University, Houston, TX 77005",NA
"1138","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Davis","Deodate","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1139","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","O'Brien","Paul","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1140","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Habib","Nazia","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1141","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Smith","Tracey L","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101",NA
"1142","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Bruiners","Natalie","Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103",NA
"1143","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Sidman","Richard L","Department of Neurology, Harvard Medical School, Boston, MA 02115",NA
"1144","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Gennaro","Maria L","Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103",NA
"1145","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Lattime","Edmund C","Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901",NA
"1146","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Libutti","Steven K","Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901",NA
"1147","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Whitford","Paul C","Department of Physics and Center for Theoretical Biological Physics, Northeastern University, Boston, MA 02115",NA
"1148","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Burley","Stephen K","Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901",NA
"1149","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Onuchic","José N","Center for Theoretical Biological Physics, Rice University, Houston, TX 77005","jonuchic@rice.edu"
"1150","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Arap","Wadih","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101","jonuchic@rice.edu"
"1151","34234013","10.1073/pnas.2105739118","Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.","Development of effective vaccines against coronavirus disease 2019 (COVID-19) is a global imperative. Rapid immunization of the entire human population against a widespread, continually evolving, and highly pathogenic virus is an unprecedented challenge, and different vaccine approaches are being pursued. Engineered filamentous bacteriophage (phage) particles have unique potential in vaccine development due to their inherent immunogenicity, genetic plasticity, stability, cost-effectiveness for l","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","AAVP; COVID-19; SARS-CoV-2; gene delivery; phage display; Administration, Inhalation; Animals; Bacteriophages; COVID-19; COVID-19 Vaccines; Dependovirus; Drug Storage; Female; Immunization Programs; Immunogenicity, Vaccine; Mice; Mice, Inbred BALB C; Proof of Concept Study; Temperature","Pasqualini","Renata","Rutgers Cancer Institute of New Jersey, Newark, NJ 07101","jonuchic@rice.edu"
"1152","34234012","10.1073/pnas.2024302118","Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.","The COVID-19 pandemic caused by SARS-CoV-2 is an unprecedentedly significant health threat, prompting the need for rapidly developing antiviral drugs for the treatment. Drug repurposing is currently one of the most tangible options for rapidly developing drugs for emerging and reemerging viruses. In general, drug repurposing starts with virtual screening of approved drugs employing various computational methods. However, the actual hit rate of virtual screening is very low, and most of the predi","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","SARS-CoV-2; cell-based assay; docking-based virtual screening; drug combinations; drug repurposing; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Humans; User-Computer Interface; Vero Cells","Jang","Woo Dae","Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea",NA
"1153","34234012","10.1073/pnas.2024302118","Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.","The COVID-19 pandemic caused by SARS-CoV-2 is an unprecedentedly significant health threat, prompting the need for rapidly developing antiviral drugs for the treatment. Drug repurposing is currently one of the most tangible options for rapidly developing drugs for emerging and reemerging viruses. In general, drug repurposing starts with virtual screening of approved drugs employing various computational methods. However, the actual hit rate of virtual screening is very low, and most of the predi","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","SARS-CoV-2; cell-based assay; docking-based virtual screening; drug combinations; drug repurposing; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Humans; User-Computer Interface; Vero Cells","Jeon","Sangeun","Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea",NA
"1154","34234012","10.1073/pnas.2024302118","Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.","The COVID-19 pandemic caused by SARS-CoV-2 is an unprecedentedly significant health threat, prompting the need for rapidly developing antiviral drugs for the treatment. Drug repurposing is currently one of the most tangible options for rapidly developing drugs for emerging and reemerging viruses. In general, drug repurposing starts with virtual screening of approved drugs employing various computational methods. However, the actual hit rate of virtual screening is very low, and most of the predi","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","SARS-CoV-2; cell-based assay; docking-based virtual screening; drug combinations; drug repurposing; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Humans; User-Computer Interface; Vero Cells","Kim","Seungtaek","Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea","leesy@kaist.ac.kr"
"1155","34234012","10.1073/pnas.2024302118","Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.","The COVID-19 pandemic caused by SARS-CoV-2 is an unprecedentedly significant health threat, prompting the need for rapidly developing antiviral drugs for the treatment. Drug repurposing is currently one of the most tangible options for rapidly developing drugs for emerging and reemerging viruses. In general, drug repurposing starts with virtual screening of approved drugs employing various computational methods. However, the actual hit rate of virtual screening is very low, and most of the predi","2021","07","19","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","SARS-CoV-2; cell-based assay; docking-based virtual screening; drug combinations; drug repurposing; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Humans; User-Computer Interface; Vero Cells","Lee","Sang Yup","Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea","leesy@kaist.ac.kr"
"1156","34234008","10.1136/bmjqs-2021-012990","Patient-level and hospital-level variation and related time trends in COVID-19 case fatality rates during the first pandemic wave in England: multilevel modelling analysis of routine data.","A report suggesting large between-hospital variations in mortality after admission for COVID-19 in England attracted much media attention but used crude rates. We aimed to quantify these variations between hospitals and over time during England's first wave (March to July 2020) and assess available patient-level and hospital-level predictors to explain those variations. We used administrative data for England, augmented by hospital-level information. Admissions were extracted with COVID-19 codes","2021","07","11","BMJ Qual Saf","BMJ quality &amp; safety","COVID-19; health services research; mortality (standardised mortality ratios); statistical process control; statistics","Bottle","Alex","Dr Foster Unit, School of Public Health, Imperial College London Faculty of Medicine, London, UK robert.bottle@imperial.ac","robert.bottle@imperial.ac.uk"
"1157","34234008","10.1136/bmjqs-2021-012990","Patient-level and hospital-level variation and related time trends in COVID-19 case fatality rates during the first pandemic wave in England: multilevel modelling analysis of routine data.","A report suggesting large between-hospital variations in mortality after admission for COVID-19 in England attracted much media attention but used crude rates. We aimed to quantify these variations between hospitals and over time during England's first wave (March to July 2020) and assess available patient-level and hospital-level predictors to explain those variations. We used administrative data for England, augmented by hospital-level information. Admissions were extracted with COVID-19 codes","2021","07","11","BMJ Qual Saf","BMJ quality &amp; safety","COVID-19; health services research; mortality (standardised mortality ratios); statistical process control; statistics","Faitna","Puji","Dr Foster Unit, School of Public Health, Imperial College London Faculty of Medicine, London, UK",NA
"1158","34234008","10.1136/bmjqs-2021-012990","Patient-level and hospital-level variation and related time trends in COVID-19 case fatality rates during the first pandemic wave in England: multilevel modelling analysis of routine data.","A report suggesting large between-hospital variations in mortality after admission for COVID-19 in England attracted much media attention but used crude rates. We aimed to quantify these variations between hospitals and over time during England's first wave (March to July 2020) and assess available patient-level and hospital-level predictors to explain those variations. We used administrative data for England, augmented by hospital-level information. Admissions were extracted with COVID-19 codes","2021","07","11","BMJ Qual Saf","BMJ quality &amp; safety","COVID-19; health services research; mortality (standardised mortality ratios); statistical process control; statistics","Aylin","Paul P","Dr Foster Unit, School of Public Health, Imperial College London Faculty of Medicine, London, UK",NA
"1159","34234003","10.1136/bmjopen-2021-049851corr1","Correction: When COVID-19 enters in a community setting: an exploratory qualitative study of community perspectives on COVID-19 affecting mental well-being.",NA,"2021","07","24","BMJ Open","BMJ open",NA,NA,NA,NA,NA
"1160","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Song","Dongli","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1161","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Prahl","Mary","Department of Pediatrics, Division of Pediatric Infectious Diseases and Global Health, University of California San Francisco, San Francisco, California, USA",NA
"1162","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Gaw","Stephanie L","Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA",NA
"1163","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Narasimhan","Sudha Rani","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1164","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Rai","Daljeet S","Department of Family Medicine, Stanford University School of Medicine, Stanford, California, USA",NA
"1165","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Huang","Angela","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1166","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Flores","Claudia V","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1167","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Lin","Christine Y","Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA",NA
"1168","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Jigmeddagva","Unurzul","Department of Pediatrics, Division of Pediatric Infectious Diseases and Global Health, University of California San Francisco, San Francisco, California, USA",NA
"1169","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Wu","Alan","Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1170","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Warrier","Lakshmi","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1171","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Levan","Justine","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1172","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Nguyen","Catherine B T","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1173","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Callaway","Perri","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1174","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Farrington","Lila","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1175","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Acevedo","Gonzalo R","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1176","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Gonzalez","Veronica J","Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA",NA
"1177","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Vaaben","Anna","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"1178","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Nguyen","Phuong","Department of Pathology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1179","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Atmosfera","Elda","Department of Pathology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1180","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Marleau","Constance","Department of Pathology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1181","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Anderson","Christina","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1182","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Misra","Sonya","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1183","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Stemmle","Monica","Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA",NA
"1184","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Cortes","Maria","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1185","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","McAuley","Jennifer","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1186","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Metz","Nicole","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1187","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Patel","Rupalee","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1188","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Nudelman","Matthew","Department of Pediatrics, Marshall University, Huntington, West Virginia, USA",NA
"1189","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Abraham","Susan","Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA",NA
"1190","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Byrne","James","Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Santa Clara Valley Medical Center, San Jose, California, USA",NA
"1191","34234001","10.1136/bmjopen-2021-053036","Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","To investigate maternal immunoglobulins' (IgM, IgG) response to SARS-CoV-2 infection during pregnancy and IgG transplacental transfer, to characterise neonatal antibody response to SARS-CoV-2 infection, and to longitudinally follow actively and passively acquired antibodies in infants. A prospective observational study. Public healthcare system in Santa Clara County (California, USA). Women with symptomatic or asymptomatic SARS-CoV-2 infection during pregnancy and their infants were enrolled bet","2021","07","13","BMJ Open","BMJ open","COVID-19; immunology; neonatology; paediatric infectious disease &amp; immunisation","Jegatheesan","Priya","Department of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA Priya.Jegatheesan@hhs.sccgov","Priya.Jegatheesan@hhs.sccgov.org"
"1192","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Rück","Christian","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1193","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Mataix-Cols","David","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1194","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Malki","Kinda","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1195","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Adler","Mats","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1196","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Flygare","Oskar","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1197","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Runeson","Bo","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1198","34233997","10.1136/bmjopen-2021-049302","Swedish nationwide time series analysis of influenza and suicide deaths from 1910 to 1978.","There is concern that the COVID-19 pandemic will be associated with an increase in suicides, but evidence supporting a link between pandemics and suicide is limited. Using data from the three influenza pandemics of the 20th century, we aimed to investigate whether an association exists between influenza deaths and suicide deaths. Time series analysis. Sweden. Deaths from influenza and suicides extracted from the Statistical Yearbook of Sweden for 1910-1978, covering three pandemics (the Spanish ","2021","07","13","BMJ Open","BMJ open","COVID-19; mental health; suicide &amp; self-harm; COVID-19; Female; Hong Kong; Humans; Influenza, Human; Male; Pandemics; SARS-CoV-2; Suicide; Sweden","Sidorchuk","Anna","Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet &amp",NA
"1199","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Hu","Yiying","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1200","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Guo","Jianying","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1201","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Li","Guanqiao","School of Medicine and Vanke School of Public Health Beijing, Tsinghua University, Beijing, China",NA
"1202","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Lu","Xi","School of Medicine and Vanke School of Public Health Beijing, Tsinghua University, Beijing, China",NA
"1203","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Li","Xiang","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1204","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Zhang","Yuan","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1205","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Cong","Lin","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1206","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Kang","Yanni","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1207","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Jia","Xiaoyu","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China",NA
"1208","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Shi","Xuanling","School of Medicine and Vanke School of Public Health Beijing, Tsinghua University, Beijing, China",NA
"1209","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Xie","Guotong","Ping An Healthcare Technology, Ping An Insurance Group Company of China, Shenzhen, China zhanglinqi@tsinghua.edu.cn XIEGUOTONG@pingan.com","zhanglinqi@tsinghua.edu.cn"
"1210","34233974","10.1136/bmjopen-2020-045886","Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.","This study quantified how the efficiency of testing and contact tracing impacts the spread of COVID-19. The average time interval between infection and quarantine, whether asymptomatic cases are tested or not, and initial delays to beginning a testing and tracing programme were investigated. We developed a novel individual-level network model, called CoTECT (Testing Efficiency and Contact Tracing model for COVID-19), using key parameters from recent studies to quantify the impacts of testing and","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; public health; COVID-19; Contact Tracing; Humans; Pandemics; SARS-CoV-2; Scandinavian and Nordic Countries","Zhang","Linqi","School of Medicine and Vanke School of Public Health Beijing, Tsinghua University, Beijing, China zhanglinqi@tsinghua.edu.cn XIEGUOTONG@pingan.com","zhanglinqi@tsinghua.edu.cn"
"1211","34233970","10.1136/bmjopen-2020-045386","Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.","To evaluate the level of worry and its influencing factors during the COVID-19 epidemic among teachers in Henan Province in China. A cross-sectional study was conducted. We designed a cross-sectional survey that included 88 611 teachers from three cities in Henan Province, China between 4 February 2020 and 12 February 2020. Level of worry was measured using a five-item Likert scale, with 1 being 'not worried' and 5 being 'very worried'. The OR and 95% CI of potential influencing factors for leve","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; psychiatry; public health; Adult; Anxiety; COVID-19; China; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Wang","Yanqing","College of Public Health, Zhengzhou University, Zhengzhou, Henan, China",NA
"1212","34233970","10.1136/bmjopen-2020-045386","Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.","To evaluate the level of worry and its influencing factors during the COVID-19 epidemic among teachers in Henan Province in China. A cross-sectional study was conducted. We designed a cross-sectional survey that included 88 611 teachers from three cities in Henan Province, China between 4 February 2020 and 12 February 2020. Level of worry was measured using a five-item Likert scale, with 1 being 'not worried' and 5 being 'very worried'. The OR and 95% CI of potential influencing factors for leve","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; psychiatry; public health; Adult; Anxiety; COVID-19; China; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Li","Quanman","College of Public Health, Zhengzhou University, Zhengzhou, Henan, China",NA
"1213","34233970","10.1136/bmjopen-2020-045386","Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.","To evaluate the level of worry and its influencing factors during the COVID-19 epidemic among teachers in Henan Province in China. A cross-sectional study was conducted. We designed a cross-sectional survey that included 88 611 teachers from three cities in Henan Province, China between 4 February 2020 and 12 February 2020. Level of worry was measured using a five-item Likert scale, with 1 being 'not worried' and 5 being 'very worried'. The OR and 95% CI of potential influencing factors for leve","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; psychiatry; public health; Adult; Anxiety; COVID-19; China; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Tarimo","Clifford Silver","College of Public Health, Zhengzhou University, Zhengzhou, Henan, China",NA
"1214","34233970","10.1136/bmjopen-2020-045386","Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.","To evaluate the level of worry and its influencing factors during the COVID-19 epidemic among teachers in Henan Province in China. A cross-sectional study was conducted. We designed a cross-sectional survey that included 88 611 teachers from three cities in Henan Province, China between 4 February 2020 and 12 February 2020. Level of worry was measured using a five-item Likert scale, with 1 being 'not worried' and 5 being 'very worried'. The OR and 95% CI of potential influencing factors for leve","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; psychiatry; public health; Adult; Anxiety; COVID-19; China; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Wu","Cuiping","College of Public Health, Zhengzhou University, Zhengzhou, Henan, China",NA
"1215","34233970","10.1136/bmjopen-2020-045386","Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.","To evaluate the level of worry and its influencing factors during the COVID-19 epidemic among teachers in Henan Province in China. A cross-sectional study was conducted. We designed a cross-sectional survey that included 88 611 teachers from three cities in Henan Province, China between 4 February 2020 and 12 February 2020. Level of worry was measured using a five-item Likert scale, with 1 being 'not worried' and 5 being 'very worried'. The OR and 95% CI of potential influencing factors for leve","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; psychiatry; public health; Adult; Anxiety; COVID-19; China; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Miao","Yudong","College of Public Health, Zhengzhou University, Zhengzhou, Henan, China meldon@zzu.edu.cn jianwuzzu@163","meldon@zzu.edu.cn"
"1216","34233970","10.1136/bmjopen-2020-045386","Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.","To evaluate the level of worry and its influencing factors during the COVID-19 epidemic among teachers in Henan Province in China. A cross-sectional study was conducted. We designed a cross-sectional survey that included 88 611 teachers from three cities in Henan Province, China between 4 February 2020 and 12 February 2020. Level of worry was measured using a five-item Likert scale, with 1 being 'not worried' and 5 being 'very worried'. The OR and 95% CI of potential influencing factors for leve","2021","07","13","BMJ Open","BMJ open","COVID-19; epidemiology; psychiatry; public health; Adult; Anxiety; COVID-19; China; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; SARS-CoV-2; Surveys and Questionnaires","Wu","Jian","College of Public Health, Zhengzhou University, Zhengzhou, Henan, China meldon@zzu.edu.cn jianwuzzu@163","meldon@zzu.edu.cn"
"1217","34233956","10.1136/medethics-2021-107555","What's yours is ours: waiving intellectual property protections for COVID-19 vaccines.","This paper gives an ethical argument for temporarily waiving intellectual property (IP) protections for COVID-19 vaccines. It examines two proposals under discussion at the World Trade Organization (WTO): the India/South Africa proposal and the WTO Director General proposal. Section I explains the background leading up to the WTO debate. Section II rebuts ethical arguments for retaining current IP protections, which appeal to benefiting society by spurring innovation and protecting rightful owne","2021","07","11","J Med Ethics","Journal of medical ethics","COVID-19; allocation of health care resources; ethics","Jecker","Nancy S","Department of Bioethics &amp",NA
"1218","34233956","10.1136/medethics-2021-107555","What's yours is ours: waiving intellectual property protections for COVID-19 vaccines.","This paper gives an ethical argument for temporarily waiving intellectual property (IP) protections for COVID-19 vaccines. It examines two proposals under discussion at the World Trade Organization (WTO): the India/South Africa proposal and the WTO Director General proposal. Section I explains the background leading up to the WTO debate. Section II rebuts ethical arguments for retaining current IP protections, which appeal to benefiting society by spurring innovation and protecting rightful owne","2021","07","11","J Med Ethics","Journal of medical ethics","COVID-19; allocation of health care resources; ethics","Atuire","Caesar A","Department of Philosophy and Classics, University of Ghana, Accra, Accra, Ghana",NA
"1219","34233955","10.1136/medethics-2021-107700","A focused protection vaccination strategy: why we should not target children with COVID-19 vaccination policies.",NA,"2021","07","11","J Med Ethics","Journal of medical ethics","ethics; ethics- medical; ethics- research","Giubilini","Alberto","Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK alberto.giubilini@philosophy.ox.ac","alberto.giubilini@philosophy.ox.ac.uk"
"1220","34233955","10.1136/medethics-2021-107700","A focused protection vaccination strategy: why we should not target children with COVID-19 vaccination policies.",NA,"2021","07","11","J Med Ethics","Journal of medical ethics","ethics; ethics- medical; ethics- research","Gupta","Sunetra","Department of Zoology, University of Oxford, Oxford, UK",NA
"1221","34233955","10.1136/medethics-2021-107700","A focused protection vaccination strategy: why we should not target children with COVID-19 vaccination policies.",NA,"2021","07","11","J Med Ethics","Journal of medical ethics","ethics; ethics- medical; ethics- research","Heneghan","Carl","Centre for Evidence-Based Medicine, University of Oxford, Oxford, UK",NA
"1222","34233952","10.1126/scitranslmed.abj6984","Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance.",NA,"2021","07","12","Sci Transl Med","Science translational medicine","COVID-19; Humans; Public Health; RNA, Viral; SARS-CoV-2","Layne","Scott P","Saint Johns Cancer Institute, Santa Monica, CA and is Emeritus Professor at the Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, USA. Email: scottplayne@gmail","scottplayne@gmail.com"
"1223","34233952","10.1126/scitranslmed.abj6984","Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance.",NA,"2021","07","12","Sci Transl Med","Science translational medicine","COVID-19; Humans; Public Health; RNA, Viral; SARS-CoV-2","Taubenberger","Jeffery K","Saint Johns Cancer Institute, Santa Monica, CA and is Emeritus Professor at the Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, USA. Email: scottplayne@gmail","scottplayne@gmail.com"
"1224","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Spanakis","Elias K","Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD ispanakis@som.umaryland","ispanakis@som.umaryland.edu"
"1225","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Yoo","Ashley","Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD",NA
"1226","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Ajayi","Oluwagbemiga N","Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD",NA
"1227","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Siddiqui","Tariq","Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD",NA
"1228","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Khan","Mohd M","Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD",NA
"1229","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Seliger","Stephen L","Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD",NA
"1230","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Klonoff","David C","Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA",NA
"1231","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Feng","Zhaoyong","Department of Pharmaceutical Health Services Research-Pharmaceutical Research Computing, University of Maryland School of Pharmacy, Baltimore, MD",NA
"1232","34233926","10.2337/dc20-2350","Excess Mortality in COVID-19-Positive Versus COVID-19-Negative Inpatients With Diabetes: A Nationwide Study.",NA,"2021","07","08","Diabetes Care","Diabetes care",NA,"Sorkin","John D","Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Medical Center, Baltimore, MD",NA
"1233","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Harrison","Elizabeth","Washington University, St. Louis, Missouri",NA
"1234","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Garbutt","Jane","Washington University, St. Louis, Missouri jgarbutt@wustl","jgarbutt@wustl.edu"
"1235","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Sterkel","Randall","Washington University, St. Louis, Missouri",NA
"1236","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Dodd","Sherry","Washington University, St. Louis, Missouri",NA
"1237","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Wang","Ruoyun","Washington University, St. Louis, Missouri",NA
"1238","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Newland","Jason","Washington University, St. Louis, Missouri",NA
"1239","34233918","10.1542/peds.2021-052106","Collaborating to Advocate in Primary Care for Children During COVID-19.",NA,"2021","07","08","Pediatrics","Pediatrics",NA,"Plax","Katie","Washington University, St. Louis, Missouri",NA
"1240","34233917","10.1158/1055-9965.EPI-21-0230","Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium.","Most studies investigating the impact of coronavirus infectious disease 19 (COVID-19) on mortality among cancer patients were performed in a hospital-setting and the evidence is thus based on a selected and frail subset of patients. This study evaluates the excess mortality during the first wave of COVID-19 in a nationwide, prevalent cancer cohort in Belgium. Mortality was studied among almost 240,000 cancer patients diagnosed between 2013-2018 and alive on January 1st, 2020. The observed number","2021","07","08","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Silversmit","Geert","Research Department, Belgian Cancer Registry",NA
"1241","34233917","10.1158/1055-9965.EPI-21-0230","Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium.","Most studies investigating the impact of coronavirus infectious disease 19 (COVID-19) on mortality among cancer patients were performed in a hospital-setting and the evidence is thus based on a selected and frail subset of patients. This study evaluates the excess mortality during the first wave of COVID-19 in a nationwide, prevalent cancer cohort in Belgium. Mortality was studied among almost 240,000 cancer patients diagnosed between 2013-2018 and alive on January 1st, 2020. The observed number","2021","07","08","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Verdoodt","Freija","Research Department, Belgian Cancer Registry",NA
"1242","34233917","10.1158/1055-9965.EPI-21-0230","Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium.","Most studies investigating the impact of coronavirus infectious disease 19 (COVID-19) on mortality among cancer patients were performed in a hospital-setting and the evidence is thus based on a selected and frail subset of patients. This study evaluates the excess mortality during the first wave of COVID-19 in a nationwide, prevalent cancer cohort in Belgium. Mortality was studied among almost 240,000 cancer patients diagnosed between 2013-2018 and alive on January 1st, 2020. The observed number","2021","07","08","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Van Damme","Nancy","Research Department, Belgian Cancer Registry",NA
"1243","34233917","10.1158/1055-9965.EPI-21-0230","Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium.","Most studies investigating the impact of coronavirus infectious disease 19 (COVID-19) on mortality among cancer patients were performed in a hospital-setting and the evidence is thus based on a selected and frail subset of patients. This study evaluates the excess mortality during the first wave of COVID-19 in a nationwide, prevalent cancer cohort in Belgium. Mortality was studied among almost 240,000 cancer patients diagnosed between 2013-2018 and alive on January 1st, 2020. The observed number","2021","07","08","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"De Schutter","Harlinde","Research Department, Belgian Cancer Registry",NA
"1244","34233917","10.1158/1055-9965.EPI-21-0230","Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium.","Most studies investigating the impact of coronavirus infectious disease 19 (COVID-19) on mortality among cancer patients were performed in a hospital-setting and the evidence is thus based on a selected and frail subset of patients. This study evaluates the excess mortality during the first wave of COVID-19 in a nationwide, prevalent cancer cohort in Belgium. Mortality was studied among almost 240,000 cancer patients diagnosed between 2013-2018 and alive on January 1st, 2020. The observed number","2021","07","08","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Van Eycken","Liesbet","Research Department, Belgian Cancer Registry elizabeth.vaneycken@kankerregister","elizabeth.vaneycken@kankerregister.org"
"1245","34233916","10.1158/1055-9965.EPI-21-0445","Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research.","Since the start of the COVID-19 pandemic, Asian Americans have been subjected to rising overt discrimination and violent hate crimes, highlighting the health implications of racism toward Asian Americans. As Asian Americans are the only group for whom cancer is the leading cause of death, these manifestations of anti-Asian racism provoke the question of the impact of racism across the cancer continuum for Asian Americans. In this Commentary, we describe how the myth of the ""model minority"" overl","2021","07","10","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Dee","Edward Christopher","Harvard Medical School, Boston, Massachusetts",NA
"1246","34233916","10.1158/1055-9965.EPI-21-0445","Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research.","Since the start of the COVID-19 pandemic, Asian Americans have been subjected to rising overt discrimination and violent hate crimes, highlighting the health implications of racism toward Asian Americans. As Asian Americans are the only group for whom cancer is the leading cause of death, these manifestations of anti-Asian racism provoke the question of the impact of racism across the cancer continuum for Asian Americans. In this Commentary, we describe how the myth of the ""model minority"" overl","2021","07","10","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Chen","Sophia","NYU Grossman School of Medicine, New York, New York",NA
"1247","34233916","10.1158/1055-9965.EPI-21-0445","Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research.","Since the start of the COVID-19 pandemic, Asian Americans have been subjected to rising overt discrimination and violent hate crimes, highlighting the health implications of racism toward Asian Americans. As Asian Americans are the only group for whom cancer is the leading cause of death, these manifestations of anti-Asian racism provoke the question of the impact of racism across the cancer continuum for Asian Americans. In this Commentary, we describe how the myth of the ""model minority"" overl","2021","07","10","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Santos","Patricia Mae Garcia","Memorial Sloan Kettering Radiation Oncology Residency Program, New York, New York",NA
"1248","34233916","10.1158/1055-9965.EPI-21-0445","Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research.","Since the start of the COVID-19 pandemic, Asian Americans have been subjected to rising overt discrimination and violent hate crimes, highlighting the health implications of racism toward Asian Americans. As Asian Americans are the only group for whom cancer is the leading cause of death, these manifestations of anti-Asian racism provoke the question of the impact of racism across the cancer continuum for Asian Americans. In this Commentary, we describe how the myth of the ""model minority"" overl","2021","07","10","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Wu","Shirley Z","NYU Grossman School of Medicine, New York, New York",NA
"1249","34233916","10.1158/1055-9965.EPI-21-0445","Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research.","Since the start of the COVID-19 pandemic, Asian Americans have been subjected to rising overt discrimination and violent hate crimes, highlighting the health implications of racism toward Asian Americans. As Asian Americans are the only group for whom cancer is the leading cause of death, these manifestations of anti-Asian racism provoke the question of the impact of racism across the cancer continuum for Asian Americans. In this Commentary, we describe how the myth of the ""model minority"" overl","2021","07","10","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Cheng","Iona","UCSF Department of Epidemiology &amp",NA
"1250","34233916","10.1158/1055-9965.EPI-21-0445","Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research.","Since the start of the COVID-19 pandemic, Asian Americans have been subjected to rising overt discrimination and violent hate crimes, highlighting the health implications of racism toward Asian Americans. As Asian Americans are the only group for whom cancer is the leading cause of death, these manifestations of anti-Asian racism provoke the question of the impact of racism across the cancer continuum for Asian Americans. In this Commentary, we describe how the myth of the ""model minority"" overl","2021","07","10","Cancer Epidemiol Biomarkers Prev","Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",NA,"Gomez","Scarlett Lin","UCSF Department of Epidemiology &amp","scarlett.gomez@ucsf.edu"
"1251","34233915","10.1136/openhrt-2021-001628corr1","Correction: <i>Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review</i>.",NA,"2021","07","11","Open Heart","Open heart",NA,NA,NA,NA,NA
"1252","34233902","10.1158/2159-8290.CD-NB2021-0366","COVID-19 Vaccines Complicate Breast Screening.","In a small number of people, an unexpected side effect of the COVID-19 vaccine has emerged: swollen lymph nodes on the same side of the body as the shot was given. For women who undergo breast screening soon after vaccination, such swelling can show up on a mammogram, so clinicians may need to take extra steps to educate patients about this possibility and assess the need for follow-up testing.","2021","07","08","Cancer Discov","Cancer discovery",NA,NA,NA,NA,NA
"1253","34233897","10.1136/bmj.n1726","Covid-19: Vaccines journal retracts controversial paper after editorial board members quit.",NA,"2021","07","08","BMJ","BMJ (Clinical research ed.)",NA,"Wise","Jacqui","Kent",NA
"1254","34233895","10.1136/bmj.n1684","Mandatory covid-19 vaccination for care home workers.",NA,"2021","07","14","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; England; Home Care Services; Home Health Aides; Humans; Mandatory Programs; Vaccination","Hayes","Lydia","University of Kent, UK",NA
"1255","34233895","10.1136/bmj.n1684","Mandatory covid-19 vaccination for care home workers.",NA,"2021","07","14","BMJ","BMJ (Clinical research ed.)","COVID-19; COVID-19 Vaccines; England; Home Care Services; Home Health Aides; Humans; Mandatory Programs; Vaccination","Pollock","Allyson M","Institute of Population Health Sciences, Newcastle University, Newcastle upon Tyne, UK",NA
"1256","34233894","10.1136/bmj.n1733","Asymptomatic rapid testing for SARS-CoV-2.",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Infections; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2","Taylor-Phillips","Sian","Warwick Medical School, University of Warwick, Coventry, UK s.taylor-phillips@warwick.ac","phillips@warwick.ac.uk"
"1257","34233894","10.1136/bmj.n1733","Asymptomatic rapid testing for SARS-CoV-2.",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Infections; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2","Dinnes","Jacqueline","Test Evaluation Research Group, Institute of applied Health Research, University of Birmingham, Birmingham, UK",NA
"1258","34233890","10.1136/bmj.n1728","Covid-19: Adults in poorest areas are almost four times more likely to die, inquiry finds.",NA,"2021","07","08","BMJ","BMJ (Clinical research ed.)",NA,"Mahase","Elisabeth","The BMJ",NA
"1259","34233864","10.1016/j.intimp.2021.107598","MCP-1: Function, regulation, and involvement in disease.","MCP-1 (Monocyte chemoattractant protein-1), also known as Chemokine (CC-motif) ligand 2 (CCL2), is from family of CC chemokines. It has a vital role in the process of inflammation, where it attracts or enhances the expression of other inflammatory factors/cells. It leads to the advancement of many disorders by this main mechanism of migration and infiltration of inflammatory cells like monocytes/macrophages and other cytokines at the site of inflammation. MCP-1 has been inculpated in the pathoge","2021","07","10","Int Immunopharmacol","International immunopharmacology","CCL2; COVID-19; Cancer; Endothelial dysfunction; Monocyte chemoattractant protein-1; NF-<U+0138>B; Oxidative stress","Singh","Sanjiv","Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandaha Road, Hajipur, Bihar, India. Electronic address: sanjivpg2006@yahoo","sanjivpg2006@yahoo.com"
"1260","34233864","10.1016/j.intimp.2021.107598","MCP-1: Function, regulation, and involvement in disease.","MCP-1 (Monocyte chemoattractant protein-1), also known as Chemokine (CC-motif) ligand 2 (CCL2), is from family of CC chemokines. It has a vital role in the process of inflammation, where it attracts or enhances the expression of other inflammatory factors/cells. It leads to the advancement of many disorders by this main mechanism of migration and infiltration of inflammatory cells like monocytes/macrophages and other cytokines at the site of inflammation. MCP-1 has been inculpated in the pathoge","2021","07","10","Int Immunopharmacol","International immunopharmacology","CCL2; COVID-19; Cancer; Endothelial dysfunction; Monocyte chemoattractant protein-1; NF-<U+0138>B; Oxidative stress","Anshita","D","Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandaha Road, Hajipur, Bihar, India",NA
"1261","34233864","10.1016/j.intimp.2021.107598","MCP-1: Function, regulation, and involvement in disease.","MCP-1 (Monocyte chemoattractant protein-1), also known as Chemokine (CC-motif) ligand 2 (CCL2), is from family of CC chemokines. It has a vital role in the process of inflammation, where it attracts or enhances the expression of other inflammatory factors/cells. It leads to the advancement of many disorders by this main mechanism of migration and infiltration of inflammatory cells like monocytes/macrophages and other cytokines at the site of inflammation. MCP-1 has been inculpated in the pathoge","2021","07","10","Int Immunopharmacol","International immunopharmacology","CCL2; COVID-19; Cancer; Endothelial dysfunction; Monocyte chemoattractant protein-1; NF-<U+0138>B; Oxidative stress","Ravichandiran","V","Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandaha Road, Hajipur, Bihar, India",NA
"1262","34233853","10.1016/j.jfma.2021.06.018","Nasal high flow cannula maybe prioritized in treating patients suffering from COVID-19?",NA,"2021","07","10","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi",NA,"Huang","Yung-Chia","Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan",NA
"1263","34233853","10.1016/j.jfma.2021.06.018","Nasal high flow cannula maybe prioritized in treating patients suffering from COVID-19?",NA,"2021","07","10","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi",NA,"Cheng","Chien-Yu","Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan",NA
"1264","34233853","10.1016/j.jfma.2021.06.018","Nasal high flow cannula maybe prioritized in treating patients suffering from COVID-19?",NA,"2021","07","10","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi",NA,"Lin","Chou-Jui","Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan",NA
"1265","34233853","10.1016/j.jfma.2021.06.018","Nasal high flow cannula maybe prioritized in treating patients suffering from COVID-19?",NA,"2021","07","10","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi",NA,"Lee","Shih-Wei","Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan. Electronic address: Chestman9@gmail","Chestman9@gmail.com"
"1266","34233844","10.1016/j.clinthera.2021.06.006","Running the Obstacle Course: Improving the Utilization of Bariatric Surgery in Adolescent Obesity.","The obesity epidemic in the adolescent population continues to worsen despite increased awareness. Although there is an improved understanding of the role of bariatric surgery in the treatment of obesity in adolescents, a number of barriers still prevent its widespread utilization. The lack of formal obesity-focused education in the training curricula of primary care providers (PCPs), coupled with variable distribution of comprehensive resources, creates an inhospitable environment for effective","2021","07","08","Clin Ther","Clinical therapeutics","adolescent; bariatric surgery; obesity; pediatric; sleeve gastrectomy","Mustafa","Liri","Tufts Children's Hospital, Boston, Massachusetts",NA
"1267","34233844","10.1016/j.clinthera.2021.06.006","Running the Obstacle Course: Improving the Utilization of Bariatric Surgery in Adolescent Obesity.","The obesity epidemic in the adolescent population continues to worsen despite increased awareness. Although there is an improved understanding of the role of bariatric surgery in the treatment of obesity in adolescents, a number of barriers still prevent its widespread utilization. The lack of formal obesity-focused education in the training curricula of primary care providers (PCPs), coupled with variable distribution of comprehensive resources, creates an inhospitable environment for effective","2021","07","08","Clin Ther","Clinical therapeutics","adolescent; bariatric surgery; obesity; pediatric; sleeve gastrectomy","Chernoguz","Artur","Tufts Children's Hospital, Boston, Massachusetts. Electronic address: achernoguz@tuftsmedicalcenter","achernoguz@tuftsmedicalcenter.org"
"1268","34233828","10.2533/chimia.2021.555","A Perspective on Virtual Events during the Corona Pandemic Exemplified by the CareerTrack with IBM Research Europe - Zurich.",NA,"2021","07","12","Chimia (Aarau)","Chimia","COVID-19; Europe; Humans; Pandemics","Ries","Benjamin","ETH Zurich, Vladimir-Prelog-Weg 1-6, CH-8093 Zurich",NA
"1269","34233828","10.2533/chimia.2021.555","A Perspective on Virtual Events during the Corona Pandemic Exemplified by the CareerTrack with IBM Research Europe - Zurich.",NA,"2021","07","12","Chimia (Aarau)","Chimia","COVID-19; Europe; Humans; Pandemics","Völker","Laura A","ETH Zurich, Vladimir-Prelog-Weg 1-6, CH-8093 Zurich",NA
"1270","34233828","10.2533/chimia.2021.555","A Perspective on Virtual Events during the Corona Pandemic Exemplified by the CareerTrack with IBM Research Europe - Zurich.",NA,"2021","07","12","Chimia (Aarau)","Chimia","COVID-19; Europe; Humans; Pandemics","Dubey","Romain","ETH Zurich, Vladimir-Prelog-Weg 1-6, CH-8093 Zurich",NA
"1271","34233828","10.2533/chimia.2021.555","A Perspective on Virtual Events during the Corona Pandemic Exemplified by the CareerTrack with IBM Research Europe - Zurich.",NA,"2021","07","12","Chimia (Aarau)","Chimia","COVID-19; Europe; Humans; Pandemics","Linker","Stephanie","ETH Zurich, Vladimir-Prelog-Weg 1-6, CH-8093 Zurich",NA
"1272","34233783","10.1017/S1047951121003012","Assessing the utility of screening electrocardiograms in pediatric patients following COVID-19.","To determine the utility of screening electrocardiograms after SARS-CoV-2 infection among pediatric patients in detecting myocarditis related to COVID-19. A retrospective chart review was performed at a large pediatric academic institution to identify patients with prior SARS-CoV-2 infection who received a screening electrocardiogram by their primary care providers and were subsequently referred for outpatient cardiology consultation due to an abnormal electrocardiogram. The outcomes were the re","2021","07","08","Cardiol Young","Cardiology in the young","COVID-19; SARS-CoV-2; electrocardiogram; myocarditis; pediatric cardiology","Gartenberg","Ari J","Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA",NA
"1273","34233783","10.1017/S1047951121003012","Assessing the utility of screening electrocardiograms in pediatric patients following COVID-19.","To determine the utility of screening electrocardiograms after SARS-CoV-2 infection among pediatric patients in detecting myocarditis related to COVID-19. A retrospective chart review was performed at a large pediatric academic institution to identify patients with prior SARS-CoV-2 infection who received a screening electrocardiogram by their primary care providers and were subsequently referred for outpatient cardiology consultation due to an abnormal electrocardiogram. The outcomes were the re","2021","07","08","Cardiol Young","Cardiology in the young","COVID-19; SARS-CoV-2; electrocardiogram; myocarditis; pediatric cardiology","White","Travus J","Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA",NA
"1274","34233783","10.1017/S1047951121003012","Assessing the utility of screening electrocardiograms in pediatric patients following COVID-19.","To determine the utility of screening electrocardiograms after SARS-CoV-2 infection among pediatric patients in detecting myocarditis related to COVID-19. A retrospective chart review was performed at a large pediatric academic institution to identify patients with prior SARS-CoV-2 infection who received a screening electrocardiogram by their primary care providers and were subsequently referred for outpatient cardiology consultation due to an abnormal electrocardiogram. The outcomes were the re","2021","07","08","Cardiol Young","Cardiology in the young","COVID-19; SARS-CoV-2; electrocardiogram; myocarditis; pediatric cardiology","Dang","Khoi","Division of General Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA",NA
"1275","34233783","10.1017/S1047951121003012","Assessing the utility of screening electrocardiograms in pediatric patients following COVID-19.","To determine the utility of screening electrocardiograms after SARS-CoV-2 infection among pediatric patients in detecting myocarditis related to COVID-19. A retrospective chart review was performed at a large pediatric academic institution to identify patients with prior SARS-CoV-2 infection who received a screening electrocardiogram by their primary care providers and were subsequently referred for outpatient cardiology consultation due to an abnormal electrocardiogram. The outcomes were the re","2021","07","08","Cardiol Young","Cardiology in the young","COVID-19; SARS-CoV-2; electrocardiogram; myocarditis; pediatric cardiology","Shah","Maully","Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA",NA
"1276","34233783","10.1017/S1047951121003012","Assessing the utility of screening electrocardiograms in pediatric patients following COVID-19.","To determine the utility of screening electrocardiograms after SARS-CoV-2 infection among pediatric patients in detecting myocarditis related to COVID-19. A retrospective chart review was performed at a large pediatric academic institution to identify patients with prior SARS-CoV-2 infection who received a screening electrocardiogram by their primary care providers and were subsequently referred for outpatient cardiology consultation due to an abnormal electrocardiogram. The outcomes were the re","2021","07","08","Cardiol Young","Cardiology in the young","COVID-19; SARS-CoV-2; electrocardiogram; myocarditis; pediatric cardiology","Paridon","Stephen M","Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA",NA
"1277","34233783","10.1017/S1047951121003012","Assessing the utility of screening electrocardiograms in pediatric patients following COVID-19.","To determine the utility of screening electrocardiograms after SARS-CoV-2 infection among pediatric patients in detecting myocarditis related to COVID-19. A retrospective chart review was performed at a large pediatric academic institution to identify patients with prior SARS-CoV-2 infection who received a screening electrocardiogram by their primary care providers and were subsequently referred for outpatient cardiology consultation due to an abnormal electrocardiogram. The outcomes were the re","2021","07","08","Cardiol Young","Cardiology in the young","COVID-19; SARS-CoV-2; electrocardiogram; myocarditis; pediatric cardiology","Elias","Matthew D","Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA",NA
"1278","34233777","10.1017/S0950268821001448","Uncertainty in illness and the coping styles of severe patients with COVID-19: Current status and correlation.",NA,"2021","07","08","Epidemiol Infect","Epidemiology and infection",NA,"Lan","Cai-Feng","Department of Gynecology, Fujian Medical University Union Hospital, Fuzhou350001, China",NA
"1279","34233777","10.1017/S0950268821001448","Uncertainty in illness and the coping styles of severe patients with COVID-19: Current status and correlation.",NA,"2021","07","08","Epidemiol Infect","Epidemiology and infection",NA,"Nie","Cai-Ling","Department of Gynecology, Fujian Medical University Union Hospital, Fuzhou350001, China",NA
"1280","34233777","10.1017/S0950268821001448","Uncertainty in illness and the coping styles of severe patients with COVID-19: Current status and correlation.",NA,"2021","07","08","Epidemiol Infect","Epidemiology and infection",NA,"Lin","Yan-Juan","Department of Nursing Department, Fujian Medical University Union Hospital, Fuzhou350001, China",NA
"1281","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Rausch","Anne-Kathrin","ZHAW Zurich University of Applied Sciences, School of Health Professions, Institute of Physiotherapy, Research &amp","rauh@zhaw.ch"
"1282","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Baur","Heiner","Department of Health Professions, Physiotherapy, Bern University of Applied Sciences, Murtenstrasse 10, CH-30008, Bern, Switzerland",NA
"1283","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Reicherzer","Leah","ZHAW Zurich University of Applied Sciences, School of Health Professions, Institute of Physiotherapy, Research &amp",NA
"1284","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Wirz","Markus","ZHAW Zurich University of Applied Sciences, School of Health Professions, Institute of Physiotherapy, Research &amp",NA
"1285","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Keller","Fabienne","School of Health Sciences (HESAV) - University of Applied Sciences and Arts Western Switzerland (HES-SO), Avenue de Beaumont 21, CH-1011, Lausanne, Switzerland",NA
"1286","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Opsommer","Emmanuelle","School of Health Sciences (HESAV) - University of Applied Sciences and Arts Western Switzerland (HES-SO), Avenue de Beaumont 21, CH-1011, Lausanne, Switzerland",NA
"1287","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Schoeb","Veronika","School of Health Sciences (HESAV) - University of Applied Sciences and Arts Western Switzerland (HES-SO), Avenue de Beaumont 21, CH-1011, Lausanne, Switzerland",NA
"1288","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Vercelli","Stefano","Department of Business Economics, Rehabilitation Research Laboratory 2rLab, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Stabile Piazzetta, via Violino 11, CH-6928, Manno/Landquart, Switzerland",NA
"1289","34233763","10.1186/s40945-021-00112-3","Physiotherapists' use and perceptions of digital remote physiotherapy during COVID-19 lockdown in Switzerland: an online cross-sectional survey.","The Swiss containment strategy for the COVID-19 pandemic during the first wave in spring 2020 resulted in a moratorium on non-urgent physiotherapy via regular direct patient contact. Consequently, such physiotherapy sessions declined by 84%. This study investigates the impact of this moratorium on the use of digital remote physiotherapy in Switzerland during this period and the perceptions of its use by Swiss physiotherapists (PTs). A cross-sectional online questionnaire was distributed between ","2021","07","11","Arch Physiother","Archives of physiotherapy","Pandemic; Physical therapy modalities; SARS-CoV-2; Telerehabilitation","Barbero","Marco","Department of Business Economics, Rehabilitation Research Laboratory 2rLab, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Stabile Piazzetta, via Violino 11, CH-6928, Manno/Landquart, Switzerland",NA
"1290","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Appa","Ayesha","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA. Ayesha.appa@ucsf","Ayesha.appa@ucsf.edu"
"1291","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Chamie","Gabriel","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1292","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Sawyer","Aenor","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1293","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Baltzell","Kimberly","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1294","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Dippell","Kathryn","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1295","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Ribeiro","Salu","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1296","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Duarte","Elias","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1297","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Vinden","Joanna","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1298","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Consortium","Cliahub","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1299","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Kramer-Feldman","Jonathan","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1300","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Rahdari","Shahryar","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1301","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","MacIntosh","Doug","San Francisco State University, San Francisco, USA",NA
"1302","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Nicholson","Katherine","San Francisco State University, San Francisco, USA",NA
"1303","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Im","Jonathan","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1304","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Havlir","Diane","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1305","34233752","10.1186/s13690-021-00647-8","SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.","Early in the pandemic, inadequate SARS-CoV-2 testing limited understanding of transmission. Chief among barriers to large-scale testing was unknown feasibility, particularly in non-urban areas. Our objective was to report methods of high-volume, comprehensive SARS-CoV-2 testing, offering one model to augment disease surveillance in a rural community. A community-university partnership created an operational site used to test most residents of Bolinas, California regardless of symptoms in 4 days ","2021","07","11","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; COVID-19 diagnostic testing; Feasability Studies; Rural Population","Greenhouse","Bryan","University of California, San Francisco Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA",NA
"1306","34233744","10.1186/s13054-021-03664-9","The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?",NA,"2021","07","15","Crit Care","Critical care (London, England)","COVID-19; Disease Susceptibility; Estradiol; Gonadal Steroid Hormones; Humans; Male; Severity of Illness Index; Testosterone","Stolk","Roeland F","Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands",NA
"1307","34233744","10.1186/s13054-021-03664-9","The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?",NA,"2021","07","15","Crit Care","Critical care (London, England)","COVID-19; Disease Susceptibility; Estradiol; Gonadal Steroid Hormones; Humans; Male; Severity of Illness Index; Testosterone","van Leeuwen","Henk J","Department of Intensive Care Medicine, Hospital Rijnstate, Arnhem, The Netherlands",NA
"1308","34233744","10.1186/s13054-021-03664-9","The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?",NA,"2021","07","15","Crit Care","Critical care (London, England)","COVID-19; Disease Susceptibility; Estradiol; Gonadal Steroid Hormones; Humans; Male; Severity of Illness Index; Testosterone","Kox","Matthijs","Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands",NA
"1309","34233744","10.1186/s13054-021-03664-9","The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?",NA,"2021","07","15","Crit Care","Critical care (London, England)","COVID-19; Disease Susceptibility; Estradiol; Gonadal Steroid Hormones; Humans; Male; Severity of Illness Index; Testosterone","van Borren","Marcel","Department of Laboratory Medicine, Hospital Rijnstate, Arnhem, The Netherlands",NA
"1310","34233744","10.1186/s13054-021-03664-9","The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?",NA,"2021","07","15","Crit Care","Critical care (London, England)","COVID-19; Disease Susceptibility; Estradiol; Gonadal Steroid Hormones; Humans; Male; Severity of Illness Index; Testosterone","de Boer","Hans","Department of Internal Medicine, Hospital Rijnstate, Arnhem, The Netherlands",NA
"1311","34233744","10.1186/s13054-021-03664-9","The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?",NA,"2021","07","15","Crit Care","Critical care (London, England)","COVID-19; Disease Susceptibility; Estradiol; Gonadal Steroid Hormones; Humans; Male; Severity of Illness Index; Testosterone","Pickkers","Peter","Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Peter.pickkers@radboudumc","Peter.pickkers@radboudumc.nl"
"1312","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Ma","Yinzhong","SIAT-GHMSCB Biomedical Laboratory for Major Diseases, Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan Avenue 430, Dongguan, Guangdong, China",NA
"1313","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Wang","Lisha","SIAT-GHMSCB Biomedical Laboratory for Major Diseases, Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan Avenue 430, Dongguan, Guangdong, China",NA
"1314","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Yang","Shilun","Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Xueyuan Blvd 1068, Shenzhen, Guangdong, China",NA
"1315","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Liu","Dongyu","SIAT-GHMSCB Biomedical Laboratory for Major Diseases, Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan Avenue 430, Dongguan, Guangdong, China",NA
"1316","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Zeng","Yi","Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Xueyuan Blvd 1068, Shenzhen, Guangdong, China",NA
"1317","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Lin","Lilong","SIAT-GHMSCB Biomedical Laboratory for Major Diseases, Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan Avenue 430, Dongguan, Guangdong, China",NA
"1318","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Qiu","Linhui","Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Xueyuan Blvd 1068, Shenzhen, Guangdong, China",NA
"1319","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Lu","Jiahao","SIAT-GHMSCB Biomedical Laboratory for Major Diseases, Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan Avenue 430, Dongguan, Guangdong, China",NA
"1320","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Chang","Junlei","Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Xueyuan Blvd 1068, Shenzhen, Guangdong, China. jl.chang@siat.ac","jl.chang@siat.ac.cn"
"1321","34233739","10.1186/s13287-021-02463-x","The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.","The therapeutic efficacy of mesenchymal stem cells (MSCs) of different tissue origins on metabolic disorders can be varied in many ways but remains poorly defined. Here we report a comprehensive comparison of human MSCs derived from umbilical cord Wharton's jelly (UC-MSCs), dental pulp (PU-MSCs), and adipose tissue (AD-MSCs) on the treatment of glucose and lipid metabolic disorders in type II diabetic mice. Fourteen-to-fifteen-week-old male C57BL/6 db/db mice were intravenously administered with","2021","07","12","Stem Cell Res Ther","Stem cell research &amp; therapy","Diabetes; Hyperglycemia; Insulin resistance; Lipid metabolism; Mesenchymal stem cells; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Umbilical Cord","Li","Zhihuan","SIAT-GHMSCB Biomedical Laboratory for Major Diseases, Dongguan Enlife Stem Cell Biotechnology Institute, Dongguan Avenue 430, Dongguan, Guangdong, China. aposea@163","aposea@163.com"
"1322","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Watson","Kathleen B","National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop, S107-5, Atlanta, GA, 30341, USA. iyr4@cdc","iyr4@cdc.gov"
"1323","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Whitfield","Geoffrey P","National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop, S107-5, Atlanta, GA, 30341, USA",NA
"1324","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Huntzicker","George","National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop, S107-5, Atlanta, GA, 30341, USA",NA
"1325","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Omura","John D","National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop, S107-5, Atlanta, GA, 30341, USA",NA
"1326","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Ussery","Emily","National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop, S107-5, Atlanta, GA, 30341, USA",NA
"1327","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Chen","Tiffany J","National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop, S107-5, Atlanta, GA, 30341, USA",NA
"1328","34233691","10.1186/s12966-021-01161-4","Cross-sectional study of changes in physical activity behavior during the COVID-19 pandemic among US adults.","Physical activity (PA) provides numerous health benefits relevant to the COVID-19 pandemic. However, concerns exist that PA levels may have decreased during the pandemic thus exacerbating health disparities. This study aims to determine changes in and locations for PA and reasons for decreased PA during the pandemic. Reported percentage of changes in and locations for PA and reasons for decreased PA were examined in 3829 US adults who completed the 2020 SummerStyles survey. Overall, 30% reported","2021","07","14","Int J Behav Nutr Phys Act","The international journal of behavioral nutrition and physical activity","Environment; Epidemiology; Health disparities; Adult; COVID-19; Cross-Sectional Studies; Ethnic Groups; Exercise; Female; Humans; Male; Middle Aged; SARS-CoV-2; Surveys and Questionnaires; United States; Young Adult","Fanfair","Robyn Neblett","National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA",NA
"1329","34233672","10.1186/s12931-021-01782-0","Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.","The first step in SARS-CoV-2 infection is binding of the virus to angiotensin converting enzyme 2 (ACE2) on the airway epithelium. Asthma affects over 300 million people world-wide, many of whom may encounter SARS-CoV-2. Epidemiologic data suggests that asthmatics who get infected may be at increased risk of more severe disease. Our objective was to assess whether maintenance inhaled corticosteroids (ICS), a major treatment for asthma, is associated with airway ACE2 expression in asthmatics. Lar","2021","07","14","Respir Res","Respiratory research","ACE2; Asthma; Gene expression; Large airway epithelium; Maintenance inhaled corticosteroids; SARS-CoV-2; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme 2; Asthma; COVID-19; Case-Control Studies; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Receptors, Virus; Respiratory Mucosa; SARS-CoV-2; Time Factors; Up-Regulation; Virus Internalization; Young Adult","O'Beirne","Sarah L","Department of Genetic Medicine, Weill Cornell Medical College, 1300 York Avenue, Box 164, New York, NY, 10065, USA",NA
"1330","34233672","10.1186/s12931-021-01782-0","Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.","The first step in SARS-CoV-2 infection is binding of the virus to angiotensin converting enzyme 2 (ACE2) on the airway epithelium. Asthma affects over 300 million people world-wide, many of whom may encounter SARS-CoV-2. Epidemiologic data suggests that asthmatics who get infected may be at increased risk of more severe disease. Our objective was to assess whether maintenance inhaled corticosteroids (ICS), a major treatment for asthma, is associated with airway ACE2 expression in asthmatics. Lar","2021","07","14","Respir Res","Respiratory research","ACE2; Asthma; Gene expression; Large airway epithelium; Maintenance inhaled corticosteroids; SARS-CoV-2; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme 2; Asthma; COVID-19; Case-Control Studies; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Receptors, Virus; Respiratory Mucosa; SARS-CoV-2; Time Factors; Up-Regulation; Virus Internalization; Young Adult","Salit","Jacqueline","Department of Genetic Medicine, Weill Cornell Medical College, 1300 York Avenue, Box 164, New York, NY, 10065, USA",NA
"1331","34233672","10.1186/s12931-021-01782-0","Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.","The first step in SARS-CoV-2 infection is binding of the virus to angiotensin converting enzyme 2 (ACE2) on the airway epithelium. Asthma affects over 300 million people world-wide, many of whom may encounter SARS-CoV-2. Epidemiologic data suggests that asthmatics who get infected may be at increased risk of more severe disease. Our objective was to assess whether maintenance inhaled corticosteroids (ICS), a major treatment for asthma, is associated with airway ACE2 expression in asthmatics. Lar","2021","07","14","Respir Res","Respiratory research","ACE2; Asthma; Gene expression; Large airway epithelium; Maintenance inhaled corticosteroids; SARS-CoV-2; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme 2; Asthma; COVID-19; Case-Control Studies; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Receptors, Virus; Respiratory Mucosa; SARS-CoV-2; Time Factors; Up-Regulation; Virus Internalization; Young Adult","Kaner","Robert J","Department of Genetic Medicine, Weill Cornell Medical College, 1300 York Avenue, Box 164, New York, NY, 10065, USA",NA
"1332","34233672","10.1186/s12931-021-01782-0","Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.","The first step in SARS-CoV-2 infection is binding of the virus to angiotensin converting enzyme 2 (ACE2) on the airway epithelium. Asthma affects over 300 million people world-wide, many of whom may encounter SARS-CoV-2. Epidemiologic data suggests that asthmatics who get infected may be at increased risk of more severe disease. Our objective was to assess whether maintenance inhaled corticosteroids (ICS), a major treatment for asthma, is associated with airway ACE2 expression in asthmatics. Lar","2021","07","14","Respir Res","Respiratory research","ACE2; Asthma; Gene expression; Large airway epithelium; Maintenance inhaled corticosteroids; SARS-CoV-2; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme 2; Asthma; COVID-19; Case-Control Studies; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Receptors, Virus; Respiratory Mucosa; SARS-CoV-2; Time Factors; Up-Regulation; Virus Internalization; Young Adult","Crystal","Ronald G","Department of Genetic Medicine, Weill Cornell Medical College, 1300 York Avenue, Box 164, New York, NY, 10065, USA",NA
"1333","34233672","10.1186/s12931-021-01782-0","Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.","The first step in SARS-CoV-2 infection is binding of the virus to angiotensin converting enzyme 2 (ACE2) on the airway epithelium. Asthma affects over 300 million people world-wide, many of whom may encounter SARS-CoV-2. Epidemiologic data suggests that asthmatics who get infected may be at increased risk of more severe disease. Our objective was to assess whether maintenance inhaled corticosteroids (ICS), a major treatment for asthma, is associated with airway ACE2 expression in asthmatics. Lar","2021","07","14","Respir Res","Respiratory research","ACE2; Asthma; Gene expression; Large airway epithelium; Maintenance inhaled corticosteroids; SARS-CoV-2; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme 2; Asthma; COVID-19; Case-Control Studies; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Receptors, Virus; Respiratory Mucosa; SARS-CoV-2; Time Factors; Up-Regulation; Virus Internalization; Young Adult","Strulovici-Barel","Yael","Department of Genetic Medicine, Weill Cornell Medical College, 1300 York Avenue, Box 164, New York, NY, 10065, USA. geneticmedicine@med.cornell","geneticmedicine@med.cornell.edu"
"1334","34233638","10.1186/s12879-021-06363-6","Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.","Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics. Between 5 March and 12 May 2020 in Mashhad, Iran, 1278 of 4000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptas","2021","07","12","BMC Infect Dis","BMC infectious diseases","COVID-19, SARS-COV-2; Epidemiological characteristics; Symptoms, Iran; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Cough; Cross-Sectional Studies; Diabetes Mellitus; Dyspnea; Female; Fever; Hospitalization; Humans; Infant; Infant, Newborn; Iran; Male; Middle Aged; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult","Goshayeshi","Ladan","Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1335","34233638","10.1186/s12879-021-06363-6","Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.","Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics. Between 5 March and 12 May 2020 in Mashhad, Iran, 1278 of 4000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptas","2021","07","12","BMC Infect Dis","BMC infectious diseases","COVID-19, SARS-COV-2; Epidemiological characteristics; Symptoms, Iran; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Cough; Cross-Sectional Studies; Diabetes Mellitus; Dyspnea; Female; Fever; Hospitalization; Humans; Infant; Infant, Newborn; Iran; Male; Middle Aged; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult","Akbari Rad","Mina","Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1336","34233638","10.1186/s12879-021-06363-6","Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.","Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics. Between 5 March and 12 May 2020 in Mashhad, Iran, 1278 of 4000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptas","2021","07","12","BMC Infect Dis","BMC infectious diseases","COVID-19, SARS-COV-2; Epidemiological characteristics; Symptoms, Iran; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Cough; Cross-Sectional Studies; Diabetes Mellitus; Dyspnea; Female; Fever; Hospitalization; Humans; Infant; Infant, Newborn; Iran; Male; Middle Aged; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult","Bergquist","Robert","Ingerod, SE-454 94, Brastad, Sweden",NA
"1337","34233638","10.1186/s12879-021-06363-6","Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.","Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics. Between 5 March and 12 May 2020 in Mashhad, Iran, 1278 of 4000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptas","2021","07","12","BMC Infect Dis","BMC infectious diseases","COVID-19, SARS-COV-2; Epidemiological characteristics; Symptoms, Iran; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Cough; Cross-Sectional Studies; Diabetes Mellitus; Dyspnea; Female; Fever; Hospitalization; Humans; Infant; Infant, Newborn; Iran; Male; Middle Aged; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult","Allahyari","Abolghasem","Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1338","34233638","10.1186/s12879-021-06363-6","Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.","Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics. Between 5 March and 12 May 2020 in Mashhad, Iran, 1278 of 4000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptas","2021","07","12","BMC Infect Dis","BMC infectious diseases","COVID-19, SARS-COV-2; Epidemiological characteristics; Symptoms, Iran; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Cough; Cross-Sectional Studies; Diabetes Mellitus; Dyspnea; Female; Fever; Hospitalization; Humans; Infant; Infant, Newborn; Iran; Male; Middle Aged; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult","Hashemzadeh","Kamila","Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran",NA
"1339","34233638","10.1186/s12879-021-06363-6","Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.","Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics. Between 5 March and 12 May 2020 in Mashhad, Iran, 1278 of 4000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptas","2021","07","12","BMC Infect Dis","BMC infectious diseases","COVID-19, SARS-COV-2; Epidemiological characteristics; Symptoms, Iran; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; COVID-19; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Cough; Cross-Sectional Studies; Diabetes Mellitus; Dyspnea; Female; Fever; Hospitalization; Humans; Infant; Infant, Newborn; Iran; Male; Middle Aged; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Treatment Outcome; Young Adult","Hoseini","Benyamin","Department of Health Information Technology, Neyshabur University of Medical Sciences, Neyshabur, Iran. Hoseinib1@nums.ac","Hoseinib1@nums.ac.ir"
"1340","34233629","10.1186/s12879-021-06358-3","Correction to: Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.",NA,"2021","07","11","BMC Infect Dis","BMC infectious diseases",NA,"Ryu","Sukhyun","Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, 35365, Republic of Korea. gentryu@onehealth.or","gentryu@onehealth.or.kr"
"1341","34233629","10.1186/s12879-021-06358-3","Correction to: Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.",NA,"2021","07","11","BMC Infect Dis","BMC infectious diseases",NA,"Ali","Sheikh Taslim","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China",NA
"1342","34233629","10.1186/s12879-021-06358-3","Correction to: Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.",NA,"2021","07","11","BMC Infect Dis","BMC infectious diseases",NA,"Noh","Eunbi","Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, 35365, Republic of Korea",NA
"1343","34233629","10.1186/s12879-021-06358-3","Correction to: Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.",NA,"2021","07","11","BMC Infect Dis","BMC infectious diseases",NA,"Kim","Dasom","Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, 35365, Republic of Korea",NA
"1344","34233629","10.1186/s12879-021-06358-3","Correction to: Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.",NA,"2021","07","11","BMC Infect Dis","BMC infectious diseases",NA,"Lau","Eric H Y","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China",NA
"1345","34233629","10.1186/s12879-021-06358-3","Correction to: Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.",NA,"2021","07","11","BMC Infect Dis","BMC infectious diseases",NA,"Cowling","Benjamin J","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong, Special Administrative Region of China",NA
"1346","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","O'Connell","Megan E","Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1347","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Haase","Kristen R","Faculty of Applied Science, School of Nursing, The University of British Columbia, Vancouver, British Columbia, Canada",NA
"1348","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Grewal","Karl S","Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1349","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Panyavin","Ivan","Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1350","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Kortzman","August","Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1351","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Flath","Meghan E","Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1352","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Cammer","Allison","College of Pharmacy &amp",NA
"1353","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Cosco","Theodore D","Gerontology Research Center, Department of Gerontology, Simon Fraser University, Vancouver, British Columbia, Canada",NA
"1354","34233600","10.1080/07317115.2021.1943589","Overcoming Barriers for Older Adults to Maintain Virtual Community and Social Connections during the COVID-19 Pandemic.","We describe the evaluation of remote training, an innovative use of technology to maintain older adults' virtual connection with their community and socialization, which were disrupted by the pandemic. Remote training was conducted via telephone using principles of cognitive rehabilitation and delivered by trained clinicians. We thematically analyzed trainer reflection notes and interviews with older adult participants. The main facilitators were technology training with exposure, and the main b","2021","07","08","Clin Gerontol","Clinical gerontologist","Aging; COVID-19; older adults; pandemic; social isolation; technology","Peacock","Shelley","College of Nursing, University of Saskatchewan, Saskatoon, Saskatchewan, Canada",NA
"1355","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Fang","Zhengying","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1356","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Gao","Chenni","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1357","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Cai","Yikai","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1358","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Lu","Lin","Department of Nephrology, North Huashan Hospital, Fudan University, Shanghai, PR China",NA
"1359","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Yu","Haijin","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1360","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Hussain","Hafiz Muhammad Jafar","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1361","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Chen","Zijin","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1362","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Li","Chuanlei","Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, PR China",NA
"1363","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Wei","Wenjie","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1364","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Huang","Yuhan","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1365","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Li","Xiang","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1366","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Yu","Shuwen","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1367","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Ji","Yinhong","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1368","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Weng","Qinjie","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1369","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Ouyang","Yan","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1370","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Hu","Xiaofan","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1371","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Tong","Jun","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1372","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Liu","Jian","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1373","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Liu","Mingyu","Wuhan Ninth Hospital, Wuhan, PR China",NA
"1374","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Xu","Xiaoman","Renal Department, Wuhan Ninth Hospital, Wuhan, PR China",NA
"1375","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Zha","Yixin","Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, PR China",NA
"1376","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Ye","Zhiyin","Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, PR China",NA
"1377","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Jiang","Tingting","Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, PR China",NA
"1378","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Jia","Jieshuang","Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, PR China",NA
"1379","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Liu","Jialin","Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University, School of medicine, Shanghai, PR China",NA
"1380","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Bi","Yufang","Department of Endocrinology and Metabolism disease, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1381","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Chen","Nan","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1382","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Hu","Weiguo","Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China",NA
"1383","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Wang","Huiming","Renal Department of Renmin Hospital, Renmin Hospital of Wuhan University, Wuhan, PR China",NA
"1384","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Liu","Jun","Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, PR China",NA
"1385","34233570","10.1080/0886022X.2021.1948429","A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients.","Acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) patients is associated with poor prognosis. Early prediction and intervention of AKI are vital for improving clinical outcome of COVID-19 patients. As lack of tools for early AKI detection in COVID-19 patients, this study aimed to validate the USCD-Mayo risk score in predicting hospital-acquired AKI in an extended multi-center COVID-19 cohort. Five hundred seventy-two COVID-19 patients from Wuhan Tongji Hospital Guanggu Branch, Wuh","2021","07","21","Ren Fail","Renal failure","COVID-19; acute kidney injury; proximal tubule; risk factors","Xie","Jingyuan","Department of Nephrology, Institute of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China",NA
"1386","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Tortella","G R","Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente, CIBAMA-BIOREN, Universidad de La Frontera, Temuco, Chile",NA
"1387","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Pieretti","J C","Center for Natural and Human Sciences, Universidade Federal do ABC (UFABC), Santo André, Brazil",NA
"1388","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Rubilar","O","Chemical Engineering Department, Universidad de La Frontera, Temuco, Chile",NA
"1389","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Fernández-Baldo","M","National Scientific and Technical Research Council | Conicet · INQUISAL Instituto de Química San Luis, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, San Luis, Argentina",NA
"1390","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Benavides-Mendoza","A","Departamento de Horticultura, Universidad Autónoma Agraria Antonio Narro, Saltillo, Mexico",NA
"1391","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Diez","M C","Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente, CIBAMA-BIOREN, Universidad de La Frontera, Temuco, Chile",NA
"1392","34233551","10.1080/07388551.2021.1939260","Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives.","The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic c","2021","07","08","Crit Rev Biotechnol","Critical reviews in biotechnology","(SARS-CoV-2); Silver nanoparticles; antiviral activity; copper nanoparticles; viral diseases","Seabra","A B","Center for Natural and Human Sciences, Universidade Federal do ABC (UFABC), Santo André, Brazil",NA
"1393","34233539","10.1177/10482911211029580","Confronting Two Crises: The COVID-19 Pandemic, the Opioid Epidemic, and the Industrial Hygienist.","This article was originally written for and published in the January 2021 issue of The Synergist, a monthly publication of the American Industrial Hygiene Association. The article addresses the convergence of the COVID-19 and opioid crises, the impact of the opioid crisis on the workplace and workers, and the role that industrial hygienists can play in developing workplace programs to prevent and respond to opioid misuse. While the article is specifically written for industrial hygienists","2021","07","08","New Solut","New solutions : a journal of environmental and occupational health policy : NS","COVID-19; occupational; occupational safety and health; opioid; substance use; workplace","Rosen","Jonathan","National Clearinghouse for Worker Safety and Health Training, Schenectady, NY, USA",NA
"1394","34233539","10.1177/10482911211029580","Confronting Two Crises: The COVID-19 Pandemic, the Opioid Epidemic, and the Industrial Hygienist.","This article was originally written for and published in the January 2021 issue of The Synergist, a monthly publication of the American Industrial Hygiene Association. The article addresses the convergence of the COVID-19 and opioid crises, the impact of the opioid crisis on the workplace and workers, and the role that industrial hygienists can play in developing workplace programs to prevent and respond to opioid misuse. While the article is specifically written for industrial hygienists","2021","07","08","New Solut","New solutions : a journal of environmental and occupational health policy : NS","COVID-19; occupational; occupational safety and health; opioid; substance use; workplace","Harnett","Peter","Leidos Inc, Reston, VA, USA",NA
"1395","34233532","10.1080/13548506.2021.1948579","COVID-19 vaccine hesitancy in a sample of Greek adults.","The ongoing COVID-19 global medical crisis carries a plethora of consequences and various sequelae, of which the most striking is the impact on physical and mental health. After the relaxing of imposed measures in Greece, in May 2020, a cross-sectional web survey based on a convenience sample was conducted exploring the attributions about the COVID-19 pandemic. Respondents were asked to rank their hesitancy to be vaccinated when the COVID-19 vaccine will be available and provided data on gender,","2021","07","08","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; infectious disease; pandemic; vaccine acceptance; vaccine hesitancy","Holeva","V","st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1396","34233532","10.1080/13548506.2021.1948579","COVID-19 vaccine hesitancy in a sample of Greek adults.","The ongoing COVID-19 global medical crisis carries a plethora of consequences and various sequelae, of which the most striking is the impact on physical and mental health. After the relaxing of imposed measures in Greece, in May 2020, a cross-sectional web survey based on a convenience sample was conducted exploring the attributions about the COVID-19 pandemic. Respondents were asked to rank their hesitancy to be vaccinated when the COVID-19 vaccine will be available and provided data on gender,","2021","07","08","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; infectious disease; pandemic; vaccine acceptance; vaccine hesitancy","Parlapani","E","st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1397","34233532","10.1080/13548506.2021.1948579","COVID-19 vaccine hesitancy in a sample of Greek adults.","The ongoing COVID-19 global medical crisis carries a plethora of consequences and various sequelae, of which the most striking is the impact on physical and mental health. After the relaxing of imposed measures in Greece, in May 2020, a cross-sectional web survey based on a convenience sample was conducted exploring the attributions about the COVID-19 pandemic. Respondents were asked to rank their hesitancy to be vaccinated when the COVID-19 vaccine will be available and provided data on gender,","2021","07","08","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; infectious disease; pandemic; vaccine acceptance; vaccine hesitancy","Nikopoulou","V A","st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1398","34233532","10.1080/13548506.2021.1948579","COVID-19 vaccine hesitancy in a sample of Greek adults.","The ongoing COVID-19 global medical crisis carries a plethora of consequences and various sequelae, of which the most striking is the impact on physical and mental health. After the relaxing of imposed measures in Greece, in May 2020, a cross-sectional web survey based on a convenience sample was conducted exploring the attributions about the COVID-19 pandemic. Respondents were asked to rank their hesitancy to be vaccinated when the COVID-19 vaccine will be available and provided data on gender,","2021","07","08","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; infectious disease; pandemic; vaccine acceptance; vaccine hesitancy","Nouskas","I","Deparment of Cardiology, AFFIDEA Center of Medical Diagnoses, Thessaloniki, Greece",NA
"1399","34233532","10.1080/13548506.2021.1948579","COVID-19 vaccine hesitancy in a sample of Greek adults.","The ongoing COVID-19 global medical crisis carries a plethora of consequences and various sequelae, of which the most striking is the impact on physical and mental health. After the relaxing of imposed measures in Greece, in May 2020, a cross-sectional web survey based on a convenience sample was conducted exploring the attributions about the COVID-19 pandemic. Respondents were asked to rank their hesitancy to be vaccinated when the COVID-19 vaccine will be available and provided data on gender,","2021","07","08","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; infectious disease; pandemic; vaccine acceptance; vaccine hesitancy","Diakogiannis","I","st Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece",NA
"1400","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Seman","Stefan","Faculty of Sport and Physical Education, University of Belgrade, Belgrade 11000, Serbia",NA
"1401","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Drailov","Sanja Srzentic","Institute for Molecular Genetics and Genetic Engineering, Belgrade 11000, Serbia",NA
"1402","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Ilic","Vladimir","Faculty of Sport and Physical Education, University of Belgrade, Belgrade 11000, Serbia",NA
"1403","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Teic","Milorad","Division of Cardiology, Clinical Center of Serbia, University of Belgrade, Belgrade 11000, Serbia",NA
"1404","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Stojiljkovic","Stanimir","Faculty of Sport and Physical Education, University of Belgrade, Belgrade 11000, Serbia",NA
"1405","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Arena","Ross","Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL 60612, USA",NA
"1406","34233523","10.1177/15353702211028543","Physical activity and exercise as an essential medical strategy for the COVID-19 pandemic and beyond.","COVID-19 disease has been a problem in today's society, which has worldwide effects on different areas, especially on the economy; also, from a health perspective, the disease affects the daily life quality. Physical activity is one major positive factor with regard to enhancing life quality, as it can improve the whole psychological, social, and physical health conditions. Current measures such as social distancing are focused on preventing the viral spread. However, the consequences on other a","2021","07","08","Exp Biol Med (Maywood)","Experimental biology and medicine (Maywood, N.J.)","Coronavirus; SARS-CoV-2; exercise; infective disease; physical activity; public health","Popovic","Dejana","Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL 60612, USA",NA
"1407","34233506","10.1177/01455613211030348","Renin-Angiotensin-Aldosterone System Imbalance and Altered Aquaporin Activity: A New Perspective for COVID-19-Associated Xerostomia.",NA,"2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal",NA,"Jain","Amit","Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1408","34233506","10.1177/01455613211030348","Renin-Angiotensin-Aldosterone System Imbalance and Altered Aquaporin Activity: A New Perspective for COVID-19-Associated Xerostomia.",NA,"2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal",NA,"Lamperti","Massimo","Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1409","34233506","10.1177/01455613211030348","Renin-Angiotensin-Aldosterone System Imbalance and Altered Aquaporin Activity: A New Perspective for COVID-19-Associated Xerostomia.",NA,"2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal",NA,"Lobo","Francisco A","Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates",NA
"1410","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Avci","Hakan","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1411","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Karabulut","Burak","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1412","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Eken","Hazal Duygu","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1413","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Farasoglu","Abdussamet","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1414","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Çakil","Tolga","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1415","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Çoruk","Sedef","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1416","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Özel","Hanife","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1417","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Kaya","Namik Kemal","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1418","34233498","10.1177/01455613211028493","Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.","To evaluate the otolaryngology-specific symptoms that occur after receiving the Covid-19 vaccine and its possible side effects in patients who had Covid-19 infection in the last 6 months before the vaccination. The study comprised 3383 health care workers who were vaccinated against Covid 19. After excluding, the study was conducted with 1710 (51%) participants who agreed to answer the study questions. The participants were divided into 2 groups according to the history of Covid-19 positivity in","2021","07","08","Ear Nose Throat J","Ear, nose, &amp; throat journal","anosmia; coronavirus; smell disorders; vaccination","Özbalta","Seva Öztürk","Department of Ear, Nose and Throat Diseases, University of Health Sciences, Istanbul Kartal Dr Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey",NA
"1419","34233453","10.23812/21-137-L","Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.",NA,"2021","07","13","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","aerosolization; hyaluronic acid; hypertonic saline; mild COVID-19; topical antibiotics; viral shedding; xylitol; Administration, Intranasal; COVID-19; Humans; Nebulizers and Vaporizers; SARS-CoV-2; Saline Solution, Hypertonic; Virus Shedding","Varricchio","At","UOSD Video-Endoscopia delle VAS, P.O. San Gennaro - ASL Napoli 1-centro, Naples, Italy",NA
"1420","34233453","10.23812/21-137-L","Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.",NA,"2021","07","13","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","aerosolization; hyaluronic acid; hypertonic saline; mild COVID-19; topical antibiotics; viral shedding; xylitol; Administration, Intranasal; COVID-19; Humans; Nebulizers and Vaporizers; SARS-CoV-2; Saline Solution, Hypertonic; Virus Shedding","La Mantia","I","ENT Department, University of Catania, Catania, Italy",NA
"1421","34233453","10.23812/21-137-L","Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.",NA,"2021","07","13","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","aerosolization; hyaluronic acid; hypertonic saline; mild COVID-19; topical antibiotics; viral shedding; xylitol; Administration, Intranasal; COVID-19; Humans; Nebulizers and Vaporizers; SARS-CoV-2; Saline Solution, Hypertonic; Virus Shedding","Brunese","F P","Primary Care Paediatrics, ASL Caserta, Italy",NA
"1422","34233453","10.23812/21-137-L","Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.",NA,"2021","07","13","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","aerosolization; hyaluronic acid; hypertonic saline; mild COVID-19; topical antibiotics; viral shedding; xylitol; Administration, Intranasal; COVID-19; Humans; Nebulizers and Vaporizers; SARS-CoV-2; Saline Solution, Hypertonic; Virus Shedding","Varricchio","Al","ENT Department, Ospedale Santobono, Naples, Italy",NA
"1423","34233453","10.23812/21-137-L","Viral shedding in symptomatic patients with mild COVID-19: an experience with nebulized nasal treatment.",NA,"2021","07","13","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","aerosolization; hyaluronic acid; hypertonic saline; mild COVID-19; topical antibiotics; viral shedding; xylitol; Administration, Intranasal; COVID-19; Humans; Nebulizers and Vaporizers; SARS-CoV-2; Saline Solution, Hypertonic; Virus Shedding","Ciprandi","G","Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy",NA
"1424","34233401","10.1111/ijcp.14231","Avoiding COVID-19 hospital outbreaks: RT-PCR swab and clinical assessment.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; Disease Outbreaks; Hospitals; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Allievi","Luca","Department of Cardiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy",NA
"1425","34233401","10.1111/ijcp.14231","Avoiding COVID-19 hospital outbreaks: RT-PCR swab and clinical assessment.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; Disease Outbreaks; Hospitals; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Bongarzoni","Amedeo","Department of Cardiology, ASST Santi Paolo e Carlo, Milan, Italy",NA
"1426","34233401","10.1111/ijcp.14231","Avoiding COVID-19 hospital outbreaks: RT-PCR swab and clinical assessment.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; Disease Outbreaks; Hospitals; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Tassinario","Guido","Department of Cardiology, ASST Santi Paolo e Carlo, Milan, Italy",NA
"1427","34233401","10.1111/ijcp.14231","Avoiding COVID-19 hospital outbreaks: RT-PCR swab and clinical assessment.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; Disease Outbreaks; Hospitals; Humans; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2","Carugo","Stefano","Department of Cardiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy",NA
"1428","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Aydin","Fatma","Department of Pediatrics, Division of Pediatric Rheumatology, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1429","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Kurt","Tuba","Department of Pediatrics, Division of Pediatric Rheumatology, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1430","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Sezer","Müge","Department of Pediatrics, Division of Pediatric Rheumatology, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1431","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Tekgöz","Nilüfer","Department of Pediatrics, Division of Pediatric Rheumatology, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1432","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Ekici Tekin","Zahide","Department of Pediatrics, Division of Pediatric Rheumatology, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1433","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Kanik Yüksek","Saliha","Department of Pediatric Infectious Diseases, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1434","34233400","10.1111/ijcp.14030","Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Biological Therapy; COVID-19; Child; Humans; Pandemics; Rheumatic Diseases; SARS-CoV-2","Çelikel Acar","Banu","Department of Pediatrics, Division of Pediatric Rheumatology, Ministry of Health, Ankara City Hospital, Ankara, Turkey",NA
"1435","34233398","10.1111/ijcp.14026","COVID-19: Fighting anxiety with multi-media.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Anxiety; Anxiety Disorders; COVID-19; Cross-Sectional Studies; Humans; SARS-CoV-2","Fu","Bao","Department of Critical Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China",NA
"1436","34233398","10.1111/ijcp.14026","COVID-19: Fighting anxiety with multi-media.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Anxiety; Anxiety Disorders; COVID-19; Cross-Sectional Studies; Humans; SARS-CoV-2","Chen","Fang","Department of Critical Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China",NA
"1437","34233398","10.1111/ijcp.14026","COVID-19: Fighting anxiety with multi-media.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Anxiety; Anxiety Disorders; COVID-19; Cross-Sectional Studies; Humans; SARS-CoV-2","Fu","Xiaoyun","Department of Critical Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China",NA
"1438","34233397","10.1111/ijcp.14261","Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; European Continental Ancestry Group; Humans; New York City; Renal Insufficiency, Chronic; SARS-CoV-2","Yamada","Takayuki","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA",NA
"1439","34233397","10.1111/ijcp.14261","Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; European Continental Ancestry Group; Humans; New York City; Renal Insufficiency, Chronic; SARS-CoV-2","Mikami","Takahisa","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA",NA
"1440","34233397","10.1111/ijcp.14261","Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; European Continental Ancestry Group; Humans; New York City; Renal Insufficiency, Chronic; SARS-CoV-2","Chopra","Nitin","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA",NA
"1441","34233397","10.1111/ijcp.14261","Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; European Continental Ancestry Group; Humans; New York City; Renal Insufficiency, Chronic; SARS-CoV-2","Miyashita","Hirotaka","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA",NA
"1442","34233397","10.1111/ijcp.14261","Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; European Continental Ancestry Group; Humans; New York City; Renal Insufficiency, Chronic; SARS-CoV-2","Chernyavsky","Svetlana","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA",NA
"1443","34233397","10.1111/ijcp.14261","Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","COVID-19; European Continental Ancestry Group; Humans; New York City; Renal Insufficiency, Chronic; SARS-CoV-2","Miyashita","Satoshi","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA",NA
"1444","34233396","10.1111/ijcp.14136","The burnout and workload impact on recurrent COVID-19: Analysis of two healthcare professionals.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Burnout, Psychological; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Health Personnel; Humans; SARS-CoV-2; Surveys and Questionnaires; Workload","Kutlu","Ömer","Department of Dermatology and Venereology, School of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey",NA
"1445","34233396","10.1111/ijcp.14136","The burnout and workload impact on recurrent COVID-19: Analysis of two healthcare professionals.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Burnout, Psychological; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Health Personnel; Humans; SARS-CoV-2; Surveys and Questionnaires; Workload","Özdemir Çetinkaya","Pinar","Department of Dermatology and Venereology, Nazilli State Hospital, Aydin, Turkey",NA
"1446","34233396","10.1111/ijcp.14136","The burnout and workload impact on recurrent COVID-19: Analysis of two healthcare professionals.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Burnout, Psychological; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Health Personnel; Humans; SARS-CoV-2; Surveys and Questionnaires; Workload","Hanifi Kandemir","Mehmet","Department of Internal Medicine, Elbistan State Hospital, Kahramanmaras, Turkey",NA
"1447","34233396","10.1111/ijcp.14136","The burnout and workload impact on recurrent COVID-19: Analysis of two healthcare professionals.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Burnout, Psychological; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Health Personnel; Humans; SARS-CoV-2; Surveys and Questionnaires; Workload","Temel","Mehmet Turgut","Department of Emergency Services, Dogansehir State Hospital, Malatya, Turkey",NA
"1448","34233396","10.1111/ijcp.14136","The burnout and workload impact on recurrent COVID-19: Analysis of two healthcare professionals.",NA,"2021","07","13","Int J Clin Pract","International journal of clinical practice","Burnout, Psychological; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Health Personnel; Humans; SARS-CoV-2; Surveys and Questionnaires; Workload","Aybal","Tahsin","Department of Radiology, Sarikamis State Hospital, Kars, Turkey",NA
"1449","34233388","10.3906/sag-2105-116","Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.","Background COVID-19 disease may present with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID-19 who had no comorbid disease. Material and Methods This retrospective designed study included 217 patients with Covid PCR positive and typically COVID-19 clinic. The patients were classified into asymptomatic, non-se","2021","07","08","Turk J Med Sci","Turkish journal of medical sciences","3rd trimester; Covid-19; Pregnancy; ferritin; severe disease","Bozkurt","Fatma",NA,NA
"1450","34233388","10.3906/sag-2105-116","Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.","Background COVID-19 disease may present with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID-19 who had no comorbid disease. Material and Methods This retrospective designed study included 217 patients with Covid PCR positive and typically COVID-19 clinic. The patients were classified into asymptomatic, non-se","2021","07","08","Turk J Med Sci","Turkish journal of medical sciences","3rd trimester; Covid-19; Pregnancy; ferritin; severe disease","Çoskun","Ömer",NA,NA
"1451","34233388","10.3906/sag-2105-116","Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.","Background COVID-19 disease may present with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID-19 who had no comorbid disease. Material and Methods This retrospective designed study included 217 patients with Covid PCR positive and typically COVID-19 clinic. The patients were classified into asymptomatic, non-se","2021","07","08","Turk J Med Sci","Turkish journal of medical sciences","3rd trimester; Covid-19; Pregnancy; ferritin; severe disease","Yeleç","Sevda",NA,NA
"1452","34233388","10.3906/sag-2105-116","Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.","Background COVID-19 disease may present with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID-19 who had no comorbid disease. Material and Methods This retrospective designed study included 217 patients with Covid PCR positive and typically COVID-19 clinic. The patients were classified into asymptomatic, non-se","2021","07","08","Turk J Med Sci","Turkish journal of medical sciences","3rd trimester; Covid-19; Pregnancy; ferritin; severe disease","Bekçibasi","Muhammed",NA,NA
"1453","34233388","10.3906/sag-2105-116","Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.","Background COVID-19 disease may present with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID-19 who had no comorbid disease. Material and Methods This retrospective designed study included 217 patients with Covid PCR positive and typically COVID-19 clinic. The patients were classified into asymptomatic, non-se","2021","07","08","Turk J Med Sci","Turkish journal of medical sciences","3rd trimester; Covid-19; Pregnancy; ferritin; severe disease","Asena","Muhammet",NA,NA
"1454","34233388","10.3906/sag-2105-116","Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.","Background COVID-19 disease may present with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID-19 who had no comorbid disease. Material and Methods This retrospective designed study included 217 patients with Covid PCR positive and typically COVID-19 clinic. The patients were classified into asymptomatic, non-se","2021","07","08","Turk J Med Sci","Turkish journal of medical sciences","3rd trimester; Covid-19; Pregnancy; ferritin; severe disease","Bagli","Ihsan",NA,NA
"1455","34233346","10.1038/s41586-021-03744-4","Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.","Vaccine-induced immune thrombotic thrombocytopaenia (VITT) is a rare adverse effect of COVID-19 adenoviral vector vaccines<sup>1-3</sup>. VITT resembles heparin-induced thrombocytopaenia (HIT) in that it is associated with platelet-activating antibodies against platelet factor 4 (PF4)<sup>4</sup>; however, patients with VITT develop thrombocytopaenia and thrombosis without exposure to heparin. Here we sought to determine the binding site on PF4 of antibodies from patients with VITT. Using alanin","2021","07","22","Nature","Nature",NA,"Huynh","Angela","Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"1456","34233346","10.1038/s41586-021-03744-4","Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.","Vaccine-induced immune thrombotic thrombocytopaenia (VITT) is a rare adverse effect of COVID-19 adenoviral vector vaccines<sup>1-3</sup>. VITT resembles heparin-induced thrombocytopaenia (HIT) in that it is associated with platelet-activating antibodies against platelet factor 4 (PF4)<sup>4</sup>; however, patients with VITT develop thrombocytopaenia and thrombosis without exposure to heparin. Here we sought to determine the binding site on PF4 of antibodies from patients with VITT. Using alanin","2021","07","22","Nature","Nature",NA,"Kelton","John G","Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"1457","34233346","10.1038/s41586-021-03744-4","Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.","Vaccine-induced immune thrombotic thrombocytopaenia (VITT) is a rare adverse effect of COVID-19 adenoviral vector vaccines<sup>1-3</sup>. VITT resembles heparin-induced thrombocytopaenia (HIT) in that it is associated with platelet-activating antibodies against platelet factor 4 (PF4)<sup>4</sup>; however, patients with VITT develop thrombocytopaenia and thrombosis without exposure to heparin. Here we sought to determine the binding site on PF4 of antibodies from patients with VITT. Using alanin","2021","07","22","Nature","Nature",NA,"Arnold","Donald M","Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada",NA
"1458","34233346","10.1038/s41586-021-03744-4","Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.","Vaccine-induced immune thrombotic thrombocytopaenia (VITT) is a rare adverse effect of COVID-19 adenoviral vector vaccines<sup>1-3</sup>. VITT resembles heparin-induced thrombocytopaenia (HIT) in that it is associated with platelet-activating antibodies against platelet factor 4 (PF4)<sup>4</sup>; however, patients with VITT develop thrombocytopaenia and thrombosis without exposure to heparin. Here we sought to determine the binding site on PF4 of antibodies from patients with VITT. Using alanin","2021","07","22","Nature","Nature",NA,"Daka","Mercy","Department of Biochemistry and Biomedical Sciences, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada",NA
"1459","34233346","10.1038/s41586-021-03744-4","Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.","Vaccine-induced immune thrombotic thrombocytopaenia (VITT) is a rare adverse effect of COVID-19 adenoviral vector vaccines<sup>1-3</sup>. VITT resembles heparin-induced thrombocytopaenia (HIT) in that it is associated with platelet-activating antibodies against platelet factor 4 (PF4)<sup>4</sup>; however, patients with VITT develop thrombocytopaenia and thrombosis without exposure to heparin. Here we sought to determine the binding site on PF4 of antibodies from patients with VITT. Using alanin","2021","07","22","Nature","Nature",NA,"Nazy","Ishac","Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. nazyi@mcmaster","nazyi@mcmaster.ca"
"1460","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Mahajan","Niraj N","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1461","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Pophalkar","Madhura","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1462","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Patil","Sarika","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1463","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Yewale","Bhagyashree","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1464","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Chaaithanya","Itta Krishna","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1465","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Mahale","Smita D","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1466","34233345","10.1097/AOG.0000000000004529","Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India.",NA,"2021","07","07","Obstet Gynecol","Obstetrics and gynecology",NA,"Gajbhiye","Rahul K","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"1467","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","La Porta","Edoardo","Department of Cardionephrology, Istituto Clinico Di Alta Specialità (ICLAS), Rapallo, Italy",NA
"1468","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Lanino","Luca","Department of Internal Medicine (DIMI), University of Genoa, Genoa, Italy",NA
"1469","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Calatroni","Marta","Division of Nephrology, Humanitas Clinical and Research Center, Milan, Italy",NA
"1470","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Caramella","Elena","Division of Nephrology and Dialysis, Ospedale Sant'Anna, San Fermo della Battaglia, Como, Italy",NA
"1471","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Avella","Alessandro","Division of Nephrology and Dialysis, Ospedale di Circolo e Fondazione Macchi, Varese, Italy",NA
"1472","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Quinn","Caroline","Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA",NA
"1473","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Faragli","Alessandro","Department of Internal Medicine and Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany",NA
"1474","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Estienne","Luca","Department of Nephrology and Dialysis, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy",NA
"1475","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Alogna","Alessio","Department of Internal Medicine and Cardiology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany",NA
"1476","34233334","10.1159/000515172","Volume Balance in Chronic Kidney Disease: Evaluation Methodologies and Innovation Opportunities.","Patients affected by chronic kidney disease are at a risk of cardiovascular morbidity and mortality. Body fluids unbalance is one of the main characteristics of this condition, as fluid overload is highly prevalent in patients affected by the cardiorenal syndrome. We describe the state of the art and new insights into body volume evaluation. The mechanisms behind fluid balance are often complex, mainly because of the interplay of multiple regulatory systems. Consequently, its management may be c","2021","07","07","Kidney Blood Press Res","Kidney &amp; blood pressure research","Body water; Chronic kidney failure; Electric impedance; Heart failure; Telemedicine","Esposito","Pasquale","Division of Nephrology, Department of Internal Medicine, Dialysis and Transplantation, University of Genoa and IRCCS Policlinico San Martino, Genoa, Italy",NA
"1477","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Zhu","Li",NA,NA
"1478","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Zhang","Yunwen",NA,NA
"1479","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Yang","Zhengrong",NA,NA
"1480","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Li","Baisheng",NA,NA
"1481","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Feng","Tiejian",NA,NA
"1482","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Zou","Xuan",NA,NA
"1483","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"He","Jianfan",NA,NA
"1484","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"He","Taiping",NA,NA
"1485","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Li","Junling",NA,NA
"1486","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Liu","Ning",NA,NA
"1487","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Li","Wei",NA,NA
"1488","34233324","10.1159/000517717","Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody.",NA,"2021","07","07","Intervirology","Intervirology",NA,"Wang","Xiaohui",NA,NA
"1489","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","Revon-Riviere","Gabriel","Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France",NA
"1490","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","Ninove","Laetitia","Unité des Virus Émergents (UVE) Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1491","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","Min","Victoria","Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France",NA
"1492","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","Rome","Angélique","Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France",NA
"1493","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","Coze","Carole","Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France",NA
"1494","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","Verschuur","Arnauld","Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France",NA
"1495","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","de Lamballerie","Xavier","Unité des Virus Émergents (UVE) Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France",NA
"1496","34233234","10.1016/j.ejca.2021.06.002","The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.","COVID-19 infection in paediatric patients with cancer is severe or critical in 20% of the patients. It can therefore directly affect paediatric patients with cancer and/or their care. We aimed at evaluating the safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults (AYA) with solid tumour. This study includes a retrospective analysis of safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine administered to patients, =16 years old, under treatment for a solid","2021","07","23","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","AYA; Covid-19; Oncology; Paediatric oncology; Serology; Vaccine","André","Nicolas","Department of Pediatric Immunology, Hematology and Oncology, Children Hospital of La Timone, AP-HM, Marseille, France",NA
"1497","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Nigg","Carina","Institute of Sport Science, University of Bern, Bremgartenstrasse 145, 3012, Bern, Switzerland","carina.nigg@ispw.unibe.ch"
"1498","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Oriwol","Doris","Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Engler-Bunte-Ring 15, 76131, Karlsruhe, Germany","doris.oriwol@partner.kit.edu"
"1499","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Wunsch","Kathrin","Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Engler-Bunte-Ring 15, 76131, Karlsruhe, Germany. Electronic address: kathrin.wunsch@kit","kathrin.wunsch@kit.edu"
"1500","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Burchartz","Alexander","Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Engler-Bunte-Ring 15, 76131, Karlsruhe, Germany. Electronic address: alexander.burchartz@kit","alexander.burchartz@kit.edu"
"1501","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Kolb","Simon","Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Engler-Bunte-Ring 15, 76131, Karlsruhe, Germany. Electronic address: simon.kolb@kit","simon.kolb@kit.edu"
"1502","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Worth","Annette","Institute of Movement and Sport, University of Education Karlsruhe, Bismarckstraße 10, 76133, Karlsruhe, Germany. Electronic address: annette.worth@ph-karlsruhe",NA
"1503","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Woll","Alexander","Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Engler-Bunte-Ring 15, 76131, Karlsruhe, Germany. Electronic address: alexander.woll@kit","alexander.woll@kit.edu"
"1504","34233210","10.1016/j.healthplace.2021.102619","Population density predicts youth's physical activity changes during Covid-19 - Results from the MoMo study.","Children in Germany showed positive physical activity changes during the first Covid-19 lockdown in April 2020, but it is unclear how the changes relate to population density, which we investigated in a longitudinal sample of 1711 youth (4-17 years). For each ten citizens more per km<sup>2</sup>, less positive physical activity changes were observed. For example, a child living in an area with 100 citizens/km<sup>2</sup> increased daily life physical activity by 44.50 min/day, whereas a child li","2021","07","21","Health Place","Health &amp; place","Adolescents; Built environment; Children; Lockdown; Rural; Urban","Niessner","Claudia","Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Engler-Bunte-Ring 15, 76131, Karlsruhe, Germany. Electronic address: claudia.niessner@kit","claudia.niessner@kit.edu"
"1505","34233155","10.1016/j.envres.2021.111637","The impact of COVID-19 pandemic on sustainable development goals - A survey.","COVID-19 pandemic is the biggest challenge facing humanity after the 1918 Flu pandemic. The pandemic also poses a massive challenge to the achievement of Sustainable Development Goals (SDGs). Meeting this challenge requires a comprehensive investigation of the impact of the pandemic on sustainability. In this work, publications related to the impact of COVID-19 on sustainability in the Web of Science database were explored systematically by using bibliometrics techniques and meta-analysis approa","2021","07","24","Environ Res","Environmental research","Bibliometrics; COVID-19; SDGs; Sustainability; Visualization","Wang","Qiang","School of Economics and Management, China University of Petroleum (East China), Qingdao, 266580, People's Republic of China","wangqiang7@upc.edu.cn"
"1506","34233155","10.1016/j.envres.2021.111637","The impact of COVID-19 pandemic on sustainable development goals - A survey.","COVID-19 pandemic is the biggest challenge facing humanity after the 1918 Flu pandemic. The pandemic also poses a massive challenge to the achievement of Sustainable Development Goals (SDGs). Meeting this challenge requires a comprehensive investigation of the impact of the pandemic on sustainability. In this work, publications related to the impact of COVID-19 on sustainability in the Web of Science database were explored systematically by using bibliometrics techniques and meta-analysis approa","2021","07","24","Environ Res","Environmental research","Bibliometrics; COVID-19; SDGs; Sustainability; Visualization","Huang","Rui","School of Economics and Management, China University of Petroleum (East China), Qingdao, 266580, People's Republic of China",NA
"1507","34233149","10.1016/j.jinf.2021.07.001","Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination.",NA,"2021","07","18","J Infect","The Journal of infection","COVID-19; Dilution; SARS-CoV-2; Vaccination; mRNA vaccine","Favresse","Julien","University of Namur, Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, Rue Saint-Luc, 8 - 5004, Bouge, Namur, Belgium","julien.favresse@slbo.be"
"1508","34233149","10.1016/j.jinf.2021.07.001","Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination.",NA,"2021","07","18","J Infect","The Journal of infection","COVID-19; Dilution; SARS-CoV-2; Vaccination; mRNA vaccine","Douxfils","Jonathan","University of Namur, Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, Rue Saint-Luc, 8 - 5004, Bouge, Namur, Belgium",NA
"1509","34233146","10.1164/rccm.202106-1467ED","Bacterial Coinfection in COVID-19 and Influenza Pneumonia.",NA,"2021","07","07","Am J Respir Crit Care Med","American journal of respiratory and critical care medicine",NA,"Musher","Daniel M","Infectious Disease Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States",NA
"1510","34233142","10.1152/ajplung.00246.2021","Reply to Eisenhut.",NA,"2021","07","13","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","CFTR; COVID-19; ENaC; GPCR; SARS-CoV-2; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels","Abdel Hameid","Reem","Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1511","34233142","10.1152/ajplung.00246.2021","Reply to Eisenhut.",NA,"2021","07","13","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","CFTR; COVID-19; ENaC; GPCR; SARS-CoV-2; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels","Cormet-Boyaka","Estelle","Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio",NA
"1512","34233142","10.1152/ajplung.00246.2021","Reply to Eisenhut.",NA,"2021","07","13","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","CFTR; COVID-19; ENaC; GPCR; SARS-CoV-2; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels","Kuebler","Wolfgang M","Institute of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany",NA
"1513","34233142","10.1152/ajplung.00246.2021","Reply to Eisenhut.",NA,"2021","07","13","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","CFTR; COVID-19; ENaC; GPCR; SARS-CoV-2; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels","Uddin","Mohammed","Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1514","34233142","10.1152/ajplung.00246.2021","Reply to Eisenhut.",NA,"2021","07","13","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","CFTR; COVID-19; ENaC; GPCR; SARS-CoV-2; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Sodium Channels","Berdiev","Bakhrom K","Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates",NA
"1515","34233136","10.1152/ajpheart.00325.2021","Reply to Vaz.",NA,"2021","07","13","Am J Physiol Heart Circ Physiol","American journal of physiology. Heart and circulatory physiology","COVID-19; SARS-CoV-2; coronavirus; influenza; vascular function","Stickford","Abigail S L","Department of Health &amp",NA
"1516","34233136","10.1152/ajpheart.00325.2021","Reply to Vaz.",NA,"2021","07","13","Am J Physiol Heart Circ Physiol","American journal of physiology. Heart and circulatory physiology","COVID-19; SARS-CoV-2; coronavirus; influenza; vascular function","Stickford","Jonathon L","Department of Health &amp",NA
"1517","34233136","10.1152/ajpheart.00325.2021","Reply to Vaz.",NA,"2021","07","13","Am J Physiol Heart Circ Physiol","American journal of physiology. Heart and circulatory physiology","COVID-19; SARS-CoV-2; coronavirus; influenza; vascular function","Ratchford","Stephen M","Department of Health &amp",NA
"1518","34233121","10.1044/2021_AJSLP-20-00297","The Impact of the COVID-19 Public Health Crisis on Communication and Quality of Life: Insights From a Community of Stroke and Brain Trauma Survivors.","Purpose The COVID-19 pandemic has led to stay-at-home orders and social distancing guidelines that have the potential to greatly impact individuals' behavior and social engagement. Adults recovering from stroke or other brain trauma, who often have communication difficulties and other long-term challenges, are a population already at risk of isolation and lower quality of life. We investigated the impact of public health guidelines and related behavioral changes on self-perceptions of communicat","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Adult; Brain Injuries, Traumatic; COVID-19; Communication; Humans; Pandemics; Public Health; Quality of Life; SARS-CoV-2; Stroke; Survivors","Fama","Mackenzie E","Department of Speech, Language, and Hearing Sciences, The George Washington University, Washington, DC",NA
"1519","34233121","10.1044/2021_AJSLP-20-00297","The Impact of the COVID-19 Public Health Crisis on Communication and Quality of Life: Insights From a Community of Stroke and Brain Trauma Survivors.","Purpose The COVID-19 pandemic has led to stay-at-home orders and social distancing guidelines that have the potential to greatly impact individuals' behavior and social engagement. Adults recovering from stroke or other brain trauma, who often have communication difficulties and other long-term challenges, are a population already at risk of isolation and lower quality of life. We investigated the impact of public health guidelines and related behavioral changes on self-perceptions of communicat","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Adult; Brain Injuries, Traumatic; COVID-19; Communication; Humans; Pandemics; Public Health; Quality of Life; SARS-CoV-2; Stroke; Survivors","Hatfield","Brooke","Stroke Comeback Center, Vienna, VA",NA
"1520","34233121","10.1044/2021_AJSLP-20-00297","The Impact of the COVID-19 Public Health Crisis on Communication and Quality of Life: Insights From a Community of Stroke and Brain Trauma Survivors.","Purpose The COVID-19 pandemic has led to stay-at-home orders and social distancing guidelines that have the potential to greatly impact individuals' behavior and social engagement. Adults recovering from stroke or other brain trauma, who often have communication difficulties and other long-term challenges, are a population already at risk of isolation and lower quality of life. We investigated the impact of public health guidelines and related behavioral changes on self-perceptions of communicat","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Adult; Brain Injuries, Traumatic; COVID-19; Communication; Humans; Pandemics; Public Health; Quality of Life; SARS-CoV-2; Stroke; Survivors","Coyle","Suzanne","Stroke Comeback Center, Vienna, VA",NA
"1521","34233121","10.1044/2021_AJSLP-20-00297","The Impact of the COVID-19 Public Health Crisis on Communication and Quality of Life: Insights From a Community of Stroke and Brain Trauma Survivors.","Purpose The COVID-19 pandemic has led to stay-at-home orders and social distancing guidelines that have the potential to greatly impact individuals' behavior and social engagement. Adults recovering from stroke or other brain trauma, who often have communication difficulties and other long-term challenges, are a population already at risk of isolation and lower quality of life. We investigated the impact of public health guidelines and related behavioral changes on self-perceptions of communicat","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Adult; Brain Injuries, Traumatic; COVID-19; Communication; Humans; Pandemics; Public Health; Quality of Life; SARS-CoV-2; Stroke; Survivors","Richman","Melissa S","Stroke Comeback Center, Vienna, VA",NA
"1522","34233121","10.1044/2021_AJSLP-20-00297","The Impact of the COVID-19 Public Health Crisis on Communication and Quality of Life: Insights From a Community of Stroke and Brain Trauma Survivors.","Purpose The COVID-19 pandemic has led to stay-at-home orders and social distancing guidelines that have the potential to greatly impact individuals' behavior and social engagement. Adults recovering from stroke or other brain trauma, who often have communication difficulties and other long-term challenges, are a population already at risk of isolation and lower quality of life. We investigated the impact of public health guidelines and related behavioral changes on self-perceptions of communicat","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","Adult; Brain Injuries, Traumatic; COVID-19; Communication; Humans; Pandemics; Public Health; Quality of Life; SARS-CoV-2; Stroke; Survivors","Georgeadis","Amy C","Stroke Comeback Center, Vienna, VA",NA
"1523","34233109","10.1056/NEJMc2108479","Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Brinkley-Rubinstein","Lauren","University of North Carolina at Chapel Hill, Chapel Hill, NC lauren_brinkley@med.unc","brinkley@med.unc.edu"
"1524","34233109","10.1056/NEJMc2108479","Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Peterson","Meghan","University of North Carolina at Chapel Hill, Chapel Hill, NC lauren_brinkley@med.unc","brinkley@med.unc.edu"
"1525","34233109","10.1056/NEJMc2108479","Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Martin","Rosemarie","Brown University, Providence, RI",NA
"1526","34233109","10.1056/NEJMc2108479","Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Chan","Philip","Miriam Hospital, Providence, RI",NA
"1527","34233109","10.1056/NEJMc2108479","Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Berk","Justin","Warren Alpert Medical School at Brown University, Providence, RI",NA
"1528","34233102","10.1056/NEJMe2111369","Audio Interview: How Well Are Covid-19 Vaccines Working?",NA,"2021","07","20","N Engl J Med","The New England journal of medicine","Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Testing; COVID-19 Vaccines; China; Disease Transmission, Infectious; Humans; Immunogenicity, Vaccine; Prisoners; SARS-CoV-2; Vaccine Potency; Vaccines, Inactivated","Rubin","Eric J",NA,NA
"1529","34233102","10.1056/NEJMe2111369","Audio Interview: How Well Are Covid-19 Vaccines Working?",NA,"2021","07","20","N Engl J Med","The New England journal of medicine","Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Testing; COVID-19 Vaccines; China; Disease Transmission, Infectious; Humans; Immunogenicity, Vaccine; Prisoners; SARS-CoV-2; Vaccine Potency; Vaccines, Inactivated","Baden","Lindsey R",NA,NA
"1530","34233102","10.1056/NEJMe2111369","Audio Interview: How Well Are Covid-19 Vaccines Working?",NA,"2021","07","20","N Engl J Med","The New England journal of medicine","Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Testing; COVID-19 Vaccines; China; Disease Transmission, Infectious; Humans; Immunogenicity, Vaccine; Prisoners; SARS-CoV-2; Vaccine Potency; Vaccines, Inactivated","Morrissey","Stephen",NA,NA
"1531","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Jara","Alejandro","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1532","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Undurraga","Eduardo A","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1533","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"González","Cecilia","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1534","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Paredes","Fabio","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1535","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Fontecilla","Tomás","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1536","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Jara","Gonzalo","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1537","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Pizarro","Alejandra","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1538","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Acevedo","Johanna","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1539","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Leo","Katherine","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1540","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Leon","Francisco","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1541","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Sans","Carlos","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1542","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Leighton","Paulina","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1543","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Suárez","Pamela","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1544","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"García-Escorza","Heriberto","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1545","34233097","10.1056/NEJMoa2107715","Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.","Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021. We used a prospective national cohort, including participants 16 years of age or older who were affiliate","2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Araos","Rafael","From the Ministry of Health (A.J., C.G., F.P., T.F., G.J., A.P., J.A., K.L., F.L., C.S., P.L., P.S., H.G.-E., R.A.), Facultad de Matemáticas (A.J.) and Escuela de Gobierno (E.A.U.), Pontificia Universidad Católica de Chile, Millennium Nucleus Center for the Discovery of Structures in Complex Data (A.J.), Millennium Initiative for Collaborative Research in Bacterial Resistance (E.A.U., R.A.), the Research Center for Integrated Disaster Risk Management (E.A.U.), Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo (R.A.), and the Advanced Center for Chronic Diseases (R.A.) - all in Santiago, Chile",NA
"1546","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Edara","Venkata-Viswanadh","Emory University School of Medicine, Atlanta, GA",NA
"1547","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Pinsky","Benjamin A","Stanford University School of Medicine, Stanford, CA",NA
"1548","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Suthar","Mehul S","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1549","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Lai","Lilin","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1550","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Davis-Gardner","Meredith E","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1551","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Floyd","Katharine","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1552","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Flowers","Maria W","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1553","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Wrammert","Jens","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1554","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Hussaini","Laila","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1555","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Ciric","Caroline Rose","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1556","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Bechnak","Sarah","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1557","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Stephens","Kathy","Emory University School of Medicine, Atlanta, GA msuthar@emory","msuthar@emory.edu"
"1558","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Graham","Barney S","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1559","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Bayat Mokhtari","Elham","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1560","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Mudvari","Prakriti","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1561","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Boritz","Eli","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1562","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Creanga","Adrian","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1563","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Pegu","Amarendra","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1564","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Derrien-Colemyn","Alexandrine","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1565","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Henry","Amy R","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1566","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Gagne","Matthew","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1567","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Douek","Daniel C","National Institute of Allergy and Infectious Diseases, Bethesda, MD",NA
"1568","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Sahoo","Malaya K","Stanford University School of Medicine, Stanford, CA",NA
"1569","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Sibai","Mamdouh","Stanford University School of Medicine, Stanford, CA",NA
"1570","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Solis","Daniel","Stanford University School of Medicine, Stanford, CA",NA
"1571","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Webby","Richard J","St. Jude Children's Research Hospital, Memphis, TN",NA
"1572","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Jeevan","Trushar","St. Jude Children's Research Hospital, Memphis, TN",NA
"1573","34233096","10.1056/NEJMc2107799","Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.",NA,"2021","07","24","N Engl J Med","The New England journal of medicine",NA,"Fabrizio","Thomas P","St. Jude Children's Research Hospital, Memphis, TN",NA
"1574","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Katsuta","Tomohiro","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1575","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Shimizu","Naoki","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1576","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Okada","Kenji","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1577","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Tanaka-Taya","Keiko","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1578","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Nakano","Takashi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1579","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Kamiya","Hajime","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1580","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Amo","Kiyoko","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1581","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Ishiwada","Naruhiko","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1582","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Iwata","Satoshi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1583","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Oshiro","Makoto","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1584","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Okabe","Nobuhiko","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1585","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Kira","Ryutaro","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1586","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Korematsu","Seigo","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1587","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Suga","Shigeru","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1588","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Tsugawa","Takeshi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1589","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Nishimura","Naoko","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1590","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Hishiki","Haruka","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1591","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Fujioka","Masashi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1592","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Hosoya","Mitsuaki","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1593","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Mizuno","Yumi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1594","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Mine","Mahito","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1595","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Miyairi","Isao","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1596","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Miyazaki","Chiaki","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1597","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Morioka","Ichiro","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1598","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Morishima","Tsuneo","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1599","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Yoshikawa","Tetsushi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1600","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Wada","Taizo","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1601","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Azuma","Hiroshi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1602","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Kusuhara","Koichi","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1603","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Ouchi","Kazunobu","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1604","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Saitoh","Akihiko","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1605","34233075","10.1111/ped.14912","The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.","Coronavirus disease 2019 (COVID-19) pandemic has affected the lives of young and old people. Most reports on pediatric cases suggest that children experience fewer and milder symptoms than adults do. This is the first nationwide study that focused on pediatric cases reported by pediatricians, including those with no or mild symptoms, in Japan. We analyzed the epidemiological and clinical characteristics, and transmission patterns of 840 pediatric (&lt;16 years old) COVID-19 cases reported betwee","2021","07","07","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; epidemiology; household contact; pediatrics; school closure","Moriuchi","Hiroyuki","The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan",NA
"1606","34233009","10.4414/smw.2021.20529","Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.","Mortality rates of COVID-19 patients hospitalised in intensive care units (ICUs) are generally high. Availability of ICU resources might influence clinical outcomes. The aim of this study was to examine the clinical course of the 42 patients treated during the first epidemic wave between 2 March and 20 May 2020 at the tertiary ICU of the Bern University Hospital, where staffing, equipment and drugs were not limited. For this descriptive study, retrospective data of the first COVID-19 wave in an ","2021","07","15","Swiss Med Wkly","Swiss medical weekly","Adult; Aged; Aged, 80 and over; COVID-19; Critical Care; Epidemics; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Switzerland; Workforce","Jeitziner","Marie-Madlen","Department of Intensive Care Medicine, Bern University Hospital, Inselspital, University of Bern, Switzerland",NA
"1607","34233009","10.4414/smw.2021.20529","Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.","Mortality rates of COVID-19 patients hospitalised in intensive care units (ICUs) are generally high. Availability of ICU resources might influence clinical outcomes. The aim of this study was to examine the clinical course of the 42 patients treated during the first epidemic wave between 2 March and 20 May 2020 at the tertiary ICU of the Bern University Hospital, where staffing, equipment and drugs were not limited. For this descriptive study, retrospective data of the first COVID-19 wave in an ","2021","07","15","Swiss Med Wkly","Swiss medical weekly","Adult; Aged; Aged, 80 and over; COVID-19; Critical Care; Epidemics; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Switzerland; Workforce","Jenni-Moser","Béatrice","Department of Intensive Care Medicine, Bern University Hospital, Inselspital, University of Bern, Switzerland",NA
"1608","34233009","10.4414/smw.2021.20529","Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.","Mortality rates of COVID-19 patients hospitalised in intensive care units (ICUs) are generally high. Availability of ICU resources might influence clinical outcomes. The aim of this study was to examine the clinical course of the 42 patients treated during the first epidemic wave between 2 March and 20 May 2020 at the tertiary ICU of the Bern University Hospital, where staffing, equipment and drugs were not limited. For this descriptive study, retrospective data of the first COVID-19 wave in an ","2021","07","15","Swiss Med Wkly","Swiss medical weekly","Adult; Aged; Aged, 80 and over; COVID-19; Critical Care; Epidemics; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Switzerland; Workforce","Yok-Ai","Que","Department of Intensive Care Medicine, Bern University Hospital, Inselspital, University of Bern, Switzerland",NA
"1609","34233009","10.4414/smw.2021.20529","Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.","Mortality rates of COVID-19 patients hospitalised in intensive care units (ICUs) are generally high. Availability of ICU resources might influence clinical outcomes. The aim of this study was to examine the clinical course of the 42 patients treated during the first epidemic wave between 2 March and 20 May 2020 at the tertiary ICU of the Bern University Hospital, where staffing, equipment and drugs were not limited. For this descriptive study, retrospective data of the first COVID-19 wave in an ","2021","07","15","Swiss Med Wkly","Swiss medical weekly","Adult; Aged; Aged, 80 and over; COVID-19; Critical Care; Epidemics; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Switzerland; Workforce","Thurnheer Zürcher","Maria Christine","Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Switzerland",NA
"1610","34233009","10.4414/smw.2021.20529","Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.","Mortality rates of COVID-19 patients hospitalised in intensive care units (ICUs) are generally high. Availability of ICU resources might influence clinical outcomes. The aim of this study was to examine the clinical course of the 42 patients treated during the first epidemic wave between 2 March and 20 May 2020 at the tertiary ICU of the Bern University Hospital, where staffing, equipment and drugs were not limited. For this descriptive study, retrospective data of the first COVID-19 wave in an ","2021","07","15","Swiss Med Wkly","Swiss medical weekly","Adult; Aged; Aged, 80 and over; COVID-19; Critical Care; Epidemics; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Switzerland; Workforce","Furrer","Hansjakob","Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Switzerland",NA
"1611","34233009","10.4414/smw.2021.20529","Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit.","Mortality rates of COVID-19 patients hospitalised in intensive care units (ICUs) are generally high. Availability of ICU resources might influence clinical outcomes. The aim of this study was to examine the clinical course of the 42 patients treated during the first epidemic wave between 2 March and 20 May 2020 at the tertiary ICU of the Bern University Hospital, where staffing, equipment and drugs were not limited. For this descriptive study, retrospective data of the first COVID-19 wave in an ","2021","07","15","Swiss Med Wkly","Swiss medical weekly","Adult; Aged; Aged, 80 and over; COVID-19; Critical Care; Epidemics; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Switzerland; Workforce","Jakob","Stephan","Department of Intensive Care Medicine, Bern University Hospital, Inselspital, University of Bern, Switzerland",NA
"1612","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Li","Jiuxing","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1613","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Zhang","Zijie","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1614","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Gu","Jimmy","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1615","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Stacey","Hannah D","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1616","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Ang","Jann C","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1617","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Capretta","Alfredo","Department of Chemistry and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada",NA
"1618","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Filipe","Carlos D M","Department of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada",NA
"1619","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Mossman","Karen L","Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1620","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Balion","Cynthia","Department of Pathology and Molecular Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1621","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Salena","Bruno J","Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1622","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Yamamura","Deborah","Department of Pathology and Molecular Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1623","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Soleymani","Leyla","Department of Engineering Physics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L7, Canada",NA
"1624","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Miller","Matthew S","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1625","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Brennan","John D","Department of Chemistry and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada",NA
"1626","34232998","10.1093/nar/gkab574","Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.","We performed in vitro selection experiments to identify DNA aptamers for the S1 subunit of the SARS-CoV-2 spike protein (S1 protein). Using a pool of pre-structured random DNA sequences, we obtained over 100 candidate aptamers after 13 cycles of enrichment under progressively more stringent selection pressure. The top 10 sequences all exhibited strong binding to the S1 protein. Two aptamers, named MSA1 (Kd = 1.8 nM) and MSA5 (Kd = 2.7 nM), were assessed for binding to the heat-treated S1 protein","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Li","Yingfu","Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada",NA
"1627","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Lavigne","Marc","Institut Pasteur, Département de Virologie. CNRS UMR 3569, Paris, France",NA
"1628","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Helynck","Olivier","Institut Pasteur, Unité de Chimie et Biocatalyse. CNRS UMR 3523, Paris, France",NA
"1629","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Rigolet","Pascal","Institut Curie, Université Paris-Saclay, CNRS UMR 9187, Inserm U1196, Orsay, France",NA
"1630","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Boudria-Souilah","Rofia","Institut Pasteur, Département de Virologie. CNRS UMR 3569, Paris, France",NA
"1631","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Nowakowski","Mireille","Institut Pasteur, Plateforme de Production et Purification de Protéines Recombinantes, C2RT, CNRS UMR 3528, Paris, France",NA
"1632","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Baron","Bruno","Institut Pasteur, Plateforme de Biophysique Moléculaire, C2RT, CNRS UMR 3528, Paris, France",NA
"1633","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Brülé","Sébastien","Institut Pasteur, Plateforme de Biophysique Moléculaire, C2RT, CNRS UMR 3528, Paris, France",NA
"1634","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Hoos","Sylviane","Institut Pasteur, Plateforme de Biophysique Moléculaire, C2RT, CNRS UMR 3528, Paris, France",NA
"1635","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Raynal","Bertrand","Institut Pasteur, Plateforme de Biophysique Moléculaire, C2RT, CNRS UMR 3528, Paris, France",NA
"1636","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Guittat","Lionel","Université Sorbonne Paris Nord, INSERM U978, Labex Inflamex, F-93017 Bobigny, France",NA
"1637","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Beauvineau","Claire","Institut Curie, Université Paris-Saclay, CNRS UMR 9187, Inserm U1196, Orsay, France",NA
"1638","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Petres","Stéphane","Institut Pasteur, Plateforme de Production et Purification de Protéines Recombinantes, C2RT, CNRS UMR 3528, Paris, France",NA
"1639","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Granzhan","Anton","Institut Curie, Université Paris-Saclay, CNRS UMR 9187, Inserm U1196, Orsay, France",NA
"1640","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Guillon","Jean","Inserm U1212, CNRS UMR 5320, Laboratoire ARNA, UFR des Sciences Pharmaceutiques, Université de Bordeaux, Bordeaux, France",NA
"1641","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Pratviel","Geneviève","CNRS UPR 8241, Université Paul Sabatier, Laboratoire de Chimie de Coordination, Toulouse, France",NA
"1642","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Teulade-Fichou","Marie-Paule","Institut Curie, Université Paris-Saclay, CNRS UMR 9187, Inserm U1196, Orsay, France",NA
"1643","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"England","Patrick","Institut Pasteur, Plateforme de Biophysique Moléculaire, C2RT, CNRS UMR 3528, Paris, France",NA
"1644","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Mergny","Jean-Louis","Laboratoire d'optique et Biosciences, Ecole Polytechnique, Inserm U1182, CNRS UMR7645, Institut Polytechnique de Paris, Palaiseau, France",NA
"1645","34232992","10.1093/nar/gkab571","SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.","The multidomain non-structural protein 3 (Nsp3) is the largest protein encoded by coronavirus (CoV) genomes and several regions of this protein are essential for viral replication. Of note, SARS-CoV Nsp3 contains a SARS-Unique Domain (SUD), which can bind Guanine-rich non-canonical nucleic acid structures called G-quadruplexes (G4) and is essential for SARS-CoV replication. We show herein that the SARS-CoV-2 Nsp3 protein also contains a SUD domain that interacts with G4s. Indeed, interactions be","2021","07","21","Nucleic Acids Res","Nucleic acids research",NA,"Munier-Lehmann","Hélène","Institut Pasteur, Unité de Chimie et Biocatalyse. CNRS UMR 3523, Paris, France",NA
"1646","34232978","10.5858/arpa.2020-0820-SA","A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.","-The purpose of this review is to compare three coronavirus diseases: severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2 viruses, respectively. -To cover the following topics: clinical considerations, viral characteristics, pathology, immune response, pathogenesis, and the prognosis associated with each coronavirus human disease in humans. -Clinically, flu-like symptoms are usual ","2021","07","07","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Barth","Rolf F","Department of Pathology (RF Barth, Parwani), S.P. Technical Editor (Retired) Departments of Neurosurgery and Radiation Oncology (Carpenter), The Ohio State University Columbus, Ohio",NA
"1647","34232978","10.5858/arpa.2020-0820-SA","A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.","-The purpose of this review is to compare three coronavirus diseases: severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2 viruses, respectively. -To cover the following topics: clinical considerations, viral characteristics, pathology, immune response, pathogenesis, and the prognosis associated with each coronavirus human disease in humans. -Clinically, flu-like symptoms are usual ","2021","07","07","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Buja","L Maximillian","Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas (Buja)",NA
"1648","34232978","10.5858/arpa.2020-0820-SA","A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.","-The purpose of this review is to compare three coronavirus diseases: severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2 viruses, respectively. -To cover the following topics: clinical considerations, viral characteristics, pathology, immune response, pathogenesis, and the prognosis associated with each coronavirus human disease in humans. -Clinically, flu-like symptoms are usual ","2021","07","07","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Barth","Alison L","Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA (AL Barth)",NA
"1649","34232978","10.5858/arpa.2020-0820-SA","A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.","-The purpose of this review is to compare three coronavirus diseases: severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2 viruses, respectively. -To cover the following topics: clinical considerations, viral characteristics, pathology, immune response, pathogenesis, and the prognosis associated with each coronavirus human disease in humans. -Clinically, flu-like symptoms are usual ","2021","07","07","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Carpenter","David E","Department of Pathology (RF Barth, Parwani), S.P. Technical Editor (Retired) Departments of Neurosurgery and Radiation Oncology (Carpenter), The Ohio State University Columbus, Ohio",NA
"1650","34232978","10.5858/arpa.2020-0820-SA","A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.","-The purpose of this review is to compare three coronavirus diseases: severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19) caused by SARS-CoV, MERS-CoV, and SARS-CoV-2 viruses, respectively. -To cover the following topics: clinical considerations, viral characteristics, pathology, immune response, pathogenesis, and the prognosis associated with each coronavirus human disease in humans. -Clinically, flu-like symptoms are usual ","2021","07","07","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Parwani","Anil V","Department of Pathology (RF Barth, Parwani), S.P. Technical Editor (Retired) Departments of Neurosurgery and Radiation Oncology (Carpenter), The Ohio State University Columbus, Ohio",NA
"1651","34232921","10.1097/INF.0000000000003257","COVID-19 Can Cause Severe Intussusception in Infants: Case Report and Literature Review.","COVID-19 may cause intussusception in infants. We report on a case of severe ileo-colic intussusception in an infant with COVID-19 who required an ileo-colic resection. A literature review revealed 9 other cases with COVID-19 and intussusception. In this article, we will discuss the management and treatment of the first reported case of intussusception associated with COVID-19 in Italy.","2021","07","07","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Noviello","Carmine","Pediatric Surgery Unit, Salesi Children Hospital, Ancona, Italy Pediatric Surgery, Department of Women, Children, General, and Specialist Surgery, Campania University ""Luigi Vanvitelli,"" Napoli, Italy Department of Woman and Child Health and Public Health, Division of Neonatology, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1652","34232921","10.1097/INF.0000000000003257","COVID-19 Can Cause Severe Intussusception in Infants: Case Report and Literature Review.","COVID-19 may cause intussusception in infants. We report on a case of severe ileo-colic intussusception in an infant with COVID-19 who required an ileo-colic resection. A literature review revealed 9 other cases with COVID-19 and intussusception. In this article, we will discuss the management and treatment of the first reported case of intussusception associated with COVID-19 in Italy.","2021","07","07","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Bollettini","Taisia","Pediatric Surgery Unit, Salesi Children Hospital, Ancona, Italy Pediatric Surgery, Department of Women, Children, General, and Specialist Surgery, Campania University ""Luigi Vanvitelli,"" Napoli, Italy Department of Woman and Child Health and Public Health, Division of Neonatology, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1653","34232921","10.1097/INF.0000000000003257","COVID-19 Can Cause Severe Intussusception in Infants: Case Report and Literature Review.","COVID-19 may cause intussusception in infants. We report on a case of severe ileo-colic intussusception in an infant with COVID-19 who required an ileo-colic resection. A literature review revealed 9 other cases with COVID-19 and intussusception. In this article, we will discuss the management and treatment of the first reported case of intussusception associated with COVID-19 in Italy.","2021","07","07","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Mercedes","Romano","Pediatric Surgery Unit, Salesi Children Hospital, Ancona, Italy Pediatric Surgery, Department of Women, Children, General, and Specialist Surgery, Campania University ""Luigi Vanvitelli,"" Napoli, Italy Department of Woman and Child Health and Public Health, Division of Neonatology, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1654","34232921","10.1097/INF.0000000000003257","COVID-19 Can Cause Severe Intussusception in Infants: Case Report and Literature Review.","COVID-19 may cause intussusception in infants. We report on a case of severe ileo-colic intussusception in an infant with COVID-19 who required an ileo-colic resection. A literature review revealed 9 other cases with COVID-19 and intussusception. In this article, we will discuss the management and treatment of the first reported case of intussusception associated with COVID-19 in Italy.","2021","07","07","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Papparella","Alfonso","Pediatric Surgery Unit, Salesi Children Hospital, Ancona, Italy Pediatric Surgery, Department of Women, Children, General, and Specialist Surgery, Campania University ""Luigi Vanvitelli,"" Napoli, Italy Department of Woman and Child Health and Public Health, Division of Neonatology, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1655","34232921","10.1097/INF.0000000000003257","COVID-19 Can Cause Severe Intussusception in Infants: Case Report and Literature Review.","COVID-19 may cause intussusception in infants. We report on a case of severe ileo-colic intussusception in an infant with COVID-19 who required an ileo-colic resection. A literature review revealed 9 other cases with COVID-19 and intussusception. In this article, we will discuss the management and treatment of the first reported case of intussusception associated with COVID-19 in Italy.","2021","07","07","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Nobile","Stefano","Pediatric Surgery Unit, Salesi Children Hospital, Ancona, Italy Pediatric Surgery, Department of Women, Children, General, and Specialist Surgery, Campania University ""Luigi Vanvitelli,"" Napoli, Italy Department of Woman and Child Health and Public Health, Division of Neonatology, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1656","34232921","10.1097/INF.0000000000003257","COVID-19 Can Cause Severe Intussusception in Infants: Case Report and Literature Review.","COVID-19 may cause intussusception in infants. We report on a case of severe ileo-colic intussusception in an infant with COVID-19 who required an ileo-colic resection. A literature review revealed 9 other cases with COVID-19 and intussusception. In this article, we will discuss the management and treatment of the first reported case of intussusception associated with COVID-19 in Italy.","2021","07","07","Pediatr Infect Dis J","The Pediatric infectious disease journal",NA,"Cobellis","Giovanni","Pediatric Surgery Unit, Salesi Children Hospital, Ancona, Italy Pediatric Surgery, Department of Women, Children, General, and Specialist Surgery, Campania University ""Luigi Vanvitelli,"" Napoli, Italy Department of Woman and Child Health and Public Health, Division of Neonatology, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy",NA
"1657","34232852","10.1080/08897077.2021.1941513","Are COVID-19 health-related and socioeconomic stressors associated with increases in cannabis use in individuals who use cannabis for recreational purposes?","Background: The COVID-19 pandemic and associated public health measures implemented to mitigate transmission may increase stress, which, in turn, can be associated with changes in cannabis use. This study examined the associations between health-related and socioeconomic stressors associated with the COVID-19 pandemic, and reported increases in cannabis use. Indirect effects of health-related and socioeconomic stressors on increased cannabis use through cannabis coping motives were also t","2021","07","07","Subst Abus","Substance abuse","COVID-19; Cannabis use; coping motives; mediation; stressors","Sznitman","Sharon","School of Public Health, University of Haifa, Haifa, Israel",NA
"1658","34232852","10.1080/08897077.2021.1941513","Are COVID-19 health-related and socioeconomic stressors associated with increases in cannabis use in individuals who use cannabis for recreational purposes?","Background: The COVID-19 pandemic and associated public health measures implemented to mitigate transmission may increase stress, which, in turn, can be associated with changes in cannabis use. This study examined the associations between health-related and socioeconomic stressors associated with the COVID-19 pandemic, and reported increases in cannabis use. Indirect effects of health-related and socioeconomic stressors on increased cannabis use through cannabis coping motives were also t","2021","07","07","Subst Abus","Substance abuse","COVID-19; Cannabis use; coping motives; mediation; stressors","Rosenberg","Dennis","School of Public Health, University of Haifa, Haifa, Israel",NA
"1659","34232852","10.1080/08897077.2021.1941513","Are COVID-19 health-related and socioeconomic stressors associated with increases in cannabis use in individuals who use cannabis for recreational purposes?","Background: The COVID-19 pandemic and associated public health measures implemented to mitigate transmission may increase stress, which, in turn, can be associated with changes in cannabis use. This study examined the associations between health-related and socioeconomic stressors associated with the COVID-19 pandemic, and reported increases in cannabis use. Indirect effects of health-related and socioeconomic stressors on increased cannabis use through cannabis coping motives were also t","2021","07","07","Subst Abus","Substance abuse","COVID-19; Cannabis use; coping motives; mediation; stressors","Lewis","Nehama","Department of Communication Studies, University of Haifa, Haifa, Israel",NA
"1660","34232849","10.1080/07448481.2021.1926268","Psychosocial adjustment of U.S. college students in the early months of the COVID-19 pandemic.","Examine the psychosocial adjustment of U.S. college and university students during the early months of the COVID-19 pandemic. Participants: Higher education students in the U.S. (N = 228), recruited between March 2020 and May 2020. Methods: Participants completed self-report measures regarding their psychosocial functioning online. Qualitative and quantitative methods were used to explore participants' psychosocial adjustment. Results: Participants reported increased ","2021","07","07","J Am Coll Health","Journal of American college health : J of ACH","COVID-19; College; mental health; stress","Okado","Yuko","Department of Psychology, California State University, Fullerton, California, USA",NA
"1661","34232849","10.1080/07448481.2021.1926268","Psychosocial adjustment of U.S. college students in the early months of the COVID-19 pandemic.","Examine the psychosocial adjustment of U.S. college and university students during the early months of the COVID-19 pandemic. Participants: Higher education students in the U.S. (N = 228), recruited between March 2020 and May 2020. Methods: Participants completed self-report measures regarding their psychosocial functioning online. Qualitative and quantitative methods were used to explore participants' psychosocial adjustment. Results: Participants reported increased ","2021","07","07","J Am Coll Health","Journal of American college health : J of ACH","COVID-19; College; mental health; stress","Scaramella","Courtney","Department of Psychology, California State University, Fullerton, California, USA",NA
"1662","34232849","10.1080/07448481.2021.1926268","Psychosocial adjustment of U.S. college students in the early months of the COVID-19 pandemic.","Examine the psychosocial adjustment of U.S. college and university students during the early months of the COVID-19 pandemic. Participants: Higher education students in the U.S. (N = 228), recruited between March 2020 and May 2020. Methods: Participants completed self-report measures regarding their psychosocial functioning online. Qualitative and quantitative methods were used to explore participants' psychosocial adjustment. Results: Participants reported increased ","2021","07","07","J Am Coll Health","Journal of American college health : J of ACH","COVID-19; College; mental health; stress","Nguyen","Ha M","Department of Psychology, California State University, Fullerton, California, USA",NA
"1663","34232849","10.1080/07448481.2021.1926268","Psychosocial adjustment of U.S. college students in the early months of the COVID-19 pandemic.","Examine the psychosocial adjustment of U.S. college and university students during the early months of the COVID-19 pandemic. Participants: Higher education students in the U.S. (N = 228), recruited between March 2020 and May 2020. Methods: Participants completed self-report measures regarding their psychosocial functioning online. Qualitative and quantitative methods were used to explore participants' psychosocial adjustment. Results: Participants reported increased ","2021","07","07","J Am Coll Health","Journal of American college health : J of ACH","COVID-19; College; mental health; stress","Mendoza","Benjamin","Department of Psychology, California State University, Fullerton, California, USA",NA
"1664","34232849","10.1080/07448481.2021.1926268","Psychosocial adjustment of U.S. college students in the early months of the COVID-19 pandemic.","Examine the psychosocial adjustment of U.S. college and university students during the early months of the COVID-19 pandemic. Participants: Higher education students in the U.S. (N = 228), recruited between March 2020 and May 2020. Methods: Participants completed self-report measures regarding their psychosocial functioning online. Qualitative and quantitative methods were used to explore participants' psychosocial adjustment. Results: Participants reported increased ","2021","07","07","J Am Coll Health","Journal of American college health : J of ACH","COVID-19; College; mental health; stress","Watarastaporn","Tanya","Stanford Department of Human Biology, University, Stanford, California, USA",NA
"1665","34232823","10.1080/21688370.2021.1937013","The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.","Blood-gas barrier (BGB) or alveolar-capillary barrier is the primary tissue barrier affected by coronavirus disease 2019 (COVID-19). Comprising alveolar epithelial cells (AECs), endothelial cells (ECs) and the extracellular matrix (ECM) in between, the BGB is damaged following the action of multiple pro-inflammatory cytokines during acute inflammation. The infection of AECs and ECs with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen behind COVID-19, triggers an inflam","2021","07","07","Tissue Barriers","Tissue barriers","Blood-gas barrier; COVID-19; adherens junction; alveolar epithelial cell; alveolar-capillary barrier; coronavirus disease 2019; endothelial cell; extracellular matrix; severe acute respiratory syndrome coronavirus 2; tight junction","Shirvaliloo","Milad","Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"1666","34232822","10.3928/01484834-20210616-10","Nurse Practitioner Student Perceptions of a Pilot Simulated Gerontologic Telehealth Visit.","Recently published nurse practitioner (NP) education organization recommendations and telehealth equipment acquisition necessitated integration of telehealth simulation into NP curricula at a large, public university. The COVID-19 pandemic and associated rapid uptake of telehealth accelerated the need for evidence-supported research in tele-health simulation in NP education. A formative gerontologic simulation scenario using telehealth robot technology was developed by synthesizing best practice","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"LaManna","Jacqueline B",NA,NA
"1667","34232822","10.3928/01484834-20210616-10","Nurse Practitioner Student Perceptions of a Pilot Simulated Gerontologic Telehealth Visit.","Recently published nurse practitioner (NP) education organization recommendations and telehealth equipment acquisition necessitated integration of telehealth simulation into NP curricula at a large, public university. The COVID-19 pandemic and associated rapid uptake of telehealth accelerated the need for evidence-supported research in tele-health simulation in NP education. A formative gerontologic simulation scenario using telehealth robot technology was developed by synthesizing best practice","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Eckhoff","Dawn O",NA,NA
"1668","34232822","10.3928/01484834-20210616-10","Nurse Practitioner Student Perceptions of a Pilot Simulated Gerontologic Telehealth Visit.","Recently published nurse practitioner (NP) education organization recommendations and telehealth equipment acquisition necessitated integration of telehealth simulation into NP curricula at a large, public university. The COVID-19 pandemic and associated rapid uptake of telehealth accelerated the need for evidence-supported research in tele-health simulation in NP education. A formative gerontologic simulation scenario using telehealth robot technology was developed by synthesizing best practice","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Duncan","Jodi",NA,NA
"1669","34232822","10.3928/01484834-20210616-10","Nurse Practitioner Student Perceptions of a Pilot Simulated Gerontologic Telehealth Visit.","Recently published nurse practitioner (NP) education organization recommendations and telehealth equipment acquisition necessitated integration of telehealth simulation into NP curricula at a large, public university. The COVID-19 pandemic and associated rapid uptake of telehealth accelerated the need for evidence-supported research in tele-health simulation in NP education. A formative gerontologic simulation scenario using telehealth robot technology was developed by synthesizing best practice","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Anderson","Mindi",NA,NA
"1670","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Scott","Ann D",NA,NA
"1671","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Cone","April",NA,NA
"1672","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Creed","Joan M",NA,NA
"1673","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Custer","Sabra S",NA,NA
"1674","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Davis","Victoria H",NA,NA
"1675","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Gibbs","Shelli",NA,NA
"1676","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Herbert Harris","Eboni",NA,NA
"1677","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Jackson","Joynelle R",NA,NA
"1678","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Pate","Leigh B",NA,NA
"1679","34232818","10.3928/01484834-20210616-07","Rapid Transition to Online Learning for Baccalaureate Students: Teamwork During a Pandemic.","This article describes how a college of nursing (CON) converted its traditional undergraduate academic program to a 100% online program within 2 weeks of being informed of the need for curricular modifications due to the COVID-19 pandemic. The college faculty met online prior to implementation to discuss student needs and special considerations. Clinical simulation experiences were developed based on International Association for Clinical Simulation and Learning (INACSL) standards and delivered ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Vick","Lori L",NA,NA
"1680","34232817","10.3928/01484834-20210616-06","Coordinating Clinical Rotations During the Novel Corona Virus 2 Pandemic.","The outbreak of COVID-19 cases and deaths caused havoc in the medical, social, and education arenas, turning the normal routine into a new normal. Health care facilities across the state of Florida closed clinical training sites. Nursing students who were in scheduled clinical rotations suddenly were removed from assigned clinical sites. When students were no longer able to attend their clinical rotations due to COVID-19, panic ensued for students and educators. After clinical rotations came to ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Callender","Lynelle Fifianne",NA,NA
"1681","34232817","10.3928/01484834-20210616-06","Coordinating Clinical Rotations During the Novel Corona Virus 2 Pandemic.","The outbreak of COVID-19 cases and deaths caused havoc in the medical, social, and education arenas, turning the normal routine into a new normal. Health care facilities across the state of Florida closed clinical training sites. Nursing students who were in scheduled clinical rotations suddenly were removed from assigned clinical sites. When students were no longer able to attend their clinical rotations due to COVID-19, panic ensued for students and educators. After clinical rotations came to ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"LuValle Johnson","Arlene",NA,NA
"1682","34232817","10.3928/01484834-20210616-06","Coordinating Clinical Rotations During the Novel Corona Virus 2 Pandemic.","The outbreak of COVID-19 cases and deaths caused havoc in the medical, social, and education arenas, turning the normal routine into a new normal. Health care facilities across the state of Florida closed clinical training sites. Nursing students who were in scheduled clinical rotations suddenly were removed from assigned clinical sites. When students were no longer able to attend their clinical rotations due to COVID-19, panic ensued for students and educators. After clinical rotations came to ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Clark","Jennifer Nicole",NA,NA
"1683","34232817","10.3928/01484834-20210616-06","Coordinating Clinical Rotations During the Novel Corona Virus 2 Pandemic.","The outbreak of COVID-19 cases and deaths caused havoc in the medical, social, and education arenas, turning the normal routine into a new normal. Health care facilities across the state of Florida closed clinical training sites. Nursing students who were in scheduled clinical rotations suddenly were removed from assigned clinical sites. When students were no longer able to attend their clinical rotations due to COVID-19, panic ensued for students and educators. After clinical rotations came to ","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Terrero de la Osa","Ada",NA,NA
"1684","34232816","10.3928/01484834-20210616-09","Fear of Contagion Among Nursing Students in the Era of COVID-19.","COVID-19 quickly spread to pandemic proportions, resulting in anxiety and fear for many students. The Fear of Contagion model was explored in first-semester nursing students. This study used a qualitative design with content analysis of narrative responses to questions derived from the Fear of Contagion model and an a priori template based on the model. The results included five themes: (a) doing their part to prevent the spread but wanting to do more; (b) making specific behavior changes to pre","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Thornton","Tina M",NA,NA
"1685","34232816","10.3928/01484834-20210616-09","Fear of Contagion Among Nursing Students in the Era of COVID-19.","COVID-19 quickly spread to pandemic proportions, resulting in anxiety and fear for many students. The Fear of Contagion model was explored in first-semester nursing students. This study used a qualitative design with content analysis of narrative responses to questions derived from the Fear of Contagion model and an a priori template based on the model. The results included five themes: (a) doing their part to prevent the spread but wanting to do more; (b) making specific behavior changes to pre","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Decker","Sally A",NA,NA
"1686","34232816","10.3928/01484834-20210616-09","Fear of Contagion Among Nursing Students in the Era of COVID-19.","COVID-19 quickly spread to pandemic proportions, resulting in anxiety and fear for many students. The Fear of Contagion model was explored in first-semester nursing students. This study used a qualitative design with content analysis of narrative responses to questions derived from the Fear of Contagion model and an a priori template based on the model. The results included five themes: (a) doing their part to prevent the spread but wanting to do more; (b) making specific behavior changes to pre","2021","07","07","J Nurs Educ","The Journal of nursing education",NA,"Roe","Elizabeth A",NA,NA
"1687","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Campochiaro","C","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy",NA
"1688","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"De Luca","G","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy",NA
"1689","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Farina","N","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy",NA
"1690","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Vignale","D","Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy",NA
"1691","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Palmisano","A","Department of Radiology, IRCCS San Raffaele Hospital, Milan, Italy",NA
"1692","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Matucci-Cerinic","M","Department of Experimental and Clinical Medicine, University of Florence and Division of Rheumatology AOUC, Florence, Italy",NA
"1693","34232807","10.1080/03009742.2021.1932582","Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis.",NA,"2021","07","07","Scand J Rheumatol","Scandinavian journal of rheumatology",NA,"Dagna","L","Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy",NA
"1694","34232805","10.1080/13543776.2021.1953474","Inhibitory activities of bipyrazoles: a patent review.","Bipyrazole is constituted from two pyrazole units either in their fully aromatic or partially hydrogenated forms. Pyrazoles are widely available in pharmaceutical and agrochemical products. Some pyrazoles are essential parts of commercial drugs in the market. This inspired us to collect the pharmacological activities of bipyrazoles that have potential therapeutic behaviours in several biological aspects but none of them were included in commercial drugs. This review covers all biological and pha","2021","07","07","Expert Opin Ther Pat","Expert opinion on therapeutic patents","anti-inflammatory; anticancer; antimicrobial; antitubercular; bipyrazoles; enzymes inhibitors; pyrazoles; pyrazolines","Abbas","Ashraf A","Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt",NA
"1695","34232805","10.1080/13543776.2021.1953474","Inhibitory activities of bipyrazoles: a patent review.","Bipyrazole is constituted from two pyrazole units either in their fully aromatic or partially hydrogenated forms. Pyrazoles are widely available in pharmaceutical and agrochemical products. Some pyrazoles are essential parts of commercial drugs in the market. This inspired us to collect the pharmacological activities of bipyrazoles that have potential therapeutic behaviours in several biological aspects but none of them were included in commercial drugs. This review covers all biological and pha","2021","07","07","Expert Opin Ther Pat","Expert opinion on therapeutic patents","anti-inflammatory; anticancer; antimicrobial; antitubercular; bipyrazoles; enzymes inhibitors; pyrazoles; pyrazolines","Abdellattif","Magda H","Department of Chemistry, College of Science, Faif University, P.O. Box 11099, Taif 21944, Saudi Arabia",NA
"1696","34232805","10.1080/13543776.2021.1953474","Inhibitory activities of bipyrazoles: a patent review.","Bipyrazole is constituted from two pyrazole units either in their fully aromatic or partially hydrogenated forms. Pyrazoles are widely available in pharmaceutical and agrochemical products. Some pyrazoles are essential parts of commercial drugs in the market. This inspired us to collect the pharmacological activities of bipyrazoles that have potential therapeutic behaviours in several biological aspects but none of them were included in commercial drugs. This review covers all biological and pha","2021","07","07","Expert Opin Ther Pat","Expert opinion on therapeutic patents","anti-inflammatory; anticancer; antimicrobial; antitubercular; bipyrazoles; enzymes inhibitors; pyrazoles; pyrazolines","Dawood","Kamal M","Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt",NA
"1697","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Kumar","Sonali","Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, New Delhi, India",NA
"1698","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Shanker","Ozasvi R","Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, New Delhi, India",NA
"1699","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Kumari","Neeraj","Department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1700","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Tripathi","Manjari","Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1701","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Chandra","P Sarat","Department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1702","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Dixit","Aparna Banerjee","Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, New Delhi, India",NA
"1703","34232801","10.1080/14728222.2021.1953475","Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.","Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to ","2021","07","20","Expert Opin Ther Targets","Expert opinion on therapeutic targets","Coronavirus; covid-19; cyclophilins; drug repurposing; estrogen receptors exportin; histone deacetylases; neurological complications; sars-cov-2; ubiquitin/proteosome system","Banerjee","Jyotirmoy","Department of Biophysics All India Institute of Medical Sciences (AIIMS), New Delhi, India",NA
"1704","34232781","10.1089/jchc.20.07.0062","Correctional Nurses on the Front Lines of the COVID-19 Pandemic: Omaha System Guidelines Documentation Case Study.","During a pandemic, basic public health precautions must be taken across settings and populations. However, confinement conditions change what can be done in correctional settings. Correctional nursing (CN) care, like all nursing care, needs to be named and encoded to be recognized and used to generate data that will advance the discipline and maintain standards of care. The Omaha System is a standardized interprofessional terminology that has been used since 1992 to guide and document care. In 2","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Omaha System; correctional nursing; guidelines; interventions; COVID-19; Correctional Facilities; Documentation; Humans; Nurses; Nursing Care; Practice Guidelines as Topic; SARS-CoV-2; United States","Novacek","Lindsay","Department of Public Health, Forsyth County, Winston-Salem, North Carolina, USA",NA
"1705","34232781","10.1089/jchc.20.07.0062","Correctional Nurses on the Front Lines of the COVID-19 Pandemic: Omaha System Guidelines Documentation Case Study.","During a pandemic, basic public health precautions must be taken across settings and populations. However, confinement conditions change what can be done in correctional settings. Correctional nursing (CN) care, like all nursing care, needs to be named and encoded to be recognized and used to generate data that will advance the discipline and maintain standards of care. The Omaha System is a standardized interprofessional terminology that has been used since 1992 to guide and document care. In 2","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Omaha System; correctional nursing; guidelines; interventions; COVID-19; Correctional Facilities; Documentation; Humans; Nurses; Nursing Care; Practice Guidelines as Topic; SARS-CoV-2; United States","Shelton","Deborah","University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA",NA
"1706","34232781","10.1089/jchc.20.07.0062","Correctional Nurses on the Front Lines of the COVID-19 Pandemic: Omaha System Guidelines Documentation Case Study.","During a pandemic, basic public health precautions must be taken across settings and populations. However, confinement conditions change what can be done in correctional settings. Correctional nursing (CN) care, like all nursing care, needs to be named and encoded to be recognized and used to generate data that will advance the discipline and maintain standards of care. The Omaha System is a standardized interprofessional terminology that has been used since 1992 to guide and document care. In 2","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Omaha System; correctional nursing; guidelines; interventions; COVID-19; Correctional Facilities; Documentation; Humans; Nurses; Nursing Care; Practice Guidelines as Topic; SARS-CoV-2; United States","Luethy","Rebecca","Centurion, LLC, Irvine, California, USA",NA
"1707","34232781","10.1089/jchc.20.07.0062","Correctional Nurses on the Front Lines of the COVID-19 Pandemic: Omaha System Guidelines Documentation Case Study.","During a pandemic, basic public health precautions must be taken across settings and populations. However, confinement conditions change what can be done in correctional settings. Correctional nursing (CN) care, like all nursing care, needs to be named and encoded to be recognized and used to generate data that will advance the discipline and maintain standards of care. The Omaha System is a standardized interprofessional terminology that has been used since 1992 to guide and document care. In 2","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Omaha System; correctional nursing; guidelines; interventions; COVID-19; Correctional Facilities; Documentation; Humans; Nurses; Nursing Care; Practice Guidelines as Topic; SARS-CoV-2; United States","Medley-Lane","B Sue","Centurion, LLC, Irvine, California, USA",NA
"1708","34232781","10.1089/jchc.20.07.0062","Correctional Nurses on the Front Lines of the COVID-19 Pandemic: Omaha System Guidelines Documentation Case Study.","During a pandemic, basic public health precautions must be taken across settings and populations. However, confinement conditions change what can be done in correctional settings. Correctional nursing (CN) care, like all nursing care, needs to be named and encoded to be recognized and used to generate data that will advance the discipline and maintain standards of care. The Omaha System is a standardized interprofessional terminology that has been used since 1992 to guide and document care. In 2","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Omaha System; correctional nursing; guidelines; interventions; COVID-19; Correctional Facilities; Documentation; Humans; Nurses; Nursing Care; Practice Guidelines as Topic; SARS-CoV-2; United States","McLane","Tara M","University of Minnesota School of Nursing, Minneapolis, Minnesota, USA",NA
"1709","34232781","10.1089/jchc.20.07.0062","Correctional Nurses on the Front Lines of the COVID-19 Pandemic: Omaha System Guidelines Documentation Case Study.","During a pandemic, basic public health precautions must be taken across settings and populations. However, confinement conditions change what can be done in correctional settings. Correctional nursing (CN) care, like all nursing care, needs to be named and encoded to be recognized and used to generate data that will advance the discipline and maintain standards of care. The Omaha System is a standardized interprofessional terminology that has been used since 1992 to guide and document care. In 2","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Omaha System; correctional nursing; guidelines; interventions; COVID-19; Correctional Facilities; Documentation; Humans; Nurses; Nursing Care; Practice Guidelines as Topic; SARS-CoV-2; United States","Monsen","Karen A","University of Minnesota School of Nursing, Minneapolis, Minnesota, USA",NA
"1710","34232770","10.1177/19458924211027798","Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.","Coronavirus disease 2019 (COVID-19) has caused a global pandemic. Higher expression of the virus receptor angiotensin-converting enzyme 2 (ACE2) in the nasal mucosa may be associated with high transmissibility and asymptomatic infection. In COVID-19, the elucidation of the determinants of ACE2 expression at nasal tissue level is crucial. The development of strategies to downregulate ACE2 expression in nasal epithelial cells might reduce transmission and be useful as a novel therapeutic approach.","2021","07","07","Am J Rhinol Allergy","American journal of rhinology &amp; allergy","Japanese cedar pollen; airway epithelial cell; angiotensin-converting enzyme 2; chronic rhinosinusitis; coronavirus disease 2019; eosinophilic chronic rhinosinusitis; seasonal allergic rhinitis; severe acute respiratory syndrome coronavirus 2; short-chain fatty acids","Takabayashi","Tetsuji","423University of Fukui, Yoshida-gun, Fukui, Japan",NA
"1711","34232770","10.1177/19458924211027798","Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.","Coronavirus disease 2019 (COVID-19) has caused a global pandemic. Higher expression of the virus receptor angiotensin-converting enzyme 2 (ACE2) in the nasal mucosa may be associated with high transmissibility and asymptomatic infection. In COVID-19, the elucidation of the determinants of ACE2 expression at nasal tissue level is crucial. The development of strategies to downregulate ACE2 expression in nasal epithelial cells might reduce transmission and be useful as a novel therapeutic approach.","2021","07","07","Am J Rhinol Allergy","American journal of rhinology &amp; allergy","Japanese cedar pollen; airway epithelial cell; angiotensin-converting enzyme 2; chronic rhinosinusitis; coronavirus disease 2019; eosinophilic chronic rhinosinusitis; seasonal allergic rhinitis; severe acute respiratory syndrome coronavirus 2; short-chain fatty acids","Yoshida","Kanako","423University of Fukui, Yoshida-gun, Fukui, Japan",NA
"1712","34232770","10.1177/19458924211027798","Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.","Coronavirus disease 2019 (COVID-19) has caused a global pandemic. Higher expression of the virus receptor angiotensin-converting enzyme 2 (ACE2) in the nasal mucosa may be associated with high transmissibility and asymptomatic infection. In COVID-19, the elucidation of the determinants of ACE2 expression at nasal tissue level is crucial. The development of strategies to downregulate ACE2 expression in nasal epithelial cells might reduce transmission and be useful as a novel therapeutic approach.","2021","07","07","Am J Rhinol Allergy","American journal of rhinology &amp; allergy","Japanese cedar pollen; airway epithelial cell; angiotensin-converting enzyme 2; chronic rhinosinusitis; coronavirus disease 2019; eosinophilic chronic rhinosinusitis; seasonal allergic rhinitis; severe acute respiratory syndrome coronavirus 2; short-chain fatty acids","Imoto","Yoshimasa","423University of Fukui, Yoshida-gun, Fukui, Japan",NA
"1713","34232770","10.1177/19458924211027798","Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.","Coronavirus disease 2019 (COVID-19) has caused a global pandemic. Higher expression of the virus receptor angiotensin-converting enzyme 2 (ACE2) in the nasal mucosa may be associated with high transmissibility and asymptomatic infection. In COVID-19, the elucidation of the determinants of ACE2 expression at nasal tissue level is crucial. The development of strategies to downregulate ACE2 expression in nasal epithelial cells might reduce transmission and be useful as a novel therapeutic approach.","2021","07","07","Am J Rhinol Allergy","American journal of rhinology &amp; allergy","Japanese cedar pollen; airway epithelial cell; angiotensin-converting enzyme 2; chronic rhinosinusitis; coronavirus disease 2019; eosinophilic chronic rhinosinusitis; seasonal allergic rhinitis; severe acute respiratory syndrome coronavirus 2; short-chain fatty acids","Schleimer","Robert P","244Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"1714","34232770","10.1177/19458924211027798","Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.","Coronavirus disease 2019 (COVID-19) has caused a global pandemic. Higher expression of the virus receptor angiotensin-converting enzyme 2 (ACE2) in the nasal mucosa may be associated with high transmissibility and asymptomatic infection. In COVID-19, the elucidation of the determinants of ACE2 expression at nasal tissue level is crucial. The development of strategies to downregulate ACE2 expression in nasal epithelial cells might reduce transmission and be useful as a novel therapeutic approach.","2021","07","07","Am J Rhinol Allergy","American journal of rhinology &amp; allergy","Japanese cedar pollen; airway epithelial cell; angiotensin-converting enzyme 2; chronic rhinosinusitis; coronavirus disease 2019; eosinophilic chronic rhinosinusitis; seasonal allergic rhinitis; severe acute respiratory syndrome coronavirus 2; short-chain fatty acids","Fujieda","Shigeharu","423University of Fukui, Yoshida-gun, Fukui, Japan",NA
"1715","34232761","10.1089/jchc.20.04.0026","The COVID-19 Epidemic and the Prison System in Italy.","On March 7 and 8, 2020, revolts erupted in numerous Italian prisons after the announcement of regulations to contain the spread of COVID-19 in prisons. On April 2, 2020, the first prisoner died of COVID-19, and as of April 9, 58 prisoners and 178 penitentiary police officers have tested positive for the virus. The situation in Italy is made all the more dramatic because of endemic overcrowding: As of April 3, 2020, there were 56,830 prisoners in institutions meant for a maximum of 47,000 people,","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Italy; pandemic; prison; public health; COVID-19; Epidemics; Humans; Italy; Male; Police; Prisoners; Prisons; Public Health; SARS-CoV-2","Cingolani","Mariano","Department of Law, Institute of Legal Medicine, University of Macerata, Italy",NA
"1716","34232761","10.1089/jchc.20.04.0026","The COVID-19 Epidemic and the Prison System in Italy.","On March 7 and 8, 2020, revolts erupted in numerous Italian prisons after the announcement of regulations to contain the spread of COVID-19 in prisons. On April 2, 2020, the first prisoner died of COVID-19, and as of April 9, 58 prisoners and 178 penitentiary police officers have tested positive for the virus. The situation in Italy is made all the more dramatic because of endemic overcrowding: As of April 3, 2020, there were 56,830 prisoners in institutions meant for a maximum of 47,000 people,","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Italy; pandemic; prison; public health; COVID-19; Epidemics; Humans; Italy; Male; Police; Prisoners; Prisons; Public Health; SARS-CoV-2","Caraceni","Lina","Department of Law, Institute of Legal Medicine, University of Macerata, Italy",NA
"1717","34232761","10.1089/jchc.20.04.0026","The COVID-19 Epidemic and the Prison System in Italy.","On March 7 and 8, 2020, revolts erupted in numerous Italian prisons after the announcement of regulations to contain the spread of COVID-19 in prisons. On April 2, 2020, the first prisoner died of COVID-19, and as of April 9, 58 prisoners and 178 penitentiary police officers have tested positive for the virus. The situation in Italy is made all the more dramatic because of endemic overcrowding: As of April 3, 2020, there were 56,830 prisoners in institutions meant for a maximum of 47,000 people,","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Italy; pandemic; prison; public health; COVID-19; Epidemics; Humans; Italy; Male; Police; Prisoners; Prisons; Public Health; SARS-CoV-2","Cannovo","Nunzia","Department of Bioethics, University of Naples, Italy",NA
"1718","34232761","10.1089/jchc.20.04.0026","The COVID-19 Epidemic and the Prison System in Italy.","On March 7 and 8, 2020, revolts erupted in numerous Italian prisons after the announcement of regulations to contain the spread of COVID-19 in prisons. On April 2, 2020, the first prisoner died of COVID-19, and as of April 9, 58 prisoners and 178 penitentiary police officers have tested positive for the virus. The situation in Italy is made all the more dramatic because of endemic overcrowding: As of April 3, 2020, there were 56,830 prisoners in institutions meant for a maximum of 47,000 people,","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; Italy; pandemic; prison; public health; COVID-19; Epidemics; Humans; Italy; Male; Police; Prisoners; Prisons; Public Health; SARS-CoV-2","Fedeli","Piergiorgio","School of Law, Institute of Legal Medicine, University of Camerino, Italy",NA
"1719","34232758","10.1089/jchc.20.05.0044","Solitary Anosmia/Ageusia in Prison: Results From a COVID-19 Cluster.","A prison setting with its congregate environment is at high risk for widespread transmission of respiratory illnesses. Identifying COVID-19 cases as early as possible and isolating cases and tracing contacts is critical to halting the spread of this disease. The Centers for Disease Control and Prevention (CDC) added new loss of taste or smell to its list of symptoms and, initially, only if associated with at least one of six other symptoms. The CDC has since updated the guidance to remove this q","2021","07","22","J Correct Health Care","Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","COVID-19; SARS CoV-2; ageusia; anosmia; prison; smell; taste; Ageusia; Anosmia; COVID-19; Humans; Mass Screening; Prisons; SARS-CoV-2; Smell; Taste","Gwathney","Jamal K","Metropolitan Correctional Center San Diego, Federal Bureau of Prisons, San Diego, California, USA",NA
"1720","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Silva","Angélica Baptista","National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1721","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Sindico","Sergio Ricardo Ferreira","Institute of Scientific and Technological Communication and Information in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1722","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Carneiro","Ana Carolina","SAS Brasil-Health, Joy and Sustainability, São Paulo, Brazil",NA
"1723","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Henrique","Sávio Mourão","SAS Brasil-Health, Joy and Sustainability, São Paulo, Brazil",NA
"1724","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Fernandes","Arthur Gustavo","SAS Brasil-Health, Joy and Sustainability, São Paulo, Brazil",NA
"1725","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Gomes","Joyker Peçanha","Institute of Scientific and Technological Communication and Information in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1726","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Marinho","Thaysa Pereira","Health Surveillance Department, Niterói Municipal Health Foundation, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1727","34232749","10.1089/tmj.2021.0145","COVID-19 Remote Consultation Services and Population in Health Inequity-Concentrating Territories: A Scoping Review.","Background: This review aimed to map initiatives for measuring the satisfaction of vulnerable populations with teleconsultation services offered by public and private health care providers in their territories, during the coronavirus disease (COVID-19) pandemic. Systematic studies on the opinions of people most affected by health inequities are limited. Therefore, we included evaluations of teleconsultation-based services offered to socioeconomically disadvantaged and clinically","2021","07","07","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","Outcome and Process Assessment; health care; social determinants of health; telehealth; telemedicine","Fernandes","Valcler Rangel","Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil",NA
"1728","34232715","10.12968/bjcn.2021.26.7.338","Evidence-based strategies to promote vaccine acceptance.","The success of a vaccination programme depends upon its coverage so that it provides herd immunity. Vaccine hesitancy has the potential to undermine a vaccine programme. Evidence suggests that some strategies are more effective in promoting vaccination uptake. Community nurses should help in the promotion of vaccination uptake using evidence-based interventions and through 'Making Every Contact Count'.","2021","07","15","Br J Community Nurs","British journal of community nursing","COVID-19; Influenza; Vaccination; Vaccine hesitancy; Vaccine uptake; COVID-19 Vaccines; Community Health Nursing; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Immunization Programs; Patient Acceptance of Health Care","While","Alison","Emeritus Professor of Community Nursing, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London",NA
"1729","34232713","10.12968/bjcn.2021.26.7.318","How district nurses can support team wellbeing during the pandemic and beyond.","The COVID-19 pandemic has required rapid adaptation of the community nursing service, including the introduction of online communication platforms to prevent COVID-19 transmission among staff. Remote working has protected the workforce in the community from being decimated through team sickness, but has resulted in nurses who are feeling anxious and isolated from their colleagues while experiencing increased workloads, with complex and often emotionally challenging situations. The pressures of c","2021","07","15","Br J Community Nurs","British journal of community nursing","Community nursing; District nurse; Open communication; Remote working; Team wellbeing; COVID-19; Communication; Community Health Nursing; Humans; Nurse's Role; Patient Care Team; State Medicine; United Kingdom; Workload","Merchant","Jayne","Community Team Sister, Burnley East District Nursing Team, East Lancashire Hospitals Trust, Burnley, Lancashire",NA
"1730","34232712","10.12968/bjcn.2021.26.7.328","Rising to the challenge: a COVID-19 vaccination service for the housebound population.","The COVID-19 pandemic has necessitated innovations in practice in almost all areas of healthcare, not least community nursing services. This article details how one organisation planned and executed a home vaccination programme for housebound members of the population in its remit. It discusses the challenges faced by the team, as well as the key learnings achieved from this programme, which will guide future home immunisation programmes. Implementation of this programme required excellent coord","2021","07","15","Br J Community Nurs","British journal of community nursing","COVID-19; Community nursing; Home immunisation; Housebound people; Public health; COVID-19 Vaccines; Home Care Services; Homebound Persons; Humans; Mass Vaccination; State Medicine; United Kingdom","Murphy","Patricia","District Nurse, Croydon Health Services NHS Trust, Croydon",NA
"1731","34232708","10.1128/JCM.00811-21","Indeterminate QuantiFERON Gold Plus results reveal deficient IFN-<U+03B3> responses in severely ill COVID-19 patients.","Background: SARS-CoV-2 is a novel positive-sense single stranded RNA virus that has caused a recent pandemic. Most patients have a mild disease course, while approximately 20 percent have moderate-to-severe disease, often requiring hospitalization and, in some cases, care in the intensive care unit. Results: By investigating a perceived increased rate of indeterminate QuantiFERON®-TB Gold Plus results in hospitalized COVID patients, we demonstrate that severely ill COVID-19 patient","2021","07","07","J Clin Microbiol","Journal of clinical microbiology",NA,"Ward","Jeremy D","Department of Pathology &amp",NA
"1732","34232708","10.1128/JCM.00811-21","Indeterminate QuantiFERON Gold Plus results reveal deficient IFN-<U+03B3> responses in severely ill COVID-19 patients.","Background: SARS-CoV-2 is a novel positive-sense single stranded RNA virus that has caused a recent pandemic. Most patients have a mild disease course, while approximately 20 percent have moderate-to-severe disease, often requiring hospitalization and, in some cases, care in the intensive care unit. Results: By investigating a perceived increased rate of indeterminate QuantiFERON®-TB Gold Plus results in hospitalized COVID patients, we demonstrate that severely ill COVID-19 patient","2021","07","07","J Clin Microbiol","Journal of clinical microbiology",NA,"Cornaby","Caleb","Immunology, Histocompatibility and Immunogenetics Laboratories/McLendon Clinical Laboratories UNC Hospitals, Chapel Hill, NC, USA",NA
"1733","34232708","10.1128/JCM.00811-21","Indeterminate QuantiFERON Gold Plus results reveal deficient IFN-<U+03B3> responses in severely ill COVID-19 patients.","Background: SARS-CoV-2 is a novel positive-sense single stranded RNA virus that has caused a recent pandemic. Most patients have a mild disease course, while approximately 20 percent have moderate-to-severe disease, often requiring hospitalization and, in some cases, care in the intensive care unit. Results: By investigating a perceived increased rate of indeterminate QuantiFERON®-TB Gold Plus results in hospitalized COVID patients, we demonstrate that severely ill COVID-19 patient","2021","07","07","J Clin Microbiol","Journal of clinical microbiology",NA,"Schmitz","John","Department of Pathology &amp",NA
"1734","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Micheletti","Serena","Child Neurology and Psychiatry Unit, ASST Spedali Civili of Brescia, Italy",NA
"1735","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Galli","Jessica","Child Neurology and Psychiatry Unit, ASST Spedali Civili of Brescia, Italy",NA
"1736","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Scaglioni","Vera","Child Neurology and Psychiatry Unit, ASST Spedali Civili of Brescia, Italy",NA
"1737","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Renzetti","Stefano","Unit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Italy",NA
"1738","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Scarano","Elisa","Department of Clinical and Experimental Sciences, University of Brescia, Italy",NA
"1739","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Foresti","Valentina","Department of Clinical and Experimental Sciences, University of Brescia, Italy",NA
"1740","34232698","10.1044/2021_AJSLP-20-00222","Promoting Language Skills in Children With Neuromotor and Intellectual Disorders: Telepractice at the Time of SARS-CoV-2.","Purpose The aim of this pilot study is to gather preliminary results on the effectiveness of intensive, parent-oriented, telepractice-based intervention to improve language skills in preschool children with neuromotor and intellectual disorders. Method Nine preschool children (M = 63 months, SD = 8.7 months) underwent a telepractice program 4 times a week designed to promote speech, lexical, and syntactic skills. Families were remotely connected from home with the therapists, who c","2021","07","19","Am J Speech Lang Pathol","American journal of speech-language pathology","COVID-19; Child, Preschool; Humans; Language; Pilot Projects; SARS-CoV-2; Speech","Fazzi","Elisa","Child Neurology and Psychiatry Unit, ASST Spedali Civili of Brescia, Italy",NA
"1741","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Daoud","Beatrice","Antony's Private Hospital, Antony, France beatricedaoud@hotmail","beatricedaoud@hotmail.com"
"1742","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Cazejust","Julien","Antony's Private Hospital, Antony, France",NA
"1743","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Tavolaro","Sebastian","Antony's Private Hospital, Antony, France",NA
"1744","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Durand","Sebastien","Antony's Private Hospital, Antony, France",NA
"1745","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Pommier","Romain","Antony's Private Hospital, Antony, France",NA
"1746","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Hamrouni","Adel","Antony's Private Hospital, Antony, France",NA
"1747","34232691","10.2214/AJR.21.25947","Reply to ""Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known"".",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Bornet","Gregoire","Antony's Private Hospital, Antony, France",NA
"1748","34232689","10.2214/AJR.21.25891","Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known.",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Forero","Paula Andrea","Fundación Santa Fe de Bogotá, Bogotá, Colombia paulaforero1129@gmail","paulaforero1129@gmail.com"
"1749","34232689","10.2214/AJR.21.25891","Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known.",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Cadavid","Luis Fernando Pulido","Fundación Santa Fe de Bogotá, Bogotá, Colombia",NA
"1750","34232689","10.2214/AJR.21.25891","Spectral CT for Coronavirus Disease (COVID-19) Diagnosis: More Is Yet to Be Known.",NA,"2021","07","07","AJR Am J Roentgenol","AJR. American journal of roentgenology",NA,"Moreno","Ángela","Fundación Santa Fe de Bogotá, Bogotá, Colombia",NA
"1751","34232578","10.4088/JCP.21m13874","Depression, Anxiety, and Mother-Infant Bonding in Women Seeking Treatment for Postpartum Depression Before and During the COVID-19 Pandemic.","Objective: The conditions created by the COVID-19 pandemic could negatively affect maternal mental health and the mother-infant relationship. The aim of this study is to determine the impact of the COVID-19 pandemic on depression, anxiety, and mother-infant bonding among women seeking treatment for postpartum depression (PPD). Methods: Baseline data collected in two separate randomized controlled trials of a psychoeducational intervention for PPD in the same geographic region, one prior to COVID","2021","07","14","J Clin Psychiatry","The Journal of clinical psychiatry","Adolescent; Adult; Anxiety; COVID-19; Depression, Postpartum; Female; Humans; Infant; Infant, Newborn; Mother-Child Relations; Mothers; Object Attachment; Ontario; Pandemics; Risk Factors; Self Report; Severity of Illness Index; Young Adult","Layton","Haley","Health Research Methodology Graduate Program, McMaster University, Hamilton, Ontario, Canada","laytonh@mcmaster.ca"
"1752","34232578","10.4088/JCP.21m13874","Depression, Anxiety, and Mother-Infant Bonding in Women Seeking Treatment for Postpartum Depression Before and During the COVID-19 Pandemic.","Objective: The conditions created by the COVID-19 pandemic could negatively affect maternal mental health and the mother-infant relationship. The aim of this study is to determine the impact of the COVID-19 pandemic on depression, anxiety, and mother-infant bonding among women seeking treatment for postpartum depression (PPD). Methods: Baseline data collected in two separate randomized controlled trials of a psychoeducational intervention for PPD in the same geographic region, one prior to COVID","2021","07","14","J Clin Psychiatry","The Journal of clinical psychiatry","Adolescent; Adult; Anxiety; COVID-19; Depression, Postpartum; Female; Humans; Infant; Infant, Newborn; Mother-Child Relations; Mothers; Object Attachment; Ontario; Pandemics; Risk Factors; Self Report; Severity of Illness Index; Young Adult","Owais","Sawayra","MD/PhD Program, McMaster University, Hamilton, Ontario, Canada",NA
"1753","34232578","10.4088/JCP.21m13874","Depression, Anxiety, and Mother-Infant Bonding in Women Seeking Treatment for Postpartum Depression Before and During the COVID-19 Pandemic.","Objective: The conditions created by the COVID-19 pandemic could negatively affect maternal mental health and the mother-infant relationship. The aim of this study is to determine the impact of the COVID-19 pandemic on depression, anxiety, and mother-infant bonding among women seeking treatment for postpartum depression (PPD). Methods: Baseline data collected in two separate randomized controlled trials of a psychoeducational intervention for PPD in the same geographic region, one prior to COVID","2021","07","14","J Clin Psychiatry","The Journal of clinical psychiatry","Adolescent; Adult; Anxiety; COVID-19; Depression, Postpartum; Female; Humans; Infant; Infant, Newborn; Mother-Child Relations; Mothers; Object Attachment; Ontario; Pandemics; Risk Factors; Self Report; Severity of Illness Index; Young Adult","Savoy","Calan D","Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada",NA
"1754","34232578","10.4088/JCP.21m13874","Depression, Anxiety, and Mother-Infant Bonding in Women Seeking Treatment for Postpartum Depression Before and During the COVID-19 Pandemic.","Objective: The conditions created by the COVID-19 pandemic could negatively affect maternal mental health and the mother-infant relationship. The aim of this study is to determine the impact of the COVID-19 pandemic on depression, anxiety, and mother-infant bonding among women seeking treatment for postpartum depression (PPD). Methods: Baseline data collected in two separate randomized controlled trials of a psychoeducational intervention for PPD in the same geographic region, one prior to COVID","2021","07","14","J Clin Psychiatry","The Journal of clinical psychiatry","Adolescent; Adult; Anxiety; COVID-19; Depression, Postpartum; Female; Humans; Infant; Infant, Newborn; Mother-Child Relations; Mothers; Object Attachment; Ontario; Pandemics; Risk Factors; Self Report; Severity of Illness Index; Young Adult","Van Lieshout","Ryan J","Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada",NA
"1755","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Geyer","Philipp E","OmicEra Diagnostics GmbH, Planegg, Germany",NA
"1756","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Arend","Florian M","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1757","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Doll","Sophia","OmicEra Diagnostics GmbH, Planegg, Germany",NA
"1758","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Louiset","Marie-Luise","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1759","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Virreira Winter","Sebastian","OmicEra Diagnostics GmbH, Planegg, Germany",NA
"1760","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Müller-Reif","Johannes B","OmicEra Diagnostics GmbH, Planegg, Germany",NA
"1761","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Torun","Furkan M","OmicEra Diagnostics GmbH, Planegg, Germany",NA
"1762","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Weigand","Michael","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1763","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Eichhorn","Peter","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1764","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Bruegel","Mathias","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1765","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Strauss","Maximilian T","OmicEra Diagnostics GmbH, Planegg, Germany",NA
"1766","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Holdt","Lesca M","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1767","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Mann","Matthias","NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"1768","34232570","10.15252/emmm.202114167","High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.","A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based proteomics to measure serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins changed significantly. Bioinformatics anal","2021","07","07","EMBO Mol Med","EMBO molecular medicine","SARS-CoV-2; biobanking; biomarker; immunoglobulins; individual-specific","Teupser","Daniel","Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany",NA
"1769","34232548","10.1111/dth.15056","COVID-19 vaccines: What dermatologists should know?","As COVID-19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID-19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID-19 vaccines will be reviewed.","2021","07","14","Dermatol Ther","Dermatologic therapy","COVID-19; dermatologist; immunomodulatory drugs; vaccine","Ayatollahi","Azin","Center for Research &amp",NA
"1770","34232548","10.1111/dth.15056","COVID-19 vaccines: What dermatologists should know?","As COVID-19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID-19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID-19 vaccines will be reviewed.","2021","07","14","Dermatol Ther","Dermatologic therapy","COVID-19; dermatologist; immunomodulatory drugs; vaccine","Hosseini","Hamed","Center for Research &amp",NA
"1771","34232548","10.1111/dth.15056","COVID-19 vaccines: What dermatologists should know?","As COVID-19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID-19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID-19 vaccines will be reviewed.","2021","07","14","Dermatol Ther","Dermatologic therapy","COVID-19; dermatologist; immunomodulatory drugs; vaccine","Firooz","Rojin","Center for Research &amp",NA
"1772","34232548","10.1111/dth.15056","COVID-19 vaccines: What dermatologists should know?","As COVID-19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID-19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID-19 vaccines will be reviewed.","2021","07","14","Dermatol Ther","Dermatologic therapy","COVID-19; dermatologist; immunomodulatory drugs; vaccine","Firooz","Alireza","Center for Research &amp",NA
"1773","34232544","10.1111/dth.15057","The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.",NA,"2021","07","15","Dermatol Ther","Dermatologic therapy",NA,"Bardazzi","Federico","Division of Dermatology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy",NA
"1774","34232544","10.1111/dth.15057","The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.",NA,"2021","07","15","Dermatol Ther","Dermatologic therapy",NA,"Abbenante","Diego","Division of Dermatology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy",NA
"1775","34232544","10.1111/dth.15057","The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.",NA,"2021","07","15","Dermatol Ther","Dermatologic therapy",NA,"Filippi","Federica","Division of Dermatology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy",NA
"1776","34232544","10.1111/dth.15057","The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.",NA,"2021","07","15","Dermatol Ther","Dermatologic therapy",NA,"Sacchelli","Lidia","Division of Dermatology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy",NA
"1777","34232544","10.1111/dth.15057","The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.",NA,"2021","07","15","Dermatol Ther","Dermatologic therapy",NA,"Loi","Camilla","Division of Dermatology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy",NA
"1778","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Chen","Zhen","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1779","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Wang","Chao","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1780","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Feng","Xu","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1781","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Nie","Litong","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1782","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Tang","Mengfan","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1783","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Zhang","Huimin","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1784","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Xiong","Yun","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1785","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Swisher","Samuel K","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1786","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Srivastava","Mrinal","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1787","34232536","10.15252/embj.2021107776","Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.","Host-virus protein-protein interactions play key roles in the lifecycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We conducted a comprehensive interactome study between the virus and host cells using tandem affinity purification and proximity labeling strategies and identified 437 human proteins as the high-confidence interacting proteins. Further characterization of these interactions and comparison to other large-scale study of cellular responses to SARS-CoV-2 infection ","2021","07","07","EMBO J","The EMBO journal","BioID2; SARS-CoV-2; SFB-TAP; host-virus protein-protein interaction; interactome","Chen","Junjie","Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA",NA
"1788","34232533","10.1002/jmv.27184","The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study.","Coronavirus disease-2019 (COVID-19) is a respiratory disease whose clinical manifestation ranges from asymptomatic to severe respiratory failure. The purpose of this study was to investigate the place of serum surfactant-D (SP-D) and angiopoetin-2 (Ang-2) levels in predicting severity of disease in patients diagnosed with COVID-19. Sixty-four patients diagnosed with COVID-19 between September 2020 and February 2021, 50 patients diagnosed with community-acquired pneumonia and a 50-member healthy ","2021","07","16","J Med Virol","Journal of medical virology","COVID-19; angiopoetin-2; lung injury; serum surfactant-D","Alay","Handan","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ataturk University, Erzurum, Turkey",NA
"1789","34232533","10.1002/jmv.27184","The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study.","Coronavirus disease-2019 (COVID-19) is a respiratory disease whose clinical manifestation ranges from asymptomatic to severe respiratory failure. The purpose of this study was to investigate the place of serum surfactant-D (SP-D) and angiopoetin-2 (Ang-2) levels in predicting severity of disease in patients diagnosed with COVID-19. Sixty-four patients diagnosed with COVID-19 between September 2020 and February 2021, 50 patients diagnosed with community-acquired pneumonia and a 50-member healthy ","2021","07","16","J Med Virol","Journal of medical virology","COVID-19; angiopoetin-2; lung injury; serum surfactant-D","Laloglu","Esra","Department of Medical Biochemistry, Faculty of Medicine, Ataturk University, Erzurum, Turkey",NA
"1790","34232526","10.1002/jmv.27176","SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.",NA,"2021","07","12","J Med Virol","Journal of medical virology",NA,"Suvvari","Tarun K","Dr. N.T.R. University of Health Sciences, Vijayawada, India",NA
"1791","34232526","10.1002/jmv.27176","SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.",NA,"2021","07","12","J Med Virol","Journal of medical virology",NA,"Rajesh","Eshwar","Madras Medical College, Chennai, India",NA
"1792","34232526","10.1002/jmv.27176","SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.",NA,"2021","07","12","J Med Virol","Journal of medical virology",NA,"D Silva","Reewen G","Belagavi Institute of Medical Sciences, Belagavi, India",NA
"1793","34232526","10.1002/jmv.27176","SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.",NA,"2021","07","12","J Med Virol","Journal of medical virology",NA,"Corriero","Anna C","Anglia Ruskin University School of Medicine, Cambridge, UK",NA
"1794","34232526","10.1002/jmv.27176","SARS-CoV-2 vaccine-induced prothrombotic immune thrombocytopenia: Promoting awareness to improve patient-doctor trust.",NA,"2021","07","12","J Med Virol","Journal of medical virology",NA,"Kutikuppala","L V Simhachalam","Dr. N.T.R. University of Health Sciences, Vijayawada, India",NA
"1795","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Singh","Yogendra","Department of Pharmacology, Maharishi Arvind College of Pharmacy, Ambabari, Jaipur, Rajasthan, India",NA
"1796","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Fuloria","Neeraj Kumar","Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia",NA
"1797","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Fuloria","Shivkanya","Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia",NA
"1798","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Subramaniyan","Vetriselvan","Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarom, Selangor, Malaysia",NA
"1799","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Meenakshi","Dhanalekshmi Unnikrishnan","College of Pharmacy, National University of Science and Technology, Muscat, Oman",NA
"1800","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Chakravarthi","Srikumar","Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarom, Selangor, Malaysia",NA
"1801","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Kumari","Usha","Faculty of Medicine, AIMST University, Bedong, Kedah, Malaysia",NA
"1802","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Joshi","Navneet","Department of Biosciences, School of Liberal Arts and Sciences, Mody University of Science and Technology, Lakshmangarh, Sikar, Rajasthan, India",NA
"1803","34232521","10.1002/jmv.27181","N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Gupta","Gaurav","Department of Pharmacology, School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India",NA
"1804","34232520","10.1002/jmv.27177","Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Bistrovic","Petra","Cardiology Department, University Hospital Dubrava, Zagreb, Croatia",NA
"1805","34232520","10.1002/jmv.27177","Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.",NA,"2021","07","14","J Med Virol","Journal of medical virology",NA,"Lucijanic","Marko","Primary Respiratory and Intensive Care Center, Dubrava University Hospital, Zagreb, Croatia",NA
"1806","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Yu","Jun-Ling","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1807","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Hou","Sai","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1808","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Feng","Ya-Ting","Department of Epidemiolgy and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China",NA
"1809","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Bu","Ge","Microbiological Laboratory, Fuyang City Center for Disease Control and Prevention, Fuyang, Anhui, China",NA
"1810","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Chen","Qing-Qing","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1811","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Meng","Zhao-Qian","Microbiological Laboratory, Fuyang City Center for Disease Control and Prevention, Fuyang, Anhui, China",NA
"1812","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Ding","Zhen-Tao","Microbiological Laboratory, Fuyang City Center for Disease Control and Prevention, Fuyang, Anhui, China",NA
"1813","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Guo","Liang-Zi","Microbiological Laboratory, Fuyang City Center for Disease Control and Prevention, Fuyang, Anhui, China",NA
"1814","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Zhou","Xue","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1815","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Wang","Meng","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1816","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Huang","Xin-Er","Department of Epidemiolgy and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China",NA
"1817","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Li","Wei-Wei","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1818","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","He","Lan","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1819","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Gong","Lei","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1820","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Sun","Yong","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1821","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Xu","Zhiwei","School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia",NA
"1822","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Pan","Hai-Feng","Department of Epidemiolgy and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China",NA
"1823","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","He","Jun","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1824","34232513","10.1002/jmv.27179","Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.","In the context of the coronavirus disease 2019 pandemic, we investigated the epidemiological and clinical characteristics of a young patient infected by avian influenza A (H5N6) virus in Anhui Province, East China, and analyzed genomic features of the pathogen in 2020. Through the cross-sectional investigation of external environment monitoring (December 29-31, 2020), 1909 samples were collected from Fuyang City. It was found that the positive rate of H5N6 was higher than other areas obviously i","2021","07","14","J Med Virol","Journal of medical virology","COVID-19; H5N6; epidemiology; genetic","Wu","Jia-Bing","Microbiological Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China",NA
"1825","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Li","Xuedi","Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada. xuedi.li@sickkids","xuedi.li@sickkids.ca"
"1826","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Vanderloo","Leigh M","Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada",NA
"1827","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Maguire","Jonathon L","Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada",NA
"1828","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Keown-Stoneman","Charles D G","Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada",NA
"1829","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Aglipay","Mary","Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada",NA
"1830","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Anderson","Laura N","Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada",NA
"1831","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Cost","Katherine Tombeau","Department of Psychiatry, The Hospital for Sick Children, Toronto, ON, Canada",NA
"1832","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Charach","Alice","Department of Psychiatry, The Hospital for Sick Children, Toronto, ON, Canada",NA
"1833","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Vanderhout","Shelley M","Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada",NA
"1834","34232489","10.17269/s41997-021-00549-w","Public health preventive measures and child health behaviours during COVID-19: a cohort study.","The primary objective was to determine the association between public health preventive measures and children's outdoor time, sleep duration, and screen time during COVID-19. A cohort study using repeated measures of exposures and outcomes was conducted in healthy children (0 to 10 years) through The Applied Research Group for Kids (TARGet Kids!) COVID-19 Study of Children and Families in Toronto, Canada, between April 14 and July 15, 2020. Parents were asked to complete questionnaires about adh","2021","07","12","Can J Public Health","Canadian journal of public health = Revue canadienne de sante publique","COVID-19; Child health behaviours; Outdoor; Public health preventive measures; Screen time; Sleep","Birken","Catherine S","Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada",NA
"1835","34232484","10.1007/s40520-021-01928-6","Coronavirus-related health literacy and perceived restrictiveness of protective measures among community-dwelling older persons in Finland.","Older people with limited health literacy may encounter difficulties in finding relevant information on COVID-19, understanding its relevance, and complying with recommended protective measures. Complying with such recommendations has required older as well as younger persons to change their daily lives in ways that have reduced their opportunities for engaging in many activities meaningful to them. To find out from what sources older people have obtained information on protective measures, the ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","Aging; COVID-19; Gerontology; Health promotion; Participation","Eronen","Johanna","Faculty of Sport and Health Sciences, Gerontology Research Center, University of Jyväskylä, P.O. Box 35, 40014, Jyväskylä, Finland. johanna.eronen@jyu","johanna.eronen@jyu.fi"
"1836","34232484","10.1007/s40520-021-01928-6","Coronavirus-related health literacy and perceived restrictiveness of protective measures among community-dwelling older persons in Finland.","Older people with limited health literacy may encounter difficulties in finding relevant information on COVID-19, understanding its relevance, and complying with recommended protective measures. Complying with such recommendations has required older as well as younger persons to change their daily lives in ways that have reduced their opportunities for engaging in many activities meaningful to them. To find out from what sources older people have obtained information on protective measures, the ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","Aging; COVID-19; Gerontology; Health promotion; Participation","Paakkari","Leena","Faculty of Sport and Health Sciences, Research Center for Health Promotion, University of Jyväskylä, Jyväskylä, Finland",NA
"1837","34232484","10.1007/s40520-021-01928-6","Coronavirus-related health literacy and perceived restrictiveness of protective measures among community-dwelling older persons in Finland.","Older people with limited health literacy may encounter difficulties in finding relevant information on COVID-19, understanding its relevance, and complying with recommended protective measures. Complying with such recommendations has required older as well as younger persons to change their daily lives in ways that have reduced their opportunities for engaging in many activities meaningful to them. To find out from what sources older people have obtained information on protective measures, the ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","Aging; COVID-19; Gerontology; Health promotion; Participation","Portegijs","Erja","Faculty of Sport and Health Sciences, Gerontology Research Center, University of Jyväskylä, P.O. Box 35, 40014, Jyväskylä, Finland",NA
"1838","34232484","10.1007/s40520-021-01928-6","Coronavirus-related health literacy and perceived restrictiveness of protective measures among community-dwelling older persons in Finland.","Older people with limited health literacy may encounter difficulties in finding relevant information on COVID-19, understanding its relevance, and complying with recommended protective measures. Complying with such recommendations has required older as well as younger persons to change their daily lives in ways that have reduced their opportunities for engaging in many activities meaningful to them. To find out from what sources older people have obtained information on protective measures, the ","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","Aging; COVID-19; Gerontology; Health promotion; Participation","Rantanen","Taina","Faculty of Sport and Health Sciences, Gerontology Research Center, University of Jyväskylä, P.O. Box 35, 40014, Jyväskylä, Finland",NA
"1839","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Malshe","Nandini","Department of Neonatology, Medical College, Bharati Vidyapeeth (Deemed To Be University), Pune, Maharashtra, India",NA
"1840","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Patnaik","Suprabha K","Department of Neonatology, Medical College, Bharati Vidyapeeth (Deemed To Be University), Pune, Maharashtra, India",NA
"1841","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Lalwani","Sanjay","Department of Pediatrics, Medical College, Bharati Vidyapeeth (Deemed To Be University), Pune, Maharashtra, India",NA
"1842","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Suryawanshi","Pradeep","Department of Neonatology, Medical College, Bharati Vidyapeeth (Deemed To Be University), Pune, Maharashtra, India",NA
"1843","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Kulkarni","Ruta","Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed To Be University), Pune-Satara Road, Katraj-Dhankawadi, Pune, Maharashtra, 411043, India",NA
"1844","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Mhaske","Suhas","Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed To Be University), Pune-Satara Road, Katraj-Dhankawadi, Pune, Maharashtra, 411043, India",NA
"1845","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Mishra","Akhilesh Chandra","Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed To Be University), Pune-Satara Road, Katraj-Dhankawadi, Pune, Maharashtra, 411043, India",NA
"1846","34232457","10.1007/s15010-021-01650-5","Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy.","COVID-19 pandemic remains a serious public health threat worldwide. In view of the limited data on the risk of perinatal transmission of SARS-CoV-2 and transfer of maternal anti-SARS-CoV-2 antibodies, the present study was undertaken. A prospective study including 57 pregnant women with a positive SARS-CoV-2 RNA test (SARS-CoV-2-RNA+) and 59 neonates born to them was conducted at Pune, India. 39 viral RNA negative (SARS-CoV-2-RNA-negative) pregnant women and their 39 neonates were included as co","2021","07","09","Infection","Infection","COVID-19; India; Neutralizing antibodies; Perinatal transmission; Pregnant women; SARS-CoV-2","Arankalle","Vidya","Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed To Be University), Pune-Satara Road, Katraj-Dhankawadi, Pune, Maharashtra, 411043, India. varankalle@yahoo","varankalle@yahoo.com"
"1847","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Chen","Xiaohua","Department of Laboratory Medicine, General Hospital of Central Theater Command, PLA, Wuhan, 430070, China",NA
"1848","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Zhou","Juan","State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China",NA
"1849","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Chen","Chen","State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China",NA
"1850","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Hou","Baidong","National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China",NA
"1851","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Ali","Ashaq","State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China",NA
"1852","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Li","Feng","State Key Laboratory of Virology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, China",NA
"1853","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Hua","Zhaolin","National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China",NA
"1854","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Wu","Yingtao","Department of Laboratory Medicine, General Hospital of Central Theater Command, PLA, Wuhan, 430070, China",NA
"1855","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Yang","Qin","Department of Laboratory Medicine, General Hospital of Central Theater Command, PLA, Wuhan, 430070, China",NA
"1856","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Chen","Min","Department of Laboratory Medicine, General Hospital of Central Theater Command, PLA, Wuhan, 430070, China",NA
"1857","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Zhang","Rong","Department of Laboratory Medicine, General Hospital of Southern Theater Command, PLA, Guangzhou, 510000, China",NA
"1858","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Huang","Qianchuan","Department of Laboratory Medicine, General Hospital of Central Theater Command, PLA, Wuhan, 430070, China. hqcwuhan@126","hqcwuhan@126.com"
"1859","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Ding","Jinya","Department of Laboratory Medicine, General Hospital of Central Theater Command, PLA, Wuhan, 430070, China. whzyydjy@163","whzyydjy@163.com"
"1860","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Zhang","Xian-En","National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. zhangxe@ibp.ac","zhangxe@ibp.ac.cn"
"1861","34232450","10.1007/s12250-021-00425-4","Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.",NA,"2021","07","09","Virol Sin","Virologica Sinica",NA,"Men","Dong","State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China. d.men@wh.iov","d.men@wh.iov.cn"
"1862","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Hamed","Maaweya E","Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia",NA
"1863","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Naeem","Asif","Research Center, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"1864","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Alkadi","Haitham","Research Center, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"1865","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Alamri","Aref A","Riyadh Regional Laboratory, Ministry of Health, Riyadh, Saudi Arabia",NA
"1866","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","AlYami","Ahmad S","Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"1867","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","AlJuryyan","Abdullah","Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"1868","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Alturaiki","Wael","Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia",NA
"1869","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Enani","Mushira","Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"1870","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Al-Shouli","Samia T","Department of Pathology, Immunology Unit, Clinical Immunology and Allergy, College of Medicine and King Khalid University Hospital, King Saud University and King Saud University Medical City, Riyadh, Saudi Arabia",NA
"1871","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Assiri","Abdullah M","Preventive Medicine Assistant Deputyship, Ministry of Health, Riyadh, Saudi Arabia",NA
"1872","34232441","10.1007/s10875-021-01061-z","Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.","The complement system, a network of highly-regulated proteins, represents a vital part of the innate immune response. Over-activation of the complement system plays an important role in inflammation, tissue damage, and infectious disease severity. The prevalence of MERS-CoV in Saudi Arabia remains significant and cases are still being reported. The role of complement in Middle East Respiratory Syndrome coronavirus (MERS-CoV) pathogenesis and complement-modulating treatment strategies has receive","2021","07","09","J Clin Immunol","Journal of clinical immunology","Chemokine; Complement system; Cytokine; Immunopathology; Lung; MERS-CoV infection","Alosaimi","Bandar","Research Center, King Fahad Medical City, Riyadh, Saudi Arabia. balosaimi@kfmc.med","balosaimi@kfmc.med.sa"
"1873","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Davidson","Sean M","The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1874","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Lukhna","Kishal","Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa",NA
"1875","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Gorog","Diana A","Postgraduate Medicine, University of Hertfordshire, UK &amp",NA
"1876","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Salama","Alan D","Department of Renal Medicine, Royal Free Hospital, London, UK",NA
"1877","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Castillo","Alejandro Rosell","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1878","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Giesz","Sara","The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1879","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Golforoush","Pelin","The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1880","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Kalkhoran","Siavash Beikoghli","The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK",NA
"1881","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Lecour","Sandrine","The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa",NA
"1882","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Imamdin","Aqeela","The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa",NA
"1883","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"do Carmo","Helison R P","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1884","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Bovi","Ticiane Gonçalez","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1885","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Perroud","Mauricio W","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1886","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Ntsekhe","Mpiko","Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa",NA
"1887","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Sposito","Andrei C","Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil",NA
"1888","34232434","10.1007/s10557-021-07223-w","Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.",NA,"2021","07","09","Cardiovasc Drugs Ther","Cardiovascular drugs and therapy",NA,"Yellon","Derek M","The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac","d.yellon@ucl.ac.uk"
"1889","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Mohanan","Parayanthala Valappil","Division of Toxicology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India. mohanpv10@gmail","mohanpv10@gmail.com"
"1890","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Sangeetha","Vijayan","Division of Toxicology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India",NA
"1891","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Sabareeswaran","Arumugham","Division of Histopathology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India",NA
"1892","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Muraleedharan","Vayalappil","Division of Artificial Internal Organs, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India",NA
"1893","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Jithin","Krishnan","Divison of Medical Instrumentation, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India",NA
"1894","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Vandana","Unnikrishnan","Division of Toxicology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India",NA
"1895","34232429","10.1007/s11356-021-15164-y","Safety of 0.5% hydrogen peroxide mist used in the disinfection gateway for COVID-19.","Hydrogen peroxide (H2O2) is a reactive chemical used in a wide range of applications. Most importantly, it is used for sterilization process in health care environment. In the present study, safety assessment of 0.5% of H2O2 and its mist intended to be used in the disinfection gateway for COVID-19 was evaluated. Skin irritation and repeated-dose inhalation toxicity studies were carried out in rabbits and rats, respectively. In Skin irritation study, Ne","2021","07","09","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Disinfectant; Hydrogen peroxide; Inhalation toxicity; NOEL; Skin irritation","Varsha","Sheela Bhasi","Division of Toxicology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Govt. of India), Biomedical Technology Wing, Poojapura, Trivandrum, Kerala, 695 012, India",NA
"1896","34232425","10.1007/s10735-021-10003-3","COVID-19 and male reproductive system: pathogenic features and possible mechanisms.","Multiorgan dysfunction is the main characteristic of severe COVID-19 patients and the involvement of male reproductive system may occur among these patients. Although there is a limited evidence to confirm the orchitis and virus presence in the semen of patients, there are concerns about the transmission of virus through the semen. In addition, reduced fertility or infertility can be seen as consequences of severe COVID-19 in recovered subjects. In this study, we aimed to review articles related","2021","07","09","J Mol Histol","Journal of molecular histology","Angiotensin-converting enzyme 2; Coronavirus disease 2019; Cytokine storm; Hypothalamicpituitarytesticular axis; Orchitis","Ardestani Zadeh","Arash","Clinical Research Development Center, Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran",NA
"1897","34232425","10.1007/s10735-021-10003-3","COVID-19 and male reproductive system: pathogenic features and possible mechanisms.","Multiorgan dysfunction is the main characteristic of severe COVID-19 patients and the involvement of male reproductive system may occur among these patients. Although there is a limited evidence to confirm the orchitis and virus presence in the semen of patients, there are concerns about the transmission of virus through the semen. In addition, reduced fertility or infertility can be seen as consequences of severe COVID-19 in recovered subjects. In this study, we aimed to review articles related","2021","07","09","J Mol Histol","Journal of molecular histology","Angiotensin-converting enzyme 2; Coronavirus disease 2019; Cytokine storm; Hypothalamicpituitarytesticular axis; Orchitis","Arab","Davood","Clinical Research Development Center, Kowsar Hospital, Semnan University of Medical Sciences, Semnan, Iran. drdavoodarab@semums.ac","drdavoodarab@semums.ac.ir"
"1898","34232419","10.1007/s10803-021-05128-z","Development, Feasibility, and Acceptability of a Nationally Relevant Parent Training to Improve Service Access During the Transition to Adulthood for Youth with ASD.","Many youth with autism spectrum disorder (ASD) face challenges accessing needed services as they transition to adulthood. The present study describes the development, feasibility and acceptability of a new intervention designed to teach parents of transition-aged youth with ASD about the adult service system and the most effective ways to access services and supports. As part of a randomized-controlled trial, the intervention-named ASSIST-was delivered to 91 participants in three states in the U","2021","07","11","J Autism Dev Disord","Journal of autism and developmental disorders","Autism spectrum disorder; Families; Intervention; Services; Transition to adulthood","Taylor","Julie Lounds","Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA. Julie.l.taylor@vanderbilt","Julie.l.taylor@vanderbilt.edu"
"1899","34232419","10.1007/s10803-021-05128-z","Development, Feasibility, and Acceptability of a Nationally Relevant Parent Training to Improve Service Access During the Transition to Adulthood for Youth with ASD.","Many youth with autism spectrum disorder (ASD) face challenges accessing needed services as they transition to adulthood. The present study describes the development, feasibility and acceptability of a new intervention designed to teach parents of transition-aged youth with ASD about the adult service system and the most effective ways to access services and supports. As part of a randomized-controlled trial, the intervention-named ASSIST-was delivered to 91 participants in three states in the U","2021","07","11","J Autism Dev Disord","Journal of autism and developmental disorders","Autism spectrum disorder; Families; Intervention; Services; Transition to adulthood","Pezzimenti","Florencia","Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA",NA
"1900","34232419","10.1007/s10803-021-05128-z","Development, Feasibility, and Acceptability of a Nationally Relevant Parent Training to Improve Service Access During the Transition to Adulthood for Youth with ASD.","Many youth with autism spectrum disorder (ASD) face challenges accessing needed services as they transition to adulthood. The present study describes the development, feasibility and acceptability of a new intervention designed to teach parents of transition-aged youth with ASD about the adult service system and the most effective ways to access services and supports. As part of a randomized-controlled trial, the intervention-named ASSIST-was delivered to 91 participants in three states in the U","2021","07","11","J Autism Dev Disord","Journal of autism and developmental disorders","Autism spectrum disorder; Families; Intervention; Services; Transition to adulthood","Burke","Meghan M","Department of Special Education, University of Illinois Urbana-Champaign, Champaign, USA",NA
"1901","34232419","10.1007/s10803-021-05128-z","Development, Feasibility, and Acceptability of a Nationally Relevant Parent Training to Improve Service Access During the Transition to Adulthood for Youth with ASD.","Many youth with autism spectrum disorder (ASD) face challenges accessing needed services as they transition to adulthood. The present study describes the development, feasibility and acceptability of a new intervention designed to teach parents of transition-aged youth with ASD about the adult service system and the most effective ways to access services and supports. As part of a randomized-controlled trial, the intervention-named ASSIST-was delivered to 91 participants in three states in the U","2021","07","11","J Autism Dev Disord","Journal of autism and developmental disorders","Autism spectrum disorder; Families; Intervention; Services; Transition to adulthood","DaWalt","Leann Smith","Waisman Center, University of Wisconsin-Madison, Madison, USA",NA
"1902","34232419","10.1007/s10803-021-05128-z","Development, Feasibility, and Acceptability of a Nationally Relevant Parent Training to Improve Service Access During the Transition to Adulthood for Youth with ASD.","Many youth with autism spectrum disorder (ASD) face challenges accessing needed services as they transition to adulthood. The present study describes the development, feasibility and acceptability of a new intervention designed to teach parents of transition-aged youth with ASD about the adult service system and the most effective ways to access services and supports. As part of a randomized-controlled trial, the intervention-named ASSIST-was delivered to 91 participants in three states in the U","2021","07","11","J Autism Dev Disord","Journal of autism and developmental disorders","Autism spectrum disorder; Families; Intervention; Services; Transition to adulthood","Lee","Chung Eun","Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA",NA
"1903","34232419","10.1007/s10803-021-05128-z","Development, Feasibility, and Acceptability of a Nationally Relevant Parent Training to Improve Service Access During the Transition to Adulthood for Youth with ASD.","Many youth with autism spectrum disorder (ASD) face challenges accessing needed services as they transition to adulthood. The present study describes the development, feasibility and acceptability of a new intervention designed to teach parents of transition-aged youth with ASD about the adult service system and the most effective ways to access services and supports. As part of a randomized-controlled trial, the intervention-named ASSIST-was delivered to 91 participants in three states in the U","2021","07","11","J Autism Dev Disord","Journal of autism and developmental disorders","Autism spectrum disorder; Families; Intervention; Services; Transition to adulthood","Rabideau","Carol","Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, USA",NA
"1905","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Monschein","Tobias","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich. tobias.monschein@meduniwien.ac","tobias.monschein@meduniwien.ac.at"
"1906","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Zrzavy","Tobias","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich",NA
"1907","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Löbermann","Micha","Abteilung für Tropenmedizin und Infektionskrankheiten, Universitätsmedizin Rostock, Rostock, Deutschland",NA
"1908","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Winkelmann","Alexander","Klinik und Poliklinik für Neurologie, Universitätsmedizin Rostock, Rostock, Deutschland",NA
"1909","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Berger","Thomas","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich",NA
"1910","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Rommer","Paulus","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich",NA
"1911","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Hartung","Hans-Peter","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich. hans-peter.hartung@uni-duesseldorf",NA
"1912","34232359","10.1007/s00115-021-01155-4","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].","The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify th","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Multiple sclerosis; Pandemic; SARS-CoV-2; Vaccination","Zettl","Uwe K","Klinik und Poliklinik für Neurologie, Neuroimmunologische Sektion, Universitätsmedizin Rostock, Rostock, Deutschland",NA
"1913","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Monschein","Tobias","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich. tobias.monschein@meduniwien.ac","tobias.monschein@meduniwien.ac.at"
"1914","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Zrzavy","Tobias","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich",NA
"1915","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Löbermann","Micha","Abteilung für Tropenmedizin und Infektionskrankheiten, Universitätsmedizin Rostock, Rostock, Deutschland",NA
"1916","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Winkelmann","Alexander","Klinik und Poliklinik für Neurologie, Universitätsmedizin Rostock, Rostock, Deutschland",NA
"1917","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Berger","Thomas","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich",NA
"1918","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Rommer","Paulus","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich",NA
"1919","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Hartung","Hans-Peter","Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich. hans-peter.hartung@uni-duesseldorf",NA
"1920","34232358","10.1007/s00115-021-01154-5","[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].","Along with the challenges posed by the globally circulating COVID-19 pandemic, there have been some epochal advances in the field of vaccine technologies. In addition to the traditionally used dead, live and protein-based vaccines, vector-based and gene-based vaccines gained enormous attention in the course of this health crisis. The aim of this article is to provide an overview of multiple sclerosis (MS) and vaccination, recent advances in the SARS-CoV-2 vaccine landscape as well as a detailed ","2021","07","09","Nervenarzt","Der Nervenarzt","COVID-19; Gene-based; SARS-CoV-2; Vaccine technologies; Vector","Zettl","Uwe K","Klinik und Poliklinik für Neurologie, Neuroimmunologische Sektion, Universitätsmedizin Rostock, Rostock, Deutschland",NA
"1921","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Radin","Jennifer M","Scripps Research Translational Institute, San Diego, California",NA
"1922","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Quer","Giorgio","Scripps Research Translational Institute, San Diego, California",NA
"1923","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Ramos","Edward","Scripps Research Translational Institute, San Diego, California",NA
"1924","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Baca-Motes","Katie","Scripps Research Translational Institute, San Diego, California",NA
"1925","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Gadaleta","Matteo","Scripps Research Translational Institute, San Diego, California",NA
"1926","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Topol","Eric J","Scripps Research Translational Institute, San Diego, California",NA
"1927","34232306","10.1001/jamanetworkopen.2021.15959","Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection.",NA,"2021","07","15","JAMA Netw Open","JAMA network open","Adolescent; Adult; Aged; COVID-19; Female; Heart Rate; Humans; Male; Middle Aged; SARS-CoV-2; Wearable Electronic Devices; Young Adult","Steinhubl","Steven R","Scripps Research Translational Institute, San Diego, California",NA
"1928","34232299","10.1093/asj/sjab275","Commentary on: The Zoom Boom: How Video Calling Impacts Attitudes Towards Aesthetic Surgery in the COVID-19 Era.",NA,"2021","07","07","Aesthet Surg J","Aesthetic surgery journal",NA,"Ugradar","Shoaib","ophthalmologist, The Jules Stein Eye Institute, UCLA, Los Angeles, CA",NA
"1929","34232299","10.1093/asj/sjab275","Commentary on: The Zoom Boom: How Video Calling Impacts Attitudes Towards Aesthetic Surgery in the COVID-19 Era.",NA,"2021","07","07","Aesthet Surg J","Aesthetic surgery journal",NA,"Massry","Guy G","ophthalmology, Division of Oculoplastic Surgery. University of Southern California, Keck School of Medicine, Los Angeles, CA",NA
"1930","34232297","10.1093/femsle/fnab091","Analysis of university student responses to the pandemic in a formal microbiology assessment.","During the coronavirus pandemic, second-year students on the B.Sc. molecular biology and genetics degree at Istanbul Technical University sat an open-ended online exam for a microbiology course in which one of the compulsory questions asked how the course had helped them during the first phase of the pandemic (April-July 2020). Fifty of 69 students gave consent for their (anonymous) responses to be analysed in order to discern any key ways in which their knowledge had been applied. The aim of th","2021","07","24","FEMS Microbiol Lett","FEMS microbiology letters","COVID-19; analysis of text; coronavirus lockdown; microbiology education; qualitative evaluation; scientific literacy","Çakar","Zeynep Petek","Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey",NA
"1931","34232297","10.1093/femsle/fnab091","Analysis of university student responses to the pandemic in a formal microbiology assessment.","During the coronavirus pandemic, second-year students on the B.Sc. molecular biology and genetics degree at Istanbul Technical University sat an open-ended online exam for a microbiology course in which one of the compulsory questions asked how the course had helped them during the first phase of the pandemic (April-July 2020). Fifty of 69 students gave consent for their (anonymous) responses to be analysed in order to discern any key ways in which their knowledge had been applied. The aim of th","2021","07","24","FEMS Microbiol Lett","FEMS microbiology letters","COVID-19; analysis of text; coronavirus lockdown; microbiology education; qualitative evaluation; scientific literacy","Redfern","James","Department of Natural Sciences, Manchester Metropolitan University, Manchester, M1 5GD, UK",NA
"1932","34232297","10.1093/femsle/fnab091","Analysis of university student responses to the pandemic in a formal microbiology assessment.","During the coronavirus pandemic, second-year students on the B.Sc. molecular biology and genetics degree at Istanbul Technical University sat an open-ended online exam for a microbiology course in which one of the compulsory questions asked how the course had helped them during the first phase of the pandemic (April-July 2020). Fifty of 69 students gave consent for their (anonymous) responses to be analysed in order to discern any key ways in which their knowledge had been applied. The aim of th","2021","07","24","FEMS Microbiol Lett","FEMS microbiology letters","COVID-19; analysis of text; coronavirus lockdown; microbiology education; qualitative evaluation; scientific literacy","Verran","Joanna","Department of Life Sciences, Manchester Metropolitan University, Manchester, M1 5GD, UK",NA
"1933","34232288","10.1210/clinem/dgab505","Role of vitamin D in COVID-19: active or passive?",NA,"2021","07","07","J Clin Endocrinol Metab","The Journal of clinical endocrinology and metabolism","COVID-19; Calcifediol; ICU admission; Vitamin D; mortality","Dawson-Hughes","Bess","Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University",NA
"1934","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Bissell","Brittany D","University of Kentucky, Lexington, KY, USA",NA
"1935","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Johnston","Jackie P","Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA",NA
"1936","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Smith","Rebecca R","Department of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA",NA
"1937","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Newsome","Andrea Sikora","University of Georgia College of Pharmacy, Augusta, GA, USA",NA
"1938","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Thompson Bastin","Melissa L","University of Kentucky, Lexington, KY, USA",NA
"1939","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Abdul-Mutakabbir","Jacinda","Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA, USA",NA
"1940","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Barlow","Ashley","The University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"1941","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Barlow","Brooke","University of Kentucky, Lexington, KY, USA",NA
"1942","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Berger","Karen","New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA",NA
"1943","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Crow","Jessica R","Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, USA",NA
"1944","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Dixit","Deepali","Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA",NA
"1945","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Jacobi","Judith","Visante, Inc., Lebanon, IN, USA",NA
"1946","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Karaoui","Lamis R","Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon",NA
"1947","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Kiser","Tyree H","Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA",NA
"1948","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Kolesar","Jill","College of Pharmacy, University of Kentucky, Lexington KY, USA",NA
"1949","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Koontz","Susannah E","Koontz Oncology Consulting LLC, Houston, TX, USA",NA
"1950","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Mattingly","T Joseph","Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, USA",NA
"1951","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Mitchell","Chelsea","Methodist University Hospital, Memphis, TN, USA",NA
"1952","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Nilges","Alexsandra","University of Kentucky College of Pharmacy, Lexington, KY, USA",NA
"1953","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Rech","Megan A","Department of Emergency Medicine, Stritch School of Medicine, Loyola University Chicago, Chicago, IL, and Loyola University Medical Center, Maywood, IL, USA",NA
"1954","34232286","10.1093/ajhp/zxab275","Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action.","In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.","2021","07","07","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","bias; equality; equity; gender; harassment; pharmacy profession","Heavner","Mojdeh S","Department of Pharmacy Practice and Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA",NA
"1955","34232205","10.1097/MD.0000000000026583","Analysis of pediatric emergency department patient volume trends during the COVID-19 pandemic.","During the early period of the COVID-19 pandemic there was a substantial decrease in pediatric emergency department (PED) visitation. The intent of this study is to report PED utilization during the COVID-19 pandemic in an urban pediatric referral center located close to the epicenter in the northeastern US.A retrospective analysis of medical records of patients visiting the PED at Robert Wood Johnson University Hospital (RWJUH) was performed. Data included: daily census, admission rate, Emergen","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Child; Emergency Service, Hospital; Female; Hospitalization; Hospitals, Pediatric; Humans; Male; Pandemics; Retrospective Studies; SARS-CoV-2; United States","Pepper","Matthew Philip","Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ",NA
"1956","34232205","10.1097/MD.0000000000026583","Analysis of pediatric emergency department patient volume trends during the COVID-19 pandemic.","During the early period of the COVID-19 pandemic there was a substantial decrease in pediatric emergency department (PED) visitation. The intent of this study is to report PED utilization during the COVID-19 pandemic in an urban pediatric referral center located close to the epicenter in the northeastern US.A retrospective analysis of medical records of patients visiting the PED at Robert Wood Johnson University Hospital (RWJUH) was performed. Data included: daily census, admission rate, Emergen","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Child; Emergency Service, Hospital; Female; Hospitalization; Hospitals, Pediatric; Humans; Male; Pandemics; Retrospective Studies; SARS-CoV-2; United States","Leva","Ernest","Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ",NA
"1957","34232205","10.1097/MD.0000000000026583","Analysis of pediatric emergency department patient volume trends during the COVID-19 pandemic.","During the early period of the COVID-19 pandemic there was a substantial decrease in pediatric emergency department (PED) visitation. The intent of this study is to report PED utilization during the COVID-19 pandemic in an urban pediatric referral center located close to the epicenter in the northeastern US.A retrospective analysis of medical records of patients visiting the PED at Robert Wood Johnson University Hospital (RWJUH) was performed. Data included: daily census, admission rate, Emergen","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Child; Emergency Service, Hospital; Female; Hospitalization; Hospitals, Pediatric; Humans; Male; Pandemics; Retrospective Studies; SARS-CoV-2; United States","Trivedy","Prerna","Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ",NA
"1958","34232205","10.1097/MD.0000000000026583","Analysis of pediatric emergency department patient volume trends during the COVID-19 pandemic.","During the early period of the COVID-19 pandemic there was a substantial decrease in pediatric emergency department (PED) visitation. The intent of this study is to report PED utilization during the COVID-19 pandemic in an urban pediatric referral center located close to the epicenter in the northeastern US.A retrospective analysis of medical records of patients visiting the PED at Robert Wood Johnson University Hospital (RWJUH) was performed. Data included: daily census, admission rate, Emergen","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Child; Emergency Service, Hospital; Female; Hospitalization; Hospitals, Pediatric; Humans; Male; Pandemics; Retrospective Studies; SARS-CoV-2; United States","Luckey","James","Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ",NA
"1959","34232205","10.1097/MD.0000000000026583","Analysis of pediatric emergency department patient volume trends during the COVID-19 pandemic.","During the early period of the COVID-19 pandemic there was a substantial decrease in pediatric emergency department (PED) visitation. The intent of this study is to report PED utilization during the COVID-19 pandemic in an urban pediatric referral center located close to the epicenter in the northeastern US.A retrospective analysis of medical records of patients visiting the PED at Robert Wood Johnson University Hospital (RWJUH) was performed. Data included: daily census, admission rate, Emergen","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Child; Emergency Service, Hospital; Female; Hospitalization; Hospitals, Pediatric; Humans; Male; Pandemics; Retrospective Studies; SARS-CoV-2; United States","Baker","Mark Douglas","Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ",NA
"1960","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Ganter","Julian","Department of Cardiovascular Surgery, University Heart Center Freiburg, Faculty of Medicine",NA
"1961","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Damjanovic","Domagoj","Department of Cardiovascular Surgery, University Heart Center Freiburg, Faculty of Medicine",NA
"1962","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Trummer","Georg","Department of Cardiovascular Surgery, University Heart Center Freiburg, Faculty of Medicine",NA
"1963","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Busch","Hans-Jörg","German Resuscitation Council (GRC), Ulm, Germany",NA
"1964","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Baldas","Klemens","Department of Anaesthesiology, Intensive Care, and Emergency Medicine, St. Josef's Hospital, Freiburg",NA
"1965","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Hänsel","Mike","Carl Gustav Carus Faculty of Medicine, Carus Teaching Center, Technische Universität Dresden, Dresden, Germany",NA
"1966","34232186","10.1097/MD.0000000000026526","Smartphone based alerting of first responders during the corona virus disease-19 pandemic: An observational study.","Smartphone alerting systems (SAS) for first responders potentially shorten the resuscitation-free interval of patients with acute cardiac arrest. During the corona virus disease-19 (COVID-19) pandemic, many systems are suspended due to potential risks for the responders.Objective of the study was to establish a concept for SAS during the COVID-19 pandemic and to evaluate whether a SAS can safely be operated in pandemic conditions.A SAS had been implemented in Freiburg (Germany) in 2018 alerting ","2021","07","13","Medicine (Baltimore)","Medicine","COVID-19; Emergency Responders; Germany; Humans; Infectious Disease Transmission, Patient-to-Professional; Pandemics; Personal Protective Equipment; Retrospective Studies; SARS-CoV-2; Smartphone","Müller","Michael Patrick","ERC Research NET, European Resuscitation Council, Niel, Belgium",NA
"1967","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Li","Xixi","Department of Geriatric Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1968","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Cai","Quan","Department of Emergency, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1969","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Jia","Ziyi","Department of Emergency, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1970","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Zhou","Yifang","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1971","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Liu","Linzi","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1972","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Zhou","Yuning","Department of Geriatric Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1973","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Zhang","Baoyan","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1974","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Ren","Luyu","Department of Psychiatry, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1975","34232185","10.1097/MD.0000000000026520","The correlation between mental health status, sleep quality, and inflammatory markers, virus negative conversion time among patients confirmed with 2019-nCoV during the COVID-19 outbreak in China: An observational study.","The 2019 coronavirus disease (COVID-19) has spread to the whole world. Psychological and sleep problems among confirmed patients have drawn extensive attention which may be highly related to immune function and inflammatory responses of people. The aim of this study is to examine the correlation of mental health status, sleep quality, and inflammatory markers, virus negative conversion time (NCT) among confirmed patients during the COVID-19 outbreak.A cross-sectional survey was conducted in this","2021","07","13","Medicine (Baltimore)","Medicine","Adolescent; Adult; Aged; COVID-19; China; Cross-Sectional Studies; Female; Health Status; Humans; Incidence; Male; Mental Health; Middle Aged; Retrospective Studies; SARS-CoV-2; Sleep; Sleep Wake Disorders; Young Adult","Tang","Yanqing","Department of Geriatric Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China",NA
"1976","34232165","10.1097/MD.0000000000025938","Disease state prediction for 2019 novel coronavirus (COVID-19) pneumonia using CT manifestations and body temperature dynamic analysis: A SQUIRE-compliant study.","2019 Novel Coronavirus (COVID-19) is a new acute infectious disease of respiratory system, posed a great threat to human health because of its strong infectivity and rapid progress. This study aimed to assess the severity of COVID-19 Pneumonia by analyzing the change of CT manifestations and body temperature.This retrospective review included 22 patients with COVID-19 pneumonia. The imaging manifestations and clinical features were observed and evaluated.Most of the infected patients were men (1","2021","07","13","Medicine (Baltimore)","Medicine","Adult; Aged; Body Temperature; COVID-19; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pandemics; Predictive Value of Tests; Retrospective Studies; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Liang","Pan","Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China",NA
"1977","34232165","10.1097/MD.0000000000025938","Disease state prediction for 2019 novel coronavirus (COVID-19) pneumonia using CT manifestations and body temperature dynamic analysis: A SQUIRE-compliant study.","2019 Novel Coronavirus (COVID-19) is a new acute infectious disease of respiratory system, posed a great threat to human health because of its strong infectivity and rapid progress. This study aimed to assess the severity of COVID-19 Pneumonia by analyzing the change of CT manifestations and body temperature.This retrospective review included 22 patients with COVID-19 pneumonia. The imaging manifestations and clinical features were observed and evaluated.Most of the infected patients were men (1","2021","07","13","Medicine (Baltimore)","Medicine","Adult; Aged; Body Temperature; COVID-19; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pandemics; Predictive Value of Tests; Retrospective Studies; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Wang","Rui","Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China",NA
"1978","34232165","10.1097/MD.0000000000025938","Disease state prediction for 2019 novel coronavirus (COVID-19) pneumonia using CT manifestations and body temperature dynamic analysis: A SQUIRE-compliant study.","2019 Novel Coronavirus (COVID-19) is a new acute infectious disease of respiratory system, posed a great threat to human health because of its strong infectivity and rapid progress. This study aimed to assess the severity of COVID-19 Pneumonia by analyzing the change of CT manifestations and body temperature.This retrospective review included 22 patients with COVID-19 pneumonia. The imaging manifestations and clinical features were observed and evaluated.Most of the infected patients were men (1","2021","07","13","Medicine (Baltimore)","Medicine","Adult; Aged; Body Temperature; COVID-19; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pandemics; Predictive Value of Tests; Retrospective Studies; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Ren","Xiu-Chun","Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China",NA
"1979","34232165","10.1097/MD.0000000000025938","Disease state prediction for 2019 novel coronavirus (COVID-19) pneumonia using CT manifestations and body temperature dynamic analysis: A SQUIRE-compliant study.","2019 Novel Coronavirus (COVID-19) is a new acute infectious disease of respiratory system, posed a great threat to human health because of its strong infectivity and rapid progress. This study aimed to assess the severity of COVID-19 Pneumonia by analyzing the change of CT manifestations and body temperature.This retrospective review included 22 patients with COVID-19 pneumonia. The imaging manifestations and clinical features were observed and evaluated.Most of the infected patients were men (1","2021","07","13","Medicine (Baltimore)","Medicine","Adult; Aged; Body Temperature; COVID-19; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pandemics; Predictive Value of Tests; Retrospective Studies; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Huang","Wen-Peng","Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China",NA
"1980","34232165","10.1097/MD.0000000000025938","Disease state prediction for 2019 novel coronavirus (COVID-19) pneumonia using CT manifestations and body temperature dynamic analysis: A SQUIRE-compliant study.","2019 Novel Coronavirus (COVID-19) is a new acute infectious disease of respiratory system, posed a great threat to human health because of its strong infectivity and rapid progress. This study aimed to assess the severity of COVID-19 Pneumonia by analyzing the change of CT manifestations and body temperature.This retrospective review included 22 patients with COVID-19 pneumonia. The imaging manifestations and clinical features were observed and evaluated.Most of the infected patients were men (1","2021","07","13","Medicine (Baltimore)","Medicine","Adult; Aged; Body Temperature; COVID-19; Disease Progression; Female; Humans; Lung; Male; Middle Aged; Pandemics; Predictive Value of Tests; Retrospective Studies; Risk Factors; SARS-CoV-2; Tomography, X-Ray Computed","Gao","Jian-Bo","Department of Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China",NA
"1981","34232150","10.1097/ACM.0000000000004225","What Role Should Resistance Play in Training Health Professionals?","The role that resistance plays in medicine and medical education is ill-defined. Although physicians and students have been involved in protests related to the COVID-19 pandemic, structural racism, police brutality, and gender inequity, resistance has not been prominent in medical education's discourses, and medical education has not supported students' role and responsibility in developing professional approaches to resistance. While learners should not pick and choose what aspects of medical e","2021","07","07","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Ellaway","Rachel H","R.H. Ellaway is professor, Department of Community Health Sciences, and director, Office of Health and Medical Education Scholarship, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"1982","34232150","10.1097/ACM.0000000000004225","What Role Should Resistance Play in Training Health Professionals?","The role that resistance plays in medicine and medical education is ill-defined. Although physicians and students have been involved in protests related to the COVID-19 pandemic, structural racism, police brutality, and gender inequity, resistance has not been prominent in medical education's discourses, and medical education has not supported students' role and responsibility in developing professional approaches to resistance. While learners should not pick and choose what aspects of medical e","2021","07","07","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Wyatt","Tasha R","R.H. Ellaway is professor, Department of Community Health Sciences, and director, Office of Health and Medical Education Scholarship, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",NA
"1983","34232147","10.1097/MCC.0000000000000858","How trustworthy guidelines can impact outcomes.","If developed using rigorous methods and produced in a timely manner, clinical practice guidelines have the potential to improve patient outcomes. Although the COVID-19 pandemic has highlighted the challenges involved in generating reliable clinical guidance, it has also provided an opportunity to address these challenges. New research addressing drugs for COVID-19 is being produced at unprecedented rates. Incorporating this new knowledge into patient care can be daunting for the average clinicia","2021","07","07","Curr Opin Crit Care","Current opinion in critical care",NA,"Rochwerg","Bram","Department of Medicine Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada HCor Research Institute, Hospital do Coração, São Paulo, Brazil INSERM 1152, University of Paris, Paris, France David Geffen School of Medicine, University of California, Los Angeles, USA",NA
"1984","34232147","10.1097/MCC.0000000000000858","How trustworthy guidelines can impact outcomes.","If developed using rigorous methods and produced in a timely manner, clinical practice guidelines have the potential to improve patient outcomes. Although the COVID-19 pandemic has highlighted the challenges involved in generating reliable clinical guidance, it has also provided an opportunity to address these challenges. New research addressing drugs for COVID-19 is being produced at unprecedented rates. Incorporating this new knowledge into patient care can be daunting for the average clinicia","2021","07","07","Curr Opin Crit Care","Current opinion in critical care",NA,"Kawano-Dourado","Leticia","Department of Medicine Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada HCor Research Institute, Hospital do Coração, São Paulo, Brazil INSERM 1152, University of Paris, Paris, France David Geffen School of Medicine, University of California, Los Angeles, USA",NA
"1985","34232147","10.1097/MCC.0000000000000858","How trustworthy guidelines can impact outcomes.","If developed using rigorous methods and produced in a timely manner, clinical practice guidelines have the potential to improve patient outcomes. Although the COVID-19 pandemic has highlighted the challenges involved in generating reliable clinical guidance, it has also provided an opportunity to address these challenges. New research addressing drugs for COVID-19 is being produced at unprecedented rates. Incorporating this new knowledge into patient care can be daunting for the average clinicia","2021","07","07","Curr Opin Crit Care","Current opinion in critical care",NA,"Qadir","Nida","Department of Medicine Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada HCor Research Institute, Hospital do Coração, São Paulo, Brazil INSERM 1152, University of Paris, Paris, France David Geffen School of Medicine, University of California, Los Angeles, USA",NA
"1986","34232139","10.1097/MOH.0000000000000666","Mechanisms of immunothrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2. Over the past year, COVID-19 has posed a significant threat to global health. Although the infection is associated with mild symptoms in many patients, a significant proportion of patients develop a prothrombotic state due to a combination of alterations in coagulation and immune cell function. The purpose of this review is to discuss the pathophysiological characteristics of C","2021","07","07","Curr Opin Hematol","Current opinion in hematology",NA,"Portier","Irina","University of Utah Molecular Medicine Program Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"1987","34232139","10.1097/MOH.0000000000000666","Mechanisms of immunothrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2. Over the past year, COVID-19 has posed a significant threat to global health. Although the infection is associated with mild symptoms in many patients, a significant proportion of patients develop a prothrombotic state due to a combination of alterations in coagulation and immune cell function. The purpose of this review is to discuss the pathophysiological characteristics of C","2021","07","07","Curr Opin Hematol","Current opinion in hematology",NA,"Campbell","Robert A","University of Utah Molecular Medicine Program Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"1988","34232139","10.1097/MOH.0000000000000666","Mechanisms of immunothrombosis in COVID-19.","Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2. Over the past year, COVID-19 has posed a significant threat to global health. Although the infection is associated with mild symptoms in many patients, a significant proportion of patients develop a prothrombotic state due to a combination of alterations in coagulation and immune cell function. The purpose of this review is to discuss the pathophysiological characteristics of C","2021","07","07","Curr Opin Hematol","Current opinion in hematology",NA,"Denorme","Frederik","University of Utah Molecular Medicine Program Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA",NA
"1989","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Favresse","Julien","Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium",NA
"1990","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Bayart","Jean-Louis","Department of Laboratory Medicine, Clinique St-Pierre, Ottignies, Belgium",NA
"1991","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Mullier","François","Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur, Belgium",NA
"1992","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Elsen","Marc","Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium",NA
"1993","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Eucher","Christine","Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium",NA
"1994","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Van Eeckhoudt","Sandrine","Department of Internal Medicine, Clinique St-Luc Bouge, Namur, Belgium",NA
"1995","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Roy","Tatiana","Department of Laboratory Medicine, Clinique St-Pierre, Ottignies, Belgium",NA
"1996","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Wieers","Gregoire","Department of Internal Medicine, Clinique St-Pierre, Ottignies, Belgium",NA
"1997","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Laurent","Christine","Department of Internal Medicine, Université catholique de Louvain, CHU UCL Namur, Namur, Belgium",NA
"1998","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Dogné","Jean-Michel","Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium",NA
"1999","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Closset","Mélanie","Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur, Belgium",NA
"2000","34232116","10.1080/22221751.2021.1953403","Antibody titres decline 3-month post-vaccination with BNT162b2.","Several studies reported on the humoral response in subjects having received the BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months post-vaccination are currently lacking and are important to drive the future vaccination strategy. The CRO-VAX HCP study is an ongoing multicentre, prospective and interventional study designed to assess the antibody response in a population of healthcare professionals who had received two doses of the BNT162b2 mRNA COVID-19 vaccine","2021","07","23","Emerg Microbes Infect","Emerging microbes &amp; infections","BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine","Douxfils","Jonathan","Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium",NA
"2001","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Gunawardana","Manjula","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2002","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Breslin","Jessica","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2003","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Cortez","John M","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2004","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Rivera","Sofia","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2005","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Webster","Simon","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2006","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Ibarrondo","F Javier","University of California, Los Angelesgrid.19006.3e, Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA",NA
"2007","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Yang","Otto O","University of California, Los Angelesgrid.19006.3e, Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA",NA
"2008","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Pyles","Richard B","Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA",NA
"2009","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Ramirez","Christina M","University of California, Los Angelesgrid.19006.3e, Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles, California, USA",NA
"2010","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Adler","Amy P","Jumpstart Research Consulting, LLC, Santa Fe, New Mexico, USA",NA
"2011","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Anton","Peter A","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2012","34232081","10.1128/mSphere.00542-21","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","Public health practices and high vaccination rates currently represent the primary interventions for managing the spread of coronavirus disease 2019 (COVID-19). We initiated a clinical study based on frequent, longitudinal workplace disease surveillance to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission among employees and their household members. We hypothesized that the study would reduce the economic burden and loss of productivity of both individuals and sma","2021","07","07","mSphere","mSphere","SARS-CoV-2; antibodies; asymptomatic; long-term infection; serology; surveillance; workplace","Baum","Marc M","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA",NA
"2013","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Xu","Jidong","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2014","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Mao","Junyong","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2015","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Han","Xiao","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2016","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Shi","Fushan","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2017","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Gao","Qin","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2018","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Wang","Tingjun","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2019","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Zhang","Zhenning","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2020","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Shan","Ying","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2021","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Fang","Weihuan","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2022","34232065","10.1128/JVI.00853-21","Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.","Porcine epidemic diarrhea virus (PEDV) is an enteric coronavirus causing acute intestinal infection in pigs, with high mortality often seen in neonatal pigs. The newborns rely on innate immune responses against invading pathogens because of lacking adaptive immunity. However, how PEDV disables the innate immunity of newborns towards severe infection remains unknown. We found that PEDV infection led to reduced expression of histone deacetylases (HDACs), especially HDAC1 in porcine IPEC-J2 cells. ","2021","07","07","J Virol","Journal of virology",NA,"Li","Xiaoliang","Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China",NA
"2023","34232008","","[Occupational health in the COVID-19 era].","Preventive actions have reached a new height in the COVID-19 pandemic and since there is not a specific treatment yet, while the vaccines demonstrate their effectiveness and gradually are applied to the population, preventive measures are still recommended. Among these actions, occupational health faces challenges, since a significant part of the population is economically active and have had to suspend work, and in the current context, return-to-work measures have been implemented. The care and","2021","07","09","Rev Med Inst Mex Seguro Soc","Revista medica del Instituto Mexicano del Seguro Social","Coronavirus Infections; Health Personnel; Occupational Health; Occupational Risks; COVID-19; Health Personnel; Humans; Occupational Exposure; Occupational Health; Pandemics; SARS-CoV-2","Moreno-Torres","Luis Antonio","Instituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada Estatal Jalisco, Fomento a la Salud. Guadalajara, Jalisco, México",NA
"2024","34232002","10.36849/JDD.5544","Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.",NA,"2021","07","15","J Drugs Dermatol","Journal of drugs in dermatology : JDD","COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Humans; Janus Kinase 1; Pyrimidines; Respiratory Distress Syndrome; Sulfonamides","Uppal","Shelley K",NA,NA
"2025","34232002","10.36849/JDD.5544","Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.",NA,"2021","07","15","J Drugs Dermatol","Journal of drugs in dermatology : JDD","COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Humans; Janus Kinase 1; Pyrimidines; Respiratory Distress Syndrome; Sulfonamides","Kearns","Donovan G",NA,NA
"2026","34232002","10.36849/JDD.5544","Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.",NA,"2021","07","15","J Drugs Dermatol","Journal of drugs in dermatology : JDD","COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Humans; Janus Kinase 1; Pyrimidines; Respiratory Distress Syndrome; Sulfonamides","Chat","Vipawee S",NA,NA
"2027","34232002","10.36849/JDD.5544","Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.",NA,"2021","07","15","J Drugs Dermatol","Journal of drugs in dermatology : JDD","COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Humans; Janus Kinase 1; Pyrimidines; Respiratory Distress Syndrome; Sulfonamides","Wu","Jashin J",NA,NA
"2028","34231984","","[Severe COVID-19 and outcomes in patients with rheumatic disease].","Infections increase morbidity and mortality in patients with autoimmune disorders; however, this association has not been established in rheumatic diseases and SARS-CoV-2 infection. To describe the clinical characteristics and mortality of patients with rheumatic diseases and severe COVID-19. Observational and descriptive case series in patients with rheumatic diseases and severe SARS-CoV-2 infection, confirmed by PCR or pulmonary tomography, hospitalized in Mexico City from March to August 2020","2021","07","09","Rev Med Inst Mex Seguro Soc","Revista medica del Instituto Mexicano del Seguro Social","Coronavirus Infections; Hospital Mortality; Rheumatic Diseases; COVID-19; Female; Hospitalization; Humans; Mexico; Middle Aged; Rheumatic Diseases; SARS-CoV-2","Galicia-Lucas","Uriel Josette","Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades ""Dr. Bernardo Sepúlveda Gutiérrez"", Departamento de Reumatología. Ciudad de México, México",NA
"2029","34231984","","[Severe COVID-19 and outcomes in patients with rheumatic disease].","Infections increase morbidity and mortality in patients with autoimmune disorders; however, this association has not been established in rheumatic diseases and SARS-CoV-2 infection. To describe the clinical characteristics and mortality of patients with rheumatic diseases and severe COVID-19. Observational and descriptive case series in patients with rheumatic diseases and severe SARS-CoV-2 infection, confirmed by PCR or pulmonary tomography, hospitalized in Mexico City from March to August 2020","2021","07","09","Rev Med Inst Mex Seguro Soc","Revista medica del Instituto Mexicano del Seguro Social","Coronavirus Infections; Hospital Mortality; Rheumatic Diseases; COVID-19; Female; Hospitalization; Humans; Mexico; Middle Aged; Rheumatic Diseases; SARS-CoV-2","Ramírez-Pérez","Astrid Asminda","Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades ""Dr. Bernardo Sepúlveda Gutiérrez"", Departamento de Reumatología. Ciudad de México, México",NA
"2030","34231968","10.1002/smi.3078","Physical activity levels and mental health burden of healthcare workers during COVID-19 lockdown.","The outbreak of COVID-19 has precipitated international lockdown measures to curb disease transmissions. The closure of public activity spaces as well as changes in pandemic workload may disrupt healthcare workers' physical activity and self-care routines. We sought to examine the association between physical activity levels and mental health burden of healthcare workers during the COVID-19 lockdown in Singapore. This cross-sectional study comprised of an multidomain survey that was administered","2021","07","12","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","Organizational stress interventions/prevention; anxiety; depression; mental health; physical activity; stress","Kua","Zaylea","Department of Psychological Medicine, Changi General Hospital, Singapore",NA
"2031","34231968","10.1002/smi.3078","Physical activity levels and mental health burden of healthcare workers during COVID-19 lockdown.","The outbreak of COVID-19 has precipitated international lockdown measures to curb disease transmissions. The closure of public activity spaces as well as changes in pandemic workload may disrupt healthcare workers' physical activity and self-care routines. We sought to examine the association between physical activity levels and mental health burden of healthcare workers during the COVID-19 lockdown in Singapore. This cross-sectional study comprised of an multidomain survey that was administered","2021","07","12","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","Organizational stress interventions/prevention; anxiety; depression; mental health; physical activity; stress","Hamzah","Fadzil","Department of Sport &amp",NA
"2032","34231968","10.1002/smi.3078","Physical activity levels and mental health burden of healthcare workers during COVID-19 lockdown.","The outbreak of COVID-19 has precipitated international lockdown measures to curb disease transmissions. The closure of public activity spaces as well as changes in pandemic workload may disrupt healthcare workers' physical activity and self-care routines. We sought to examine the association between physical activity levels and mental health burden of healthcare workers during the COVID-19 lockdown in Singapore. This cross-sectional study comprised of an multidomain survey that was administered","2021","07","12","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","Organizational stress interventions/prevention; anxiety; depression; mental health; physical activity; stress","Tan","Pei T","Clinical Trials &amp",NA
"2033","34231968","10.1002/smi.3078","Physical activity levels and mental health burden of healthcare workers during COVID-19 lockdown.","The outbreak of COVID-19 has precipitated international lockdown measures to curb disease transmissions. The closure of public activity spaces as well as changes in pandemic workload may disrupt healthcare workers' physical activity and self-care routines. We sought to examine the association between physical activity levels and mental health burden of healthcare workers during the COVID-19 lockdown in Singapore. This cross-sectional study comprised of an multidomain survey that was administered","2021","07","12","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","Organizational stress interventions/prevention; anxiety; depression; mental health; physical activity; stress","Ong","Li J","Department of Dietetics, Changi General Hospital, Singapore",NA
"2034","34231968","10.1002/smi.3078","Physical activity levels and mental health burden of healthcare workers during COVID-19 lockdown.","The outbreak of COVID-19 has precipitated international lockdown measures to curb disease transmissions. The closure of public activity spaces as well as changes in pandemic workload may disrupt healthcare workers' physical activity and self-care routines. We sought to examine the association between physical activity levels and mental health burden of healthcare workers during the COVID-19 lockdown in Singapore. This cross-sectional study comprised of an multidomain survey that was administered","2021","07","12","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","Organizational stress interventions/prevention; anxiety; depression; mental health; physical activity; stress","Tan","Benedict","Department of Sport &amp",NA
"2035","34231968","10.1002/smi.3078","Physical activity levels and mental health burden of healthcare workers during COVID-19 lockdown.","The outbreak of COVID-19 has precipitated international lockdown measures to curb disease transmissions. The closure of public activity spaces as well as changes in pandemic workload may disrupt healthcare workers' physical activity and self-care routines. We sought to examine the association between physical activity levels and mental health burden of healthcare workers during the COVID-19 lockdown in Singapore. This cross-sectional study comprised of an multidomain survey that was administered","2021","07","12","Stress Health","Stress and health : journal of the International Society for the Investigation of Stress","Organizational stress interventions/prevention; anxiety; depression; mental health; physical activity; stress","Huang","Zhongwei","Department of Obstetrics &amp",NA
"2036","34231953","10.1002/jgc4.1465","Genetic counselor experiences with telehealth before and after COVID-19.","While genetic counselor (GC) utilization of telehealth has increased in recent years, the onset of the COVID-19 pandemic significantly accelerated the adoption of telehealth for many. We investigated GC experiences with telehealth including perceived advantages, disadvantages, and barriers using a one-time online survey of GCs who provided direct patient care in recent years. The survey examined experiences with telehealth before and after the onset of COVID-19. We made broad comparisons to find","2021","07","07","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counselors; telemedicine","Mills","Rachel","MS Genetic Counseling Program, University of North Carolina Greensboro, Greensboro, NC, USA",NA
"2037","34231953","10.1002/jgc4.1465","Genetic counselor experiences with telehealth before and after COVID-19.","While genetic counselor (GC) utilization of telehealth has increased in recent years, the onset of the COVID-19 pandemic significantly accelerated the adoption of telehealth for many. We investigated GC experiences with telehealth including perceived advantages, disadvantages, and barriers using a one-time online survey of GCs who provided direct patient care in recent years. The survey examined experiences with telehealth before and after the onset of COVID-19. We made broad comparisons to find","2021","07","07","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counselors; telemedicine","MacFarlane","Ian M","Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN, USA",NA
"2038","34231953","10.1002/jgc4.1465","Genetic counselor experiences with telehealth before and after COVID-19.","While genetic counselor (GC) utilization of telehealth has increased in recent years, the onset of the COVID-19 pandemic significantly accelerated the adoption of telehealth for many. We investigated GC experiences with telehealth including perceived advantages, disadvantages, and barriers using a one-time online survey of GCs who provided direct patient care in recent years. The survey examined experiences with telehealth before and after the onset of COVID-19. We made broad comparisons to find","2021","07","07","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counselors; telemedicine","Caleshu","Colleen","GeneMatters, LLC, Minneapolis, MN, USA",NA
"2039","34231953","10.1002/jgc4.1465","Genetic counselor experiences with telehealth before and after COVID-19.","While genetic counselor (GC) utilization of telehealth has increased in recent years, the onset of the COVID-19 pandemic significantly accelerated the adoption of telehealth for many. We investigated GC experiences with telehealth including perceived advantages, disadvantages, and barriers using a one-time online survey of GCs who provided direct patient care in recent years. The survey examined experiences with telehealth before and after the onset of COVID-19. We made broad comparisons to find","2021","07","07","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counselors; telemedicine","Ringler","Margaret A","Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN, USA",NA
"2040","34231953","10.1002/jgc4.1465","Genetic counselor experiences with telehealth before and after COVID-19.","While genetic counselor (GC) utilization of telehealth has increased in recent years, the onset of the COVID-19 pandemic significantly accelerated the adoption of telehealth for many. We investigated GC experiences with telehealth including perceived advantages, disadvantages, and barriers using a one-time online survey of GCs who provided direct patient care in recent years. The survey examined experiences with telehealth before and after the onset of COVID-19. We made broad comparisons to find","2021","07","07","J Genet Couns","Journal of genetic counseling","COVID-19; genetic counselors; telemedicine","Zierhut","Heather A","Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN, USA",NA
"2041","34231951","10.1002/iid3.482","A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia.","A neutrophilic infiltrate characterizes bacterial pneumonia. Macrophage infiltration is similarly characteristic of the viral pneumonia caused by SARS-CoV-2. These infiltrating macrophages, while phagocytic and capable of engulfing virus laden alveolar cells, are also rich in tissue factor-a thromboplastin. This prothrombotic aspect likely explains how a respiratory virus whose malign effects should be confined to the oropharynx, bronchi and lungs, can cause a panoply of extra-pulmonary organ di","2021","07","07","Immun Inflamm Dis","Immunity, inflammation and disease","blood tissues; human animals; infections; viral retroviral","Bull","Brian S","Department of Pathology and Human Anatomy School of Medicine, Loma Linda University, Loma Linda, California, USA",NA
"2042","34231951","10.1002/iid3.482","A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia.","A neutrophilic infiltrate characterizes bacterial pneumonia. Macrophage infiltration is similarly characteristic of the viral pneumonia caused by SARS-CoV-2. These infiltrating macrophages, while phagocytic and capable of engulfing virus laden alveolar cells, are also rich in tissue factor-a thromboplastin. This prothrombotic aspect likely explains how a respiratory virus whose malign effects should be confined to the oropharynx, bronchi and lungs, can cause a panoply of extra-pulmonary organ di","2021","07","07","Immun Inflamm Dis","Immunity, inflammation and disease","blood tissues; human animals; infections; viral retroviral","Hay","Karen L","Department of Pathology and Human Anatomy School of Medicine, Loma Linda University, Loma Linda, California, USA",NA
"2043","34231941","10.1002/bmb.21558","General considerations for online teaching practices in bioinformatics in the time of COVID-19.","The COVID-19 pandemic is promoting online education. In this concern, not only online teaching of wet laboratory practices is being challenging, but also online teaching of practices in bioinformatics. Here, I discuss the problematic of online teaching practices in bioinformatics and provide fundamental guidelines, especially oriented for beginner educators, that can help in the time of the pandemic.","2021","07","07","Biochem Mol Biol Educ","Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology","COVID-19 pandemic; bioinformatics; online teaching; planning for teaching; practices in bioinformatics","Arenas","Miguel","CINBIO, Universidade de Vigo, Vigo, Spain",NA
"2044","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Deng","Jieping","Department of Microbiology and Immunology",NA
"2045","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Pan","Junping","Department of Microbiology and Immunology",NA
"2046","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Qiu","Minghui","Department of Microbiology and Immunology",NA
"2047","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Mao","Lipeng","Department of Microbiology and Immunology",NA
"2048","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Wang","Zhigang","Affiliated Huaqiao Hospital, Jinan University, Guangzhou, China",NA
"2049","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Zhu","Guodong","Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China",NA
"2050","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Gao","Lijuan","Department of Microbiology and Immunology",NA
"2051","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Su","Jun","Affiliated Huaqiao Hospital, Jinan University, Guangzhou, China",NA
"2052","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Hu","Yutian","Meng Yi Center Limited, Macau, China",NA
"2053","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Luo","Oscar Junhong","Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China",NA
"2054","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Chen","Guobing","Department of Microbiology and Immunology",NA
"2055","34231935","10.1002/JLB.4MA0621-020R","Identification of HLA-A2 restricted CD8<sup>+</sup> T cell epitopes in SARS-CoV-2 structural proteins.","The outbreak of coronavirus disease 2019 (COVID-19) has now become a pandemic, and the etiologic agent is the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). T cell mediated immune responses play an important role in virus controlling; however, the understanding of the viral protein immunogenicity and the mechanisms of the induced responses are still limited. So, identification of specific epitopes and exploring their immunogenic properties would provide valuable information. In ou","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","CD8+ T cells; SARS-CoV-2; epitope; structural protein","Wang","Pengcheng","Department of Microbiology and Immunology",NA
"2056","34231924","10.1002/gps.5600","Assessment of anxiety in elderly population during the COVID-19 pandemic and the impact of compulsory home-stay in the central districts of Ankara, Turkey: A quantitative, qualitative mixed method study.","This study aimed to determine the level of anxiety in elderly individuals during the COVID-19 pandemic in Ankara province of Turkey and determine its associated factors. A quantitative, qualitative mixed-method study performed in 1-10 June 2020 during the compulsory home-stay for elderly people in Turkey. The quantitative study was conducted using a structured online questionnaire with 278 participants aged 65 or older. The Geriatric Anxiety Inventory (GAI) was used to assess the anxiety. An in-","2021","07","21","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19 pandemic; anxiety; compulsory home-stay; elderly","Sirin","Hulya","Public Health Department, University of Health Sciences, Ankara, Turkey",NA
"2057","34231924","10.1002/gps.5600","Assessment of anxiety in elderly population during the COVID-19 pandemic and the impact of compulsory home-stay in the central districts of Ankara, Turkey: A quantitative, qualitative mixed method study.","This study aimed to determine the level of anxiety in elderly individuals during the COVID-19 pandemic in Ankara province of Turkey and determine its associated factors. A quantitative, qualitative mixed-method study performed in 1-10 June 2020 during the compulsory home-stay for elderly people in Turkey. The quantitative study was conducted using a structured online questionnaire with 278 participants aged 65 or older. The Geriatric Anxiety Inventory (GAI) was used to assess the anxiety. An in-","2021","07","21","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19 pandemic; anxiety; compulsory home-stay; elderly","Ahmadi","Ahmad Abed","Public Health Department, University of Health Sciences, Ankara, Turkey",NA
"2058","34231924","10.1002/gps.5600","Assessment of anxiety in elderly population during the COVID-19 pandemic and the impact of compulsory home-stay in the central districts of Ankara, Turkey: A quantitative, qualitative mixed method study.","This study aimed to determine the level of anxiety in elderly individuals during the COVID-19 pandemic in Ankara province of Turkey and determine its associated factors. A quantitative, qualitative mixed-method study performed in 1-10 June 2020 during the compulsory home-stay for elderly people in Turkey. The quantitative study was conducted using a structured online questionnaire with 278 participants aged 65 or older. The Geriatric Anxiety Inventory (GAI) was used to assess the anxiety. An in-","2021","07","21","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19 pandemic; anxiety; compulsory home-stay; elderly","Ketrez","Gamze","Public Health Department, University of Health Sciences, Ankara, Turkey",NA
"2059","34231924","10.1002/gps.5600","Assessment of anxiety in elderly population during the COVID-19 pandemic and the impact of compulsory home-stay in the central districts of Ankara, Turkey: A quantitative, qualitative mixed method study.","This study aimed to determine the level of anxiety in elderly individuals during the COVID-19 pandemic in Ankara province of Turkey and determine its associated factors. A quantitative, qualitative mixed-method study performed in 1-10 June 2020 during the compulsory home-stay for elderly people in Turkey. The quantitative study was conducted using a structured online questionnaire with 278 participants aged 65 or older. The Geriatric Anxiety Inventory (GAI) was used to assess the anxiety. An in-","2021","07","21","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19 pandemic; anxiety; compulsory home-stay; elderly","Ozbeyaz","Cagri","Public Health Department, University of Health Sciences, Ankara, Turkey",NA
"2060","34231924","10.1002/gps.5600","Assessment of anxiety in elderly population during the COVID-19 pandemic and the impact of compulsory home-stay in the central districts of Ankara, Turkey: A quantitative, qualitative mixed method study.","This study aimed to determine the level of anxiety in elderly individuals during the COVID-19 pandemic in Ankara province of Turkey and determine its associated factors. A quantitative, qualitative mixed-method study performed in 1-10 June 2020 during the compulsory home-stay for elderly people in Turkey. The quantitative study was conducted using a structured online questionnaire with 278 participants aged 65 or older. The Geriatric Anxiety Inventory (GAI) was used to assess the anxiety. An in-","2021","07","21","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19 pandemic; anxiety; compulsory home-stay; elderly","Dikmen","Asiye Ugras","Public Health Department, Gazi University, Ankara, Turkey",NA
"2061","34231924","10.1002/gps.5600","Assessment of anxiety in elderly population during the COVID-19 pandemic and the impact of compulsory home-stay in the central districts of Ankara, Turkey: A quantitative, qualitative mixed method study.","This study aimed to determine the level of anxiety in elderly individuals during the COVID-19 pandemic in Ankara province of Turkey and determine its associated factors. A quantitative, qualitative mixed-method study performed in 1-10 June 2020 during the compulsory home-stay for elderly people in Turkey. The quantitative study was conducted using a structured online questionnaire with 278 participants aged 65 or older. The Geriatric Anxiety Inventory (GAI) was used to assess the anxiety. An in-","2021","07","21","Int J Geriatr Psychiatry","International journal of geriatric psychiatry","COVID-19 pandemic; anxiety; compulsory home-stay; elderly","Ozkan","Secil","Public Health Department, Gazi University, Ankara, Turkey",NA
"2062","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Yu","Hui","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2063","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Zhou","Anqi","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2064","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Liu","Jiayi","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2065","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Tang","Yufei","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2066","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Yuan","Quan","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2067","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Man","Yi","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2068","34231923","10.1002/JLB.6MR0621-760RR","Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved.","As the most successful therapy for missing teeth, dental implant has become increasingly prevalent around the world. A lot of papers have reported diverse local risk factors affecting the success and survival rate of dental implants, either for a short or a long period. However, there are also many types of systemic disorders or relatively administrated medicine that may jeopardize the security and success of dental implant treatment. Additionally, the coronavirus disease 2019 pandemic also pose","2021","07","07","J Leukoc Biol","Journal of leukocyte biology","dental implant; systemic disorder risk factors; systemic medication risk factors; systemic risk factors","Xiang","Lin","State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China",NA
"2069","34231912","10.1002/jhbs.22097","Battling coronavirus and mental illness in South Korea.",NA,"2021","07","23","J Hist Behav Sci","Journal of the history of the behavioral sciences",NA,"Yoo","Theodore Jun","Department of Korean Language and Literature, Yonsei University, Seoul, South Korea",NA
"2070","34231909","10.1111/1468-5922.12687","Coronavirus: does its activation of archetypes of evil cause added psychological suffering?","Fear and grief caused by the pandemic have produced a powerful unconscious narrative in the collective psyche that the coronavirus is driven by an innately evil, and possibly divine, force. The resulting archetypal dimension of fear causes an extra layer of psychological suffering in individuals. This paper discusses how and why this narrative was created and why it is so compelling by looking at 1) the myth-making nature of the human psyche, 2) the psychodynamics of fear that drive the narrativ","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Archetypen; Biochemie; Coronavirus; Pandemie; Transzendente Funktion; archetipi; archetypes; archétypes; arquetipos; biochemistry; biochimica; biochimie; bioquímica; böse; coronavirus; evil; fonction transcendante; función trascendente; funzione trascendente; mal; male; pandemia; pandemic; pandémie; transcendent function; unus mundus; <U+0430><U+0440><U+0445><U+0435><U+0442><U+0438><U+043F><U+044B>; <U+0431><U+0438><U+043E><U+0445><U+0438><U+043C><U+0438><U+044F>; <U+0437><U+043B><U+043E>; <U+043A><U+043E><U+0440><U+043E><U+043D><U+0430><U+0432><U+0438><U+0440><U+0443><U+0441>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F>; <U+0442><U+0440><U+0430><U+043D><U+0441><U+0446><U+0435><U+043D><U+0434><U+0435><U+043D><U+0442><U+043D><U+0430><U+044F> <U+0444><U+0443><U+043D><U+043A><U+0446><U+0438><U+044F>; <U+4E00><U+5143><U+4E16><U+754C>; <U+539F><U+578B>; <U+65B0><U+51A0><U+75C5><U+6BD2>; <U+751F><U+7269><U+5316><U+5B66>; <U+75AB><U+60C5>; <U+8D85><U+8D8A><U+529F><U+80FD>; <U+90AA><U+6076>; Adult; COVID-19; Fear; Health Knowledge, Attitudes, Practice; Humans; Imagination; Psychological Trauma","van den Berg-Cook","Nancy","Zeist, The Netherlands",NA
"2071","34231908","10.1111/1468-5922.12688","Clinical experiences during the COVID-19 pandemic.","Most of the clinical experiences discussed in this article arose from monthly Zoom meetings at Rome's Italian Centre of Analytical Psychology (CIPA). We set up a discussion group in April 2020, one month after lockdown began in Italy, and these monthly online meetings continue to this day. All senior analysts and analysts-in-training at Rome's CIPA, whose backgrounds range from child and adolescent psychotherapy to adult psychotherapy and analysis, to sandplay therapy and medicine and psychiatry","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID-19 pandemic; COVID-19 pandemisch; COVID-19<U+65B0><U+51A0><U+75AB><U+60C5>; Dekonstruktion; Politik; Rekonstruktion; Religion; Wirtschaft; contagio emocional e infeccioso; contagio emotivo e infettivo; contagion émotionnelle infectieuse; deconstrucción; deconstruction; decostruzione; die Gegenwart; déconstruction; economia; economy; economía; el presente; emotional and infective contagion; emotionale und infektiöse Ansteckung; le présent; pandemia COVID-19; pandémie de COVID-19; politica; politics; politique; política; presente; reconstrucción; reconstruction; religion; religione; religión; ricostruzione; the present; économie; <U+0434><U+0435><U+043A><U+043E><U+043D><U+0441><U+0442><U+0440><U+0443><U+043A><U+0446><U+0438><U+044F>; <U+043D><U+0430><U+0441><U+0442><U+043E><U+044F><U+0449><U+0435><U+0435>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F> <U+043A><U+043E><U+0440><U+043E><U+043D><U+0430><U+0432><U+0438><U+0440><U+0443><U+0441><U+0430>; <U+043F><U+043E><U+043B><U+0438><U+0442><U+0438><U+043A><U+0430>; <U+0440><U+0435><U+043A><U+043E><U+043D><U+0441><U+0442><U+0440><U+0443><U+043A><U+0446><U+0438><U+044F>; <U+0440><U+0435><U+043B><U+0438><U+0433><U+0438><U+044F>; <U+044D><U+043A><U+043E><U+043D><U+043E><U+043C><U+0438><U+043A><U+0430>; <U+044D><U+043C><U+043E><U+0446><U+0438><U+043E><U+043D><U+0430><U+043B><U+044C><U+043D><U+043E><U+0435> <U+0438> <U+0438><U+043D><U+0444><U+0435><U+043A><U+0446><U+0438><U+043E><U+043D><U+043D><U+043E><U+0435> <U+0437><U+0430><U+0440><U+0430><U+0436><U+0435><U+043D><U+0438><U+0435>; <U+5B97><U+6559>; <U+5F53><U+4E0B>; <U+60C5><U+611F><U+4E0E><U+60C5><U+7EEA><U+7684><U+4F20><U+67D3>; <U+653F><U+7B56>; <U+7834><U+574F>; <U+7ECF><U+6D4E>; <U+91CD><U+5EFA>; Adult; COVID-19; Humans; Middle Aged; Personal Narratives as Topic; Physical Distancing; Professional-Patient Relations; Psychoanalytic Therapy; Rome; Telecommunications; Telemedicine; Young Adult","Agnello","Irene","Rome",NA
"2072","34231908","10.1111/1468-5922.12688","Clinical experiences during the COVID-19 pandemic.","Most of the clinical experiences discussed in this article arose from monthly Zoom meetings at Rome's Italian Centre of Analytical Psychology (CIPA). We set up a discussion group in April 2020, one month after lockdown began in Italy, and these monthly online meetings continue to this day. All senior analysts and analysts-in-training at Rome's CIPA, whose backgrounds range from child and adolescent psychotherapy to adult psychotherapy and analysis, to sandplay therapy and medicine and psychiatry","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID-19 pandemic; COVID-19 pandemisch; COVID-19<U+65B0><U+51A0><U+75AB><U+60C5>; Dekonstruktion; Politik; Rekonstruktion; Religion; Wirtschaft; contagio emocional e infeccioso; contagio emotivo e infettivo; contagion émotionnelle infectieuse; deconstrucción; deconstruction; decostruzione; die Gegenwart; déconstruction; economia; economy; economía; el presente; emotional and infective contagion; emotionale und infektiöse Ansteckung; le présent; pandemia COVID-19; pandémie de COVID-19; politica; politics; politique; política; presente; reconstrucción; reconstruction; religion; religione; religión; ricostruzione; the present; économie; <U+0434><U+0435><U+043A><U+043E><U+043D><U+0441><U+0442><U+0440><U+0443><U+043A><U+0446><U+0438><U+044F>; <U+043D><U+0430><U+0441><U+0442><U+043E><U+044F><U+0449><U+0435><U+0435>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F> <U+043A><U+043E><U+0440><U+043E><U+043D><U+0430><U+0432><U+0438><U+0440><U+0443><U+0441><U+0430>; <U+043F><U+043E><U+043B><U+0438><U+0442><U+0438><U+043A><U+0430>; <U+0440><U+0435><U+043A><U+043E><U+043D><U+0441><U+0442><U+0440><U+0443><U+043A><U+0446><U+0438><U+044F>; <U+0440><U+0435><U+043B><U+0438><U+0433><U+0438><U+044F>; <U+044D><U+043A><U+043E><U+043D><U+043E><U+043C><U+0438><U+043A><U+0430>; <U+044D><U+043C><U+043E><U+0446><U+0438><U+043E><U+043D><U+0430><U+043B><U+044C><U+043D><U+043E><U+0435> <U+0438> <U+0438><U+043D><U+0444><U+0435><U+043A><U+0446><U+0438><U+043E><U+043D><U+043D><U+043E><U+0435> <U+0437><U+0430><U+0440><U+0430><U+0436><U+0435><U+043D><U+0438><U+0435>; <U+5B97><U+6559>; <U+5F53><U+4E0B>; <U+60C5><U+611F><U+4E0E><U+60C5><U+7EEA><U+7684><U+4F20><U+67D3>; <U+653F><U+7B56>; <U+7834><U+574F>; <U+7ECF><U+6D4E>; <U+91CD><U+5EFA>; Adult; COVID-19; Humans; Middle Aged; Personal Narratives as Topic; Physical Distancing; Professional-Patient Relations; Psychoanalytic Therapy; Rome; Telecommunications; Telemedicine; Young Adult","Giubellini","Chiara","Rome",NA
"2073","34231907","10.1111/1468-5922.12689","The archetype of the apocalypse. Analysing the pandemics of racism, COVID-19 and climate change.","What we are witnessing in the present time in human history, in the 2020's, is a vortex of intersecting pandemics - jolting revelations that are unfolding with a terrific energy and force - so much so that we cannot ignore them or escape them. These include the world-wide pandemics of racism, COVID-19 and climate change. This paper argues that all of these swirling pandemics are manifestations of the archetype of the apocalypse, which is constellating now in a very powerful way. Any one of these","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Apokalypse; Archetyp; Enthüllung; Klimawandel; Rassenkomplex; Rassismus; apocalipsis; apocalisse; apocalypse; archetipo; archetype; archétype; arquetipo; cambiamento climatico; cambio climático; changement climatique; climate change; complejo racial; complesso razziale; complexe racial; pandemia; pandemic; pandémie; racial complex; racism; racisme; racismo; razzismo; revelación; revelation; rivelazione; révélation; <U+0430><U+043F><U+043E><U+043A><U+0430><U+043B><U+0438><U+043F><U+0441><U+0438><U+0441>; <U+0430><U+0440><U+0445><U+0435><U+0442><U+0438><U+043F>; <U+0438><U+0437><U+043C><U+0435><U+043D><U+0435><U+043D><U+0438><U+0435> <U+043A><U+043B><U+0438><U+043C><U+0430><U+0442><U+0430>; <U+043E><U+0442><U+043A><U+0440><U+043E><U+0432><U+0435><U+043D><U+0438><U+0435>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F>; <U+0440><U+0430><U+0441><U+0438><U+0437><U+043C>; <U+0440><U+0430><U+0441><U+043E><U+0432><U+044B><U+0439> <U+043A><U+043E><U+043C><U+043F><U+043B><U+0435><U+043A><U+0441>; <U+539F><U+578B>; <U+542F><U+793A><U+5F55>; <U+63ED><U+793A>; <U+65CF><U+60C5><U+7ED3>; <U+6C14><U+5019><U+53D8><U+5316>; <U+6D41><U+884C><U+75C5>; <U+79CD><U+65CF>; COVID-19; Climate Change; Enslavement; Homicide; Humans; Police; Political Activism; Psychoanalytic Theory; Racism; United States","Grevatt","William K","Los Angeles, USA",NA
"2074","34231904","10.1111/1468-5922.12682","COVID-19/Black Lives Matter.",NA,"2021","07","13","J Anal Psychol","The Journal of analytical psychology","African Americans; COVID-19; Humans; Political Activism; Racism","Dowd","Amanda",NA,NA
"2075","34231903","10.1111/1468-5922.12683","Working online due to the COVID-19 pandemic: a research and literature review.","Given the contemporary situation of many analysts in the world now being forced to work online due to the effects of the COVID-19 pandemic, it is important to review the working online issue. Substantial debate over previous years has questioned whether a genuine analytic process can unfold through online work. This debate is reviewed with the conclusion that such a process is not necessarily precluded. Research outcomes are then reviewed to highlight those things that can facilitate positive ou","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID-19; Enthemmung; Quarantäne; Selbstisolation; Teleanalyse; alianza terapéutica; alleanza terapeutica; alliance thérapeutique; auto-isolamento; auto-isolement; autoaislamiento; cuarentena; desinhibición; disinhibition; disinibizione; désinhibition; en ligne; online; quarantaine; quarantena; quarantine; self-isolation; tele-análisis; teleanalisi; teleanalysis; therapeutic alliance; therapeutische Allianz; télé-analyse; <U+043A><U+0430><U+0440><U+0430><U+043D><U+0442><U+0438><U+043D>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043E><U+043D><U+043B><U+0430><U+0439><U+043D>; <U+0440><U+0430><U+0441><U+0442><U+043E><U+0440><U+043C><U+043E><U+0436><U+0435><U+043D><U+043D><U+043E><U+0441><U+0442><U+044C>; <U+0441><U+0430><U+043C><U+043E><U+0438><U+0437><U+043E><U+043B><U+044F><U+0446><U+0438><U+044F>; <U+0442><U+0435><U+043B><U+0435><U+0430><U+043D><U+0430><U+043B><U+0438><U+0437>; <U+0442><U+0435><U+0440><U+0430><U+043F><U+0435><U+0432><U+0442><U+0438><U+0447><U+0435><U+0441><U+043A><U+0438><U+0439> <U+0430><U+043B><U+044C><U+044F><U+043D><U+0441>; <U+53BB><U+6291><U+5236><U+5316>; <U+6CBB><U+7597><U+8054><U+76DF>; <U+7EBF><U+4E0A>; <U+7EBF><U+4E0A><U+5206><U+6790>; <U+81EA><U+6211><U+5B64><U+7ACB>; <U+9694><U+79BB>; COVID-19; Humans; Physical Distancing; Psychoanalytic Therapy; Telecommunications; Telemedicine; Therapeutic Alliance","Merchant","John","Sydney, Australia",NA
"2076","34231901","10.1111/1468-5922.12674","Brazil: hate and intolerance in times of pandemic in a mixed-race country.","This paper intends to analyse the current political and social situation in Brazil and show how this context has influenced the management of the public health crisis generated by the COVID-19 pandemic. To this end, the authors conducted an investigation into Brazil's historical roots, which have not only engendered deep class differences but, also, social psychopathologies such as dissociation and perversion. Finally, this paper presents a symbolic analysis of social exclusion and how the mythi","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Brasil; Brasile; Brasilien; Brazil; Brésil; COVID-19; Inklusion; Narzißmus; Psychopathologie; gemischtrassig; inclusion; inclusione; inclusión; mezcla de razas; mixed-race; narcisismo; narcissism; narcissisme; population métissée; psicopatologia; psicopatología; psychopathologie; psychopathology; razza mista; <U+0411><U+0440><U+0430><U+0437><U+0438><U+043B><U+0438><U+044F>; <U+0432><U+043A><U+043B><U+044E><U+0447><U+0435><U+043D><U+0438><U+0435> (<U+0438><U+043D><U+043A><U+043B><U+044E><U+0437><U+0438><U+044F>); <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043D><U+0430><U+0440><U+0446><U+0438><U+0441><U+0441><U+0438><U+0437><U+043C>; <U+043F><U+0441><U+0438><U+0445><U+043E><U+043F><U+0430><U+0442><U+043E><U+043B><U+043E><U+0433><U+0438><U+044F>; <U+0441><U+043C><U+0435><U+0448><U+0430><U+043D><U+043D><U+0430><U+044F> <U+0440><U+0430><U+0441><U+0430>; <U+542B><U+7EB3>; <U+591A><U+6C11><U+65CF><U+6DF7><U+5408>; <U+5DF4><U+897F>; <U+5FC3><U+7406><U+75C5><U+7406>; <U+81EA><U+604B>; Brazil; COVID-19; Colonialism; Culture; Enslavement; Humans; Politics; Prejudice; Psychoanalytic Theory; Social Inclusion; Social Isolation","Gadotti","Claudia Morelli","São Paulo, Brazil",NA
"2077","34231901","10.1111/1468-5922.12674","Brazil: hate and intolerance in times of pandemic in a mixed-race country.","This paper intends to analyse the current political and social situation in Brazil and show how this context has influenced the management of the public health crisis generated by the COVID-19 pandemic. To this end, the authors conducted an investigation into Brazil's historical roots, which have not only engendered deep class differences but, also, social psychopathologies such as dissociation and perversion. Finally, this paper presents a symbolic analysis of social exclusion and how the mythi","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Brasil; Brasile; Brasilien; Brazil; Brésil; COVID-19; Inklusion; Narzißmus; Psychopathologie; gemischtrassig; inclusion; inclusione; inclusión; mezcla de razas; mixed-race; narcisismo; narcissism; narcissisme; population métissée; psicopatologia; psicopatología; psychopathologie; psychopathology; razza mista; <U+0411><U+0440><U+0430><U+0437><U+0438><U+043B><U+0438><U+044F>; <U+0432><U+043A><U+043B><U+044E><U+0447><U+0435><U+043D><U+0438><U+0435> (<U+0438><U+043D><U+043A><U+043B><U+044E><U+0437><U+0438><U+044F>); <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043D><U+0430><U+0440><U+0446><U+0438><U+0441><U+0441><U+0438><U+0437><U+043C>; <U+043F><U+0441><U+0438><U+0445><U+043E><U+043F><U+0430><U+0442><U+043E><U+043B><U+043E><U+0433><U+0438><U+044F>; <U+0441><U+043C><U+0435><U+0448><U+0430><U+043D><U+043D><U+0430><U+044F> <U+0440><U+0430><U+0441><U+0430>; <U+542B><U+7EB3>; <U+591A><U+6C11><U+65CF><U+6DF7><U+5408>; <U+5DF4><U+897F>; <U+5FC3><U+7406><U+75C5><U+7406>; <U+81EA><U+604B>; Brazil; COVID-19; Colonialism; Culture; Enslavement; Humans; Politics; Prejudice; Psychoanalytic Theory; Social Inclusion; Social Isolation","Valente","Vera Lucia Colson","São Paulo, Brazil",NA
"2078","34231900","10.1111/1468-5922.12697","Intersections of personal vs. collective trauma during the COVID-19 pandemic: the hijacking of the human imagination.","This paper explores how the deadly shadow of COVID-19 passing over the Earth constitutes a collective trauma that frequently opens up or 'triggers' un-remembered personal trauma, and it provides clinical examples of these intersections. The paper further explores how the human imagination, which we normally utilize to make meaning out of traumatic experience, can be hijacked by fear - leading to avoidance of suffering and to illusory formulations and alternative realities such as conspiracy theo","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Black Lives Matter; COVID-19; Coronavirus; Verleugnung des Todes; Verschwörungstheorien; collective trauma; conspiracy theories; denial of death; déni de la mort; kollektives Trauma; negación de la muerte; negazione della morte; teorie della cospirazione; teorías conspirativas; théories du complot; trauma colectivo; trauma collettivo; traumatisme collectif; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043A><U+043E><U+043B><U+043B><U+0435><U+043A><U+0442><U+0438><U+0432><U+043D><U+0430><U+044F> <U+0442><U+0440><U+0430><U+0432><U+043C><U+0430>; <U+043E><U+0442><U+0440><U+0438><U+0446><U+0430><U+043D><U+0438><U+0435> <U+0441><U+043C><U+0435><U+0440><U+0442><U+0438>; <U+0442><U+0435><U+043E><U+0440><U+0438><U+0438> <U+0437><U+0430><U+0433><U+043E><U+0432><U+043E><U+0440><U+0430>; <U+5BF9><U+6B7B><U+4EA1><U+7684><U+5426><U+8BA4>; <U+65B0><U+51A0><U+75C5><U+6BD2>; <U+9634><U+8C0B><U+8BBA>; <U+96C6><U+4F53><U+521B><U+4F24>; <U+9ED1><U+4EBA><U+751F><U+547D><U+91CD><U+8981>; Adult; COVID-19; Fear; Humans; Imagination; Political Activism; Professional-Patient Relations; Psychoanalytic Therapy; Psychological Trauma; Racism; Telemedicine","Kalsched","Donald","Santa Fe, USA",NA
"2079","34231899","10.1111/1468-5922.12675","George Floyd's death and COVID-19: inflection points in the Anthropocene Era?","George Floyd's death, the COVID-19 pandemic and climate change are on a continuum from the immediate shock of viewing a video-recorded murder, to millions dying worldwide from disease, to deaths related to climate change accumulating over a millennium. They participate in the powerful archetypes of death and inequality. 'Increase', Hexagram 42 in the I Ching, archetypically addresses inequalities at all levels - racial, economic, political and the profound imbalance between humans and the enviro","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Analytische Psychologie; COVID-19; Jung; Kultur; Schatten; analytical psychology; archetipico; archetypal; archetypisch; archétypal; arquetípico; cultura; culture; ombra; ombre; psicologia analitica; psicología analítica; psychologie analytique; shadow; sombra; <U+042E><U+043D><U+0433>; <U+0430><U+043D><U+0430><U+043B><U+0438><U+0442><U+0438><U+0447><U+0435><U+0441><U+043A><U+0430><U+044F> <U+043F><U+0441><U+0438><U+0445><U+043E><U+043B><U+043E><U+0433><U+0438><U+044F>; <U+0430><U+0440><U+0445><U+0435><U+0442><U+0438><U+043F><U+0438><U+0447><U+0435><U+0441><U+043A><U+043E><U+0435>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043A><U+0443><U+043B><U+044C><U+0442><U+0443><U+0440><U+0430>; <U+0442><U+0435><U+043D><U+044C>; <U+5206><U+6790><U+5FC3><U+7406><U+5B66>; <U+539F><U+578B>; <U+6587><U+5316>; <U+8363><U+683C>; <U+9634><U+5F71>; COVID-19; Homicide; Humans; Police; Psychoanalytic Theory; Racism; Socioeconomic Factors; United States","Merritt","Dennis","Milwaukee, Wisconsin",NA
"2080","34231897","10.1111/1468-5922.12676","Archetypes of the pandemic.","This paper attempts to read the psychological and emotional impact of the COVID-19 pandemic through the archetypal images contained in patients' dreams. In these dreams, symbols related to the power of nature and to extreme danger are paired with feelings of detachment that seem to point to a traumatic dissociation, due to the archetypal experience that erupts in familiar surroundings. Through the humanization of the ineffable experience, dissociation, which in the beginning of the pandemic show","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Archetyp; Dissoziation; Distanzierung; Gefühle; Heimat; Natur; Pandemie; Trauma; Träume; archetipo; archetype; archétype; arquetipo; au-delà; beyond; casa; chez-soi; desapego; detachment; disociación; dissociation; dissociazione; distacco; dreams; détachement; feelings; home; más-allá-de; natura; naturaleza; nature; oltre; pandemia; pandemic; pandémie; rêves; sentimenti; sentiments; sentimientos; sogni; sueños; trauma; traumatisme; <U+0430><U+0440><U+0445><U+0435><U+0442><U+0438><U+043F>; <U+0434><U+0438><U+0441><U+0441><U+043E><U+0446><U+0438><U+0430><U+0446><U+0438><U+044F>; <U+0434><U+043E><U+043C>; <U+0437><U+0430> <U+043F><U+0440><U+0435><U+0434><U+0435><U+043B><U+0430><U+043C><U+0438>; <U+043E><U+0442><U+0447><U+0443><U+0436><U+0434><U+0435><U+043D><U+043D><U+043E><U+0441><U+0442><U+044C>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F>; <U+043F><U+0440><U+0438><U+0440><U+043E><U+0434><U+0430>; <U+0441><U+043D><U+043E><U+0432><U+0438><U+0434><U+0435><U+043D><U+0438><U+044F>; <U+0442><U+0440><U+0430><U+0432><U+043C><U+0430>; <U+0447><U+0443><U+0432><U+0441><U+0442><U+0432><U+0430>; <U+539F><U+578B><U+3001><U+8D85><U+8D8A><U+3001><U+5265><U+79BB><U+3001><U+89E3><U+79BB><U+3001><U+68A6><U+3001><U+611F><U+53D7><U+3001><U+5BB6><U+3001><U+81EA><U+7136><U+3001><U+75AB><U+60C5><U+3001><U+521B><U+4F24>; Adult; COVID-19; Dreams; Humans; Professional-Patient Relations; Psychoanalytic Interpretation; Psychoanalytic Therapy; Psychotherapeutic Processes","Sacco German","Betty","Switzerland",NA
"2081","34231896","10.1111/1468-5922.12677","Reflections on a wounded and bleeding temenos.","COVID-19, Black Lives Matter, and financial and political turmoil have uprooted our sense of personal and collective safety and predictability. Analysts are faced with professional and personal challenges, as well as a charge to help make sense of this new normal. This reflective piece focuses on the author's thoughts on a wounded and bleeding temenos. She grapples with the new reality of analysis carried out via technology (e.g. Zoom or telehealth). The article interweaves personal experiences ","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID-19; Chassidic stories; Telemedizin; Temenos; Träume; Wandel; Zoom; chassidische Geschichten; contes hassidiques; destructif; destructive; destructivo; distruttivo; dreams; espace thérapeutique; espacio terapéutico; historias Jasídicas; rêves; sogni; spazio terapeutico; storie chassidiche; sueños; telehealth; telesalud; telesalute; temenos; therapeutic space; therapeutischer Raum; transformación; transformation; transformazione; téménos; zerstörerisch; <U+0434><U+0435><U+0441><U+0442><U+0440><U+0443><U+043A><U+0442><U+0438><U+0432><U+043D><U+043E><U+0435>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+0441><U+043D><U+043E><U+0432><U+0438><U+0434><U+0435><U+043D><U+0438><U+044F>; <U+0442><U+0435><U+043C><U+0435><U+043D><U+043E><U+0441>; <U+0442><U+0435><U+0440><U+0430><U+043F><U+0435><U+0432><U+0442><U+0438><U+0447><U+0435><U+0441><U+043A><U+043E><U+0435> <U+043F><U+0440><U+043E><U+0441><U+0442><U+0440><U+0430><U+043D><U+0441><U+0442><U+0432><U+043E>; <U+0442><U+0440><U+0430><U+043D><U+0441><U+0444><U+043E><U+0440><U+043C><U+0430><U+0446><U+0438><U+044F>; <U+0445><U+0430><U+0441><U+0441><U+0438><U+0434><U+0441><U+043A><U+0438><U+0435> <U+043F><U+0440><U+0438><U+0442><U+0447><U+0438>; <U+5FD2><U+58A8><U+8BFA><U+65AF>; <U+68A6>; <U+6CBB><U+7597><U+7A7A><U+95F4>; <U+72B9><U+592A><U+6559><U+6545><U+4E8B>; <U+7834><U+574F><U+6027>; <U+8F6C><U+5316>; Adult; COVID-19; Humans; Judaism; Psychoanalytic Therapy; Religion and Psychology; Telemedicine","Zeiger","Robin B","Israel",NA
"2082","34231895","10.1111/1468-5922.12678","Adolescents coping with the COVID-19 pandemic: 'every day is like another Sunday'.","COVID-19 has upended the way analysts and psychotherapists practice. Many use the phone for their sessions, many are using video platforms, and many use a combination of the two. Work with adolescents is very challenging in this new modality because of the loss of in-person connection and immediate non-verbal cues. The public health restrictions put in place to manage COVID-19 spread are at odds with the adolescent tasks of adventuring, experimenting and gaining new experiences. In addition, inc","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Adoleszenz; Bewältigung; Bion; COVID-19; adolescence; adolescencia; adolescenza; afrontamiento; coping; faire face; gestione; terapia virtual; terapia virtuale; thérapie virtuelle; virtual therapy; virtuelle Therapie; <U+0411><U+0438><U+043E><U+043D>; <U+0432><U+0438><U+0440><U+0442><U+0443><U+0430><U+043B><U+044C><U+043D><U+0430><U+044F> <U+0442><U+0435><U+0440><U+0430><U+043F><U+0438><U+044F>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043A><U+043E><U+043F><U+0438><U+043D><U+0433>; <U+043F><U+043E><U+0434><U+0440><U+043E><U+0441><U+0442><U+043A><U+043E><U+0432><U+044B><U+0439> <U+0432><U+043E><U+0437><U+0440><U+0430><U+0441><U+0442>; <U+5E94><U+5BF9>; <U+6BD4><U+6602>; <U+865A><U+62DF><U+6CBB><U+7597>; <U+9752><U+5C11><U+5E74>; Adaptation, Psychological; Adolescent; Adolescent Behavior; COVID-19; Humans; Male; Professional-Patient Relations; Psychoanalytic Therapy; Telemedicine","Tyminski","Robert","San Francisco",NA
"2083","34231894","10.1111/1468-5922.12679","Together - apart: in touch in a time of separation.","This paper explores the experience of working as a Jungian analyst through the various phases of the global COVID-19 pandemic, examining the importance of the physical containing space alongside the analyst's internal mind and how technology can both help and hinder understanding. A number of clinical vignettes illustrate the challenge of communicating over a distance, paying particular attention to the way countertransference phenomena can become re-attuned. Reference is made to mythology and s","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Abstand; COVID-19; Hoffnung; Pandemie; Separation; Technologie; distance; distancia; distanza; en ligne; esperanza; espoir; hope; online; pandemia; pandemic; pandémie; separación; separation; separazione; speranza; séparation; technologie; technology; tecnologia; tecnología; <U+041A><U+043E><U+0432><U+0438><U+0434>-19; <U+043D><U+0430><U+0434><U+0435><U+0436><U+0434><U+0430>; <U+043E><U+043D><U+043B><U+0430><U+0439><U+043D>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F>; <U+0440><U+0430><U+0441><U+0441><U+0442><U+043E><U+044F><U+043D><U+0438><U+0435>; <U+0441><U+0435><U+043F><U+0430><U+0440><U+0430><U+0446><U+0438><U+044F>; <U+0442><U+0435><U+0445><U+043D><U+043E><U+043B><U+043E><U+0433><U+0438><U+0438>; <U+5206><U+79BB>; <U+5E0C><U+671B>; <U+6280><U+672F>; <U+75AB><U+60C5>; <U+7EBF><U+4E0A>; <U+8DDD><U+79BB>; Adult; COVID-19; Countertransference; Humans; Jungian Theory; Physical Distancing; Professional-Patient Relations; Psychoanalytic Therapy; Telemedicine","Mathew","Marilyn A F","London",NA
"2084","34231893","10.1111/1468-5922.12690","Essential anxiety: COVID-19 in analytic practice.","This paper explores the impact of the COVID-19 pandemic on my relationship with analysands and my inner world. I reflect on the role of the archetypal Self during times of existential anxiety that may lead to an experience of 'essential anxiety'. This term refers to a meeting by a fearful ego with an inward recognition of the Self, when faced with threat. The efforts to curb the spread of the pandemic changed our ways of life, while the virus itself threatened our existence in debilitating or ou","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID-19; Individuation; Jung; Jungianische Online-Analyse; Körper als Container; Online-Arbeit; Soi archétypal; Sé archetipico; Sí MIsmo arquetípico; Träume; analisi junghiana online; analyse Jungienne en ligne; analyse en ligne; angoisse; angoisse essentielle; angoisse existentielle; angoscia; angoscia esistenziale; angoscia essenziale; ansiedad; ansiedad esencial; ansiedad existencial; anxiety; análisis Junguiano online; archetypal Self; archetypisches Selbst; body-as-container; corpo come contenitore; cuerpo-como-contenedor; dreams; espiritual; essential anxiety; essentielle Angst; existential anxiety; individuación; individuation; individuazione; lavoro online; le corps en tant que contenant; on-line Jungian analysis; on-line work; rêves; sogni; spiritual; spirituale; spirituel; spirituell; sueños; trabajo online; Ängstlichkeit; <U+042E><U+043D><U+0433>; <U+0430><U+0440><U+0445><U+0435><U+0442><U+0438><U+043F><U+0438><U+0447><U+0435><U+0441><U+043A><U+0430><U+044F> <U+0421><U+0430><U+043C><U+043E><U+0441><U+0442><U+044C>; <U+0434><U+0443><U+0445><U+043E><U+0432><U+043D><U+043E><U+0435>; <U+0438><U+043D><U+0434><U+0438><U+0432><U+0438><U+0434><U+0443><U+0430><U+0446><U+0438><U+044F>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043E><U+043D><U+043B><U+0430><U+0439><U+043D> <U+0430><U+043D><U+0430><U+043B><U+0438><U+0437>; <U+043E><U+043D><U+043B><U+0430><U+0439><U+043D> <U+0440><U+0430><U+0431><U+043E><U+0442><U+0430>; <U+0441><U+043D><U+043E><U+0432><U+0438><U+0434><U+0435><U+043D><U+0438><U+044F>; <U+0441><U+0443><U+0449><U+043D><U+043E><U+0441><U+0442><U+043D><U+0430><U+044F> <U+0442><U+0440><U+0435><U+0432><U+043E><U+0433><U+0430>; <U+0442><U+0435><U+043B><U+043E> <U+043A><U+0430><U+043A> <U+043A><U+043E><U+043D><U+0442><U+0435><U+0439><U+043D><U+0435><U+0440>; <U+0442><U+0440><U+0435><U+0432><U+043E><U+0433><U+0430>; <U+044D><U+043A><U+0437><U+0438><U+0441><U+0442><U+0435><U+043D><U+0446><U+0438><U+0430><U+043B><U+044C><U+043D><U+0430><U+044F> <U+0442><U+0440><U+0435><U+0432><U+043E><U+0433><U+0430>; <U+539F><U+578B>; <U+5728><U+7EBF><U+8363><U+683C><U+5206><U+6790>; <U+57FA><U+672C><U+7126><U+8651>; <U+5B58><U+5728><U+7126><U+8651>; <U+68A6>; <U+7075><U+6027>; <U+7126><U+8651>; <U+7EBF><U+4E0A><U+5DE5><U+4F5C>; <U+81EA><U+6027>; <U+81EA><U+6027><U+5316>; <U+8363><U+683C>; <U+8EAB><U+4F53><U+5BB9><U+5668>; Adult; Anxiety; COVID-19; Health Personnel; Humans; Individuation; Jungian Theory; Professional-Patient Relations; Psychoanalytic Therapy; Self-Control; Switzerland; Telemedicine","Schellinski","Kristina","Geneva, Switzerland",NA
"2085","34231891","10.1111/1468-5922.12692","Things fall apart. The cultural complex in contemporary times<sup>1</sup>.","These extraordinary months due to COVID-19 and the Black Lives Matter protests, set as they are against a backdrop of the increasingly worrying climate emergency, have brought fear, anxiety and discord across the globe. But we have also experienced a deepening of our understanding of our connectedness, protests against injustice, expressions of social concern and a demand for change. The concept of the cultural complex as developed by Singer &amp; Kimbles (2004) offers a helpful means of connect","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Black Lives Matter; Klimakatastrophe; Kultureller Komplex; Rassismus; Weißsein; blancheur de peau; climate emergency; complejo cultural; complesso culturale; complexe culturel; cultural complex; emergencia climática; emergenza climatica; essere bianchi; lo blanco; racism; racisme; racismo; razzismo; urgence climatique; whiteness; <U+0431><U+0435><U+043B><U+044B><U+0435>; <U+043A><U+043B><U+0438><U+043C><U+0430><U+0442><U+0438><U+0447><U+0435><U+0441><U+043A><U+0430><U+044F> <U+0447><U+0440><U+0435><U+0437><U+0432><U+044B><U+0447><U+0430><U+0439><U+043D><U+0430><U+044F> <U+0441><U+0438><U+0442><U+0443><U+0430><U+0446><U+0438><U+044F>; <U+043A><U+0443><U+043B><U+044C><U+0442><U+0443><U+0440><U+043D><U+044B><U+0439> <U+043A><U+043E><U+043C><U+043F><U+043B><U+0435><U+043A><U+0441>; <U+0440><U+0430><U+0441><U+0438><U+0437><U+043C>; <U+6587><U+5316><U+60C5><U+7ED3>; <U+6C14><U+5019><U+5371><U+673A>; <U+767D><U+4EBA>; <U+79CD><U+65CF><U+4E3B><U+4E49>; <U+9ED1><U+4EBA><U+751F><U+547D><U+91CD><U+8981>; Adult; African Americans; COVID-19; England; Humans; Political Activism; Racism; Unconscious, Psychology","Morgan","Helen","London, UK",NA
"2086","34231889","10.1111/1468-5922.12672","Dreams and COVID-19.","This work originates from reflections on the observation of recurring themes in dreams of patients in psychoanalytic treatment during the most restrictive lockdown period in Italy (March - May 2020). The authors focus on the peculiar dialogic state between consciousness and the unconscious that arose following a collective event such as that of the pandemic, which determined the activation of complex personal nuclei, compensatory effects of the unconscious psyche and new perspective functions. T","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Ansteckung; COVID-19; Neumann; Traum; Trauma; collective unconscious; contagio; contagion; dream; inconscient collectif; inconscient individuel; inconsciente colectivo; inconsciente individual; inconscio collettivo; inconscio personale; individual unconscious; individuell unbewußt; kollektiv unbewußt; rêve; sogno; sueño; trauma; traumatisme; <U+041D><U+043E><U+0439><U+043C><U+0430><U+043D><U+043D>; <U+0438><U+043D><U+0434><U+0438><U+0432><U+0438><U+0434><U+0443><U+0430><U+043B><U+044C><U+043D><U+043E><U+0435> <U+0431><U+0435><U+0441><U+0441><U+043E><U+0437><U+043D><U+0430><U+0442><U+0435><U+043B><U+044C><U+043D><U+043E><U+0435>; <U+0438><U+043D><U+0444><U+0435><U+043A><U+0446><U+0438><U+044F>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043A><U+043E><U+043B><U+043B><U+0435><U+043A><U+0442><U+0438><U+0432><U+043D><U+043E><U+0435> <U+0431><U+0435><U+0441><U+0441><U+043E><U+0437><U+043D><U+0430><U+0442><U+0435><U+043B><U+044C><U+043D><U+043E><U+0435>; <U+0441><U+043D><U+043E><U+0432><U+0438><U+0434><U+0435><U+043D><U+0438><U+0435>; <U+0442><U+0440><U+0430><U+0432><U+043C><U+0430>; <U+4E2A><U+4F53><U+65E0><U+610F><U+8BC6>; <U+4F20><U+67D3>; <U+521B><U+4F24>; <U+68A6>; <U+8BFA><U+4F0A><U+66FC>; <U+96C6><U+4F53><U+65E0><U+610F><U+8BC6>; Adult; COVID-19; Dreams; Humans; Italy; Physical Distancing; Psychoanalytic Interpretation; Psychoanalytic Therapy; Telemedicine; Unconscious, Psychology","Di Renzo","Magda","Rome, Italy",NA
"2087","34231889","10.1111/1468-5922.12672","Dreams and COVID-19.","This work originates from reflections on the observation of recurring themes in dreams of patients in psychoanalytic treatment during the most restrictive lockdown period in Italy (March - May 2020). The authors focus on the peculiar dialogic state between consciousness and the unconscious that arose following a collective event such as that of the pandemic, which determined the activation of complex personal nuclei, compensatory effects of the unconscious psyche and new perspective functions. T","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Ansteckung; COVID-19; Neumann; Traum; Trauma; collective unconscious; contagio; contagion; dream; inconscient collectif; inconscient individuel; inconsciente colectivo; inconsciente individual; inconscio collettivo; inconscio personale; individual unconscious; individuell unbewußt; kollektiv unbewußt; rêve; sogno; sueño; trauma; traumatisme; <U+041D><U+043E><U+0439><U+043C><U+0430><U+043D><U+043D>; <U+0438><U+043D><U+0434><U+0438><U+0432><U+0438><U+0434><U+0443><U+0430><U+043B><U+044C><U+043D><U+043E><U+0435> <U+0431><U+0435><U+0441><U+0441><U+043E><U+0437><U+043D><U+0430><U+0442><U+0435><U+043B><U+044C><U+043D><U+043E><U+0435>; <U+0438><U+043D><U+0444><U+0435><U+043A><U+0446><U+0438><U+044F>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043A><U+043E><U+043B><U+043B><U+0435><U+043A><U+0442><U+0438><U+0432><U+043D><U+043E><U+0435> <U+0431><U+0435><U+0441><U+0441><U+043E><U+0437><U+043D><U+0430><U+0442><U+0435><U+043B><U+044C><U+043D><U+043E><U+0435>; <U+0441><U+043D><U+043E><U+0432><U+0438><U+0434><U+0435><U+043D><U+0438><U+0435>; <U+0442><U+0440><U+0430><U+0432><U+043C><U+0430>; <U+4E2A><U+4F53><U+65E0><U+610F><U+8BC6>; <U+4F20><U+67D3>; <U+521B><U+4F24>; <U+68A6>; <U+8BFA><U+4F0A><U+66FC>; <U+96C6><U+4F53><U+65E0><U+610F><U+8BC6>; Adult; COVID-19; Dreams; Humans; Italy; Physical Distancing; Psychoanalytic Interpretation; Psychoanalytic Therapy; Telemedicine; Unconscious, Psychology","Tagliacozzi","Bruno","Rome, Italy",NA
"2088","34231888","10.1111/1468-5922.12694","Art in support of life: Caravaggio and the plague.","In the struggle with COVID-19, art offered a way to face the solitude of the lockdown. The focus of this paper is primarily on Caravaggio's painting The Seven Works of Mercy, with references to other paintings to amplify some aspects of the artist's approach to life and his uniqueness in the artistic landscape of his time. Darkness was part of Caravaggio's research for spiritual truth and by entering the stories of his life and exploring the tales told through imaginative expression in his paint","2021","07","13","J Anal Psychol","The Journal of analytical psychology","Aktive Imagination; Barmherzigkeit; COVID-19; Caravaggio; Dunkelheit; Jung; Le Caravage; Manierismo; Manierismus; Maniérisme; Mannerism; Pandemie; Realism; Realismo; Realismus; Réalisme; buio; compasión; compassion; darkness; forethought; manierismo; mercy; misericordia; noirceur; oscuridad; pandemia; pandemic; pandémie; pensiero anticipatorio; premeditación; prévoyance; realismo; <U+041A><U+0430><U+0440><U+0430><U+0432><U+0430><U+0434><U+0436><U+043E>; <U+041A><U+043E><U+0432><U+0438><U+0434>-19; <U+042E><U+043D><U+0433>; <U+043C><U+0430><U+043D><U+044C><U+0435><U+0440><U+0438><U+0437><U+043C>; <U+043C><U+0438><U+043B><U+043E><U+0441><U+0435><U+0440><U+0434><U+0438><U+0435>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F>; <U+043F><U+0440><U+0435><U+0434><U+0443><U+0441><U+043C><U+043E><U+0442><U+0440><U+0438><U+0442><U+0435><U+043B><U+044C><U+043D><U+043E><U+0441><U+0442><U+044C>; <U+0440><U+0435><U+0430><U+043B><U+0438><U+0437><U+043C>; <U+0442><U+044C><U+043C><U+0430>; <U+5361><U+74E6><U+62C9><U+4E54>, <U+8363><U+683C>, <U+65B0><U+51A0>, <U+5584><U+884C>, <U+75AB><U+60C5>, <U+602A><U+7656>, <U+73B0><U+5B9E><U+4E3B><U+4E49>, <U+9ED1><U+6697>, <U+6DF1><U+8C0B><U+8FDC><U+8651>; COVID-19; History, 16th Century; History, 17th Century; History, 21st Century; Humans; Paintings; Plague; Religion and Psychology","Vezzoli","Caterina","Milan, Italy",NA
"2089","34231887","10.1111/1468-5922.12695","Processing trauma in psychoanalysis in 'real' time and in dreams: the convergence of past, present and future during COVID-19.","In the current collective unrest, we and our analysands are living in real time and need vantage points from which to make meaning, as subjective experience of time is collapsing. For many analysands, the past is being relived in the present, with no imaginable future. During the time of COVID-19, dreams are providing a valuable mechanism in working with atemporal emotional trauma, previously uncontextualized. Dream metaphor can provide a transitional space to move around in within the analytic ","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID; COVID-19; Covid; Psychoanalyse; Trauma; Träume; dreams; psicoanalisi; psicoanálisis; psychanalyse; psychoanalysis; rêves; sogni; sueños; trauma; traumatisme; <U+043A><U+043E><U+0432><U+0438><U+0434>; <U+043F><U+0441><U+0438><U+0445><U+043E><U+0430><U+043D><U+0430><U+043B><U+0438><U+0437>; <U+0441><U+043D><U+043E><U+0432><U+0438><U+0434><U+0435><U+043D><U+0438><U+044F>; <U+0442><U+0440><U+0430><U+0432><U+043C><U+0430>; <U+521B><U+4F24>; <U+5FC3><U+7406><U+5206><U+6790>; <U+65B0><U+51A0>; <U+68A6>; Adult; COVID-19; Dreams; Humans; Psychoanalytic Interpretation; Psychoanalytic Therapy; Psychological Trauma","Bryon","Deborah","Denver, USA",NA
"2090","34231886","10.1111/1468-5922.12673","COVID-19, precarity and loneliness.","In this paper I discuss Jungian psychological work of the trauma and loss experienced in reaction to COVID-19 with a man who represents a clinical composite. The issues of precarity, a concept used by the philosopher Judith Butler, are combined with the notions of lack and absence of French psychoanalyst André Green. The psychological and societal situation of precarity aroused the man's childhood issues that were long repressed. The loneliness, isolation and death from COVID-19 mirrored his per","2021","07","13","J Anal Psychol","The Journal of analytical psychology","COVID-19; Einsamkeit; Trauer; Trauma; Unsicherheit; dolor; dolore; douleur; global pandemic; globale Pandemie; grief; loneliness; pandemia global; pandemia globale; pandémie globale; precariedad; precarietà; precarity; précarité; soledad; solitude; solitudine; trauma; traumatisme; <U+0433><U+043E><U+0440><U+0435>; <U+043A><U+043E><U+0432><U+0438><U+0434>-19; <U+043D><U+0435><U+0441><U+0442><U+0430><U+0431><U+0438><U+043B><U+044C><U+043D><U+043E><U+0441><U+0442><U+044C>; <U+043E><U+0434><U+0438><U+043D><U+043E><U+0447><U+0435><U+0441><U+0442><U+0432><U+043E>; <U+043F><U+0430><U+043D><U+0434><U+0435><U+043C><U+0438><U+044F>; <U+0442><U+0440><U+0430><U+0432><U+043C><U+0430>; <U+5168><U+7403><U+75AB><U+60C5>; <U+521B><U+4F24>; <U+52A8><U+8361>; <U+54C0><U+4F24>; <U+5B64><U+72EC>; Adult; Adverse Childhood Experiences; COVID-19; Ego; Humans; Jungian Theory; Loneliness; Male; Psychoanalytic Therapy; Psychological Trauma; Telecommunications; Telemedicine","Schwartz","Susan","Arizona, USA",NA
"2091","34231871","10.33963/KP.a2021.0056","Recurrent pulmonary embolism in patient after COVID-19 treated with percutaneous and surgical approach.",NA,"2021","07","07","Kardiol Pol","Kardiologia polska",NA,"Kosiorek","Aneta","Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. anetakosiorek7@gmail","anetakosiorek7@gmail.com"
"2092","34231871","10.33963/KP.a2021.0056","Recurrent pulmonary embolism in patient after COVID-19 treated with percutaneous and surgical approach.",NA,"2021","07","07","Kardiol Pol","Kardiologia polska",NA,"Kosowski","Michal","Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland",NA
"2093","34231871","10.33963/KP.a2021.0056","Recurrent pulmonary embolism in patient after COVID-19 treated with percutaneous and surgical approach.",NA,"2021","07","07","Kardiol Pol","Kardiologia polska",NA,"Reczuch","Krzysztof","Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland",NA
"2094","34231871","10.33963/KP.a2021.0056","Recurrent pulmonary embolism in patient after COVID-19 treated with percutaneous and surgical approach.",NA,"2021","07","07","Kardiol Pol","Kardiologia polska",NA,"Zymlinski","Robert","Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland",NA
"2095","34231871","10.33963/KP.a2021.0056","Recurrent pulmonary embolism in patient after COVID-19 treated with percutaneous and surgical approach.",NA,"2021","07","07","Kardiol Pol","Kardiologia polska",NA,"Kuliczkowski","Wiktor","Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland",NA
"2096","34231858","","[Clozapine treatment and COVID-19: continue despite leukocytopenia and increase of clozapine serum levels].","Clozapine is an antipsychotic with clozapine-induced agranulocytosis (CIA) as a rare, but potentially life-threatening side-effect, for which the white blood cell count and absolute neutrophil count are routinely monitored. Observed leukopenia may lead to more frequent monitoring, or even acute discontinuation of clozapine treatment. COVID-19 may cause deviating blood parameters such as leukopenia, and more exceptionally even granulocytopenia, just as clozapine does. In case of a SARS-CoV-2 infe","2021","07","08","Tijdschr Psychiatr","Tijdschrift voor psychiatrie","Antipsychotic Agents; COVID-19; Clozapine; Humans; Leukopenia; SARS-CoV-2; Schizophrenia","Smits","F",NA,NA
"2097","34231858","","[Clozapine treatment and COVID-19: continue despite leukocytopenia and increase of clozapine serum levels].","Clozapine is an antipsychotic with clozapine-induced agranulocytosis (CIA) as a rare, but potentially life-threatening side-effect, for which the white blood cell count and absolute neutrophil count are routinely monitored. Observed leukopenia may lead to more frequent monitoring, or even acute discontinuation of clozapine treatment. COVID-19 may cause deviating blood parameters such as leukopenia, and more exceptionally even granulocytopenia, just as clozapine does. In case of a SARS-CoV-2 infe","2021","07","08","Tijdschr Psychiatr","Tijdschrift voor psychiatrie","Antipsychotic Agents; COVID-19; Clozapine; Humans; Leukopenia; SARS-CoV-2; Schizophrenia","Bogers","J P A M",NA,NA
"2098","34231858","","[Clozapine treatment and COVID-19: continue despite leukocytopenia and increase of clozapine serum levels].","Clozapine is an antipsychotic with clozapine-induced agranulocytosis (CIA) as a rare, but potentially life-threatening side-effect, for which the white blood cell count and absolute neutrophil count are routinely monitored. Observed leukopenia may lead to more frequent monitoring, or even acute discontinuation of clozapine treatment. COVID-19 may cause deviating blood parameters such as leukopenia, and more exceptionally even granulocytopenia, just as clozapine does. In case of a SARS-CoV-2 infe","2021","07","08","Tijdschr Psychiatr","Tijdschrift voor psychiatrie","Antipsychotic Agents; COVID-19; Clozapine; Humans; Leukopenia; SARS-CoV-2; Schizophrenia","de Leeuw","M",NA,NA
"2099","34231857","",NA,NA,"2021","07","19","Tijdschr Psychiatr","Tijdschrift voor psychiatrie","COVID-19; Humans; SARS-CoV-2","De Picker","L J",NA,NA
"2100","34231845","10.1093/pubmed/fdab274","Covid-19 and the social suffering attached to it.",NA,"2021","07","07","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cabatbat","Katherine Pia M","De La Salle University, Theology and Religious Education Department, 2401 Taft Ave, Malate, Manila 1004, Philippines",NA
"2101","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Passos","Valéria Maria de Azeredo","Faculdade de Medicina, Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil",NA
"2102","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Brant","Luisa Campos Caldeira","Faculdade de Medicina, Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil",NA
"2103","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Pinheiro","Pedro Cisalpino","Faculdade de Medicina, Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil",NA
"2104","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Correa","Paulo Roberto Lopes","Secretaria Municipal de Saúde - Belo Horizonte (MG), Brasil",NA
"2105","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Machado","Isis Eloah","Escola de Medicina, Universidade Federal de Ouro Preto - Ouro Preto (MG), Brasil",NA
"2106","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Santos","Mayara Rocha","Secretaria Municipal de Saúde - Belo Horizonte (MG), Brasil",NA
"2107","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Ribeiro","Antonio Luiz Pinho","Faculdade de Medicina, Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil",NA
"2108","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Paixão","Lucia Maria Miana","Secretaria Municipal de Saúde - Belo Horizonte (MG), Brasil",NA
"2109","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Pimenta Junior","Fabiano Geraldo","Secretaria Municipal de Saúde - Belo Horizonte (MG), Brasil",NA
"2110","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Souza","Maria de Fatima Marinho de","Vital Strategies - São Paulo (SP), Brasil",NA
"2111","34231827","10.1590/1980-549720210025","Higher mortality during the COVID-19 pandemic in socially vulnerable areas in Belo Horizonte: implications for vaccine prioritization.","To assess mortality during the COVID-19 pandemic according to social vulnerability by areas of Belo Horizonte (BH), aiming at strategies for vaccination. Ecological study with mortality analysis according to census tracts classified by the Health Vulnerability Index, a composite indicator that includes socioeconomic and sanitation variables. Deaths by natural causes and by COVID-19 were obtained from the ""Mortality Information System"", between the 10th and 43rd epidemiological weeks (EW) of 2020","2021","07","08","Rev Bras Epidemiol","Revista brasileira de epidemiologia = Brazilian journal of epidemiology","Aged; Brazil; COVID-19; Humans; Mortality; Pandemics; SARS-CoV-2; Vaccines","Malta","Deborah Carvalho","Escola de Enfermagem, Universidade Federal de Minas Gerais - Belo Horizonte (MG), Brasil",NA
"2112","34231825","10.31744/einstein_journal/2021AO5830","Influenza vaccination coverage in elderly and high-risk adults: characterization of associated factors.","To evaluate the prevalence and factors associated with non-vaccination against influenza in the risk group. A cross-sectional, population-based study, carried out in the city of Rio Grande (RS). The outcome was defined as belonging to risk groups and not having been vaccinated in the last 12 months. Demographic, socioeconomic, behavioral variables, and access for health services were analyzed. In this study, 680 individuals participated. The prevalence was 46.0% (95%CI: 41.8-50.3), ranging from ","2021","07","08","Einstein (Sao Paulo)","Einstein (Sao Paulo, Brazil)","Aged; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Pregnancy; SARS-CoV-2; Vaccination; Vaccination Coverage; Young Adult","Meneghini","Kevin Francisco Durigon","Faculdade de Medicina, Universidade Federal do Rio Grande, Rio Grande, RS, Brazil",NA
"2113","34231825","10.31744/einstein_journal/2021AO5830","Influenza vaccination coverage in elderly and high-risk adults: characterization of associated factors.","To evaluate the prevalence and factors associated with non-vaccination against influenza in the risk group. A cross-sectional, population-based study, carried out in the city of Rio Grande (RS). The outcome was defined as belonging to risk groups and not having been vaccinated in the last 12 months. Demographic, socioeconomic, behavioral variables, and access for health services were analyzed. In this study, 680 individuals participated. The prevalence was 46.0% (95%CI: 41.8-50.3), ranging from ","2021","07","08","Einstein (Sao Paulo)","Einstein (Sao Paulo, Brazil)","Aged; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Pregnancy; SARS-CoV-2; Vaccination; Vaccination Coverage; Young Adult","Hood","Camila Furtado","Faculdade de Medicina, Universidade Católica de Pelotas, Pelotas, RS, Brazil",NA
"2114","34231825","10.31744/einstein_journal/2021AO5830","Influenza vaccination coverage in elderly and high-risk adults: characterization of associated factors.","To evaluate the prevalence and factors associated with non-vaccination against influenza in the risk group. A cross-sectional, population-based study, carried out in the city of Rio Grande (RS). The outcome was defined as belonging to risk groups and not having been vaccinated in the last 12 months. Demographic, socioeconomic, behavioral variables, and access for health services were analyzed. In this study, 680 individuals participated. The prevalence was 46.0% (95%CI: 41.8-50.3), ranging from ","2021","07","08","Einstein (Sao Paulo)","Einstein (Sao Paulo, Brazil)","Aged; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Pregnancy; SARS-CoV-2; Vaccination; Vaccination Coverage; Young Adult","Menezes","Letícia Oliveira de","Faculdade de Medicina, Universidade Católica de Pelotas, Pelotas, RS, Brazil",NA
"2115","34231825","10.31744/einstein_journal/2021AO5830","Influenza vaccination coverage in elderly and high-risk adults: characterization of associated factors.","To evaluate the prevalence and factors associated with non-vaccination against influenza in the risk group. A cross-sectional, population-based study, carried out in the city of Rio Grande (RS). The outcome was defined as belonging to risk groups and not having been vaccinated in the last 12 months. Demographic, socioeconomic, behavioral variables, and access for health services were analyzed. In this study, 680 individuals participated. The prevalence was 46.0% (95%CI: 41.8-50.3), ranging from ","2021","07","08","Einstein (Sao Paulo)","Einstein (Sao Paulo, Brazil)","Aged; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Pregnancy; SARS-CoV-2; Vaccination; Vaccination Coverage; Young Adult","Mendoza-Sassi","Raúl Andrés","Faculdade de Medicina, Universidade Federal do Rio Grande, Rio Grande, RS, Brazil",NA
"2116","34231825","10.31744/einstein_journal/2021AO5830","Influenza vaccination coverage in elderly and high-risk adults: characterization of associated factors.","To evaluate the prevalence and factors associated with non-vaccination against influenza in the risk group. A cross-sectional, population-based study, carried out in the city of Rio Grande (RS). The outcome was defined as belonging to risk groups and not having been vaccinated in the last 12 months. Demographic, socioeconomic, behavioral variables, and access for health services were analyzed. In this study, 680 individuals participated. The prevalence was 46.0% (95%CI: 41.8-50.3), ranging from ","2021","07","08","Einstein (Sao Paulo)","Einstein (Sao Paulo, Brazil)","Aged; COVID-19; Cross-Sectional Studies; Female; Humans; Influenza Vaccines; Influenza, Human; Pregnancy; SARS-CoV-2; Vaccination; Vaccination Coverage; Young Adult","Dumith","Samuel Carvalho","Faculdade de Medicina, Universidade Federal do Rio Grande, Rio Grande, RS, Brazil",NA
"2117","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Silva","Mariana Soares da","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2118","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Demoliner","Meriane","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2119","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Hansen","Alana Witt","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2120","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Gularte","Juliana Schons","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2121","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Silveira","Flávio","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2122","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Heldt","Fágner Henrique","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2123","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Filippi","Micheli","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2124","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Pereira","Vyctoria Malayhka de Abreu Góes","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2125","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Silva","Francini Pereira da","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2126","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Mallmann","Larissa","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2127","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Fink","Pietra","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2128","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Silva","Luana Letícia da","Secretaria Municipal da Saúde, Campo Bom, Rio Grande do Sul, Brazil",NA
"2129","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Weber","Matheus Nunes","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2130","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Almeida","Paula Rodrigues de","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2131","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Fleck","Juliane Deise","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2132","34231823","10.1590/S1678-9946202163058","Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.","Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of ","2021","07","08","Rev Inst Med Trop Sao Paulo","Revista do Instituto de Medicina Tropical de Sao Paulo","Brazil; COVID-19; Humans; Male; Reinfection; SARS-CoV-2","Spilki","Fernando Rosado","Universidade Feevale, Laboratório de Microbiologia Molecular, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"2133","34231818","10.5935/0103-507X.20210045","Reply to: Memory box: possibilities to support grief in the intensive care unit during the COVID-19 pandemic.",NA,"2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Grief; Humans; Intensive Care Units; Pandemics; SARS-CoV-2","Luiz","Thábata da Silva Cardoso","Hospital Universitário Antônio Pedro, Universidade Federal Fluminense - Niterói (RJ), Brasil",NA
"2134","34231818","10.5935/0103-507X.20210045","Reply to: Memory box: possibilities to support grief in the intensive care unit during the COVID-19 pandemic.",NA,"2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Grief; Humans; Intensive Care Units; Pandemics; SARS-CoV-2","Silva Filho","Orli Carvalho da","Instituto Nacional da Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fundação Oswaldo Cruz - Rio de Janeiro (RJ), Brasil",NA
"2135","34231818","10.5935/0103-507X.20210045","Reply to: Memory box: possibilities to support grief in the intensive care unit during the COVID-19 pandemic.",NA,"2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Grief; Humans; Intensive Care Units; Pandemics; SARS-CoV-2","Ventura","Tânia Cristina Camacho","Hospital Universitário Antônio Pedro, Universidade Federal Fluminense - Niterói (RJ), Brasil",NA
"2136","34231818","10.5935/0103-507X.20210045","Reply to: Memory box: possibilities to support grief in the intensive care unit during the COVID-19 pandemic.",NA,"2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Grief; Humans; Intensive Care Units; Pandemics; SARS-CoV-2","Dresch","Virginia","Instituto de Psicologia, Universidade Federal Fluminense - Niterói (RJ), Brasil",NA
"2137","34231817","10.5935/0103-507X.20210044","To: Memory box: possibilities to support grief in the intensive care unit during the COVID-19 pandemic.",NA,"2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Grief; Humans; Intensive Care Units; Pandemics; SARS-CoV-2","Yasri","Sora","Primary Consultant Center - Bangkok, Tailândia",NA
"2138","34231817","10.5935/0103-507X.20210044","To: Memory box: possibilities to support grief in the intensive care unit during the COVID-19 pandemic.",NA,"2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Grief; Humans; Intensive Care Units; Pandemics; SARS-CoV-2","Wiwanitkit","Viroj","Dr DY Patil University - Pune, Índia",NA
"2139","34231815","10.5935/0103-507X.20210042","NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH COVID-19.","COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. The clinical presentation is predominantly respiratory symptoms; however, in the current literature, several neurological manifestations associated with SARS-CoV-2 infection have been described. The authors present the clinical case of a 45-year-old man hospitalized for pneumonia with a positive test result for SARS-CoV-2, without a neurological history, who, on the sixteenth day of hospitalization, presented a ","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Hospitalization; Humans; Male; Middle Aged; Nervous System Diseases; Pneumonia, Viral; SARS-CoV-2; Seizures","Silva","Filipa Sofia Camacho Alves da","Serviço de Medicina Interna, Centro Hospitalar de Setúbal - EPE - Setúbal, Portugal",NA
"2140","34231815","10.5935/0103-507X.20210042","NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH COVID-19.","COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. The clinical presentation is predominantly respiratory symptoms; however, in the current literature, several neurological manifestations associated with SARS-CoV-2 infection have been described. The authors present the clinical case of a 45-year-old man hospitalized for pneumonia with a positive test result for SARS-CoV-2, without a neurological history, who, on the sixteenth day of hospitalization, presented a ","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Hospitalization; Humans; Male; Middle Aged; Nervous System Diseases; Pneumonia, Viral; SARS-CoV-2; Seizures","Bucur","Alexei","Unidade de Terapia Intensiva, Hospital Beatriz Ângelo - Lisboa, Portugal",NA
"2141","34231815","10.5935/0103-507X.20210042","NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH COVID-19.","COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. The clinical presentation is predominantly respiratory symptoms; however, in the current literature, several neurological manifestations associated with SARS-CoV-2 infection have been described. The authors present the clinical case of a 45-year-old man hospitalized for pneumonia with a positive test result for SARS-CoV-2, without a neurological history, who, on the sixteenth day of hospitalization, presented a ","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Hospitalization; Humans; Male; Middle Aged; Nervous System Diseases; Pneumonia, Viral; SARS-CoV-2; Seizures","Rosado","Steeve Neves","Unidade de Terapia Intensiva, Hospital Beatriz Ângelo - Lisboa, Portugal",NA
"2142","34231815","10.5935/0103-507X.20210042","NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH COVID-19.","COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. The clinical presentation is predominantly respiratory symptoms; however, in the current literature, several neurological manifestations associated with SARS-CoV-2 infection have been described. The authors present the clinical case of a 45-year-old man hospitalized for pneumonia with a positive test result for SARS-CoV-2, without a neurological history, who, on the sixteenth day of hospitalization, presented a ","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Hospitalization; Humans; Male; Middle Aged; Nervous System Diseases; Pneumonia, Viral; SARS-CoV-2; Seizures","Balhana","Sílvia Dos Santos","Unidade de Terapia Intensiva, Hospital Beatriz Ângelo - Lisboa, Portugal",NA
"2143","34231815","10.5935/0103-507X.20210042","NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH COVID-19.","COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. The clinical presentation is predominantly respiratory symptoms; however, in the current literature, several neurological manifestations associated with SARS-CoV-2 infection have been described. The authors present the clinical case of a 45-year-old man hospitalized for pneumonia with a positive test result for SARS-CoV-2, without a neurological history, who, on the sixteenth day of hospitalization, presented a ","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","COVID-19; Hospitalization; Humans; Male; Middle Aged; Nervous System Diseases; Pneumonia, Viral; SARS-CoV-2; Seizures","Meneses-Oliveira","Carlos Manuel","Unidade de Terapia Intensiva, Hospital Beatriz Ângelo - Lisboa, Portugal",NA
"2144","34231814","10.5935/0103-507X.20210041","Influenza B infection and Kawasaki disease in an adolescent during the COVID-19 pandemic: a case report.","We report a case of Influenza B infection and Kawasaki disease in an adolescent, diagnosed during the COVID-19 pandemic. An asthmatic female adolescent presented with fever and flu-like symptoms for 7 days and was admitted with acute respiratory failure requiring mechanical ventilation. She progressed with hemodynamic instability responsive to vasoactive drugs. Antibiotic therapy and support measures were introduced, showing progressive hemodynamics and respiratory improvement, however with pers","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adolescent; COVID-19; Female; Hospitalization; Humans; Influenza B virus; Influenza, Human; Mucocutaneous Lymph Node Syndrome; Respiration, Artificial; Respiratory Insufficiency","Silveira","Jéssica de Oliveira","Unidade de Terapia Intensiva Pediátrica, Hospital Israelita Albert Einstein - São Paulo (SP), Brasil",NA
"2145","34231814","10.5935/0103-507X.20210041","Influenza B infection and Kawasaki disease in an adolescent during the COVID-19 pandemic: a case report.","We report a case of Influenza B infection and Kawasaki disease in an adolescent, diagnosed during the COVID-19 pandemic. An asthmatic female adolescent presented with fever and flu-like symptoms for 7 days and was admitted with acute respiratory failure requiring mechanical ventilation. She progressed with hemodynamic instability responsive to vasoactive drugs. Antibiotic therapy and support measures were introduced, showing progressive hemodynamics and respiratory improvement, however with pers","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adolescent; COVID-19; Female; Hospitalization; Humans; Influenza B virus; Influenza, Human; Mucocutaneous Lymph Node Syndrome; Respiration, Artificial; Respiratory Insufficiency","Pegoraro","Mariana Grando","Unidade de Terapia Intensiva Pediátrica, Hospital Municipal Vila Santa Catarina Dr. Gilson de Cássia Marques de Carvalho - São Paulo (SP), Brasil",NA
"2146","34231814","10.5935/0103-507X.20210041","Influenza B infection and Kawasaki disease in an adolescent during the COVID-19 pandemic: a case report.","We report a case of Influenza B infection and Kawasaki disease in an adolescent, diagnosed during the COVID-19 pandemic. An asthmatic female adolescent presented with fever and flu-like symptoms for 7 days and was admitted with acute respiratory failure requiring mechanical ventilation. She progressed with hemodynamic instability responsive to vasoactive drugs. Antibiotic therapy and support measures were introduced, showing progressive hemodynamics and respiratory improvement, however with pers","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adolescent; COVID-19; Female; Hospitalization; Humans; Influenza B virus; Influenza, Human; Mucocutaneous Lymph Node Syndrome; Respiration, Artificial; Respiratory Insufficiency","Ferranti","Juliana Ferreira","Unidade de Terapia Intensiva Pediátrica, Instituto da Criança, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2147","34231814","10.5935/0103-507X.20210041","Influenza B infection and Kawasaki disease in an adolescent during the COVID-19 pandemic: a case report.","We report a case of Influenza B infection and Kawasaki disease in an adolescent, diagnosed during the COVID-19 pandemic. An asthmatic female adolescent presented with fever and flu-like symptoms for 7 days and was admitted with acute respiratory failure requiring mechanical ventilation. She progressed with hemodynamic instability responsive to vasoactive drugs. Antibiotic therapy and support measures were introduced, showing progressive hemodynamics and respiratory improvement, however with pers","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adolescent; COVID-19; Female; Hospitalization; Humans; Influenza B virus; Influenza, Human; Mucocutaneous Lymph Node Syndrome; Respiration, Artificial; Respiratory Insufficiency","Bousso","Albert","Unidade de Terapia Intensiva Pediátrica, Hospital Municipal Vila Santa Catarina Dr. Gilson de Cássia Marques de Carvalho - São Paulo (SP), Brasil",NA
"2148","34231814","10.5935/0103-507X.20210041","Influenza B infection and Kawasaki disease in an adolescent during the COVID-19 pandemic: a case report.","We report a case of Influenza B infection and Kawasaki disease in an adolescent, diagnosed during the COVID-19 pandemic. An asthmatic female adolescent presented with fever and flu-like symptoms for 7 days and was admitted with acute respiratory failure requiring mechanical ventilation. She progressed with hemodynamic instability responsive to vasoactive drugs. Antibiotic therapy and support measures were introduced, showing progressive hemodynamics and respiratory improvement, however with pers","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adolescent; COVID-19; Female; Hospitalization; Humans; Influenza B virus; Influenza, Human; Mucocutaneous Lymph Node Syndrome; Respiration, Artificial; Respiratory Insufficiency","Renattini","Tadeu Silveira Martins","Unidade de Terapia Intensiva Pediátrica, Hospital Municipal Vila Santa Catarina Dr. Gilson de Cássia Marques de Carvalho - São Paulo (SP), Brasil",NA
"2149","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Ururahy","Raul Dos Reis","Departamento de Clínica Médica, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2150","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Gallo","César Albuquerque","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2151","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Besen","Bruno Adler Maccagnan Pinheiro","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2152","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Carvalho","Marcelo Ticianelli de","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2153","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Ribeiro","José Mauro","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2154","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Zigaib","Rogério","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2155","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Mendes","Pedro Vitale","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2156","34231800","10.5935/0103-507X.20210027","Bedside clinical data subphenotypes of critically ill COVID-19 patients: a cohort study.","To identify more severe COVID-19 presentations. Consecutive intensive care unit-admitted patients were subjected to a stepwise clustering method. Data from 147 patients who were on average 56 ± 16 years old with a Simplified Acute Physiological Score 3 of 72 ± 18, of which 103 (70%) needed mechanical ventilation and 46 (31%) died in the intensive care unit, were analyzed. From the clustering algorithm, two well-defined groups were found based on maximal heart rate [Cluster A: 104 (95%CI 99 - 109","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Adult; Aged; Algorithms; COVID-19; Cluster Analysis; Cohort Studies; Critical Care; Critical Illness; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Patient Selection; Phenotype; Respiration, Artificial; Respiratory Rate; Retrospective Studies; Severity of Illness Index","Park","Marcelo","Departamento de Emergência, Unidade de Terapia Intensiva, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo - São Paulo (SP), Brasil",NA
"2157","34231799","10.5935/0103-507X.20210026","Description of physical rehabilitation in intensive care units in Argentina: usual practice and during the COVID-19 pandemic. Online survey.","To describe the usual practice of mobility therapy in the adult intensive care unit for patients with and without COVID-19. Online survey in which physical therapists working in an adult intensive care unit in Argentina participated. Sixteen multiple-choice or single-response questions grouped into three sections were asked. The first section addressed personal, professional and work environment data. The second section presented questions regarding usual care, and the third focused on practices","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Activities of Daily Living; Adult; Argentina; COVID-19; Critical Care; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Muscle Strength; Physical Therapists; Respiration, Artificial; Surveys and Questionnaires","Bertozzi","Matias Nicolás","Sanatorio Anchorena San Martín - Buenos Aires, Argentina",NA
"2158","34231799","10.5935/0103-507X.20210026","Description of physical rehabilitation in intensive care units in Argentina: usual practice and during the COVID-19 pandemic. Online survey.","To describe the usual practice of mobility therapy in the adult intensive care unit for patients with and without COVID-19. Online survey in which physical therapists working in an adult intensive care unit in Argentina participated. Sixteen multiple-choice or single-response questions grouped into three sections were asked. The first section addressed personal, professional and work environment data. The second section presented questions regarding usual care, and the third focused on practices","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Activities of Daily Living; Adult; Argentina; COVID-19; Critical Care; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Muscle Strength; Physical Therapists; Respiration, Artificial; Surveys and Questionnaires","Cagide","Sabrina","Sanatorio Anchorena San Martín - Buenos Aires, Argentina",NA
"2159","34231799","10.5935/0103-507X.20210026","Description of physical rehabilitation in intensive care units in Argentina: usual practice and during the COVID-19 pandemic. Online survey.","To describe the usual practice of mobility therapy in the adult intensive care unit for patients with and without COVID-19. Online survey in which physical therapists working in an adult intensive care unit in Argentina participated. Sixteen multiple-choice or single-response questions grouped into three sections were asked. The first section addressed personal, professional and work environment data. The second section presented questions regarding usual care, and the third focused on practices","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Activities of Daily Living; Adult; Argentina; COVID-19; Critical Care; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Muscle Strength; Physical Therapists; Respiration, Artificial; Surveys and Questionnaires","Navarro","Emiliano","Sanatorio Anchorena San Martín - Buenos Aires, Argentina",NA
"2160","34231799","10.5935/0103-507X.20210026","Description of physical rehabilitation in intensive care units in Argentina: usual practice and during the COVID-19 pandemic. Online survey.","To describe the usual practice of mobility therapy in the adult intensive care unit for patients with and without COVID-19. Online survey in which physical therapists working in an adult intensive care unit in Argentina participated. Sixteen multiple-choice or single-response questions grouped into three sections were asked. The first section addressed personal, professional and work environment data. The second section presented questions regarding usual care, and the third focused on practices","2021","07","12","Rev Bras Ter Intensiva","Revista Brasileira de terapia intensiva","Activities of Daily Living; Adult; Argentina; COVID-19; Critical Care; Critical Illness; Cross-Sectional Studies; Humans; Intensive Care Units; Muscle Strength; Physical Therapists; Respiration, Artificial; Surveys and Questionnaires","Accoce","Matias","Sanatorio Anchorena San Martín - Buenos Aires, Argentina",NA
"2161","34231797","10.36660/abc.20200724","Relationship between Right Ventricular Strain Signs in Electrocardiography and Levels of Biomarkers Associated with COVID-19 Pneumonia Severity.","The novel coronavirus disease (COVID-19) may lead to severe disease that can cause death. COVID-19 is known to affect the cardiovascular system. Early detection of the progression to the severe disease stage that affects the cardiovascular system may play a critical role in the treatment of COVID-19. To explore the possible relationship between the COVID-19 pneumonia and right ventricular strain findings on electrocardiography (ECG). We conducted a retrospective study of 141 hospitalized patient","2021","07","07","Arq Bras Cardiol","Arquivos brasileiros de cardiologia",NA,"Polat","Veli","Departamento de Cardiologia, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istambul - Turquia",NA
"2162","34231797","10.36660/abc.20200724","Relationship between Right Ventricular Strain Signs in Electrocardiography and Levels of Biomarkers Associated with COVID-19 Pneumonia Severity.","The novel coronavirus disease (COVID-19) may lead to severe disease that can cause death. COVID-19 is known to affect the cardiovascular system. Early detection of the progression to the severe disease stage that affects the cardiovascular system may play a critical role in the treatment of COVID-19. To explore the possible relationship between the COVID-19 pneumonia and right ventricular strain findings on electrocardiography (ECG). We conducted a retrospective study of 141 hospitalized patient","2021","07","07","Arq Bras Cardiol","Arquivos brasileiros de cardiologia",NA,"Bozcali","Evin","Departamento de Cardiologia, Prof. Dr. Cemil Tascioglu City Hospital, Istambul - Turquia",NA
"2163","34231797","10.36660/abc.20200724","Relationship between Right Ventricular Strain Signs in Electrocardiography and Levels of Biomarkers Associated with COVID-19 Pneumonia Severity.","The novel coronavirus disease (COVID-19) may lead to severe disease that can cause death. COVID-19 is known to affect the cardiovascular system. Early detection of the progression to the severe disease stage that affects the cardiovascular system may play a critical role in the treatment of COVID-19. To explore the possible relationship between the COVID-19 pneumonia and right ventricular strain findings on electrocardiography (ECG). We conducted a retrospective study of 141 hospitalized patient","2021","07","07","Arq Bras Cardiol","Arquivos brasileiros de cardiologia",NA,"Yasar","Kadriye Kart","Departamento de Doenças Infecciosas e Microbiologia Clínica, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istambul - Turquia",NA
"2164","34231797","10.36660/abc.20200724","Relationship between Right Ventricular Strain Signs in Electrocardiography and Levels of Biomarkers Associated with COVID-19 Pneumonia Severity.","The novel coronavirus disease (COVID-19) may lead to severe disease that can cause death. COVID-19 is known to affect the cardiovascular system. Early detection of the progression to the severe disease stage that affects the cardiovascular system may play a critical role in the treatment of COVID-19. To explore the possible relationship between the COVID-19 pneumonia and right ventricular strain findings on electrocardiography (ECG). We conducted a retrospective study of 141 hospitalized patient","2021","07","07","Arq Bras Cardiol","Arquivos brasileiros de cardiologia",NA,"Karaosmanoglu","Hayat Kumbasar","Departamento de Doenças Infecciosas e Microbiologia Clínica, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istambul - Turquia",NA
"2165","34231797","10.36660/abc.20200724","Relationship between Right Ventricular Strain Signs in Electrocardiography and Levels of Biomarkers Associated with COVID-19 Pneumonia Severity.","The novel coronavirus disease (COVID-19) may lead to severe disease that can cause death. COVID-19 is known to affect the cardiovascular system. Early detection of the progression to the severe disease stage that affects the cardiovascular system may play a critical role in the treatment of COVID-19. To explore the possible relationship between the COVID-19 pneumonia and right ventricular strain findings on electrocardiography (ECG). We conducted a retrospective study of 141 hospitalized patient","2021","07","07","Arq Bras Cardiol","Arquivos brasileiros de cardiologia",NA,"Akturk","Ibrahim Faruk","Departamento de Cardiologia, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istambul - Turquia",NA
"2166","34231787","10.1590/1518-8345.4805.3422","Child health vulnerabilities during the COVID-19 pandemic in Brazil and Portugal.","to analyze the vulnerabilities of children in the access to primary health care during the COVID-19 pandemic in Brazil and Portugal. documentary study based on Brazilian and Portuguese governmental guidelines issued between March and August 2020 regarding access of children to primary health care. Thematic analysis was based on the precepts of health vulnerability. 13 documents were issued in both countries addressing access to vaccination and childcare. Due to the SARS-CoV-2, restrictions were ","2021","07","08","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Brazil; COVID-19; Child; Child Health; Female; Humans; Infant; Pandemics; Portugal; SARS-CoV-2","Cabral","Ivone Evangelista","Universidade Federal do Rio de Janeiro, Escola de Enfermagem Anna Nery, Rio de Janeiro, RJ, Brazil",NA
"2167","34231787","10.1590/1518-8345.4805.3422","Child health vulnerabilities during the COVID-19 pandemic in Brazil and Portugal.","to analyze the vulnerabilities of children in the access to primary health care during the COVID-19 pandemic in Brazil and Portugal. documentary study based on Brazilian and Portuguese governmental guidelines issued between March and August 2020 regarding access of children to primary health care. Thematic analysis was based on the precepts of health vulnerability. 13 documents were issued in both countries addressing access to vaccination and childcare. Due to the SARS-CoV-2, restrictions were ","2021","07","08","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Brazil; COVID-19; Child; Child Health; Female; Humans; Infant; Pandemics; Portugal; SARS-CoV-2","Pestana-Santos","Márcia","Escola Superior de Enfermagem de Coimbra, Unidade de Investigação em Ciências da Saúde-Enfermagem, Coimbra, Portugal",NA
"2168","34231787","10.1590/1518-8345.4805.3422","Child health vulnerabilities during the COVID-19 pandemic in Brazil and Portugal.","to analyze the vulnerabilities of children in the access to primary health care during the COVID-19 pandemic in Brazil and Portugal. documentary study based on Brazilian and Portuguese governmental guidelines issued between March and August 2020 regarding access of children to primary health care. Thematic analysis was based on the precepts of health vulnerability. 13 documents were issued in both countries addressing access to vaccination and childcare. Due to the SARS-CoV-2, restrictions were ","2021","07","08","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Brazil; COVID-19; Child; Child Health; Female; Humans; Infant; Pandemics; Portugal; SARS-CoV-2","Ciuffo","Lia Leão","Universidade Federal do Rio de Janeiro, Escola de Enfermagem Anna Nery, Rio de Janeiro, RJ, Brazil",NA
"2169","34231787","10.1590/1518-8345.4805.3422","Child health vulnerabilities during the COVID-19 pandemic in Brazil and Portugal.","to analyze the vulnerabilities of children in the access to primary health care during the COVID-19 pandemic in Brazil and Portugal. documentary study based on Brazilian and Portuguese governmental guidelines issued between March and August 2020 regarding access of children to primary health care. Thematic analysis was based on the precepts of health vulnerability. 13 documents were issued in both countries addressing access to vaccination and childcare. Due to the SARS-CoV-2, restrictions were ","2021","07","08","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Brazil; COVID-19; Child; Child Health; Female; Humans; Infant; Pandemics; Portugal; SARS-CoV-2","Nunes","Yan do Rosario","Universidade Federal do Rio de Janeiro, Escola de Enfermagem Anna Nery, Rio de Janeiro, RJ, Brazil",NA
"2170","34231787","10.1590/1518-8345.4805.3422","Child health vulnerabilities during the COVID-19 pandemic in Brazil and Portugal.","to analyze the vulnerabilities of children in the access to primary health care during the COVID-19 pandemic in Brazil and Portugal. documentary study based on Brazilian and Portuguese governmental guidelines issued between March and August 2020 regarding access of children to primary health care. Thematic analysis was based on the precepts of health vulnerability. 13 documents were issued in both countries addressing access to vaccination and childcare. Due to the SARS-CoV-2, restrictions were ","2021","07","08","Rev Lat Am Enfermagem","Revista latino-americana de enfermagem","Brazil; COVID-19; Child; Child Health; Female; Humans; Infant; Pandemics; Portugal; SARS-CoV-2","Lomba","Maria de Lurdes Lopes de Freitas","Escola Superior de Enfermagem de Coimbra, Unidade de Investigação em Ciências da Saúde-Enfermagem, Coimbra, Portugal",NA
"2171","34231777","10.1590/0037-8682-0162-2021","SARS-CoV-2 nucleic acid shedding is variable for every person.","Considering the persistent positivity on RT-qPCR tests, the results of SARS-CoV-2 were monitored to evaluate the viral RNA shedding period. Between March and June 2020, the sequential results of 29 healthcare workers' were monitored using RT-qPCR. More than 50% of the individuals remained RT-qPCR positive after 14 days. Furthermore, this is the first study to describe positive RT-qPCR for SARS-CoV-2 in a healthcare worker with mild symptoms 95 days after the first positive test. Sequential RT-qP","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; Nucleic Acids; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Virus Shedding","Lima-Morales","Daiana de","Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Experimental, Laboratório de Pesquisa em Resistência Bacteriana (Labresis), Porto Alegre, RS, Brasil",NA
"2172","34231777","10.1590/0037-8682-0162-2021","SARS-CoV-2 nucleic acid shedding is variable for every person.","Considering the persistent positivity on RT-qPCR tests, the results of SARS-CoV-2 were monitored to evaluate the viral RNA shedding period. Between March and June 2020, the sequential results of 29 healthcare workers' were monitored using RT-qPCR. More than 50% of the individuals remained RT-qPCR positive after 14 days. Furthermore, this is the first study to describe positive RT-qPCR for SARS-CoV-2 in a healthcare worker with mild symptoms 95 days after the first positive test. Sequential RT-qP","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; Nucleic Acids; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Virus Shedding","Wink","Priscila Lamb","Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Experimental, Laboratório de Pesquisa em Resistência Bacteriana (Labresis), Porto Alegre, RS, Brasil",NA
"2173","34231777","10.1590/0037-8682-0162-2021","SARS-CoV-2 nucleic acid shedding is variable for every person.","Considering the persistent positivity on RT-qPCR tests, the results of SARS-CoV-2 were monitored to evaluate the viral RNA shedding period. Between March and June 2020, the sequential results of 29 healthcare workers' were monitored using RT-qPCR. More than 50% of the individuals remained RT-qPCR positive after 14 days. Furthermore, this is the first study to describe positive RT-qPCR for SARS-CoV-2 in a healthcare worker with mild symptoms 95 days after the first positive test. Sequential RT-qP","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; Nucleic Acids; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Virus Shedding","Volpato","Fabiana Caroline Zempulski","Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Experimental, Laboratório de Pesquisa em Resistência Bacteriana (Labresis), Porto Alegre, RS, Brasil",NA
"2174","34231777","10.1590/0037-8682-0162-2021","SARS-CoV-2 nucleic acid shedding is variable for every person.","Considering the persistent positivity on RT-qPCR tests, the results of SARS-CoV-2 were monitored to evaluate the viral RNA shedding period. Between March and June 2020, the sequential results of 29 healthcare workers' were monitored using RT-qPCR. More than 50% of the individuals remained RT-qPCR positive after 14 days. Furthermore, this is the first study to describe positive RT-qPCR for SARS-CoV-2 in a healthcare worker with mild symptoms 95 days after the first positive test. Sequential RT-qP","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; Nucleic Acids; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Virus Shedding","Camargo","Joíza Lins","Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Experimental, Laboratório de Pesquisa em Resistência Bacteriana (Labresis), Porto Alegre, RS, Brasil",NA
"2175","34231777","10.1590/0037-8682-0162-2021","SARS-CoV-2 nucleic acid shedding is variable for every person.","Considering the persistent positivity on RT-qPCR tests, the results of SARS-CoV-2 were monitored to evaluate the viral RNA shedding period. Between March and June 2020, the sequential results of 29 healthcare workers' were monitored using RT-qPCR. More than 50% of the individuals remained RT-qPCR positive after 14 days. Furthermore, this is the first study to describe positive RT-qPCR for SARS-CoV-2 in a healthcare worker with mild symptoms 95 days after the first positive test. Sequential RT-qP","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; Nucleic Acids; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Virus Shedding","de-Paris","Fernanda","Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Experimental, Laboratório de Pesquisa em Resistência Bacteriana (Labresis), Porto Alegre, RS, Brasil",NA
"2176","34231777","10.1590/0037-8682-0162-2021","SARS-CoV-2 nucleic acid shedding is variable for every person.","Considering the persistent positivity on RT-qPCR tests, the results of SARS-CoV-2 were monitored to evaluate the viral RNA shedding period. Between March and June 2020, the sequential results of 29 healthcare workers' were monitored using RT-qPCR. More than 50% of the individuals remained RT-qPCR positive after 14 days. Furthermore, this is the first study to describe positive RT-qPCR for SARS-CoV-2 in a healthcare worker with mild symptoms 95 days after the first positive test. Sequential RT-qP","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; Nucleic Acids; RNA, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Virus Shedding","Barth","Afonso Luís","Hospital de Clínicas de Porto Alegre, Centro de Pesquisa Experimental, Laboratório de Pesquisa em Resistência Bacteriana (Labresis), Porto Alegre, RS, Brasil",NA
"2177","34231776","10.1590/0037-8682-0314-2021","Pulmonary Tuberculosis in a Patient with COVID-19 Pneumonia.",NA,"2021","07","12","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; SARS-CoV-2; Tuberculosis, Pulmonary","Fonseca","Cyro Antonio","Hospital Unimed Rio, Rio de Janeiro, RJ, Brasil",NA
"2178","34231776","10.1590/0037-8682-0314-2021","Pulmonary Tuberculosis in a Patient with COVID-19 Pneumonia.",NA,"2021","07","12","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; SARS-CoV-2; Tuberculosis, Pulmonary","Zanetti","Gláucia","Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil",NA
"2179","34231776","10.1590/0037-8682-0314-2021","Pulmonary Tuberculosis in a Patient with COVID-19 Pneumonia.",NA,"2021","07","12","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","COVID-19; Humans; SARS-CoV-2; Tuberculosis, Pulmonary","Marchiori","Edson","Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil",NA
"2180","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Martinez","Edson Zangiacomi","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2181","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Passos","Afonso Dinis Costa","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2182","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Fabbro","Amaury Lelis Dal","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2183","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Silva","Anderson Soares da","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2184","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Escarso","Andreia Cássia","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2185","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Pazin-Filho","Antônio","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Divisões de Imunologia Clínica, Emergência e Doenças Infecciosas, e Unidade de Emergência, Ribeirão Preto, SP, Brasil",NA
"2186","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Fonseca","Benedito Antônio Lopes da","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Clínica Médica, Ribeirão Preto, SP, Brasil",NA
"2187","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Maciel","Benedito Carlos","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Divisão de Cardiologia do Departamento de Clínica Médica, Ribeirão Preto, SP, Brasil",NA
"2188","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Araújo","Daniel Cardoso de Almeida E","Secretaria Municipal de Saúde de Ribeirão Preto, Divisão de Vigilância Epidemiológica, Ribeirão Preto, SP, Brasil",NA
"2189","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Clé","Diego Villa","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Imagens Médicas, Hematologia e Oncologia Clínica, Ribeirão Preto, SP, Brasil",NA
"2190","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Gaspar","Gilberto Gambero","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Clínica Médica, Ribeirão Preto, SP, Brasil",NA
"2191","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Santos","Jair Lício Ferreira Dos","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2192","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Ferreira","Janise Braga Barros","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2193","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Souza","João Paulo","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2194","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Mello","Luane Marques de","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2195","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Santos","Luciane Loures Dos","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2196","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Passos","Luzia Márcia Romanholi","Secretaria Municipal de Saúde de Ribeirão Preto, Divisão de Vigilância Epidemiológica, Ribeirão Preto, SP, Brasil",NA
"2197","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Siconelli","Márcio Junio Lima","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Clínica Médica, Ribeirão Preto, SP, Brasil",NA
"2198","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Cavalli","Ricardo de Carvalho","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Ginecologia e Obstetrícia, Ribeirão Preto, SP, Brasil",NA
"2199","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Santana","Rodrigo de Carvalho","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Divisões de Imunologia Clínica, Emergência e Doenças Infecciosas, e Unidade de Emergência, Ribeirão Preto, SP, Brasil",NA
"2200","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Calado","Rodrigo do Tocantins","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Imagens Médicas, Hematologia e Oncologia Clínica, Ribeirão Preto, SP, Brasil",NA
"2201","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Scarpelini","Sandro","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Cirurgia, Ribeirão Preto, SP, Brasil",NA
"2202","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Bollela","Valdes Roberto","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Divisões de Imunologia Clínica, Emergência e Doenças Infecciosas, e Unidade de Emergência, Ribeirão Preto, SP, Brasil",NA
"2203","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Floriano","Vitor Gonçalves","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Clínica Médica, Ribeirão Preto, SP, Brasil",NA
"2204","34231775","10.1590/0037-8682-0210-2021","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirão Preto, Southeast Brazil: an epidemiological survey.","This epidemiological household survey aimed to estimate the prevalence of the current and past SARS-CoV-2 infections in Ribeirão Preto, a municipality of southeast Brazil. The survey was conducted in two phases using a clustered sampling scheme. The first phase spanned May 1-3 and involved 709 participants. The second phase spanned June 11-14, 2020, and involved 646 participants. During the first phase, RT-PCR performed on nasopharyngeal swabs was positive at 0.14%. The serological tests were po","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Humans; Pandemics; Prevalence; SARS-CoV-2","Bellissimo-Rodrigues","Fernando","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, SP, Brasil",NA
"2205","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Pegorari","Maycon Sousa","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2206","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Silva","Caroline de Fátima Ribeiro","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2207","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Araújo","Fabrícia Coelho de","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2208","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Silva","Juliana de Souza da","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2209","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Ohara","Daniela Gonçalves","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2210","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Matos","Alessandro Pena","Hospital Ofir Loyola, Belém, PA, Brasil",NA
"2211","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Matos","Areolino Pena","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2212","34231774","10.1590/0037-8682-0195-2020","Factors associated with social isolation and loneliness in community-dwelling older adults during pandemic times: a cross-sectional study.","Psychosocial aspects need to be discussed in the context of the Covid-19 pandemic. Currently, no studies have investigated the factors associated with social isolation and loneliness among community-dwelling older adults. Therefore, this study analyzed the association of social isolation and loneliness with socioeconomic, clinical, and health characteristics, and Covid-19-related variables, among community-dwelling older adults during the pandemic. A cross-sectional study was conducted via a tel","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Aged; Brazil; COVID-19; Cross-Sectional Studies; Humans; Independent Living; Loneliness; Middle Aged; Pandemics; SARS-CoV-2; Social Isolation","Pinto","Ana Carolina Pereira Nunes","Universidade Federal do Amapá, Curso de Fisioterapia, Macapá, AP, Brasil",NA
"2213","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Nascimento","Bruno Ramos","Universidade Federal de Minas Gerais, Hospital das Clínicas, Serviço de Cardiologia e Cirurgia Cardiovascular e Centro de Telessaúde, Belo Horizonte, MG, Brasil",NA
"2214","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Brant","Luisa Campos Caldeira","Universidade Federal de Minas Gerais, Hospital das Clínicas, Serviço de Cardiologia e Cirurgia Cardiovascular e Centro de Telessaúde, Belo Horizonte, MG, Brasil",NA
"2215","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Castro","Ana Cristina Teixeira","UNIMED-BH Cooperativa Medica, Serviço de Atendimento Móvel, Belo Horizonte, MG, Brasil",NA
"2216","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Froes","Luiz Eduardo Vieira","Universidade José do Rosário Vellano, Faculdade de Medicina, Belo Horizonte, MG, Brasil",NA
"2217","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Ribeiro","Antonio Luiz Pinho","Universidade Federal de Minas Gerais, Hospital das Clínicas, Serviço de Cardiologia e Cirurgia Cardiovascular e Centro de Telessaúde, Belo Horizonte, MG, Brasil",NA
"2218","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Teixeira","Renato Azeredo","Universidade Federal de Minas Gerais, Faculdade de Medicina, Belo Horizonte, MG, Brasil",NA
"2219","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Cruz","Larissa Vilela","UNIMED-BH Cooperativa Médica, Centro Médico, CPS Barreiro e Central de Consultas On-line, Belo Horizonte, MG, Brasil",NA
"2220","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Araújo","Cynthia Bicalho Maluf","UNIMED-BH Cooperativa Médica, Gerência de Desenvolvimento de Informações para o Negócio, Belo Horizonte, MG, Brasil",NA
"2221","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Souza","Charles Ferreira","UNIMED-BH Cooperativa Médica, Gerência de Desenvolvimento de Informações para o Negócio, Belo Horizonte, MG, Brasil",NA
"2222","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Froes","Eduardo Tomaz","UNIMED-BH Cooperativa Medica, Serviço de Atendimento Móvel, Belo Horizonte, MG, Brasil",NA
"2223","34231773","10.1590/0037-8682-0174-2021","Reduction in Hospital Admissions Associated with Coronary Events during the COVID-19 Pandemic in the Brazilian Private Health System: Data from the UNIMED-BH System.","We aimed to evaluate the impact of the new coronavirus disease 2019 on coronary hospitalizations in the Brazilian private health system. Data on coronary admissions in 2020 and a 2-year historical series were collected from the UNIMED-BH insurance system. Admission rates in 2020 reduced by 26% (95%CI, 22-30) in comparison with 2018/2019, markedly from March to May (37%) compared to the peak of the pandemic (June-September, 19%). Mortality was higher in 2020 (5.4%, 95%CI 4.5-6.4) than in 2018/201","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Brazil; COVID-19; Hospitalization; Hospitals; Humans; Pandemics; SARS-CoV-2","Souza","Soraya Diniz","UNIMED-BH Cooperativa Medica, Serviço de Atendimento Móvel, Belo Horizonte, MG, Brasil",NA
"2224","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Martinez","Edson Zangiacomi","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, SP, Brasil",NA
"2225","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Aragon","Davi Casale","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, SP, Brasil",NA
"2226","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Pontes","Carolina Moreira","Universidade Federal do Espírito Santo, Departamento de Estatística, Vitória, ES, Brasil",NA
"2227","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Nunes","Altacílio Aparecido","Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, SP, Brasil",NA
"2228","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Maciel","Ethel Leonor Noia","Universidade Federal do Espírito Santo, Programa de Pós-Graduação em Saúde Coletiva, Vitória, ES, Brasil",NA
"2229","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Jabor","Pablo","Instituto Jones dos Santos Neves, Vitória, ES, Brasil",NA
"2230","34231772","10.1590/0037-8682-0138-2021","Comorbidities and the risk of death among individuals infected by COVID-19 in Espírito Santo, Brazil.","We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. We included 212,620 individuals, =30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significan","2021","07","08","Rev Soc Bras Med Trop","Revista da Sociedade Brasileira de Medicina Tropical","Adult; Brazil; COVID-19; Comorbidity; Environment; Humans; Middle Aged; SARS-CoV-2","Zandonade","Eliana","Universidade Federal do Espírito Santo, Departamento de Estatística, Vitória, ES, Brasil",NA
"2231","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Pilecco","Flávia Bulegon","Universidade Federal de Minas Gerais, Belo Horizonte, Brasil",NA
"2232","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","McCallum","Cecilia Anne","Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brasil",NA
"2233","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Almeida","Maria da Conceição Chagas de","Rede CoVida - Ciência, Informação e Solidariedade, Salvador, Brasil",NA
"2234","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Alves","Flávia Jôse Oliveira","Rede CoVida - Ciência, Informação e Solidariedade, Salvador, Brasil",NA
"2235","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Rocha","Aline Dos Santos","Rede CoVida - Ciência, Informação e Solidariedade, Salvador, Brasil",NA
"2236","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Ortelan","Naiá","Rede CoVida - Ciência, Informação e Solidariedade, Salvador, Brasil",NA
"2237","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Gabrielli","Lígia","Rede CoVida - Ciência, Informação e Solidariedade, Salvador, Brasil",NA
"2238","34231763","10.1590/0102-311X00322320","Abortion and the COVID-19 pandemic: insights for Latin America.","The COVID-19 pandemic may accentuate existing problems, hindering access to legal abortion, with a consequent increase in unsafe abortions. This scenario may be even worse in low- and middle-income countries, especially in Latin America, where abortion laws are already restrictive and access to services is already hampered. Our objective was to understand how different countries, with an emphasis on Latin Americans, have dealt with legal abortion services in the context of the COVID-19. Thus, we","2021","07","09","Cad Saude Publica","Cadernos de saude publica","Abortion, Induced; Abortion, Legal; Brazil; COVID-19; Developing Countries; Female; Humans; Latin America; Pandemics; Pregnancy; SARS-CoV-2","Menezes","Greice Maria de Souza","Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brasil",NA
"2239","34231729","10.1590/1413-81232021266.00642021","[Spatial and temporal aspects and factors associated with the spread of Covid-19 to the interior of the State of Pernambuco, Brazil].","This study involved an ecological study between March and June 2020 consisting of a spatial and temporal analysis of the spread of Covid-19 to the interior of Pernambuco and related socioeconomic factors. Maps were generated from the incidence coefficient by municipality of residence to determine the spatial dynamics of Covid-19. The correlation between socioeconomic indicators and the coefficient in the metropolitan regions of Recife (MRR) and inland regions was studied. This coefficient was le","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Cities; Humans; Incidence; SARS-CoV-2; Spatial Analysis","Quinino","Louisiana Regadas de Macedo","Núcleo de Saúde Coletiva, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz (Fiocruz). Av. Prof. Moraes Rego s/n, Cidade Universitária. 50670-420 Recife PE Brasil",NA
"2240","34231729","10.1590/1413-81232021266.00642021","[Spatial and temporal aspects and factors associated with the spread of Covid-19 to the interior of the State of Pernambuco, Brazil].","This study involved an ecological study between March and June 2020 consisting of a spatial and temporal analysis of the spread of Covid-19 to the interior of Pernambuco and related socioeconomic factors. Maps were generated from the incidence coefficient by municipality of residence to determine the spatial dynamics of Covid-19. The correlation between socioeconomic indicators and the coefficient in the metropolitan regions of Recife (MRR) and inland regions was studied. This coefficient was le","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Cities; Humans; Incidence; SARS-CoV-2; Spatial Analysis","Vasconcellos","Flávia Helena Manhães","Departamento de Engenharia Cartográfica, Universidade Federal de Pernambuco (UFPE). Recife PE Brasil",NA
"2241","34231729","10.1590/1413-81232021266.00642021","[Spatial and temporal aspects and factors associated with the spread of Covid-19 to the interior of the State of Pernambuco, Brazil].","This study involved an ecological study between March and June 2020 consisting of a spatial and temporal analysis of the spread of Covid-19 to the interior of Pernambuco and related socioeconomic factors. Maps were generated from the incidence coefficient by municipality of residence to determine the spatial dynamics of Covid-19. The correlation between socioeconomic indicators and the coefficient in the metropolitan regions of Recife (MRR) and inland regions was studied. This coefficient was le","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Cities; Humans; Incidence; SARS-CoV-2; Spatial Analysis","Diniz","Isabel Soares","Departamento de Estatística, UFPE. Recife PE Brasil",NA
"2242","34231729","10.1590/1413-81232021266.00642021","[Spatial and temporal aspects and factors associated with the spread of Covid-19 to the interior of the State of Pernambuco, Brazil].","This study involved an ecological study between March and June 2020 consisting of a spatial and temporal analysis of the spread of Covid-19 to the interior of Pernambuco and related socioeconomic factors. Maps were generated from the incidence coefficient by municipality of residence to determine the spatial dynamics of Covid-19. The correlation between socioeconomic indicators and the coefficient in the metropolitan regions of Recife (MRR) and inland regions was studied. This coefficient was le","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Cities; Humans; Incidence; SARS-CoV-2; Spatial Analysis","Aguiar","Lucilene Rafael","Faculdade de Enfermagem Nossa Senhora das Graças, Universidade de Pernambuco. Recife PE Brasil",NA
"2243","34231729","10.1590/1413-81232021266.00642021","[Spatial and temporal aspects and factors associated with the spread of Covid-19 to the interior of the State of Pernambuco, Brazil].","This study involved an ecological study between March and June 2020 consisting of a spatial and temporal analysis of the spread of Covid-19 to the interior of Pernambuco and related socioeconomic factors. Maps were generated from the incidence coefficient by municipality of residence to determine the spatial dynamics of Covid-19. The correlation between socioeconomic indicators and the coefficient in the metropolitan regions of Recife (MRR) and inland regions was studied. This coefficient was le","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Cities; Humans; Incidence; SARS-CoV-2; Spatial Analysis","Ramos","Yasmim Talita de Moraes","Núcleo de Saúde Coletiva, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz (Fiocruz). Av. Prof. Moraes Rego s/n, Cidade Universitária. 50670-420 Recife PE Brasil",NA
"2244","34231729","10.1590/1413-81232021266.00642021","[Spatial and temporal aspects and factors associated with the spread of Covid-19 to the interior of the State of Pernambuco, Brazil].","This study involved an ecological study between March and June 2020 consisting of a spatial and temporal analysis of the spread of Covid-19 to the interior of Pernambuco and related socioeconomic factors. Maps were generated from the incidence coefficient by municipality of residence to determine the spatial dynamics of Covid-19. The correlation between socioeconomic indicators and the coefficient in the metropolitan regions of Recife (MRR) and inland regions was studied. This coefficient was le","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Cities; Humans; Incidence; SARS-CoV-2; Spatial Analysis","Bastiani","Fernanda De","Departamento de Estatística, UFPE. Recife PE Brasil",NA
"2245","34231728","10.1590/1413-81232021266.44142020","Mental health and internet use by university students: coping strategies in the context of COVID-19.","The aim of this study was to estimate the prevalence of Common Mental Disorders (CMD) among university students and analyze the relation between disorders and internet use and the use of coping strategies in the face of social isolation during the COVID-19 pandemic. We conducted a quantitative cross-sectional study using a non-probability sample of 275 students. Data was collected online using the Self-Reporting Questionnaire, Problematic Internet Use Scale and a coping strategies inventory. We ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adaptation, Psychological; COVID-19; Cross-Sectional Studies; Humans; Internet; Internet Use; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Mota","Daniela Cristina Belchior","Curso de Psicologia, Centro Universitário UniAcademia. R. Halfeld 1.179, Centro. 36016-000 Juiz de Fora MG Brasil",NA
"2246","34231728","10.1590/1413-81232021266.44142020","Mental health and internet use by university students: coping strategies in the context of COVID-19.","The aim of this study was to estimate the prevalence of Common Mental Disorders (CMD) among university students and analyze the relation between disorders and internet use and the use of coping strategies in the face of social isolation during the COVID-19 pandemic. We conducted a quantitative cross-sectional study using a non-probability sample of 275 students. Data was collected online using the Self-Reporting Questionnaire, Problematic Internet Use Scale and a coping strategies inventory. We ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adaptation, Psychological; COVID-19; Cross-Sectional Studies; Humans; Internet; Internet Use; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Silva","Yury Vasconcellos da","Curso de Psicologia, Centro Universitário UniAcademia. R. Halfeld 1.179, Centro. 36016-000 Juiz de Fora MG Brasil",NA
"2247","34231728","10.1590/1413-81232021266.44142020","Mental health and internet use by university students: coping strategies in the context of COVID-19.","The aim of this study was to estimate the prevalence of Common Mental Disorders (CMD) among university students and analyze the relation between disorders and internet use and the use of coping strategies in the face of social isolation during the COVID-19 pandemic. We conducted a quantitative cross-sectional study using a non-probability sample of 275 students. Data was collected online using the Self-Reporting Questionnaire, Problematic Internet Use Scale and a coping strategies inventory. We ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adaptation, Psychological; COVID-19; Cross-Sectional Studies; Humans; Internet; Internet Use; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Costa","Thaís Aparecida Ferreira","Curso de Psicologia, Centro Universitário UniAcademia. R. Halfeld 1.179, Centro. 36016-000 Juiz de Fora MG Brasil",NA
"2248","34231728","10.1590/1413-81232021266.44142020","Mental health and internet use by university students: coping strategies in the context of COVID-19.","The aim of this study was to estimate the prevalence of Common Mental Disorders (CMD) among university students and analyze the relation between disorders and internet use and the use of coping strategies in the face of social isolation during the COVID-19 pandemic. We conducted a quantitative cross-sectional study using a non-probability sample of 275 students. Data was collected online using the Self-Reporting Questionnaire, Problematic Internet Use Scale and a coping strategies inventory. We ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adaptation, Psychological; COVID-19; Cross-Sectional Studies; Humans; Internet; Internet Use; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Aguiar","Magna Helena da Cunha","Curso de Psicologia, Centro Universitário UniAcademia. R. Halfeld 1.179, Centro. 36016-000 Juiz de Fora MG Brasil",NA
"2249","34231728","10.1590/1413-81232021266.44142020","Mental health and internet use by university students: coping strategies in the context of COVID-19.","The aim of this study was to estimate the prevalence of Common Mental Disorders (CMD) among university students and analyze the relation between disorders and internet use and the use of coping strategies in the face of social isolation during the COVID-19 pandemic. We conducted a quantitative cross-sectional study using a non-probability sample of 275 students. Data was collected online using the Self-Reporting Questionnaire, Problematic Internet Use Scale and a coping strategies inventory. We ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adaptation, Psychological; COVID-19; Cross-Sectional Studies; Humans; Internet; Internet Use; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Marques","Maria Eduarda de Melo","Curso de Psicologia, Centro Universitário UniAcademia. R. Halfeld 1.179, Centro. 36016-000 Juiz de Fora MG Brasil",NA
"2250","34231728","10.1590/1413-81232021266.44142020","Mental health and internet use by university students: coping strategies in the context of COVID-19.","The aim of this study was to estimate the prevalence of Common Mental Disorders (CMD) among university students and analyze the relation between disorders and internet use and the use of coping strategies in the face of social isolation during the COVID-19 pandemic. We conducted a quantitative cross-sectional study using a non-probability sample of 275 students. Data was collected online using the Self-Reporting Questionnaire, Problematic Internet Use Scale and a coping strategies inventory. We ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adaptation, Psychological; COVID-19; Cross-Sectional Studies; Humans; Internet; Internet Use; Mental Health; Pandemics; SARS-CoV-2; Students; Universities","Monaquezi","Ricardo Manes","Curso de Psicologia, Centro Universitário UniAcademia. R. Halfeld 1.179, Centro. 36016-000 Juiz de Fora MG Brasil",NA
"2251","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Silva","Rodolfo Souza da","Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul (UFRGS). R. Ramiro Barcelos 2400, Campus Saúde. 90035-003 Porto Alegre RS Brasil",NA
"2252","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Schmtiz","Carlos André Aita","TelessaúdeRS, UFRGS. Porto Alegre RS Brasil",NA
"2253","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Harzheim","Erno","Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul (UFRGS). R. Ramiro Barcelos 2400, Campus Saúde. 90035-003 Porto Alegre RS Brasil",NA
"2254","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Molina-Bastos","Cynthia Goulart","Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul (UFRGS). R. Ramiro Barcelos 2400, Campus Saúde. 90035-003 Porto Alegre RS Brasil",NA
"2255","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Oliveira","Elise Botteselle de","TelessaúdeRS, UFRGS. Porto Alegre RS Brasil",NA
"2256","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Roman","Rudi","Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul (UFRGS). R. Ramiro Barcelos 2400, Campus Saúde. 90035-003 Porto Alegre RS Brasil",NA
"2257","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Umpierre","Roberto Nunes","Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul (UFRGS). R. Ramiro Barcelos 2400, Campus Saúde. 90035-003 Porto Alegre RS Brasil",NA
"2258","34231727","10.1590/1413-81232021266.39662020","The Role of Telehealth in the Covid-19 Pandemic: A Brazilian Experience.","SARS-CoV-2, the virus that causes Covid-19, is the third coronavirus to cause severe disease in humans and to spread globally in the past two decades. In this context, several national public health departments, including the Brazilian Ministry of Health, highlighted what was, until then, considered a support service to the health system: telehealth and telemedicine. We intend to present the actions carried out by a national telehealth service in Brazil, both as a Primary Health Care (PHC) suppo","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Pandemics; SARS-CoV-2; Telemedicine","Gonçalves","Marcelo Rodrigues","Programa de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul (UFRGS). R. Ramiro Barcelos 2400, Campus Saúde. 90035-003 Porto Alegre RS Brasil",NA
"2259","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Valentim","Ricardo Alexsandro de Medeiros","Laboratório de Inovação Tecnológica em Saúde (LAIS), Universidade Federal do Rio Grande do Norte (UFRN). Av. Nilo Peçanha 620, Petrópolis. 59012-300 Natal RN Brasil",NA
"2260","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Lima","Thaisa Santos","Ministério da Saúde. Brasília DF Brasil",NA
"2261","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Cortez","Lyane Ramalho","Departamento de Saúde Coletiva, UFRN. Natal RN Brasil",NA
"2262","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Barros","Daniele Montenegro da Silva","Laboratório de Inovação Tecnológica em Saúde (LAIS), Universidade Federal do Rio Grande do Norte (UFRN). Av. Nilo Peçanha 620, Petrópolis. 59012-300 Natal RN Brasil",NA
"2263","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Silva","Rodrigo Dantas da","Laboratório de Inovação Tecnológica em Saúde (LAIS), Universidade Federal do Rio Grande do Norte (UFRN). Av. Nilo Peçanha 620, Petrópolis. 59012-300 Natal RN Brasil",NA
"2264","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Paiva","Jailton Carlos de","Instituto Federal de Educação, Ciência e Tecnologia do Rio Grande do Norte. Natal RN Brasil",NA
"2265","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Coutinho","Karilany Dantas","Laboratório de Inovação Tecnológica em Saúde (LAIS), Universidade Federal do Rio Grande do Norte (UFRN). Av. Nilo Peçanha 620, Petrópolis. 59012-300 Natal RN Brasil",NA
"2266","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Morais","Philippi Sedir Grilo de","Programa de Pós-Graduação em Engenharia Elétrica e de Computação, UFRN. Natal RN Brasil",NA
"2267","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","Lacerda","Juciano de Sousa","Programa de Pós-Graduação em Estudos da Mídia, UFRN. Natal RN Brasil",NA
"2268","34231717","10.1590/1413-81232021266.44122020","The relevance a technology ecosystem in the Brazilian National Health Service's Covid-19 response: the case of Rio Grande do Norte, Brazil.","Technological advances play an undeniable role in strengthening health systems. With regard to digital technologies, information systems and the analysis of health data are playing a growing role in health surveillance and preparing for and responding to disease outbreaks, the theme addressed by this article within the context of the Covid-19 pandemic in the State of Rio Grande do Norte. This study departs from the assumption that digital health interventions can increase Covid-19 response capac","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Ecosystem; Humans; Pandemics; SARS-CoV-2; State Medicine; Technology","André","Fernando Rocha de","Ministério Público Federal do Rio Grande do Norte. Natal RN Brasil",NA
"2269","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Perissotto","Thais","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2270","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Silva","Thamires Clair Rodrigues Pereira da","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2271","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Miskulin","Fabricio Petermann Choueiri","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2272","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Pereira","Mariana Berwerth","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2273","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Neves","Beatriz Astolfi","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2274","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Almeida","Beatriz Cantieri","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2275","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Casagrande","Amanda Victoria","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2276","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Ribeiz","Salma Rose Imanari","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2277","34231710","10.6061/clinics/2021/e3007","Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes.","The COVID-19 pandemic brought abrupt changes when quarantine measures were implemented. Most medical students had distance learning as their main content delivery mode, but in clerkship (fifth and sixth years), in-person activities were maintained under new protocols. These different modes may have affected student mental health. This study examines mental burden and empathy in medical students during the beginning of the COVID-19 pandemic according to the year of attendance. All students attend","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","Anxiety; COVID-19; Depression; Humans; Mental Health; Pandemics; Quarantine; SARS-CoV-2; Students, Medical","Nunes","Paula Villela","Faculdade de Medicina de Jundiai, Jundiai, SP, BR",NA
"2278","34231709","10.6061/clinics/2021/e2900","Extrapulmonary onset manifestations of COVID-19.","Coronavirus disease (COVID-19) usually starts with pulmonary signs and symptoms. However, in some cases, the initial clinical presentations are extrapulmonary. This literature review aimed at summarizing and discussing the extrapulmonary onset manifestations of COVID-19. The most frequent initial extrapulmonary manifestations include hypogeusia, hyposmia, non-specific abdominal symptoms, corneal congestion, and deep venous thrombosis. Several rarer extrapulmonary manifestations in locations such","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","COVID-19; Humans; Lung; SARS-CoV-2","Finsterer","Josef","Klinik Landstrasse, Messerli Institute, Vienna, Austria",NA
"2279","34231709","10.6061/clinics/2021/e2900","Extrapulmonary onset manifestations of COVID-19.","Coronavirus disease (COVID-19) usually starts with pulmonary signs and symptoms. However, in some cases, the initial clinical presentations are extrapulmonary. This literature review aimed at summarizing and discussing the extrapulmonary onset manifestations of COVID-19. The most frequent initial extrapulmonary manifestations include hypogeusia, hyposmia, non-specific abdominal symptoms, corneal congestion, and deep venous thrombosis. Several rarer extrapulmonary manifestations in locations such","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","COVID-19; Humans; Lung; SARS-CoV-2","Scorza","Fulvio A","Disciplina de Neurociencia, Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR",NA
"2280","34231709","10.6061/clinics/2021/e2900","Extrapulmonary onset manifestations of COVID-19.","Coronavirus disease (COVID-19) usually starts with pulmonary signs and symptoms. However, in some cases, the initial clinical presentations are extrapulmonary. This literature review aimed at summarizing and discussing the extrapulmonary onset manifestations of COVID-19. The most frequent initial extrapulmonary manifestations include hypogeusia, hyposmia, non-specific abdominal symptoms, corneal congestion, and deep venous thrombosis. Several rarer extrapulmonary manifestations in locations such","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","COVID-19; Humans; Lung; SARS-CoV-2","Scorza","Carla A","Disciplina de Neurociencia, Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR",NA
"2281","34231709","10.6061/clinics/2021/e2900","Extrapulmonary onset manifestations of COVID-19.","Coronavirus disease (COVID-19) usually starts with pulmonary signs and symptoms. However, in some cases, the initial clinical presentations are extrapulmonary. This literature review aimed at summarizing and discussing the extrapulmonary onset manifestations of COVID-19. The most frequent initial extrapulmonary manifestations include hypogeusia, hyposmia, non-specific abdominal symptoms, corneal congestion, and deep venous thrombosis. Several rarer extrapulmonary manifestations in locations such","2021","07","09","Clinics (Sao Paulo)","Clinics (Sao Paulo, Brazil)","COVID-19; Humans; Lung; SARS-CoV-2","Fiorini","Ana C","Programa de Estudos Pos-Graduados em Fonoaudiologia, Pontificia Universidade Catolica de Sao Paulo (PUC-SP), Sao Paulo, SP, BR, Departamento de Fonoaudiologia, Escola Paulista de Medicina/Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR",NA
"2282","34231699","10.1590/1413-81232021267.05892021","The science between the infodemic and other post-truth narratives: challenges during the pandemic.","This essay proposes a reflection on the social phenomenon that involves communication and construction of facts and narratives around science and the pandemic. We divide the text into four parts. It begins with a rapid overview on the disinformation over health in the context of the global digital integration: in the sequence, we argue about how this phenomenon is characteristic of the post-factual era in which we live, and then critically situate the denial of science in the pandemic context. F","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Europe; Humans; Pandemics; SARS-CoV-2; Social Media","Giordani","Rubia Carla Formighieri","Programa de Pós-Graduação em Políticas Públicas, Universidade Federal do Paraná. Av. Prefeito Lothário Meissner 632, Jardim Botânico. 80210-170 Curitiba PR Brasil. rubiagiordani@gmail","rubiagiordani@gmail.com"
"2283","34231699","10.1590/1413-81232021267.05892021","The science between the infodemic and other post-truth narratives: challenges during the pandemic.","This essay proposes a reflection on the social phenomenon that involves communication and construction of facts and narratives around science and the pandemic. We divide the text into four parts. It begins with a rapid overview on the disinformation over health in the context of the global digital integration: in the sequence, we argue about how this phenomenon is characteristic of the post-factual era in which we live, and then critically situate the denial of science in the pandemic context. F","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Europe; Humans; Pandemics; SARS-CoV-2; Social Media","Donasolo","João Pedro Giordani","Curso de Ciência de Dados e Inteligência Artificial, Fundação Getúlio Vargas. Rio de Janeiro RJ Brasil",NA
"2284","34231699","10.1590/1413-81232021267.05892021","The science between the infodemic and other post-truth narratives: challenges during the pandemic.","This essay proposes a reflection on the social phenomenon that involves communication and construction of facts and narratives around science and the pandemic. We divide the text into four parts. It begins with a rapid overview on the disinformation over health in the context of the global digital integration: in the sequence, we argue about how this phenomenon is characteristic of the post-factual era in which we live, and then critically situate the denial of science in the pandemic context. F","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Europe; Humans; Pandemics; SARS-CoV-2; Social Media","Ames","Valesca Daiana Both","Programa de Pós-Graduação em Sociologia, Universidade Federal do Paraná. Curitiba PR Brasil",NA
"2285","34231699","10.1590/1413-81232021267.05892021","The science between the infodemic and other post-truth narratives: challenges during the pandemic.","This essay proposes a reflection on the social phenomenon that involves communication and construction of facts and narratives around science and the pandemic. We divide the text into four parts. It begins with a rapid overview on the disinformation over health in the context of the global digital integration: in the sequence, we argue about how this phenomenon is characteristic of the post-factual era in which we live, and then critically situate the denial of science in the pandemic context. F","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Europe; Humans; Pandemics; SARS-CoV-2; Social Media","Giordani","Rosselane Liz","Programa de Pós-Graduação em Letras, Universidade Estadual do Oeste do Paraná. Cascavel PR Brasil",NA
"2286","34231698","10.1590/1413-81232021267.04302021","Backdrop to the development of Brazil's national COVID-19 immunization plan.","The process of developing Brazil's COVID-19 immunization plan began belatedly and involved a number of experts, including a technical group responsible for defining priority groups for vaccination. This process was permeated by contradictions between the government and researchers. Finally, on 20 January 2021, the government published an updated version of the plan, which remains limited in scope. O processo de elaboração do Plano de Imunização contra Covid-19 no Brasil se iniciou tardiamente e ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Immunization; SARS-CoV-2; Vaccination","Macedo","Laylla Ribeiro","Laboratório de Epidemiologia, Universidade Federal do Espírito Santo. Av. Fernando Ferrari 514, Goiabeiras. 29075-910 Vitória ES Brasil. layllarm@hotmail","layllarm@hotmail.com"
"2287","34231698","10.1590/1413-81232021267.04302021","Backdrop to the development of Brazil's national COVID-19 immunization plan.","The process of developing Brazil's COVID-19 immunization plan began belatedly and involved a number of experts, including a technical group responsible for defining priority groups for vaccination. This process was permeated by contradictions between the government and researchers. Finally, on 20 January 2021, the government published an updated version of the plan, which remains limited in scope. O processo de elaboração do Plano de Imunização contra Covid-19 no Brasil se iniciou tardiamente e ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Immunization; SARS-CoV-2; Vaccination","Struchiner","Claudio Jose","Escola de Matemática Aplicada, Fundação Getúlio Vargas. Rio de Janeiro RJ Brasil",NA
"2288","34231698","10.1590/1413-81232021267.04302021","Backdrop to the development of Brazil's national COVID-19 immunization plan.","The process of developing Brazil's COVID-19 immunization plan began belatedly and involved a number of experts, including a technical group responsible for defining priority groups for vaccination. This process was permeated by contradictions between the government and researchers. Finally, on 20 January 2021, the government published an updated version of the plan, which remains limited in scope. O processo de elaboração do Plano de Imunização contra Covid-19 no Brasil se iniciou tardiamente e ","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Brazil; COVID-19; Humans; Immunization; SARS-CoV-2; Vaccination","Maciel","Ethel Leonor Noia","Laboratório de Epidemiologia, Universidade Federal do Espírito Santo. Av. Fernando Ferrari 514, Goiabeiras. 29075-910 Vitória ES Brasil. layllarm@hotmail","layllarm@hotmail.com"
"2289","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Prado","Nilia Maria de Brito Lima","Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia. Campus Anísio Teixeira. Rua Hormindo Barros 58 Quadra 17 Lote 58. 45029-094 Vitória da Conquista. BA Brasil. nilia.prado@ufba","nilia.prado@ufba.br"
"2290","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Biscarde","Daniela Gomes Dos Santos","Escola de Enfermagem, Universidade Federal da Bahia. Salvador BA Brasil",NA
"2291","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Pinto Junior","Elzo Pereira","Centro de Integração de Dados e Conhecimentos para a Saúde, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz. Parque Tecnológico da Bahia. Salvador BA Brasil",NA
"2292","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Santos","Hebert Luan Pereira Campos Dos","Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia. Vitória da Conquista BA Brasil",NA
"2293","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Mota","Sara Emanuela de Carvalho","Superintendência Estadual, Ministério da Saúde na Bahia. Salvador BA Brasil",NA
"2294","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Menezes","Erica Lima Costa de","Núcleo Técnico Científico de Telessaúde, Diretoria de Atenção Básica, Secretaria de Saúde do Estado da Bahia. Salvador BA Brasil",NA
"2295","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Oliveira","Josilene Silva","Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia. Campus Anísio Teixeira. Rua Hormindo Barros 58 Quadra 17 Lote 58. 45029-094 Vitória da Conquista. BA Brasil. nilia.prado@ufba","nilia.prado@ufba.br"
"2296","34231697","10.1590/1413-81232021267.00582021","Primary care-based health surveillance actions in response to the COVID-19 pandemic: contributions to the debate.","We conducted an integrated literature review aimed at reflecting on the challenges related to primary care-based health surveillance actions in response to the COVID-19 pandemic in selected countries. The study included countries with different PHC models that adopted surveillance as an approach to control the transmission of COVID-19. We performed a search in October 2020 for relevant literature and norms and guidelines related to the organization of primary health care (PHC) in response to the","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","COVID-19; Government; Humans; Pandemics; Primary Health Care; SARS-CoV-2","Santos","Adriano Maia Dos","Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia. Campus Anísio Teixeira. Rua Hormindo Barros 58 Quadra 17 Lote 58. 45029-094 Vitória da Conquista. BA Brasil. nilia.prado@ufba","nilia.prado@ufba.br"
"2297","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Malta","Deborah Carvalho","Departamento de Enfermagem Materno-Infantil e Saúde Pública, Universidade Federal de Minas Gerais. Av. Alfredo Balena 190 5º andar, Escola de Enfermagem, Santa Efigênia. 30130100 Belo Horizonte MG Brasil. dcmalta@uol.com","dcmalta@uol.com.br"
"2298","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Gomes","Crizian Saar","Programa de Pós-Graduação em Enfermagem, Escola de Enfermagem, Universidade Federal de Minas Gerais. Belo Horizonte MG Brasil",NA
"2299","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Silva","Alanna Gomes da","Programa de Pós-Graduação em Enfermagem, Escola de Enfermagem, Universidade Federal de Minas Gerais. Belo Horizonte MG Brasil",NA
"2300","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Cardoso","Laís Santos de Magalhães","Programa de Pós-Graduação em Enfermagem, Escola de Enfermagem, Universidade Federal de Minas Gerais. Belo Horizonte MG Brasil",NA
"2301","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Barros","Marilisa Berti de Azevedo","Departamento de Saúde Coletiva, Faculdade de Ciências Médicas, Universidade Estadual de Campinas. Campinas São Paulo Brasil",NA
"2302","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Lima","Margareth Guimarães","Departamento de Saúde Coletiva, Faculdade de Ciências Médicas, Universidade Estadual de Campinas. Campinas São Paulo Brasil",NA
"2303","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Souza Junior","Paulo Roberto Borges de","Instituto de Comunicação e Informação Científica e Tecnológica em Saúde, Fundação Oswaldo Cruz. Rio de Janeiro RJ Brasil",NA
"2304","34231696","10.1590/1413-81232021267.00602021","Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020.","The present study investigates the association between the self-reported diagnosis of noncommunicable disease (NCD) and the adherence to social distancing and the use of health services during the COVID-19 pandemic. This was a cross-sectional study with Brazilian adults who participated in the ConVid- Behavior Survey, conducted online between April 24 and May 24, 2020(n = 45.161). This studyconsidered the following NCDs: diabetes, hypertension, respiratory disease, heart disease, and cancer, and","2021","07","08","Cien Saude Colet","Ciencia &amp; saude coletiva","Adult; Brazil; COVID-19; Cross-Sectional Studies; Health Services; Humans; Noncommunicable Diseases; Pandemics; Physical Distancing; SARS-CoV-2","Szwarcwald","Célia Landmann","Instituto de Comunicação e Informação Científica e Tecnológica em Saúde, Fundação Oswaldo Cruz. Rio de Janeiro RJ Brasil",NA
"2305","34231649","10.1590/0004-282X-ANP-2020-0488","Telemedicine use among neurologists before and during COVID-19 pandemic.","After the public health emergency due to COVID-19 was declared in Brazil, the federal government temporarily regulated and authorized the use of telemedicine services for patient consultation, monitoring, and diagnosis. For more than a decade, neurologists have recognized the benefits of telemedicine in the acute management of stroke patients. However, as the use of telemedicine was restricted until the COVID-19 pandemic, the view of Brazilian neurologists about telemedicine is unknown. All neur","2021","07","07","Arq Neuropsiquiatr","Arquivos de neuro-psiquiatria",NA,"Aquino","Emanuelle Roberta da Silva","Academia Brasileira de Neurologia, Comissão Aberta de Telemedicina, São Paulo SP, Brazil",NA
"2306","34231649","10.1590/0004-282X-ANP-2020-0488","Telemedicine use among neurologists before and during COVID-19 pandemic.","After the public health emergency due to COVID-19 was declared in Brazil, the federal government temporarily regulated and authorized the use of telemedicine services for patient consultation, monitoring, and diagnosis. For more than a decade, neurologists have recognized the benefits of telemedicine in the acute management of stroke patients. However, as the use of telemedicine was restricted until the COVID-19 pandemic, the view of Brazilian neurologists about telemedicine is unknown. All neur","2021","07","07","Arq Neuropsiquiatr","Arquivos de neuro-psiquiatria",NA,"Domingues","Renan Barros","Academia Brasileira de Neurologia, Comissão Aberta de Telemedicina, São Paulo SP, Brazil",NA
"2307","34231649","10.1590/0004-282X-ANP-2020-0488","Telemedicine use among neurologists before and during COVID-19 pandemic.","After the public health emergency due to COVID-19 was declared in Brazil, the federal government temporarily regulated and authorized the use of telemedicine services for patient consultation, monitoring, and diagnosis. For more than a decade, neurologists have recognized the benefits of telemedicine in the acute management of stroke patients. However, as the use of telemedicine was restricted until the COVID-19 pandemic, the view of Brazilian neurologists about telemedicine is unknown. All neur","2021","07","07","Arq Neuropsiquiatr","Arquivos de neuro-psiquiatria",NA,"Mantese","Carlos Eduardo","Academia Brasileira de Neurologia, Comissão Aberta de Telemedicina, São Paulo SP, Brazil",NA
"2308","34231649","10.1590/0004-282X-ANP-2020-0488","Telemedicine use among neurologists before and during COVID-19 pandemic.","After the public health emergency due to COVID-19 was declared in Brazil, the federal government temporarily regulated and authorized the use of telemedicine services for patient consultation, monitoring, and diagnosis. For more than a decade, neurologists have recognized the benefits of telemedicine in the acute management of stroke patients. However, as the use of telemedicine was restricted until the COVID-19 pandemic, the view of Brazilian neurologists about telemedicine is unknown. All neur","2021","07","07","Arq Neuropsiquiatr","Arquivos de neuro-psiquiatria",NA,"Fantini","Francisca Goreth Malheiro Moraes","Academia Brasileira de Neurologia, Comissão de Exercício Profissional, São Paulo SP, Brazil",NA
"2309","34231649","10.1590/0004-282X-ANP-2020-0488","Telemedicine use among neurologists before and during COVID-19 pandemic.","After the public health emergency due to COVID-19 was declared in Brazil, the federal government temporarily regulated and authorized the use of telemedicine services for patient consultation, monitoring, and diagnosis. For more than a decade, neurologists have recognized the benefits of telemedicine in the acute management of stroke patients. However, as the use of telemedicine was restricted until the COVID-19 pandemic, the view of Brazilian neurologists about telemedicine is unknown. All neur","2021","07","07","Arq Neuropsiquiatr","Arquivos de neuro-psiquiatria",NA,"Nitrini","Ricardo","Academia Brasileira de Neurologia, Diretoria Científica, São Paulo SP, Brazil",NA
"2310","34231649","10.1590/0004-282X-ANP-2020-0488","Telemedicine use among neurologists before and during COVID-19 pandemic.","After the public health emergency due to COVID-19 was declared in Brazil, the federal government temporarily regulated and authorized the use of telemedicine services for patient consultation, monitoring, and diagnosis. For more than a decade, neurologists have recognized the benefits of telemedicine in the acute management of stroke patients. However, as the use of telemedicine was restricted until the COVID-19 pandemic, the view of Brazilian neurologists about telemedicine is unknown. All neur","2021","07","07","Arq Neuropsiquiatr","Arquivos de neuro-psiquiatria",NA,"Prado","Gilmar Fernandes do","Academia Brasileira de Neurologia, Diretoria Executiva, São Paulo SP, Brazil",NA
"2311","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"Basso","Caroline Rodrigues","Institute of Biotechnology, UNESP-Botucatu, SP 18607-440, Brazil. caroline.basso@unesp","caroline.basso@unesp.br"
"2312","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"Malossi","Camila Dantas","Institute of Biotechnology, UNESP-Botucatu, SP 18607-440, Brazil. caroline.basso@unesp","caroline.basso@unesp.br"
"2313","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"Haisi","Amanda","Institute of Biotechnology, UNESP-Botucatu, SP 18607-440, Brazil. caroline.basso@unesp","caroline.basso@unesp.br"
"2314","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"de Albuquerque Pedrosa","Valber","Department of Chemistry and Biochemistry, Institute of Bioscience, UNESP-Botucatu, SP 18618-000, Brazil",NA
"2315","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"Barbosa","Alexandre Naime","Department of Infectious Diseases, Dermatology, Diagnostic Imaging and Radiotherapy, Faculty of Medicine of Botucatu, UNESP-Botucatu, SP 18618-687, Brazil",NA
"2316","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"Grotto","Rejane Tommasini","Department of Medical Clinic, Faculty of Medicine of Botucatu, UNESP-Botucatu, SP 18618-687, Brazil",NA
"2317","34231576","10.1039/d1ay00737h","Fast and reliable detection of SARS-CoV-2 antibodies based on surface plasmon resonance.","Researchers worldwide have been studying alternatives to detect SARS-CoV-2 (COVID-19), and accurate and timely diagnosis is crucial for controlling the outbreaks of the disease. Surface plasmon resonance (SPR) is an effective strategy based on antibodies, and it can be used for simple and fast detection of antibodies due to COVID-19 infection. Accordingly, this paper reports on the highly sensitive and specific detection of antibody responses to SARS-CoV-2 spike (S) and nucleocapsid (N) proteins","2021","07","16","Anal Methods","Analytical methods : advancing methods and applications",NA,"Araujo Junior","João Pessoa","Institute of Biotechnology, UNESP-Botucatu, SP 18607-440, Brazil. caroline.basso@unesp","caroline.basso@unesp.br"
"2318","34231548","10.1097/ACO.0000000000001034","Ultrasound-guided regional anesthesia in COVID-19 and future pandemics: infection control.","Infection control is inherent in ultrasound-guided regional anesthesia practice, because ultrasound transducer and coupling gel can be vectors for pathogen transmission. We reviewed the current standards and recommendations of ultrasound transducer cleaning, disinfection, and safe handling of ultrasound equipment. Based on the available data, we propose a set of practical recommendations applicable to coronavirus disease 2019 (COVID-19) pandemic and future epidemics. Regional anesthesia is often","2021","07","07","Curr Opin Anaesthesiol","Current opinion in anaesthesiology",NA,"Murata","Hiroaki","Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Resident in Anesthesiology, KUL, Leuven, Belgium Department of Macroscopic Anatomy, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan",NA
"2319","34231548","10.1097/ACO.0000000000001034","Ultrasound-guided regional anesthesia in COVID-19 and future pandemics: infection control.","Infection control is inherent in ultrasound-guided regional anesthesia practice, because ultrasound transducer and coupling gel can be vectors for pathogen transmission. We reviewed the current standards and recommendations of ultrasound transducer cleaning, disinfection, and safe handling of ultrasound equipment. Based on the available data, we propose a set of practical recommendations applicable to coronavirus disease 2019 (COVID-19) pandemic and future epidemics. Regional anesthesia is often","2021","07","07","Curr Opin Anaesthesiol","Current opinion in anaesthesiology",NA,"Vanegas","Cristina","Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Resident in Anesthesiology, KUL, Leuven, Belgium Department of Macroscopic Anatomy, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan",NA
"2320","34231548","10.1097/ACO.0000000000001034","Ultrasound-guided regional anesthesia in COVID-19 and future pandemics: infection control.","Infection control is inherent in ultrasound-guided regional anesthesia practice, because ultrasound transducer and coupling gel can be vectors for pathogen transmission. We reviewed the current standards and recommendations of ultrasound transducer cleaning, disinfection, and safe handling of ultrasound equipment. Based on the available data, we propose a set of practical recommendations applicable to coronavirus disease 2019 (COVID-19) pandemic and future epidemics. Regional anesthesia is often","2021","07","07","Curr Opin Anaesthesiol","Current opinion in anaesthesiology",NA,"Ogami-Takamura","Keiko","Department of Anesthesiology and Intensive Care Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Resident in Anesthesiology, KUL, Leuven, Belgium Department of Macroscopic Anatomy, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan",NA
"2321","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Song","Lan","Department of Radiology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2322","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Zhu","Zhen Chen","Department of Radiology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2323","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Zhao","Rui Jie","Department of Radiology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2324","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Li","Peng Chang","Department of Laboratory Medicine,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2325","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Tian","Du Xue","Department of Radiology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2326","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Du","Tie Kuan","Department of Emergency,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2327","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Xu","Yan","Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2328","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Yang","Qiwen","Department of Laboratory Medicine,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2329","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Cao","Wei","Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2330","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Song","Wei","Department of Radiology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2331","34231456","10.24920/003821","Epidemiologic Features, Radiological Findings andClinical Outcomes of 19 Patients with COVID-19in a Single Center in Beijing, China.","ObjectiveTo describe the epidemiologic, clinical, laboratory, and radiological characteristics and prognoses of COVID-19 confirmed patients in a single center in Beijing, China. Methods The study retrospectively included 19 patients with nucleic acid-confirmed SARS-CoV-2 infection at our hospital from January 20 to March 5, 2020. The final follow-up date was March 14, 2020. The epidemiologic and clinical information was obtained through direct communication with the patients or their family memb","2021","07","12","Chin Med Sci J","Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","Adult; COVID-19; COVID-19 Nucleic Acid Testing; Child; China; Female; Humans; Lung; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Tomography, X-Ray Computed","Jin","Zheng Yu","Department of Radiology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp",NA
"2332","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Raja","Karan","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2333","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Daniel","Nicole","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2334","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Morrison","Susan","Department of Medicine, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2335","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Patel","Ruben","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2336","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Gerges","Jessica","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2337","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Nadeem","Komal","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2338","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Chen","Brandon","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2339","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Kang","Soo","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2340","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Patel","Mitesh","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2341","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Beggs","Donald","Department of Medicine, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2342","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Attalla","Mark","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2343","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Ballem","Naveen","Department of Medicine, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2344","34231415","10.1177/08971900211028208","Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.","Tocilizumab is an interleukin-6 receptor antagonist hypothesized to blunt the uncontrolled immune response, cytokine release syndrome, in severe COVID-19 and prevent attributable morbidity and mortality. Objective: The objective of this study was to assess the impact of tocilizumab on clinical outcomes in COVID-19-associated cytokine release syndrome. Single-center, retrospective cohort study assessing sixty-nine adult patients receiving tocilizumab for suspected COVID-19 cytokine release syndro","2021","07","07","J Pharm Pract","Journal of pharmacy practice","COVID-19; cytokine release syndrome; cytokine storm; interleukin-6 receptor antagonist; tocilizumab","Philips","Mona","Department of Pharmacy, Clara Maass Medical Center, Belleville, NJ, USA",NA
"2345","34231414","10.1177/17407745211027245","Navigating the ethics of remote research data collection.","COVID-19 has accelerated broad trends already in place toward remote research data collection and monitoring. This move implicates novel ethical and regulatory challenges which have not yet received due attention. Existing work is preliminary and does not seek to identify or grapple with the issues in a rigorous and sophisticated way. Here, we provide a framework for identifying and addressing challenges that we believe can help the research community realize the benefits of remote technologies ","2021","07","07","Clin Trials","Clinical trials (London, England)","Mobile health; remote monitoring; research ethics","Gelinas","Luke","Advarra IRB, Columbia, MD, USA",NA
"2346","34231414","10.1177/17407745211027245","Navigating the ethics of remote research data collection.","COVID-19 has accelerated broad trends already in place toward remote research data collection and monitoring. This move implicates novel ethical and regulatory challenges which have not yet received due attention. Existing work is preliminary and does not seek to identify or grapple with the issues in a rigorous and sophisticated way. Here, we provide a framework for identifying and addressing challenges that we believe can help the research community realize the benefits of remote technologies ","2021","07","07","Clin Trials","Clinical trials (London, England)","Mobile health; remote monitoring; research ethics","Morrell","Walker","Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Cambridge, MA, USA",NA
"2347","34231414","10.1177/17407745211027245","Navigating the ethics of remote research data collection.","COVID-19 has accelerated broad trends already in place toward remote research data collection and monitoring. This move implicates novel ethical and regulatory challenges which have not yet received due attention. Existing work is preliminary and does not seek to identify or grapple with the issues in a rigorous and sophisticated way. Here, we provide a framework for identifying and addressing challenges that we believe can help the research community realize the benefits of remote technologies ","2021","07","07","Clin Trials","Clinical trials (London, England)","Mobile health; remote monitoring; research ethics","White","Sarah A","Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Cambridge, MA, USA",NA
"2348","34231414","10.1177/17407745211027245","Navigating the ethics of remote research data collection.","COVID-19 has accelerated broad trends already in place toward remote research data collection and monitoring. This move implicates novel ethical and regulatory challenges which have not yet received due attention. Existing work is preliminary and does not seek to identify or grapple with the issues in a rigorous and sophisticated way. Here, we provide a framework for identifying and addressing challenges that we believe can help the research community realize the benefits of remote technologies ","2021","07","07","Clin Trials","Clinical trials (London, England)","Mobile health; remote monitoring; research ethics","Bierer","Barbara E","Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Cambridge, MA, USA",NA
"2349","34231411","10.1177/19375867211026571","Changes of Walking Activity During the First Cycle Phases of COVID-19 Pandemic: A Case Study of Seoul, Korea.","This study explores the changes in regular walking activities during the phases of the pandemic. With the spread of COVID-19 transmission, people are refraining from going out, reducing their physical activity. In South Korea, COVID-19 broke out in the 4th week of 2020 and experienced the first cycle phases of the pandemic, such as outbreak, widespread, and decline. In response to the pandemic, the government encouraged voluntary participation in social distancing campaigns, and people reduced t","2021","07","07","HERD","HERD","COVID-19; pandemic phase; physical activity; regular walking; smartphone monitoring","Park","Youngjun","Department of Architecture &amp",NA
"2350","34231411","10.1177/19375867211026571","Changes of Walking Activity During the First Cycle Phases of COVID-19 Pandemic: A Case Study of Seoul, Korea.","This study explores the changes in regular walking activities during the phases of the pandemic. With the spread of COVID-19 transmission, people are refraining from going out, reducing their physical activity. In South Korea, COVID-19 broke out in the 4th week of 2020 and experienced the first cycle phases of the pandemic, such as outbreak, widespread, and decline. In response to the pandemic, the government encouraged voluntary participation in social distancing campaigns, and people reduced t","2021","07","07","HERD","HERD","COVID-19; pandemic phase; physical activity; regular walking; smartphone monitoring","Chung","Haekwon","Swallaby Inc., Seoul, Republic of Korea",NA
"2351","34231411","10.1177/19375867211026571","Changes of Walking Activity During the First Cycle Phases of COVID-19 Pandemic: A Case Study of Seoul, Korea.","This study explores the changes in regular walking activities during the phases of the pandemic. With the spread of COVID-19 transmission, people are refraining from going out, reducing their physical activity. In South Korea, COVID-19 broke out in the 4th week of 2020 and experienced the first cycle phases of the pandemic, such as outbreak, widespread, and decline. In response to the pandemic, the government encouraged voluntary participation in social distancing campaigns, and people reduced t","2021","07","07","HERD","HERD","COVID-19; pandemic phase; physical activity; regular walking; smartphone monitoring","Park","Sohyun","Department of Architecture &amp",NA
"2352","34231409","10.1177/21501327211030135","Social Connectivity During the COVID-19 Pandemic: Disparities among Medicare Beneficiaries.","Social connections are essential for health and well-being at all ages and may be especially important for promoting health in later life. Maintaining social connections, however, became increasingly difficult during the COVID-19 pandemic when stay-at-home orders were enacted, and social distancing became necessary. This study examines the social connectivity among Medicare beneficiaries during the COVID-19 pandemic highlighting the importance technological availability, income, and race. Data f","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; medicare; racial disparities; social connectivity; Aged; COVID-19; Ethnic Groups; Humans; Medicare; Pandemics; SARS-CoV-2; United States","Jacobs","Molly","East Carolina University, Greenville, NC, USA",NA
"2353","34231409","10.1177/21501327211030135","Social Connectivity During the COVID-19 Pandemic: Disparities among Medicare Beneficiaries.","Social connections are essential for health and well-being at all ages and may be especially important for promoting health in later life. Maintaining social connections, however, became increasingly difficult during the COVID-19 pandemic when stay-at-home orders were enacted, and social distancing became necessary. This study examines the social connectivity among Medicare beneficiaries during the COVID-19 pandemic highlighting the importance technological availability, income, and race. Data f","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; medicare; racial disparities; social connectivity; Aged; COVID-19; Ethnic Groups; Humans; Medicare; Pandemics; SARS-CoV-2; United States","Ellis","Charles","East Carolina University, Greenville, NC, USA",NA
"2354","34231408","10.1177/08850666211030899","Utilization of Airway Pressure Release Ventilation as a Rescue Strategy in COVID-19 Patients: A Retrospective Analysis.","Airway Pressure Release Ventilation (APRV) is a pressure controlled intermittent mandatory mode of ventilation characterized by prolonged inspiratory time and high mean airway pressure. Several studies have demonstrated that APRV can improve oxygenation and lung recruitment in patients with Acute Respiratory Distress Syndrome (ARDS). Although most patients with COVID-19 meet the Berlin criteria for ARDS, hypoxic respiratory failure due to COVID-19 may differ from traditional ARDS as patients oft","2021","07","10","J Intensive Care Med","Journal of intensive care medicine","intensive care unit; mechanical ventilation; respiratory failure","Mahmoud","Omar","Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and Mount Sinai West Hospital, New York, NY, USA",NA
"2355","34231408","10.1177/08850666211030899","Utilization of Airway Pressure Release Ventilation as a Rescue Strategy in COVID-19 Patients: A Retrospective Analysis.","Airway Pressure Release Ventilation (APRV) is a pressure controlled intermittent mandatory mode of ventilation characterized by prolonged inspiratory time and high mean airway pressure. Several studies have demonstrated that APRV can improve oxygenation and lung recruitment in patients with Acute Respiratory Distress Syndrome (ARDS). Although most patients with COVID-19 meet the Berlin criteria for ARDS, hypoxic respiratory failure due to COVID-19 may differ from traditional ARDS as patients oft","2021","07","10","J Intensive Care Med","Journal of intensive care medicine","intensive care unit; mechanical ventilation; respiratory failure","Patadia","Deep","Division of Pulmonary and Critical Care, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside, Mount Sinai West, and Mount Sinai Beth Israel Hospital, New York, NY, USA",NA
"2356","34231408","10.1177/08850666211030899","Utilization of Airway Pressure Release Ventilation as a Rescue Strategy in COVID-19 Patients: A Retrospective Analysis.","Airway Pressure Release Ventilation (APRV) is a pressure controlled intermittent mandatory mode of ventilation characterized by prolonged inspiratory time and high mean airway pressure. Several studies have demonstrated that APRV can improve oxygenation and lung recruitment in patients with Acute Respiratory Distress Syndrome (ARDS). Although most patients with COVID-19 meet the Berlin criteria for ARDS, hypoxic respiratory failure due to COVID-19 may differ from traditional ARDS as patients oft","2021","07","10","J Intensive Care Med","Journal of intensive care medicine","intensive care unit; mechanical ventilation; respiratory failure","Salonia","James","Division of Pulmonary and Critical Care, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside, Mount Sinai West, and Mount Sinai Beth Israel Hospital, New York, NY, USA",NA
"2357","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Bierle","Dennis M","Mayo Clinic, Rochester, MN, USA",NA
"2358","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Aakre","Christopher A","Mayo Clinic, Rochester, MN, USA",NA
"2359","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Grach","Stephanie L","Mayo Clinic, Rochester, MN, USA",NA
"2360","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Salonen","Bradley R","Mayo Clinic, Rochester, MN, USA",NA
"2361","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Croghan","Ivana T","Mayo Clinic, Rochester, MN, USA",NA
"2362","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Hurt","Ryan T","Mayo Clinic, Rochester, MN, USA",NA
"2363","34231404","10.1177/21501327211030826","Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome.","To develop and implement criteria for description of post COVID syndrome based on analysis of patients presenting for evaluation at Mayo Clinic Rochester between November 2019 and August 2020. A total of 465 patients with a history of testing positive for COVID-19 were identified and their medical records reviewed. After a thorough review, utilizing the DELPHI methods by an expert panel, 42 (9%) cases were identified with persistent central sensitization (CS) symptoms persisting after the resolu","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; central sensitization; fibromyalgia; post-covid syndrome; postural orthostatic tachycardia syndrome; COVID-19; Central Nervous System Sensitization; Humans; Middle Aged; Phenotype; SARS-CoV-2","Ganesh","Ravindra","Mayo Clinic, Rochester, MN, USA",NA
"2364","34231400","10.1177/08971900211030652","Pharmacy Telehealth Services: Perspectives From an Academic Medical Center.","Telehealth allows patients to receive healthcare with the aid of technology by overcoming physical barriers. The Coronavirus Disease 2019 (COVID-19) pandemic created challenges with regards to in person patient care. The use of video visits and telehealth increased in a rapid manner due to the COVID-19 pandemic. The objective of this paper is to describe telehealth services utilized by pharmacists at a large, academic medical center. Pharmacists teaching and clinical services conducted via teleh","2021","07","07","J Pharm Pract","Journal of pharmacy practice","clinical pharmacy; pharmacy services; telemedicine","Zhou","Crystal","University of California at San Francisco School of Pharmacy, San Francisco, CA, USA",NA
"2365","34231400","10.1177/08971900211030652","Pharmacy Telehealth Services: Perspectives From an Academic Medical Center.","Telehealth allows patients to receive healthcare with the aid of technology by overcoming physical barriers. The Coronavirus Disease 2019 (COVID-19) pandemic created challenges with regards to in person patient care. The use of video visits and telehealth increased in a rapid manner due to the COVID-19 pandemic. The objective of this paper is to describe telehealth services utilized by pharmacists at a large, academic medical center. Pharmacists teaching and clinical services conducted via teleh","2021","07","07","J Pharm Pract","Journal of pharmacy practice","clinical pharmacy; pharmacy services; telemedicine","Pavlakos","Rose","University of California at San Francisco School of Pharmacy, San Francisco, CA, USA",NA
"2366","34231400","10.1177/08971900211030652","Pharmacy Telehealth Services: Perspectives From an Academic Medical Center.","Telehealth allows patients to receive healthcare with the aid of technology by overcoming physical barriers. The Coronavirus Disease 2019 (COVID-19) pandemic created challenges with regards to in person patient care. The use of video visits and telehealth increased in a rapid manner due to the COVID-19 pandemic. The objective of this paper is to describe telehealth services utilized by pharmacists at a large, academic medical center. Pharmacists teaching and clinical services conducted via teleh","2021","07","07","J Pharm Pract","Journal of pharmacy practice","clinical pharmacy; pharmacy services; telemedicine","Clark","Mackenzie","UCSF Medical Center, San Francisco, CA, USA",NA
"2367","34231400","10.1177/08971900211030652","Pharmacy Telehealth Services: Perspectives From an Academic Medical Center.","Telehealth allows patients to receive healthcare with the aid of technology by overcoming physical barriers. The Coronavirus Disease 2019 (COVID-19) pandemic created challenges with regards to in person patient care. The use of video visits and telehealth increased in a rapid manner due to the COVID-19 pandemic. The objective of this paper is to describe telehealth services utilized by pharmacists at a large, academic medical center. Pharmacists teaching and clinical services conducted via teleh","2021","07","07","J Pharm Pract","Journal of pharmacy practice","clinical pharmacy; pharmacy services; telemedicine","Jue","Vicki I","UCSF Medical Center, San Francisco, CA, USA",NA
"2368","34231400","10.1177/08971900211030652","Pharmacy Telehealth Services: Perspectives From an Academic Medical Center.","Telehealth allows patients to receive healthcare with the aid of technology by overcoming physical barriers. The Coronavirus Disease 2019 (COVID-19) pandemic created challenges with regards to in person patient care. The use of video visits and telehealth increased in a rapid manner due to the COVID-19 pandemic. The objective of this paper is to describe telehealth services utilized by pharmacists at a large, academic medical center. Pharmacists teaching and clinical services conducted via teleh","2021","07","07","J Pharm Pract","Journal of pharmacy practice","clinical pharmacy; pharmacy services; telemedicine","Clinard","Valerie B","University of California at San Francisco School of Pharmacy, San Francisco, CA, USA",NA
"2369","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Ganesh","Ravindra","Mayo Clinic, Rochester, MN, USA",NA
"2370","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Ghosh","Aditya K","Mayo Clinic, Rochester, MN, USA",NA
"2371","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Nyman","Mark A","Mayo Clinic, Rochester, MN, USA",NA
"2372","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Croghan","Ivana T","Mayo Clinic, Rochester, MN, USA",NA
"2373","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Grach","Stephanie L","Mayo Clinic, Rochester, MN, USA",NA
"2374","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Anstine","Christopher V","Mayo Clinic, Rochester, MN, USA",NA
"2375","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Salonen","Bradley R","Mayo Clinic, Rochester, MN, USA",NA
"2376","34231395","10.1177/21501327211030413","PROMIS Scales for Assessment of Persistent Post-COVID Symptoms: A Cross Sectional Study.","Persistent post-COVID symptoms are estimated to occur in up to 10% of patients who have had COVID-19. These lingering symptoms may persist for weeks to months after resolution of the acute illness. This study aimed to add insight into our understanding of certain post-acute conditions and clinical findings. The primary purpose was to determine the persistent post COVID impairments prevalence and characteristics by collecting post COVID illness data utilizing Patient-Reported Outcomes Measurement","2021","07","09","J Prim Care Community Health","Journal of primary care &amp; community health","COVID-19; PASC; PROMIS; SARS-CoV-2; fatigue; long haulers; post COVID symptoms; post COVID syndrome; social roles; survey; COVID-19; Cross-Sectional Studies; Fatigue; Female; Health Status; Humans; Quality of Life; SARS-CoV-2; Surveys and Questionnaires","Hurt","Ryan T","Mayo Clinic, Rochester, MN, USA",NA
"2377","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Lam","Lk Metthew","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2378","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Reilly","John Patrick","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2379","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Rux","Ann H","Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2380","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Murphy","Sophia","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2381","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Kuri-Cervantes","Leticia","Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2382","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Weisman","Ariel","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2383","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Ittner","Caroline Ag","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2384","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Pampena","M Betina","Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2385","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Betts","Michael","Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2386","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Wherry","E John","Penn Institute for Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2387","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Song","Wen-Chao","Penn Institute for Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2388","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Lambris","John D","Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia PA, United States",NA
"2389","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Meyer","Nuala J","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2390","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Cines","Douglas B","Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States",NA
"2391","34231390","10.1152/ajplung.00231.2021","Erythrocytes Identify Complement Activation in Patients with COVID-19.","COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multi-system organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and pre-clinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in COVID-19 patients u","2021","07","07","Am J Physiol Lung Cell Mol Physiol","American journal of physiology. Lung cellular and molecular physiology","COVID-19; Complement; Erythrocyte; Immune Adherence; Sepsis","Mangalmurti","Nilam S","Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the grid.25879.31University of Pennsylvania, Philadelphia, PA, United States",NA
"2392","34231385","10.1024/1661-8157/a003681","[CME Sonography 98/Answers: Chest Ultrasound].","CME Sonography 98/Answers: Chest Ultrasound Abstract. Chest sonography has long been an important part of ultrasound diagnostics. Historically, the first evidence found in chest sonography were pleural effusions. Peripheral consolidations (pneumonia, tumors, pulmonary embolism) and pneumothorax were added later. The COVID-19 pandemic with often massive lung infestation has significantly increased the interest in thoracic sonography. The partially specific changes caused by COVID-19 are presented","2021","07","08","Praxis (Bern 1994)","Praxis","COVID-19; Lungenembolie; Pleuraerguss; Pleural effusion; Pneumonie; Pneumothorax; pneumonia; pneumothorax; pulmonary embolism; COVID-19; Humans; Pandemics; Pleural Effusion; Pneumothorax; SARS-CoV-2; Ultrasonography","Bürge","Tobias","Ultrasound Learning Center (ULC) der European Federation of Ultrasound in Medicine and Biology (EFSUMB), Klinik Hirslanden, Zürich",NA
"2393","34231385","10.1024/1661-8157/a003681","[CME Sonography 98/Answers: Chest Ultrasound].","CME Sonography 98/Answers: Chest Ultrasound Abstract. Chest sonography has long been an important part of ultrasound diagnostics. Historically, the first evidence found in chest sonography were pleural effusions. Peripheral consolidations (pneumonia, tumors, pulmonary embolism) and pneumothorax were added later. The COVID-19 pandemic with often massive lung infestation has significantly increased the interest in thoracic sonography. The partially specific changes caused by COVID-19 are presented","2021","07","08","Praxis (Bern 1994)","Praxis","COVID-19; Lungenembolie; Pleuraerguss; Pleural effusion; Pneumonie; Pneumothorax; pneumonia; pneumothorax; pulmonary embolism; COVID-19; Humans; Pandemics; Pleural Effusion; Pneumothorax; SARS-CoV-2; Ultrasonography","Tuma","Jan","Ultrasound Learning Center (ULC) der European Federation of Ultrasound in Medicine and Biology (EFSUMB), Klinik Hirslanden, Zürich",NA
"2394","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Lehmann","Beat","Universitäres Notfallzentrum, Inselspital, Universität Bern, Bern",NA
"2395","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Baumgartner","Christine","Universitätsklinik für Allgemeine Innere Medizin, Inselspital, Universität Bern, Bern",NA
"2396","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Brill","Anne-Kathrin","Universitätsklinik für Pneumologie, Inselspital, Universität Bern, Bern",NA
"2397","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Günther","Gunar","Universitätsklinik für Pneumologie, Inselspital, Universität Bern, Bern",NA
"2398","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Nüesch","Susanne","Universitäres Notfallzentrum, Inselspital, Universität Bern, Bern",NA
"2399","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Ott","Daniel","Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Inselspital, Universität Bern, Bern",NA
"2400","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Ruder","Thomas D","Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Inselspital, Universität Bern, Bern",NA
"2401","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Thurnheer Zürcher","Maria Christine","Universitätsklinik für Infektiologie, Inselspital, Universität Bern, Bern",NA
"2402","34231383","10.1024/1661-8157/a003686","[COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]","COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Abstract. Switzerland has been severely affected by the COVID-19 pandemic. The clinical spectrum of this disease in terms of its clinical presentation and course is very broad. A correct initial evaluation in the practice or in the emergency department is important and includes history-taking and clinical examination as well as imaging and laboratory tests. Most patients with COVID-19 can be treated as outpatients. Hospit","2021","07","08","Praxis (Bern 1994)","Praxis","Bildgebung; COVID-19; Labor; Pneumonie; ambulant; ambulatoire; imagerie; imaging; laboratoire; laboratory tests; outpatient; pneumonia; pneumonie; COVID-19; Family Practice; Hospitalization; Humans; Outpatients; Pandemics; SARS-CoV-2; Switzerland","Furrer","Hansjakob","Universitätsklinik für Infektiologie, Inselspital, Universität Bern, Bern",NA
"2403","34231381","10.1024/1661-8157/a003684","[COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges].","COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges Abstract. The treatment of patients with COVID-19 is a big challenge for intensive care units: substantial additional staff and material is needed to treat the surge of patients admitted in short time. Treatment is difficult as many patients present with multiple organ failure, including acute respiratory distress syndrome (ARDS). Mostly, oxygenation is substantially impaired and compliance low, and many patie","2021","07","08","Praxis (Bern 1994)","Praxis","ARDS; COVID-19; ICU; Intensivmedizin; Pflege; Physiotherapie; détresse respiratoire; nursing; physiotherapy; physiothérapie; soins infirmiers; soins intensifs; COVID-19; Humans; Intensive Care Units; Physical Therapy Modalities; Respiratory Distress Syndrome; SARS-CoV-2","Jakob","Stephan M","Universitätsklinik für Intensivmedizin (SMJ, KM), Institut für Physiotherapie (AK), Universitätsspital Bern (Inselspital), Universität Bern, Bern",NA
"2404","34231381","10.1024/1661-8157/a003684","[COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges].","COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges Abstract. The treatment of patients with COVID-19 is a big challenge for intensive care units: substantial additional staff and material is needed to treat the surge of patients admitted in short time. Treatment is difficult as many patients present with multiple organ failure, including acute respiratory distress syndrome (ARDS). Mostly, oxygenation is substantially impaired and compliance low, and many patie","2021","07","08","Praxis (Bern 1994)","Praxis","ARDS; COVID-19; ICU; Intensivmedizin; Pflege; Physiotherapie; détresse respiratoire; nursing; physiotherapy; physiothérapie; soins infirmiers; soins intensifs; COVID-19; Humans; Intensive Care Units; Physical Therapy Modalities; Respiratory Distress Syndrome; SARS-CoV-2","Michel","Karin","Universitätsklinik für Intensivmedizin (SMJ, KM), Institut für Physiotherapie (AK), Universitätsspital Bern (Inselspital), Universität Bern, Bern",NA
"2405","34231381","10.1024/1661-8157/a003684","[COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges].","COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges Abstract. The treatment of patients with COVID-19 is a big challenge for intensive care units: substantial additional staff and material is needed to treat the surge of patients admitted in short time. Treatment is difficult as many patients present with multiple organ failure, including acute respiratory distress syndrome (ARDS). Mostly, oxygenation is substantially impaired and compliance low, and many patie","2021","07","08","Praxis (Bern 1994)","Praxis","ARDS; COVID-19; ICU; Intensivmedizin; Pflege; Physiotherapie; détresse respiratoire; nursing; physiotherapy; physiothérapie; soins infirmiers; soins intensifs; COVID-19; Humans; Intensive Care Units; Physical Therapy Modalities; Respiratory Distress Syndrome; SARS-CoV-2","Kindler","Angela","Universitätsklinik für Intensivmedizin (SMJ, KM), Institut für Physiotherapie (AK), Universitätsspital Bern (Inselspital), Universität Bern, Bern",NA
"2406","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Sitzia","C","Department of Biomedical Sciences for Health, University of Milan, Milan, Italy",NA
"2407","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Pistelli","L","Residency Program in Clinical Pathology and Clinical Biochemistry, University of Milan, Milan, Italy",NA
"2408","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Cardani","R","Biobank BioCor, Service of Laboratory Medicine1-Clinical Pathology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy",NA
"2409","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Renna","L V","Biobank BioCor, Service of Laboratory Medicine1-Clinical Pathology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy",NA
"2410","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Ranucci","M","Department of Cardiothoracic and Vascular Anesthesia and Intensive Care Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy",NA
"2411","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Carrara","M","Residency Program in Clinical Pathology and Clinical Biochemistry, University of Milan, Milan, Italy",NA
"2412","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Borlini","S","Residency Program in Clinical Pathology and Clinical Biochemistry, University of Milan, Milan, Italy",NA
"2413","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Clerici","P","Microbiology Unit, Hospital of Legnano, ASST Ovest Milanese, Italy",NA
"2414","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Rampoldi","B","Operative Unit 1 - Clinical Pathology, Department of Pathology and Laboratory medicine, I.R.C.C.S. Policlinico San Donato, San Donato Milanese, Milan, Italy",NA
"2415","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Cornetta","M","Operative Unit 1 - Clinical Pathology, Department of Pathology and Laboratory medicine, I.R.C.C.S. Policlinico San Donato, San Donato Milanese, Milan, Italy",NA
"2416","34231353","10.23812/21-163-A","Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?","Since the spreading of Sar-CoV-2 in March 2020, many serologic tests have been developed to identify antibody responses. Indeed, different commercial kits are directed against different antigens and could utilise different methods thereby triggering confusion and criticism. Here, we compared two Food and Drug Administration (FDA)-approved automatized assays that detect IgG responses against spike or nucleocapsid protein of Sars-Cov-2 virus in 127 subjects among healthcare workers of IRCCS Policl","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","IgG kinetics; Sars-Cov-2; antibody responses; long-term immunity; serological test; Antibodies, Viral; COVID-19; Humans; Immunoglobulin G; Italy; SARS-CoV-2; Sensitivity and Specificity; Spike Glycoprotein, Coronavirus; United States","Corsi-Romanelli","M","Department of Biomedical Sciences for Health, University of Milan, Milan, Italy",NA
"2417","34231348","10.23812/21-20-E","Management of patients at risk of anaphylaxis after COVID 19 vaccination.","The success of a vaccination campaign depends on the possibility of guaranteeing not only a wide distribution of effective vaccines, but also on their safety and acceptance by the population. Vaccine safety questions should be answered by correct, unbiased and evidence-based reports, and by addressing all possible problems including allergic reactions. Despite the fact that many COVID-19 vaccines are free from the majority of potentially sensitizing components, an allergic reaction can occur eve","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","COVID-19; anaphylaxis; management of allergic reaction; vaccination; Adverse Drug Reaction Reporting Systems; Anaphylaxis; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination","Gangemi","S","School and Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy",NA
"2418","34231348","10.23812/21-20-E","Management of patients at risk of anaphylaxis after COVID 19 vaccination.","The success of a vaccination campaign depends on the possibility of guaranteeing not only a wide distribution of effective vaccines, but also on their safety and acceptance by the population. Vaccine safety questions should be answered by correct, unbiased and evidence-based reports, and by addressing all possible problems including allergic reactions. Despite the fact that many COVID-19 vaccines are free from the majority of potentially sensitizing components, an allergic reaction can occur eve","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","COVID-19; anaphylaxis; management of allergic reaction; vaccination; Adverse Drug Reaction Reporting Systems; Anaphylaxis; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination","Allegra","A","Division of Hematology, Department of Human Pathology in Adulthood and Childhood ""Gaetano Barresi"", University of Messina, Messina, Italy",NA
"2419","34231348","10.23812/21-20-E","Management of patients at risk of anaphylaxis after COVID 19 vaccination.","The success of a vaccination campaign depends on the possibility of guaranteeing not only a wide distribution of effective vaccines, but also on their safety and acceptance by the population. Vaccine safety questions should be answered by correct, unbiased and evidence-based reports, and by addressing all possible problems including allergic reactions. Despite the fact that many COVID-19 vaccines are free from the majority of potentially sensitizing components, an allergic reaction can occur eve","2021","07","12","J Biol Regul Homeost Agents","Journal of biological regulators and homeostatic agents","COVID-19; anaphylaxis; management of allergic reaction; vaccination; Adverse Drug Reaction Reporting Systems; Anaphylaxis; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination","Di Gioacchino","M","Center Advanced Science and Technology, G. d'Annunzio University, Chieti, Italy",NA
"2420","34231323","10.1002/aur.2574","Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder.","Children with autism spectrum disorder (ASD) are at elevated risk for psychiatric problems in response to the COVID-19 pandemic. This risk is due to their high rates of pre-pandemic psychiatric comorbidities and the pandemic's disruption to routines and access to necessary supports. Prior research has indicated that children with ASD may experience a worsening of specific psychiatric symptoms in response to COVID-19, though this body of work is limited in scope. The present study expands this li","2021","07","07","Autism Res","Autism research : official journal of the International Society for Autism Research","COVID-19; autism spectrum disorder; children; psychiatric problems","Vasa","Roma A","Kennedy Krieger Institute, Center for Autism and Related Disorders, Baltimore, Maryland, USA",NA
"2421","34231323","10.1002/aur.2574","Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder.","Children with autism spectrum disorder (ASD) are at elevated risk for psychiatric problems in response to the COVID-19 pandemic. This risk is due to their high rates of pre-pandemic psychiatric comorbidities and the pandemic's disruption to routines and access to necessary supports. Prior research has indicated that children with ASD may experience a worsening of specific psychiatric symptoms in response to COVID-19, though this body of work is limited in scope. The present study expands this li","2021","07","07","Autism Res","Autism research : official journal of the International Society for Autism Research","COVID-19; autism spectrum disorder; children; psychiatric problems","Singh","Vini","Kennedy Krieger Institute, Center for Autism and Related Disorders, Baltimore, Maryland, USA",NA
"2422","34231323","10.1002/aur.2574","Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder.","Children with autism spectrum disorder (ASD) are at elevated risk for psychiatric problems in response to the COVID-19 pandemic. This risk is due to their high rates of pre-pandemic psychiatric comorbidities and the pandemic's disruption to routines and access to necessary supports. Prior research has indicated that children with ASD may experience a worsening of specific psychiatric symptoms in response to COVID-19, though this body of work is limited in scope. The present study expands this li","2021","07","07","Autism Res","Autism research : official journal of the International Society for Autism Research","COVID-19; autism spectrum disorder; children; psychiatric problems","Holingue","Calliope","Kennedy Krieger Institute, Center for Autism and Related Disorders, Baltimore, Maryland, USA",NA
"2423","34231323","10.1002/aur.2574","Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder.","Children with autism spectrum disorder (ASD) are at elevated risk for psychiatric problems in response to the COVID-19 pandemic. This risk is due to their high rates of pre-pandemic psychiatric comorbidities and the pandemic's disruption to routines and access to necessary supports. Prior research has indicated that children with ASD may experience a worsening of specific psychiatric symptoms in response to COVID-19, though this body of work is limited in scope. The present study expands this li","2021","07","07","Autism Res","Autism research : official journal of the International Society for Autism Research","COVID-19; autism spectrum disorder; children; psychiatric problems","Kalb","Luther G","Kennedy Krieger Institute, Center for Autism and Related Disorders, Baltimore, Maryland, USA",NA
"2424","34231323","10.1002/aur.2574","Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder.","Children with autism spectrum disorder (ASD) are at elevated risk for psychiatric problems in response to the COVID-19 pandemic. This risk is due to their high rates of pre-pandemic psychiatric comorbidities and the pandemic's disruption to routines and access to necessary supports. Prior research has indicated that children with ASD may experience a worsening of specific psychiatric symptoms in response to COVID-19, though this body of work is limited in scope. The present study expands this li","2021","07","07","Autism Res","Autism research : official journal of the International Society for Autism Research","COVID-19; autism spectrum disorder; children; psychiatric problems","Jang","Yeon","Kennedy Krieger Institute, Center for Autism and Related Disorders, Baltimore, Maryland, USA",NA
"2425","34231323","10.1002/aur.2574","Psychiatric problems during the COVID-19 pandemic in children with autism spectrum disorder.","Children with autism spectrum disorder (ASD) are at elevated risk for psychiatric problems in response to the COVID-19 pandemic. This risk is due to their high rates of pre-pandemic psychiatric comorbidities and the pandemic's disruption to routines and access to necessary supports. Prior research has indicated that children with ASD may experience a worsening of specific psychiatric symptoms in response to COVID-19, though this body of work is limited in scope. The present study expands this li","2021","07","07","Autism Res","Autism research : official journal of the International Society for Autism Research","COVID-19; autism spectrum disorder; children; psychiatric problems","Keefer","Amy","Kennedy Krieger Institute, Center for Autism and Related Disorders, Baltimore, Maryland, USA",NA
"2426","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Alfano","Gaetano","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2427","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Fontana","Francesco","Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy",NA
"2428","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Morisi","Niccolò","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2429","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Giaroni","Francesco","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2430","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Mori","Giacomo","Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy",NA
"2431","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Guaraldi","Giovanni","Clinic of Infectious Diseases, University Hospital of Modena, Modena, Italy",NA
"2432","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Magistroni","Riccardo","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2433","34231319","10.1111/hdi.12963","One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19.","The immunological mechanisms that modulate immune response to SARS-CoV-2 infection remain elusive. Little is known on the magnitude and the durability of antibody response against COVID-19. There is consensus that patients with immune dysfunction, such as dialysis patients, may be unable to mount a robust and durable humoral immunity after infections. Recent studies showed that dialysis patients seroconverted after COVID-19, but data on the durability of the immune response are missing. We repor","2021","07","07","Hemodial Int","Hemodialysis international. International Symposium on Home Hemodialysis","COVID-19; Sars-CoV-2; antibody; dialysis; immunity; vaccine","Cappelli","Gianni","Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy",NA
"2434","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Petrovan","Silviu O","BioRISC (Biosecurity Research Initiative at St Catharine's), St Catharine's College, Cambridge, CB2 1RL, U",NA
"2435","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Aldridge","David C","BioRISC (Biosecurity Research Initiative at St Catharine's), St Catharine's College, Cambridge, CB2 1RL, U",NA
"2436","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Bartlett","Harriet","Department of Zoology, University of Cambridge, The David Attenborough Building, Pembroke Street, Cambridge, CB2 3QZ, U",NA
"2437","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Bladon","Andrew J","BioRISC (Biosecurity Research Initiative at St Catharine's), St Catharine's College, Cambridge, CB2 1RL, U",NA
"2438","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Booth","Hollie","Interdisciplinary Centre for Conservation Science, Department of Zoology, University of Oxford, Oxford, OX1 3SZ, U",NA
"2439","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Broad","Steven","TRAFFIC, The David Attenborough Building, Pembroke Street, Cambridge, CB2 3QZ, U",NA
"2440","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Broom","Donald M","BioRISC (Biosecurity Research Initiative at St Catharine's), St Catharine's College, Cambridge, CB2 1RL, U",NA
"2441","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Burgess","Neil D","UNEP-WCMC, 219 Huntington Road, Cambridge, CB3 0DL, U",NA
"2442","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Cleaveland","Sarah","Institute of Biodiversity, College of Medical, Veterinary and Life Sciences, Animal Health &amp",NA
"2443","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Cunningham","Andrew A","Institute of Zoology, Zoological Society of London, London, NW1 4RY, U",NA
"2444","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Ferri","Maurizio","Italian Society of Preventive Veterinary Medicine (Simevep), Via Nizza 11, Rome, 00198, Italy",NA
"2445","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Hinsley","Amy","Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, Oxford, OX1 3SZ, U",NA
"2446","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Hua","Fangyuan","Institute of Ecology, College of Urban and Environmental Sciences, Peking University, Beijing, P.R. China",NA
"2447","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Hughes","Alice C","Centre for Integrative Conservation, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Xishuangbanna, Yunnan, 666303, P.R. China",NA
"2448","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Jones","Kate","Centre for Biodiversity and Environment Research, University College London, Gower Street, London, WC1E 6BT, U",NA
"2449","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Kelly","Moira","Wildlife Health Ghent, Department of Pathology, Bacteriology and Poultry Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, Merelbeke, B-9820, Belgium",NA
"2450","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Mayes","George","MacArthur Barstow &amp",NA
"2451","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Radakovic","Milorad","Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, U",NA
"2452","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Ugwu","Chinedu A","Africa Centre of Excellence for Genomics of Infectious Disease, Redeemers' University Ede, Osun State, Nigeria",NA
"2453","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Uddin","Nasir","Centre for Integrative Conservation, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Xishuangbanna, Yunnan, 666303, P.R. China",NA
"2454","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Veríssimo","Diogo","Interdisciplinary Centre for Conservation Science, Department of Zoology, University of Oxford, Oxford, OX1 3SZ, U",NA
"2455","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Walzer","Christian","Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna, Savoyenstraße 1, Vienna, A-1160, Austria",NA
"2456","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","White","Thomas B","Department of Zoology, University of Cambridge, The David Attenborough Building, Pembroke Street, Cambridge, CB2 3QZ, U",NA
"2457","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Wood","James L","Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, U",NA
"2458","34231315","10.1111/brv.12774","Post COVID-19: a solution scan of options for preventing future zoonotic epidemics.","The crisis generated by the emergence and pandemic spread of COVID-19 has thrown into the global spotlight the dangers associated with novel diseases, as well as the key role of animals, especially wild animals, as potential sources of pathogens to humans. There is a widespread demand for a new relationship with wild and domestic animals, including suggested bans on hunting, wildlife trade, wet markets or consumption of wild animals. However, such policies risk ignoring essential elements of the","2021","07","07","Biol Rev Camb Philos Soc","Biological reviews of the Cambridge Philosophical Society","SARS-CoV-2; coronavirus; emerging infectious disease; pandemic prevention; wildlife trade; zoonotic risk; zoonotic spillover","Sutherland","William J","BioRISC (Biosecurity Research Initiative at St Catharine's), St Catharine's College, Cambridge, CB2 1RL, U",NA
"2459","34231301","10.1111/dth.15055","Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor.",NA,"2021","07","17","Dermatol Ther","Dermatologic therapy",NA,"Mieczkowska","Karolina","Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, New York, USA",NA
"2460","34231301","10.1111/dth.15055","Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor.",NA,"2021","07","17","Dermatol Ther","Dermatologic therapy",NA,"Kaubisch","Andreas","Department of Oncology, Albert Einstein College of Medicine, Bronx, New York, USA",NA
"2461","34231301","10.1111/dth.15055","Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor.",NA,"2021","07","17","Dermatol Ther","Dermatologic therapy",NA,"McLellan","Beth N","Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, New York, USA",NA
"2462","34231299","10.1111/inm.12909","Editorial: Liminality and COVID-19 - what do we already know?",NA,"2021","07","07","Int J Ment Health Nurs","International journal of mental health nursing",NA,"Wayland","Sarah","University of New England, Armidale, New South Wales, Australia",NA
"2463","34231291","10.1111/dth.15053","Black dots in trichoscopy after COVID-19. Can it be telogen effluvium?",NA,"2021","07","13","Dermatol Ther","Dermatologic therapy",NA,"Vastarella","Maria","Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy",NA
"2464","34231291","10.1111/dth.15053","Black dots in trichoscopy after COVID-19. Can it be telogen effluvium?",NA,"2021","07","13","Dermatol Ther","Dermatologic therapy",NA,"Cantelli","Mariateresa","Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy",NA
"2465","34231291","10.1111/dth.15053","Black dots in trichoscopy after COVID-19. Can it be telogen effluvium?",NA,"2021","07","13","Dermatol Ther","Dermatologic therapy",NA,"Nappa","Paola","Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy",NA
"2466","34231291","10.1111/dth.15053","Black dots in trichoscopy after COVID-19. Can it be telogen effluvium?",NA,"2021","07","13","Dermatol Ther","Dermatologic therapy",NA,"Fabbrocini","Gabriella","Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy",NA
"2467","34231291","10.1111/dth.15053","Black dots in trichoscopy after COVID-19. Can it be telogen effluvium?",NA,"2021","07","13","Dermatol Ther","Dermatologic therapy",NA,"Ocampo-Garza","Sonia Sofía","Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy",NA
"2468","34231287","10.1111/ijcp.14607","Evaluation of the mental health of health professionals in the COVID-19 era. What mental health conditions are our health care workers facing in the new wave of coronavirus?","The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of healthcare workers (HCWs) in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This prospective cohort study comprised 2089 HCWs who completed the Generalized Anxiety Disorder 7-item (GAD-7) Scale, the Patient Health Questionnaire-9 (PHQ-9), the Impact Event Scale-Revised (IES-R), the Insomnia Severity Index (ISI), and the","2021","07","14","Int J Clin Pract","International journal of clinical practice",NA,"Martín","Josune","Research Unit, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"2469","34231287","10.1111/ijcp.14607","Evaluation of the mental health of health professionals in the COVID-19 era. What mental health conditions are our health care workers facing in the new wave of coronavirus?","The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of healthcare workers (HCWs) in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This prospective cohort study comprised 2089 HCWs who completed the Generalized Anxiety Disorder 7-item (GAD-7) Scale, the Patient Health Questionnaire-9 (PHQ-9), the Impact Event Scale-Revised (IES-R), the Insomnia Severity Index (ISI), and the","2021","07","14","Int J Clin Pract","International journal of clinical practice",NA,"Padierna","Ángel","Department of Psychiatry, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"2470","34231287","10.1111/ijcp.14607","Evaluation of the mental health of health professionals in the COVID-19 era. What mental health conditions are our health care workers facing in the new wave of coronavirus?","The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of healthcare workers (HCWs) in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This prospective cohort study comprised 2089 HCWs who completed the Generalized Anxiety Disorder 7-item (GAD-7) Scale, the Patient Health Questionnaire-9 (PHQ-9), the Impact Event Scale-Revised (IES-R), the Insomnia Severity Index (ISI), and the","2021","07","14","Int J Clin Pract","International journal of clinical practice",NA,"Villanueva","Ane","Research Unit, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"2471","34231287","10.1111/ijcp.14607","Evaluation of the mental health of health professionals in the COVID-19 era. What mental health conditions are our health care workers facing in the new wave of coronavirus?","The aims of this study were to analyse the mental health and health-related quality of life (HRQoL) of a broad sample of healthcare workers (HCWs) in Spain and to identify potential factors that have a significant effect on their mental health and HRQoL. This prospective cohort study comprised 2089 HCWs who completed the Generalized Anxiety Disorder 7-item (GAD-7) Scale, the Patient Health Questionnaire-9 (PHQ-9), the Impact Event Scale-Revised (IES-R), the Insomnia Severity Index (ISI), and the","2021","07","14","Int J Clin Pract","International journal of clinical practice",NA,"Quintana","José M","Research Unit, Galdakao-Usansolo Hospital, Galdakao, Spain",NA
"2472","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Fujii","Yutaka","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2473","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Asakura","Satoshi","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2474","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Takanobu","Keisuke","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2475","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Watanabe","Shinya","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2476","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Toyoshima","Kuniyoshi","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2477","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Mitsui","Nobuyuki","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2478","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Kako","Yuki","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2479","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Hashino","Satoshi","Health Care Center of Hokkaido University, Sapporo, Hokkaido, Japan",NA
"2480","34231285","10.1111/pcn.13287","Prevalence of depressive symptoms and psychological distress in Japanese university enrolled students before and during the Coronavirus disease 2019 pandemic.",NA,"2021","07","07","Psychiatry Clin Neurosci","Psychiatry and clinical neurosciences",NA,"Kusumi","Ichiro","Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan",NA
"2481","34231269","10.1111/jocn.15937","Professional quality of life and caring behaviours among clinical nurses during the COVID-19 pandemic.","To investigate the professional quality of life and caring behaviours among clinical nurses in Saudi Arabia during the COVID-19 pandemic. We also examined the influence of the nurses' socio-demographic and professional characteristics on the professional quality of life. Moreover, the study examined the influence of professional quality of life on caring behaviour among the nurses amid the COVID-19 pandemic. Caring is the core of the nursing profession and considered the heart of the humanistic ","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19 pandemic; caring behavior; clinical nurses; professional quality of life","Inocian","Ergie Pepito","School of Nursing, Duquesne University, Pittsburgh, PA, USA",NA
"2482","34231269","10.1111/jocn.15937","Professional quality of life and caring behaviours among clinical nurses during the COVID-19 pandemic.","To investigate the professional quality of life and caring behaviours among clinical nurses in Saudi Arabia during the COVID-19 pandemic. We also examined the influence of the nurses' socio-demographic and professional characteristics on the professional quality of life. Moreover, the study examined the influence of professional quality of life on caring behaviour among the nurses amid the COVID-19 pandemic. Caring is the core of the nursing profession and considered the heart of the humanistic ","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19 pandemic; caring behavior; clinical nurses; professional quality of life","Cruz","Jonas Preposi","Nursing Department, College of Applied Medical Sciences, Shaqra University, Shaqra, Kingdom of Saudi Arabia",NA
"2483","34231269","10.1111/jocn.15937","Professional quality of life and caring behaviours among clinical nurses during the COVID-19 pandemic.","To investigate the professional quality of life and caring behaviours among clinical nurses in Saudi Arabia during the COVID-19 pandemic. We also examined the influence of the nurses' socio-demographic and professional characteristics on the professional quality of life. Moreover, the study examined the influence of professional quality of life on caring behaviour among the nurses amid the COVID-19 pandemic. Caring is the core of the nursing profession and considered the heart of the humanistic ","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19 pandemic; caring behavior; clinical nurses; professional quality of life","Saeed Alshehry","Abdualrahman","Medical-Surgical Nursing Department, College of Nursing, King Saud University, Riyadh, Kingdom of Saudi Arabia",NA
"2484","34231269","10.1111/jocn.15937","Professional quality of life and caring behaviours among clinical nurses during the COVID-19 pandemic.","To investigate the professional quality of life and caring behaviours among clinical nurses in Saudi Arabia during the COVID-19 pandemic. We also examined the influence of the nurses' socio-demographic and professional characteristics on the professional quality of life. Moreover, the study examined the influence of professional quality of life on caring behaviour among the nurses amid the COVID-19 pandemic. Caring is the core of the nursing profession and considered the heart of the humanistic ","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19 pandemic; caring behavior; clinical nurses; professional quality of life","Alshamlani","Yousef","Nursing Department, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia",NA
"2485","34231269","10.1111/jocn.15937","Professional quality of life and caring behaviours among clinical nurses during the COVID-19 pandemic.","To investigate the professional quality of life and caring behaviours among clinical nurses in Saudi Arabia during the COVID-19 pandemic. We also examined the influence of the nurses' socio-demographic and professional characteristics on the professional quality of life. Moreover, the study examined the influence of professional quality of life on caring behaviour among the nurses amid the COVID-19 pandemic. Caring is the core of the nursing profession and considered the heart of the humanistic ","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19 pandemic; caring behavior; clinical nurses; professional quality of life","Ignacio","Ejay Hatulan","Nursing Department, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia",NA
"2486","34231269","10.1111/jocn.15937","Professional quality of life and caring behaviours among clinical nurses during the COVID-19 pandemic.","To investigate the professional quality of life and caring behaviours among clinical nurses in Saudi Arabia during the COVID-19 pandemic. We also examined the influence of the nurses' socio-demographic and professional characteristics on the professional quality of life. Moreover, the study examined the influence of professional quality of life on caring behaviour among the nurses amid the COVID-19 pandemic. Caring is the core of the nursing profession and considered the heart of the humanistic ","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19 pandemic; caring behavior; clinical nurses; professional quality of life","Tumala","Regie Buenafe","Medical-Surgical Nursing Department, College of Nursing, King Saud University, Riyadh, Kingdom of Saudi Arabia",NA
"2487","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Fteropoulli","Theodora","Medical School, University of Cyprus, Nicosia, Cyprus",NA
"2488","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Kalavana","Theano V","MindThreading, Nicosia, Cyprus",NA
"2489","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Yiallourou","Anneza","Medical School, University of Cyprus, Nicosia, Cyprus",NA
"2490","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Karaiskakis","Marios","University of Nicosia Medical School, Nicosia, Cyprus",NA
"2491","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Koliou Mazeri","Maria","Medical School, University of Cyprus, Nicosia, Cyprus",NA
"2492","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Vryonides","Stavros","Limassol General Hospital, Limassol, Cyprus",NA
"2493","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Hadjioannou","Anna","State Health Services Organization, Nicosia, Cyprus",NA
"2494","34231263","10.1111/jocn.15938","Beyond the physical risk: Psychosocial impact and coping in healthcare professionals during the COVID-19 pandemic.","This study aimed to examine the psychosocial impact and identify risk factors for poor psychosocial outcomes in healthcare professionals during the Coronavirus disease 2019 (COVID-19) pandemic in Cyprus. Healthcare professionals are in the forefront of the COVID-19 pandemic facing an unprecedented global health crisis, which can have consequences on their psychosocial health. There is a need to identify risk factors for poor psychosocial outcomes to inform the design of tailored psychological in","2021","07","07","J Clin Nurs","Journal of clinical nursing","COVID-19; Pandemic; SARS-CoV-2; anxiety; coping; depression; healthcare professionals; mental health; occupational burnout; quality of life","Nikolopoulos","Georgios K","Medical School, University of Cyprus, Nicosia, Cyprus",NA
"2495","34231255","10.1002/hpm.3264","'We did everything we could': An account of toxic leadership.","The UK government's reckless and incompetent response to Covid-19 has produced an outcome which is amongst the worst in the world, and arguably the worst in terms of deaths per 100,000 population of major countries (especially when one measures mortality from Covid in terms of cause of death on the death certificate, rather than the UK government's own measure-death of a tested individual within 28 days of testing). This article updates my initial analysis in this journal over a year ago, and tr","2021","07","07","Int J Health Plann Manage","The International journal of health planning and management","Boris Johnson; UK Covid policy; compliant scientific chiefs; disastrous outcomes; incompetence and recklessness","Paton","Calum","School of Politics and Global Studies, Keele University, Keele, Staffordshire, UK",NA
"2496","34231246","10.1002/ana.26160","Functional Neurological Disorders and COVID-19 Vaccination.",NA,"2021","07","16","Ann Neurol","Annals of neurology",NA,"Ng","Jing-Han","SingHealth, Singapore, Singapore",NA
"2497","34231246","10.1002/ana.26160","Functional Neurological Disorders and COVID-19 Vaccination.",NA,"2021","07","16","Ann Neurol","Annals of neurology",NA,"Chaudhuri","K Ray","Kings College London and Kings College Hospital, London, UK",NA
"2498","34231246","10.1002/ana.26160","Functional Neurological Disorders and COVID-19 Vaccination.",NA,"2021","07","16","Ann Neurol","Annals of neurology",NA,"Tan","Eng-King","National Neuroscience Institute, Singapore General Hospital, Singapore, Singapore",NA
"2499","34231192","10.1007/s40596-021-01504-0","Tutors' Perceptions of the Transition to Video and Simulated Patients in Pre-clinical Psychiatry Training.","The use of virtual learning in psychiatric education has been required to address COVID-19-related challenges. Research regarding the implementation of virtual teaching environments and standardized patients for simulation remains limited. Here, educators' outcomes were evaluated following a transition from in-person teaching with ""real"" patients, to a standardized patient-based simulation in pre-clerkship psychiatric clinical skills teaching for medical students. The Integrated Clinical Experie","2021","07","09","Acad Psychiatry","Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry","Curriculum; Medical education; Simulation; Standardized patients; Virtual teaching","Patel","Mitesh","University of Toronto, Toronto, Ontario, Canada. mitesh.patel@camh","mitesh.patel@camh.ca"
"2500","34231192","10.1007/s40596-021-01504-0","Tutors' Perceptions of the Transition to Video and Simulated Patients in Pre-clinical Psychiatry Training.","The use of virtual learning in psychiatric education has been required to address COVID-19-related challenges. Research regarding the implementation of virtual teaching environments and standardized patients for simulation remains limited. Here, educators' outcomes were evaluated following a transition from in-person teaching with ""real"" patients, to a standardized patient-based simulation in pre-clerkship psychiatric clinical skills teaching for medical students. The Integrated Clinical Experie","2021","07","09","Acad Psychiatry","Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry","Curriculum; Medical education; Simulation; Standardized patients; Virtual teaching","Hui","Jeanette","University of Toronto, Toronto, Ontario, Canada",NA
"2501","34231192","10.1007/s40596-021-01504-0","Tutors' Perceptions of the Transition to Video and Simulated Patients in Pre-clinical Psychiatry Training.","The use of virtual learning in psychiatric education has been required to address COVID-19-related challenges. Research regarding the implementation of virtual teaching environments and standardized patients for simulation remains limited. Here, educators' outcomes were evaluated following a transition from in-person teaching with ""real"" patients, to a standardized patient-based simulation in pre-clerkship psychiatric clinical skills teaching for medical students. The Integrated Clinical Experie","2021","07","09","Acad Psychiatry","Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry","Curriculum; Medical education; Simulation; Standardized patients; Virtual teaching","Ho","Certina","University of Toronto, Toronto, Ontario, Canada",NA
"2502","34231192","10.1007/s40596-021-01504-0","Tutors' Perceptions of the Transition to Video and Simulated Patients in Pre-clinical Psychiatry Training.","The use of virtual learning in psychiatric education has been required to address COVID-19-related challenges. Research regarding the implementation of virtual teaching environments and standardized patients for simulation remains limited. Here, educators' outcomes were evaluated following a transition from in-person teaching with ""real"" patients, to a standardized patient-based simulation in pre-clerkship psychiatric clinical skills teaching for medical students. The Integrated Clinical Experie","2021","07","09","Acad Psychiatry","Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry","Curriculum; Medical education; Simulation; Standardized patients; Virtual teaching","Mak","Christy Kei","University of Toronto, Toronto, Ontario, Canada",NA
"2503","34231192","10.1007/s40596-021-01504-0","Tutors' Perceptions of the Transition to Video and Simulated Patients in Pre-clinical Psychiatry Training.","The use of virtual learning in psychiatric education has been required to address COVID-19-related challenges. Research regarding the implementation of virtual teaching environments and standardized patients for simulation remains limited. Here, educators' outcomes were evaluated following a transition from in-person teaching with ""real"" patients, to a standardized patient-based simulation in pre-clerkship psychiatric clinical skills teaching for medical students. The Integrated Clinical Experie","2021","07","09","Acad Psychiatry","Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry","Curriculum; Medical education; Simulation; Standardized patients; Virtual teaching","Simpson","Alexander","University of Toronto, Toronto, Ontario, Canada",NA
"2504","34231192","10.1007/s40596-021-01504-0","Tutors' Perceptions of the Transition to Video and Simulated Patients in Pre-clinical Psychiatry Training.","The use of virtual learning in psychiatric education has been required to address COVID-19-related challenges. Research regarding the implementation of virtual teaching environments and standardized patients for simulation remains limited. Here, educators' outcomes were evaluated following a transition from in-person teaching with ""real"" patients, to a standardized patient-based simulation in pre-clerkship psychiatric clinical skills teaching for medical students. The Integrated Clinical Experie","2021","07","09","Acad Psychiatry","Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry","Curriculum; Medical education; Simulation; Standardized patients; Virtual teaching","Sockalingam","Sanjeev","University of Toronto, Toronto, Ontario, Canada",NA
"2505","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Qureshi","Adnan I","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA",NA
"2506","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Baskett","William I","Institute for Data Science and Informatics, University of Missouri, Columbia, MO, USA",NA
"2507","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Huang","Wei","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA",NA
"2508","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Myers","Danny","Tiger Institute for Health Innovation, Cerner Corporation, Columbia, MO, USA",NA
"2509","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Lobanova","Iryna","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA. lobanovanmu@gmail","lobanovanmu@gmail.com"
"2510","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Ishfaq","Muhammad F","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA",NA
"2511","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Naqvi","Syed Hasan","Department of Medicine, University of Missouri, Columbia, MO, USA",NA
"2512","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","French","Brandi R","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA",NA
"2513","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Chandrasekaran","Premkumar N","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA",NA
"2514","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Siddiq","Farhan","Division of Neurosurgery, University of Missouri, Columbia, MO, USA",NA
"2515","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Gomez","Camilo R","Zeenat Qureshi Stroke Insititutes and Department of Neurology, University of Missouri, One Hospital Dr. CE507, Columbia, MO, USA",NA
"2516","34231186","10.1007/s12028-021-01297-y","Intracerebral Hemorrhage and Coronavirus Disease 2019 in a Cohort of 282,718 Hospitalized Patients.","To identify whether the risk of intracerebral hemorrhage is higher in patients with coronavirus disease 2019 (COVID-19), we compared the risk factors, comorbidities, and outcomes in patients intracerebral hemorrhage and COVID-19 and those without COVID-19. We analyzed the data from the Cerner deidentified COVID-19 data set derived from 62 health care facilities. The data set included patients with an emergency department or inpatient encounter with discharge diagnoses codes that could be associa","2021","07","11","Neurocrit Care","Neurocritical care","COVID-19; Death; Disability; Electronic medical records; Intracerebral hemorrhage; SARS-CoV-2","Shyu","Chi-Ren","Institute for Data Science and Informatics, University of Missouri, Columbia, MO, USA",NA
"2517","34231129","10.1007/s12630-021-02060-9","Conduct of virtual summative anesthesiology Objective Structured Clinical Examination during the COVID-19 pandemic.",NA,"2021","07","09","Can J Anaesth","Canadian journal of anaesthesia = Journal canadien d'anesthesie","high-stakes; medical education; postgraduate; simulation; teleconferencing","Hwang","Kai Yin","Department of Anaesthesia, National University Hospital, Singapore, Singapore. kai_yin_hwang@nuhs.edu","hwang@nuhs.edu.sg"
"2518","34231129","10.1007/s12630-021-02060-9","Conduct of virtual summative anesthesiology Objective Structured Clinical Examination during the COVID-19 pandemic.",NA,"2021","07","09","Can J Anaesth","Canadian journal of anaesthesia = Journal canadien d'anesthesie","high-stakes; medical education; postgraduate; simulation; teleconferencing","Hwang","Nian Chih","Division of Anaesthesiology, Singapore General Hospital, Singapore, Singapore",NA
"2519","34231129","10.1007/s12630-021-02060-9","Conduct of virtual summative anesthesiology Objective Structured Clinical Examination during the COVID-19 pandemic.",NA,"2021","07","09","Can J Anaesth","Canadian journal of anaesthesia = Journal canadien d'anesthesie","high-stakes; medical education; postgraduate; simulation; teleconferencing","Tay","Kwang Hui","Department of Anaesthesia, National University Hospital, Singapore, Singapore",NA
"2520","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Slipczuk","Leandro","Cardiology Division, Montefiore Medical Center, 111 E 210th, Bronx, NY, 10467, USA. lslipczukb@montefiore","lslipczukb@montefiore.org"
"2521","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Castagna","Francesco","Cardiology Division, Montefiore Medical Center, 111 E 210th, Bronx, NY, 10467, USA",NA
"2522","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Schonberger","Alison","Radiology Division, Montefiore Medical Center, Bronx, NY, USA",NA
"2523","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Novogrodsky","Eitan","Radiology Division, Montefiore Medical Center, Bronx, NY, USA",NA
"2524","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Dey","Damini","Cedars-Sinai Medical Center, Los Angeles, CA, USA",NA
"2525","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Jorde","Ulrich P","Cardiology Division, Montefiore Medical Center, 111 E 210th, Bronx, NY, 10467, USA",NA
"2526","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Levsky","Jeffrey M","Albert Einstein College of Medicine, Bronx, NY, USA",NA
"2527","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Di Biase","Luigi","Cardiology Division, Montefiore Medical Center, 111 E 210th, Bronx, NY, 10467, USA",NA
"2528","34231098","10.1007/s10840-021-01029-4","Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue.","Coronary artery calcium (CAC) and epicardial adipose tissue (EAT) can predict AF in the general population. We aimed to determine if CAC and EAT measured by computed tomographic (CT) scanning can predict new-onset AF in patients admitted with COVID-19 disease. We performed a retrospective, post hoc analysis of all patients admitted to Montefiore Medical Center with a confirmed COVID-19 diagnosis from March 1st to June 23rd, 2020, who had a non-contrast CT of the chest within 5 years prior to adm","2021","07","11","J Interv Card Electrophysiol","Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","Atrial fibrillation; COVID-19; Coronary artery calcium; Epicardial adipose tissue","Garcia","Mario J","Cardiology Division, Montefiore Medical Center, 111 E 210th, Bronx, NY, 10467, USA",NA
"2529","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Esenboga","Saliha","Division of Immunology, Department of Pediatrics, School of Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey. salihaeren@yahoo","salihaeren@yahoo.com"
"2530","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Ocak","Melike","Division of Immunology, Department of Pediatrics, School of Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey",NA
"2531","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Akarsu","Aysegul","Division of Immunology, Department of Pediatrics, School of Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey",NA
"2532","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Bildik","Hacer Neslihan","Division of Immunology, Department of Pediatrics, School of Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey",NA
"2533","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Cagdas","Deniz","Division of Immunology, Department of Pediatrics, School of Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey",NA
"2534","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Iskit","Arzu Topeli","Department of Internal Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey",NA
"2535","34231093","10.1007/s10875-021-01065-9","COVID-19 in Patients with Primary Immunodeficiency.",NA,"2021","07","09","J Clin Immunol","Journal of clinical immunology",NA,"Tezcan","Ilhan","Division of Immunology, Department of Pediatrics, School of Medicine, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey",NA
"2536","34231033","10.1007/s40656-021-00443-1","COVID-19 and inequalities: the need for inclusive policy response.","In this essay, the authors analyze the COVID-19 pandemic from the perspective of inequalities and socio-economic vulnerabilities. We argue that the current pandemic has been looked at mainly through the lens of biology, leaving sociological blind spots in the response to this pandemic that have had adverse effects. We conclude with the suggestion that apart from recommendations from health sciences, policy makers must also take into account local societal structures in order to design effective ","2021","07","14","Hist Philos Life Sci","History and philosophy of the life sciences","COVID-19; Inequalities; Social policy; COVID-19; Humans; Pandemics; Socioeconomic Factors","Naz","Farah","Department of Sociology and Criminology, University of Sargodha, Sargodha, Pakistan. farah.naz@uos.edu","farah.naz@uos.edu.pk"
"2537","34231033","10.1007/s40656-021-00443-1","COVID-19 and inequalities: the need for inclusive policy response.","In this essay, the authors analyze the COVID-19 pandemic from the perspective of inequalities and socio-economic vulnerabilities. We argue that the current pandemic has been looked at mainly through the lens of biology, leaving sociological blind spots in the response to this pandemic that have had adverse effects. We conclude with the suggestion that apart from recommendations from health sciences, policy makers must also take into account local societal structures in order to design effective ","2021","07","14","Hist Philos Life Sci","History and philosophy of the life sciences","COVID-19; Inequalities; Social policy; COVID-19; Humans; Pandemics; Socioeconomic Factors","Ahmad","Muhammad","Beaconhouse College Campus, Sargodha, Pakistan",NA
"2538","34231033","10.1007/s40656-021-00443-1","COVID-19 and inequalities: the need for inclusive policy response.","In this essay, the authors analyze the COVID-19 pandemic from the perspective of inequalities and socio-economic vulnerabilities. We argue that the current pandemic has been looked at mainly through the lens of biology, leaving sociological blind spots in the response to this pandemic that have had adverse effects. We conclude with the suggestion that apart from recommendations from health sciences, policy makers must also take into account local societal structures in order to design effective ","2021","07","14","Hist Philos Life Sci","History and philosophy of the life sciences","COVID-19; Inequalities; Social policy; COVID-19; Humans; Pandemics; Socioeconomic Factors","Umair","Asad","Department of Sociology and Criminology, University of Sargodha, Sargodha, Pakistan",NA
"2539","34231028","10.1007/s00705-021-05151-6","Role of polymeric materials in preventing COVID-19 infection.","The safety of personal protective equipment (PPE) is very important, and so is the choice of materials used. The ability of electrostatic charges (ESCs) generated from the friction of engineered materials to attract or repel viruses has a significant impact on their applications. This study examined the ESCs generated on the surface of PPE used by healthcare workers to enhance their potential effectiveness in protecting the wearer from viruses. This is a crucial consideration for the newly emerg","2021","07","09","Arch Virol","Archives of virology",NA,"Abdelwahab","Sayed F","Department of Pharmaceutics and Industrial Pharmacy, Taif College of Pharmacy, Taif University, Al-Haweiah, P.O. Box 11099, Taif, 21944, Kingdom of Saudi Arabia. icpminia@yahoo","icpminia@yahoo.com"
"2540","34231028","10.1007/s00705-021-05151-6","Role of polymeric materials in preventing COVID-19 infection.","The safety of personal protective equipment (PPE) is very important, and so is the choice of materials used. The ability of electrostatic charges (ESCs) generated from the friction of engineered materials to attract or repel viruses has a significant impact on their applications. This study examined the ESCs generated on the surface of PPE used by healthcare workers to enhance their potential effectiveness in protecting the wearer from viruses. This is a crucial consideration for the newly emerg","2021","07","09","Arch Virol","Archives of virology",NA,"Mohamed","Mostafa K","Department of Production Engineering and Mechanical Design, Faculty of Engineering, Minia University, Minia, 61511, Egypt",NA
"2541","34231028","10.1007/s00705-021-05151-6","Role of polymeric materials in preventing COVID-19 infection.","The safety of personal protective equipment (PPE) is very important, and so is the choice of materials used. The ability of electrostatic charges (ESCs) generated from the friction of engineered materials to attract or repel viruses has a significant impact on their applications. This study examined the ESCs generated on the surface of PPE used by healthcare workers to enhance their potential effectiveness in protecting the wearer from viruses. This is a crucial consideration for the newly emerg","2021","07","09","Arch Virol","Archives of virology",NA,"Ali","Waheed Y","Department of Production Engineering and Mechanical Design, Faculty of Engineering, Minia University, Minia, 61511, Egypt",NA
"2542","34231028","10.1007/s00705-021-05151-6","Role of polymeric materials in preventing COVID-19 infection.","The safety of personal protective equipment (PPE) is very important, and so is the choice of materials used. The ability of electrostatic charges (ESCs) generated from the friction of engineered materials to attract or repel viruses has a significant impact on their applications. This study examined the ESCs generated on the surface of PPE used by healthcare workers to enhance their potential effectiveness in protecting the wearer from viruses. This is a crucial consideration for the newly emerg","2021","07","09","Arch Virol","Archives of virology",NA,"Ali","Ahmed S","Department of Mechanical Engineering, Faculty of Engineering, Suez Canal University, Suez, 41522, Egypt",NA
"2543","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Arenas","M","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2544","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Algara","M","Department of Radiation Oncology, Hospital del Mar, Barcelona, Spain. malgara@parcdesalutmar","malgara@parcdesalutmar.cat"
"2545","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","De Febrer","G","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2546","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Rubio","C","Department of Radiation Oncology, HM Hospitales., Madrid, Spain",NA
"2547","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Sanz","X","Department of Radiation Oncology, Hospital del Mar, Barcelona, Spain",NA
"2548","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","de la Casa","M A","Department of Radiation Oncology, HM Hospitales., Madrid, Spain",NA
"2549","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Vasco","C","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2550","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Marín","J","Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain",NA
"2551","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Fernández-Letón","P","Department of Medical Physics, HM Hospitales, Madrid, Spain",NA
"2552","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Villar","J","Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain",NA
"2553","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Torres-Royo","L","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2554","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Villares","P","Department of Internal Medicine, HM Hospitales, Madrid, Spain",NA
"2555","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Membrive","I","Department of Radiation Oncology, Hospital del Mar, Barcelona, Spain",NA
"2556","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Acosta","J","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2557","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","López-Cano","M","Department of Internal Medicine, HM Hospitales, Madrid, Spain",NA
"2558","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Araguas","P","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2559","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Quera","J","Department of Radiation Oncology, Hospital del Mar, Barcelona, Spain",NA
"2560","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Rodríguez-Tomás","F","Universitat Rovira i Virgili, Tarragona, Spain",NA
"2561","34230996","10.1007/s00066-021-01803-3","Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).","To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for pneumonia in patients with coronavirus disease 2019 (COVID-19). Inclusion criteria comprised patients with COVID-19-related moderate-severe pneumonia warranting hospitalization with supplemental O2 and not candidates for admission to the intensive care unit because of comorbidities or general status. All patients received single lung dose of 0.5 Gy. Respiratory and systemic inflammatory parameters were evaluated b","2021","07","09","Strahlenther Onkol","Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","Anti-inflammatory effects; COVID-19 pneumonia; Low-dose radiation therapy; Lung irradiation; Treatment outcome","Montero","A","Department of Radiation Oncology, HM Hospitales., Madrid, Spain",NA
"2562","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Yadav","Pragya D","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2563","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Sapkal","Gajanan N","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2564","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Ella","Raches","Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India Pin-500 078",NA
"2565","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Sahay","Rima R","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2566","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Nyayanit","Dimpal A","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2567","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Patil","Deepak Y","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2568","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Deshpande","Gururaj","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2569","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Shete","Anita M","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2570","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Gupta","Nivedita","Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India Pin-110029",NA
"2571","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Mohan","V Krishna","Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India Pin-500 078",NA
"2572","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Abraham","Priya","Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021",NA
"2573","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Panda","Samiran","Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India Pin-110029",NA
"2574","34230972","10.1093/jtm/taab104","Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy","Bhargava","Balram","Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India Pin-110029",NA
"2575","34230969","10.1093/jtm/taab098","COVID-19 in fully vaccinated Everest trekkers in Nepal.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","AstraZeneca vaccine; B.1.617.2; COVID-19; ChAdOx-1 vaccine; SARS-CoV-2; delta variant; mRNA-1273","Amatya","Bhawana","CIWEC Hospital and Travel Medicine Center, Lainchaur, Kathmandu, Nepal",NA
"2576","34230969","10.1093/jtm/taab098","COVID-19 in fully vaccinated Everest trekkers in Nepal.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","AstraZeneca vaccine; B.1.617.2; COVID-19; ChAdOx-1 vaccine; SARS-CoV-2; delta variant; mRNA-1273","Pandey","Prativa","CIWEC Hospital and Travel Medicine Center, Lainchaur, Kathmandu, Nepal",NA
"2577","34230969","10.1093/jtm/taab098","COVID-19 in fully vaccinated Everest trekkers in Nepal.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","AstraZeneca vaccine; B.1.617.2; COVID-19; ChAdOx-1 vaccine; SARS-CoV-2; delta variant; mRNA-1273","Dawadi","Suvash","CIWEC Hospital and Travel Medicine Center, Lainchaur, Kathmandu, Nepal",NA
"2578","34230969","10.1093/jtm/taab098","COVID-19 in fully vaccinated Everest trekkers in Nepal.",NA,"2021","07","07","J Travel Med","Journal of travel medicine","AstraZeneca vaccine; B.1.617.2; COVID-19; ChAdOx-1 vaccine; SARS-CoV-2; delta variant; mRNA-1273","Manandhar","Shanta","CIWEC Hospital and Travel Medicine Center, Lainchaur, Kathmandu, Nepal",NA
"2579","34230968","10.1093/her/cyab028","Does social media provide adequate health education for prevention of COVID-19? A case study of YouTube videos on social distancing and hand-washing.","Social media offers an opportune platform for educating the public about the recommended interventions during global health emergencies. This case study evaluated information in the popular social media platform YouTube about two key interventions (namely, 'social distancing' and 'hand washing') recommended during coronavirus disease-2019. Using the keywords 'social distancing' and 'hand washing', 77 and 78 videos, respectively, were selected from YouTube through pre-defined criteria. The unders","2021","07","07","Health Educ Res","Health education research",NA,"Bora","Kaustubh","ICMR-Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India",NA
"2580","34230968","10.1093/her/cyab028","Does social media provide adequate health education for prevention of COVID-19? A case study of YouTube videos on social distancing and hand-washing.","Social media offers an opportune platform for educating the public about the recommended interventions during global health emergencies. This case study evaluated information in the popular social media platform YouTube about two key interventions (namely, 'social distancing' and 'hand washing') recommended during coronavirus disease-2019. Using the keywords 'social distancing' and 'hand washing', 77 and 78 videos, respectively, were selected from YouTube through pre-defined criteria. The unders","2021","07","07","Health Educ Res","Health education research",NA,"Pagdhune","Avinash","ICMR-National Institute of Occupational Health, Ahmedabad, Gujarat, India",NA
"2581","34230968","10.1093/her/cyab028","Does social media provide adequate health education for prevention of COVID-19? A case study of YouTube videos on social distancing and hand-washing.","Social media offers an opportune platform for educating the public about the recommended interventions during global health emergencies. This case study evaluated information in the popular social media platform YouTube about two key interventions (namely, 'social distancing' and 'hand washing') recommended during coronavirus disease-2019. Using the keywords 'social distancing' and 'hand washing', 77 and 78 videos, respectively, were selected from YouTube through pre-defined criteria. The unders","2021","07","07","Health Educ Res","Health education research",NA,"Patgiri","Saurav Jyoti","ICMR-Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India",NA
"2582","34230968","10.1093/her/cyab028","Does social media provide adequate health education for prevention of COVID-19? A case study of YouTube videos on social distancing and hand-washing.","Social media offers an opportune platform for educating the public about the recommended interventions during global health emergencies. This case study evaluated information in the popular social media platform YouTube about two key interventions (namely, 'social distancing' and 'hand washing') recommended during coronavirus disease-2019. Using the keywords 'social distancing' and 'hand washing', 77 and 78 videos, respectively, were selected from YouTube through pre-defined criteria. The unders","2021","07","07","Health Educ Res","Health education research",NA,"Barman","Bhupen","Department of General Medicine, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, Meghalaya, India",NA
"2583","34230968","10.1093/her/cyab028","Does social media provide adequate health education for prevention of COVID-19? A case study of YouTube videos on social distancing and hand-washing.","Social media offers an opportune platform for educating the public about the recommended interventions during global health emergencies. This case study evaluated information in the popular social media platform YouTube about two key interventions (namely, 'social distancing' and 'hand washing') recommended during coronavirus disease-2019. Using the keywords 'social distancing' and 'hand washing', 77 and 78 videos, respectively, were selected from YouTube through pre-defined criteria. The unders","2021","07","07","Health Educ Res","Health education research",NA,"Das","Dulmoni","Department of Psychiatric Nursing, B.Sc. Nursing College Silchar, Cachar, Assam, India",NA
"2584","34230968","10.1093/her/cyab028","Does social media provide adequate health education for prevention of COVID-19? A case study of YouTube videos on social distancing and hand-washing.","Social media offers an opportune platform for educating the public about the recommended interventions during global health emergencies. This case study evaluated information in the popular social media platform YouTube about two key interventions (namely, 'social distancing' and 'hand washing') recommended during coronavirus disease-2019. Using the keywords 'social distancing' and 'hand washing', 77 and 78 videos, respectively, were selected from YouTube through pre-defined criteria. The unders","2021","07","07","Health Educ Res","Health education research",NA,"Borah","Probodh","Department of Animal Biotechnology, College of Veterinary Sciences, Guwahati, Assam, India",NA
"2585","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Barrie","Mohamed Bailor",NA,NA
"2586","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lakoh","Sulaiman",NA,NA
"2587","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kelly","J Daniel",NA,NA
"2588","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kanu","Joseph Sam",NA,NA
"2589","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Squire","James",NA,NA
"2590","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Koroma","Zikan",NA,NA
"2591","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bah","Silleh",NA,NA
"2592","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Sankoh","Osman",NA,NA
"2593","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Brima","Abdulai",NA,NA
"2594","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ansumana","Rashid",NA,NA
"2595","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Goldberg","Sarah A",NA,NA
"2596","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Chitre","Smit",NA,NA
"2597","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Osuagwu","Chidinma",NA,NA
"2598","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Maeda","Justin",NA,NA
"2599","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Barekye","Bernard",NA,NA
"2600","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Numbere","Tamuno-Wari",NA,NA
"2601","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Abdulaziz","Mohammed",NA,NA
"2602","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mounts","Anthony",NA,NA
"2603","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Blanton","Curtis",NA,NA
"2604","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Singh","Tushar",NA,NA
"2605","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Samai","Mohamed",NA,NA
"2606","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Vandi","Mohamed A",NA,NA
"2607","34230939","10.1101/2021.06.27.21259271","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","Background As of 26 March 2021, the Africa CDC had reported 4,159,055 cases of COVID-19 and 111,357 deaths among the 55 African Union Member States; however, no country has published a nationally representative serosurvey as of May 2021. Such data are vital for understanding the pandemic's progression on the continent, evaluating containment measures, and policy planning. Methods We conducted a cross-sectional, nationally representative, age-stratified serosurvey in Sierra Leone in March 2021 by","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Richardson","Eugene T",NA,NA
"2608","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Petrone","Mary E",NA,NA
"2609","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Rothman","Jessica E",NA,NA
"2610","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Breban","Mallery I",NA,NA
"2611","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ott","Isabel M",NA,NA
"2612","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Russell","Alexis",NA,NA
"2613","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lasek-Nesselquist","Erica",NA,NA
"2614","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kelly","Kevin",NA,NA
"2615","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Omerza","Greg",NA,NA
"2616","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Renzette","Nicholas",NA,NA
"2617","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Watkins","Anne E",NA,NA
"2618","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kalinich","Chaney C",NA,NA
"2619","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alpert","Tara",NA,NA
"2620","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Brito","Anderson F",NA,NA
"2621","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Earnest","Rebecca",NA,NA
"2622","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Tikhonova","Irina R",NA,NA
"2623","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Castaldi","Christopher",NA,NA
"2624","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Kelly","John P",NA,NA
"2625","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Shudt","Matthew",NA,NA
"2626","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Plitnick","Jonathan",NA,NA
"2627","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Schneider","Erasmus",NA,NA
"2628","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Murphy","Steven",NA,NA
"2629","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Neal","Caleb",NA,NA
"2630","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Laszlo","Eva",NA,NA
"2631","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Altajar","Ahmad",NA,NA
"2632","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Pearson","Claire",NA,NA
"2633","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Muyombwe","Anthony",NA,NA
"2634","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Downing","Randy",NA,NA
"2635","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Razeq","Jafar",NA,NA
"2636","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Niccolai","Linda",NA,NA
"2637","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wilson","Madeline S",NA,NA
"2638","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Anderson","Margaret L",NA,NA
"2639","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wang","Jianhui",NA,NA
"2640","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Liu","Chen",NA,NA
"2641","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hui","Pei",NA,NA
"2642","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mane","Shrikant",NA,NA
"2643","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Taylor","Bradford P",NA,NA
"2644","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hanage","William P",NA,NA
"2645","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Landry","Marie L",NA,NA
"2646","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Peaper","David R",NA,NA
"2647","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bilguvar","Kaya",NA,NA
"2648","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fauver","Joseph R",NA,NA
"2649","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Vogels","Chantal B F",NA,NA
"2650","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Gardner","Lauren M",NA,NA
"2651","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Pitzer","Virginia E",NA,NA
"2652","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"George","Kirsten St",NA,NA
"2653","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Adams","Mark D",NA,NA
"2654","34230938","10.1101/2021.07.01.21259859","Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineages.","Emerging SARS-CoV-2 variants have shaped the second year of the COVID-19 pandemic and the public health discourse around effective control measures. Evaluating the public health threat posed by a new variant is essential for appropriately adapting response efforts when community transmission is detected. However, this assessment requires that a true comparison can be made between the new variant and its predecessors because factors other than the virus genotype may influence spread and transmiss","2021","07","14","medRxiv","medRxiv : the preprint server for health sciences",NA,"Grubaugh","Nathan D",NA,NA
"2655","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Coggins","Siâ Ana A",NA,NA
"2656","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Laing","Eric D",NA,NA
"2657","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Olsen","Cara H",NA,NA
"2658","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Goguet","Emilie",NA,NA
"2659","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Moser","Matthew",NA,NA
"2660","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Jackson-Thompson","Belinda M",NA,NA
"2661","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Samuels","Emily C",NA,NA
"2662","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Pollett","Simon D",NA,NA
"2663","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Tribble","David R",NA,NA
"2664","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Davies","Julian",NA,NA
"2665","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Illinik","Luca",NA,NA
"2666","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hollis-Perry","Monique",NA,NA
"2667","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Maiolatesi","Santina E",NA,NA
"2668","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Duplessis","Christopher A",NA,NA
"2669","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ramsey","Kathleen F",NA,NA
"2670","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Reyes","Anatalio E",NA,NA
"2671","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alcorta","Yolanda",NA,NA
"2672","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wong","Mimi A",NA,NA
"2673","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wang","Gregory",NA,NA
"2674","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ortega","Orlando",NA,NA
"2675","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Parmelee","Edward",NA,NA
"2676","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lindrose","Alyssa R",NA,NA
"2677","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Snow","Andrew L",NA,NA
"2678","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Malloy","Allison M W",NA,NA
"2679","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Letizia","Andrew G",NA,NA
"2680","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Powers","John H",NA,NA
"2681","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Burgess","Timothy H",NA,NA
"2682","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Broder","Christopher C",NA,NA
"2683","34230937","10.1101/2021.06.25.21259544","Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.","mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. Single center, prospective, observational cohort study. Participants worked at Walter Reed National Military Medical Center and were seen monthly a","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mitre","Edward",NA,NA
"2684","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Drummer","Heidi E",NA,NA
"2685","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Van","Huy",NA,NA
"2686","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Klock","Ethan",NA,NA
"2687","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Zheng","Shuning",NA,NA
"2688","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wei","Zihui",NA,NA
"2689","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Boo","Irene",NA,NA
"2690","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Center","Rob J",NA,NA
"2691","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Li","Fan",NA,NA
"2692","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Bhat","Purnima",NA,NA
"2693","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ffrench","Rosemary",NA,NA
"2694","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lau","Jillian Sy",NA,NA
"2695","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"McMahon","James",NA,NA
"2696","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Laeyendecker","Oliver",NA,NA
"2697","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fernandez","Reinaldo E",NA,NA
"2698","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Manabe","Yukari C",NA,NA
"2699","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Klein","Sabra L",NA,NA
"2700","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Quinn","Thomas C",NA,NA
"2701","34230936","10.1101/2021.06.28.21259671","Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.","Current tests for SARS-CoV-2 antibodies (IgG, IgM, IgA) cannot differentiate recent and past infections. We describe a point of care, lateral flow assay for SARS-CoV-2 dIgA based on the highly selective binding of dIgA to a chimeric form of secretory component (CSC), that distinguishes dIgA from monomeric IgA. Detection of specific dIgA uses a complex of biotinylated SARS-CoV-2 receptor binding domain and streptavidin-colloidal gold. SARS-CoV-2-specific dIgA was measured both in 112 cross-sectio","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Anderson","David A",NA,NA
"2702","34230935","10.1101/2021.06.26.21259581","In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.","The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person's infectiousness are not well understood. This limits our ability to quantify the impact of interventions on viral transmission. Here, we develop data-driven viral dynamic models of SARS-CoV-2 infection and estimate key within-host parameters such as the infected cell half-life and the within-host reproductive number. We then develop a model linking VL to infectiousness, showing that a person's infectiousness ","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ke","Ruian",NA,NA
"2703","34230935","10.1101/2021.06.26.21259581","In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.","The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person's infectiousness are not well understood. This limits our ability to quantify the impact of interventions on viral transmission. Here, we develop data-driven viral dynamic models of SARS-CoV-2 infection and estimate key within-host parameters such as the infected cell half-life and the within-host reproductive number. We then develop a model linking VL to infectiousness, showing that a person's infectiousness ","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Zitzmann","Carolin",NA,NA
"2704","34230935","10.1101/2021.06.26.21259581","In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.","The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person's infectiousness are not well understood. This limits our ability to quantify the impact of interventions on viral transmission. Here, we develop data-driven viral dynamic models of SARS-CoV-2 infection and estimate key within-host parameters such as the infected cell half-life and the within-host reproductive number. We then develop a model linking VL to infectiousness, showing that a person's infectiousness ","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ho","David D",NA,NA
"2705","34230935","10.1101/2021.06.26.21259581","In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.","The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person's infectiousness are not well understood. This limits our ability to quantify the impact of interventions on viral transmission. Here, we develop data-driven viral dynamic models of SARS-CoV-2 infection and estimate key within-host parameters such as the infected cell half-life and the within-host reproductive number. We then develop a model linking VL to infectiousness, showing that a person's infectiousness ","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ribeiro","Ruy M",NA,NA
"2706","34230935","10.1101/2021.06.26.21259581","In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.","The within-host viral kinetics of SARS-CoV-2 infection and how they relate to a person's infectiousness are not well understood. This limits our ability to quantify the impact of interventions on viral transmission. Here, we develop data-driven viral dynamic models of SARS-CoV-2 infection and estimate key within-host parameters such as the infected cell half-life and the within-host reproductive number. We then develop a model linking VL to infectiousness, showing that a person's infectiousness ","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Perelson","Alan S",NA,NA
"2707","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alpert","Tara",NA,NA
"2708","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Vogels","Chantal B F",NA,NA
"2709","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Breban","Mallery I",NA,NA
"2710","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Petrone","Mary E",NA,NA
"2711","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wyllie","Anne L",NA,NA
"2712","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Grubaugh","Nathan D",NA,NA
"2713","34230934","10.1101/2021.06.21.21259289","Sequencing SARS-CoV-2 Genomes from Saliva.","Genomic sequencing is crucial to understanding the epidemiology and evolution of SARS-CoV-2. Often, genomic studies rely on remnant diagnostic material, typically nasopharyngeal swabs, as input into whole genome SARS-CoV-2 next-generation sequencing pipelines. Saliva has proven to be a safe and stable specimen for the detection of SARS-CoV-2 RNA via traditional diagnostic assays, however saliva is not commonly used for SARS-CoV-2 sequencing. Using the ARTIC Network amplicon-generation approach w","2021","07","09","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fauver","Joseph R",NA,NA
"2714","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Zhang","Chao",NA,NA
"2715","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Verma","Anurag",NA,NA
"2716","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Feng","Yuanqing",NA,NA
"2717","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Melo","Marcelo C R",NA,NA
"2718","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"McQuillan","Michael",NA,NA
"2719","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hansen","Matthew",NA,NA
"2720","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Lucas","Anastasia",NA,NA
"2721","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Park","Joseph",NA,NA
"2722","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ranciaro","Alessia",NA,NA
"2723","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Thompson","Simon",NA,NA
"2724","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Rubel","Meghan A",NA,NA
"2725","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Campbell","Michael C",NA,NA
"2726","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Beggs","William",NA,NA
"2727","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hirbo","Jibril",NA,NA
"2728","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mpoloka","Sununguko Wata",NA,NA
"2729","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Mokone","Gaonyadiwe George",NA,NA
"2730","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Center","Regeneron Genetic",NA,NA
"2731","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Nyambo","Thomas",NA,NA
"2732","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Meskel","Dawit Wolde",NA,NA
"2733","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Belay","Gurja",NA,NA
"2734","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Fokunang","Charles",NA,NA
"2735","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Njamnshi","Alfred K",NA,NA
"2736","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Omar","Sabah A",NA,NA
"2737","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Williams","Scott M",NA,NA
"2738","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Rader","Daniel",NA,NA
"2739","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ritchie","Marylyn D",NA,NA
"2740","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"de la Fuente Nunez","Cesar",NA,NA
"2741","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Sirugo","Giorgio",NA,NA
"2742","34230933","10.1101/2021.06.28.21259529","Global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection.","The COVID-19 pandemic caused by SARS-COV-2 has had a devastating impact on population health. We investigated global patterns of genetic variation and signatures of natural selection at host genes relevant to SARS-CoV-2 infection ( ACE2, TMPRSS2, DPP4 , and LY6E ). We analyzed novel data from 2,012 ethnically diverse Africans, 15,997 individuals of European (7,061) and African (8,916) ancestry recruited by the Penn Medicine BioBank (PMBB), and comparative data from 2,504 individual","2021","07","10","medRxiv","medRxiv : the preprint server for health sciences",NA,"Tishkoff","Sarah",NA,NA
"2743","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Breza","Emily",NA,NA
"2744","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Stanford","Fatima Cody",NA,NA
"2745","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alsan","Marcela",NA,NA
"2746","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Alsan","Burak",NA,NA
"2747","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Banerjee","Abhijit",NA,NA
"2748","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Chandrasekhar","Arun G",NA,NA
"2749","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Eichmeyer","Sarah",NA,NA
"2750","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Glushko","Traci",NA,NA
"2751","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Goldsmith-Pinkham","Paul",NA,NA
"2752","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Holland","Kelly",NA,NA
"2753","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Hoppe","Emily",NA,NA
"2754","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Karnani","Mohit",NA,NA
"2755","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Liegl","Sarah",NA,NA
"2756","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Loisel","Tristan",NA,NA
"2757","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Ogbu-Nwobodo","Lucy",NA,NA
"2758","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Olken","Benjamin A",NA,NA
"2759","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Torres","Carlos",NA,NA
"2760","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Vautrey","Pierre-Luc",NA,NA
"2761","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Warner","Erica",NA,NA
"2762","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Wootton","Susan",NA,NA
"2763","34230932","10.1101/2021.06.23.21259402","Doctors' and Nurses' Social Media Ads Reduced Holiday Travel and COVID-19 infections: A cluster randomized controlled trial in 13 States.","During the COVID-19 epidemic, many health professionals started using mass communication on social media to relay critical information and persuade individuals to adopt preventative health behaviors. Our group of clinicians and nurses developed and recorded short video messages to encourage viewers to stay home for the Thanksgiving and Christmas Holidays. We then conducted a two-stage clustered randomized controlled trial in 820 counties (covering 13 States) in the United States of a large-scale","2021","07","07","medRxiv","medRxiv : the preprint server for health sciences",NA,"Duflo","Esther",NA,NA
"2764","34230931","10.1101/2021.06.30.450632","Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.","The African continent is currently notable as a source of novel SARS-CoV-2 variants. The A.23 viral lineage, characterized by three spike mutations F157L, V367F and Q613H, was first identified in a Ugandan prison in July 2020, and then spilled into the general population adding additional spike mutations (R102I, L141F, E484K and P681R) to comprise lineage A.23.1 by September 2020, with this virus being designated a variant of interest (VOI) in Africa and with subsequent spread to 26 other countr","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Frazier","Laura",NA,NA
"2765","34230931","10.1101/2021.06.30.450632","Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.","The African continent is currently notable as a source of novel SARS-CoV-2 variants. The A.23 viral lineage, characterized by three spike mutations F157L, V367F and Q613H, was first identified in a Ugandan prison in July 2020, and then spilled into the general population adding additional spike mutations (R102I, L141F, E484K and P681R) to comprise lineage A.23.1 by September 2020, with this virus being designated a variant of interest (VOI) in Africa and with subsequent spread to 26 other countr","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Lubinski","Bailey",NA,NA
"2766","34230931","10.1101/2021.06.30.450632","Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.","The African continent is currently notable as a source of novel SARS-CoV-2 variants. The A.23 viral lineage, characterized by three spike mutations F157L, V367F and Q613H, was first identified in a Ugandan prison in July 2020, and then spilled into the general population adding additional spike mutations (R102I, L141F, E484K and P681R) to comprise lineage A.23.1 by September 2020, with this virus being designated a variant of interest (VOI) in Africa and with subsequent spread to 26 other countr","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Tang","Tiffany",NA,NA
"2767","34230931","10.1101/2021.06.30.450632","Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.","The African continent is currently notable as a source of novel SARS-CoV-2 variants. The A.23 viral lineage, characterized by three spike mutations F157L, V367F and Q613H, was first identified in a Ugandan prison in July 2020, and then spilled into the general population adding additional spike mutations (R102I, L141F, E484K and P681R) to comprise lineage A.23.1 by September 2020, with this virus being designated a variant of interest (VOI) in Africa and with subsequent spread to 26 other countr","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Daniel","Susan",NA,NA
"2768","34230931","10.1101/2021.06.30.450632","Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.","The African continent is currently notable as a source of novel SARS-CoV-2 variants. The A.23 viral lineage, characterized by three spike mutations F157L, V367F and Q613H, was first identified in a Ugandan prison in July 2020, and then spilled into the general population adding additional spike mutations (R102I, L141F, E484K and P681R) to comprise lineage A.23.1 by September 2020, with this virus being designated a variant of interest (VOI) in Africa and with subsequent spread to 26 other countr","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Jaimes","Javier A",NA,NA
"2769","34230931","10.1101/2021.06.30.450632","Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.","The African continent is currently notable as a source of novel SARS-CoV-2 variants. The A.23 viral lineage, characterized by three spike mutations F157L, V367F and Q613H, was first identified in a Ugandan prison in July 2020, and then spilled into the general population adding additional spike mutations (R102I, L141F, E484K and P681R) to comprise lineage A.23.1 by September 2020, with this virus being designated a variant of interest (VOI) in Africa and with subsequent spread to 26 other countr","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Whittaker","Gary",NA,NA
"2770","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Larsen","Sasha E",NA,NA
"2771","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Berube","Bryan J",NA,NA
"2772","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Pecor","Tiffany",NA,NA
"2773","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Cross","Evan",NA,NA
"2774","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Brown","Bryan P",NA,NA
"2775","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Williams","Brittany",NA,NA
"2776","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Johnson","Emma",NA,NA
"2777","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Qu","Pingping",NA,NA
"2778","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Carter","Lauren",NA,NA
"2779","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wrenn","Samuel",NA,NA
"2780","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Kepl","Elizabeth",NA,NA
"2781","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Sydeman","Claire",NA,NA
"2782","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"King","Neil P",NA,NA
"2783","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Baldwin","Susan L",NA,NA
"2784","34230930","10.1101/2021.07.02.450915","Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.","In response to the SARS-CoV-2 pandemic many vaccines have been developed and evaluated in human clinical trials. The humoral immune response magnitude, composition and efficacy of neutralizing SARS-CoV-2 are essential endpoints for these trials. Robust assays that are reproducibly precise, linear, and specific for SARS-CoV-2 antigens would be beneficial for the vaccine pipeline. In this work we describe the methodologies and clinical qualification of three SARS-CoV-2 endpoint assays. We develope","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Coler","Rhea N",NA,NA
"2785","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Karlebach","Guy",NA,NA
"2786","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Aronow","Bruce",NA,NA
"2787","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Baylin","Stephen B",NA,NA
"2788","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Butler","Daniel",NA,NA
"2789","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Foox","Jonathan",NA,NA
"2790","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Levy","Shawn",NA,NA
"2791","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Meydan","Cem",NA,NA
"2792","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Mozsary","Christopher",NA,NA
"2793","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Saravia-Butler","Amanda M",NA,NA
"2794","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Taylor","Deanne M",NA,NA
"2795","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wurtele","Eve",NA,NA
"2796","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Mason","Christopher E",NA,NA
"2797","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Beheshti","Afshin",NA,NA
"2798","34230929","10.1101/2021.07.02.450920","Betacoronavirus-specific alternate splicing.","Viruses can subvert a number of cellular processes in order to block innate antiviral responses, and many viruses interact with cellular splicing machinery. SARS-CoV-2 infection was shown to suppress global mRNA splicing, and at least 10 SARS-CoV-2 proteins bind specifically to one or more human RNAs. Here, we investigate 17 published experimental and clinical datasets related to SARS-CoV-2 infection as well as datasets from the betacoronaviruses SARS-CoV and MERS as well as Streptococcus pneumo","2021","07","10","bioRxiv","bioRxiv : the preprint server for biology",NA,"Robinson","Peter N",NA,NA
"2799","34230928","10.1101/2021.06.30.450531","Early detection of SARS-CoV-2 in circulating immune cells in a mouse model.","SARS-CoV-2 infects the respiratory tract, lung and then other organs. However, its pathogenesis remains largely unknown. We used RareScopeâ""¢ Fluorescence Light Sheet Microscopy (FLSM) and fluorescent in situ hybridization of RNA (RNA-FISH) to detect SARS-CoV-2 RNA and dissemination kinetics in mouse blood circulation. By RNA-FISH, we found that SARS-CoV-2 RNA-positive leukocytes, including CD11c cells, appeared as early as one day after infection and continued through day 10 post infection. Our","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Geng","Tingting",NA,NA
"2800","34230928","10.1101/2021.06.30.450531","Early detection of SARS-CoV-2 in circulating immune cells in a mouse model.","SARS-CoV-2 infects the respiratory tract, lung and then other organs. However, its pathogenesis remains largely unknown. We used RareScopeâ""¢ Fluorescence Light Sheet Microscopy (FLSM) and fluorescent in situ hybridization of RNA (RNA-FISH) to detect SARS-CoV-2 RNA and dissemination kinetics in mouse blood circulation. By RNA-FISH, we found that SARS-CoV-2 RNA-positive leukocytes, including CD11c cells, appeared as early as one day after infection and continued through day 10 post infection. Our","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Keilich","Spencer",NA,NA
"2801","34230928","10.1101/2021.06.30.450531","Early detection of SARS-CoV-2 in circulating immune cells in a mouse model.","SARS-CoV-2 infects the respiratory tract, lung and then other organs. However, its pathogenesis remains largely unknown. We used RareScopeâ""¢ Fluorescence Light Sheet Microscopy (FLSM) and fluorescent in situ hybridization of RNA (RNA-FISH) to detect SARS-CoV-2 RNA and dissemination kinetics in mouse blood circulation. By RNA-FISH, we found that SARS-CoV-2 RNA-positive leukocytes, including CD11c cells, appeared as early as one day after infection and continued through day 10 post infection. Our","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Tafas","Triantafyllos",NA,NA
"2802","34230928","10.1101/2021.06.30.450531","Early detection of SARS-CoV-2 in circulating immune cells in a mouse model.","SARS-CoV-2 infects the respiratory tract, lung and then other organs. However, its pathogenesis remains largely unknown. We used RareScopeâ""¢ Fluorescence Light Sheet Microscopy (FLSM) and fluorescent in situ hybridization of RNA (RNA-FISH) to detect SARS-CoV-2 RNA and dissemination kinetics in mouse blood circulation. By RNA-FISH, we found that SARS-CoV-2 RNA-positive leukocytes, including CD11c cells, appeared as early as one day after infection and continued through day 10 post infection. Our","2021","07","09","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wang","Penghua",NA,NA
"2803","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Cerutti","Gabriele",NA,NA
"2804","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Guo","Yicheng",NA,NA
"2805","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Wang","Pengfei",NA,NA
"2806","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Nair","Manoj S",NA,NA
"2807","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Huang","Yaoxing",NA,NA
"2808","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Yu","Jian",NA,NA
"2809","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Liu","Lihong",NA,NA
"2810","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Katsamba","Phinikoula S",NA,NA
"2811","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Bahna","Fabiana",NA,NA
"2812","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Reddem","Eswar R",NA,NA
"2813","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Kwong","Peter D",NA,NA
"2814","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Ho","David D",NA,NA
"2815","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Sheng","Zizhang",NA,NA
"2816","34230927","10.1101/2021.06.29.450397","Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.","Antibodies that potently neutralize SARS-CoV-2 target mainly the receptor-binding domain or the N-terminal domain (NTD). Over a dozen potently neutralizing NTD-directed antibodies have been studied structurally, and all target a single antigenic supersite in NTD (site 1). Here we report the 3.7 Å resolution cryo-EM structure of a potent NTD-directed neutralizing antibody 5-7, which recognizes a site distinct from other potently neutralizing antibodies, inserting a binding loop into an exposed hy","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Shapiro","Lawrence",NA,NA
"2817","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Shiliaev","Nikita",NA,NA
"2818","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Lukash","Tetyana",NA,NA
"2819","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Palchevska","Oksana",NA,NA
"2820","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Crossman","David K",NA,NA
"2821","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Green","Todd J",NA,NA
"2822","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Crowley","Michael R",NA,NA
"2823","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Frolova","Elena I",NA,NA
"2824","34230926","10.1101/2021.06.28.450274","Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.","One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virulence factors is the ability to interact with high affinity to the ACE2 receptor, which mediates viral entry into cells. The results of our study demonstrate that within a few passages in cell culture, both the natural isolate of SARS-CoV-2 and the recombinant, cDNA-derived variant acquire an additional ability to bind to heparan sulfate (HS). This promotes a primary attachment of viral particles to cells before their fu","2021","07","07","bioRxiv","bioRxiv : the preprint server for biology",NA,"Frolov","Ilya",NA,NA
"2825","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Park","Elizabeth",NA,NA
"2826","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Giles","Jon T",NA,NA
"2827","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Perez-Recio","Thania",NA,NA
"2828","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Pina","Paloma",NA,NA
"2829","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Depender","Christopher",NA,NA
"2830","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Gartshteyn","Yevgeniya",NA,NA
"2831","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Askanase","Anca",NA,NA
"2832","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Bathon","Joan",NA,NA
"2833","34230925","10.21203/rs.3.rs-650818/v1","Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.","BackgroundHydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) safety. Therefore, we examined the relationship between HCQ use and corrected QT (QTc) length in SLE and RA patients without clinical CV disease (CVD).MethodsOne SLE (n=352) and two RA cohorts (n=178) wit","2021","07","14","Res Sq","Research square",NA,"Geraldino-Pardilla","Laura",NA,NA
"2834","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Kozlowski","Hannah N","Institute of Biomedical Engineering University of Toronto Toronto Ontario M5S 3G9 Canada",NA
"2835","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Abdou Mohamed","Mohamed A","Institute of Biomedical Engineering University of Toronto Toronto Ontario M5S 3G9 Canada",NA
"2836","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Kim","Jisung","Institute of Biomedical Engineering University of Toronto Toronto Ontario M5S 3G9 Canada",NA
"2837","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Bell","Natalie G","Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario M5S 3H6 Canada",NA
"2838","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Zagorovsky","Kyryl","Institute of Biomedical Engineering University of Toronto Toronto Ontario M5S 3G9 Canada",NA
"2839","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Mubareka","Samira","Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario M5S 3H6 Canada",NA
"2840","34230923","10.1002/sstr.202100034","A Colorimetric Test to Differentiate Patients Infected with Influenza from COVID-19.","Patients infected with SARS-CoV-2 and influenza display similar symptoms, but treatment requirements are different. Clinicians need to accurately distinguish SARS-CoV-2 from influenza to provide appropriate treatment. Here, the authors develope a color-based technique to differentiate between patients infected with SARS-CoV-2 and influenza A using a nucleic acid enzyme-gold nanoparticle (GNP) molecular test requiring minimal equipment. The MNAzyme and GNP probes are designed to be robust to vira","2021","07","08","Small Struct","Small structures","DNAzymes; colorimetric; diagnostics; gold nanoparticles, influenza A; respiratory infections, SARS-CoV-2","Chan","Warren C W","Institute of Biomedical Engineering University of Toronto Toronto Ontario M5S 3G9 Canada",NA
"2841","34230922","10.1002/mco2.52","Risk factors associated with deep vein thrombosis in COVID-19 patients."," .","2021","07","08","MedComm (Beijing)","MedComm",NA,"Wang","Bin","Department of Ultrasound Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China",NA
"2842","34230922","10.1002/mco2.52","Risk factors associated with deep vein thrombosis in COVID-19 patients."," .","2021","07","08","MedComm (Beijing)","MedComm",NA,"Zhang","Li","Department of Ultrasound Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China",NA
"2843","34230922","10.1002/mco2.52","Risk factors associated with deep vein thrombosis in COVID-19 patients."," .","2021","07","08","MedComm (Beijing)","MedComm",NA,"Yin","Shanye","Department of Medical Oncology Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA",NA
"2844","34230922","10.1002/mco2.52","Risk factors associated with deep vein thrombosis in COVID-19 patients."," .","2021","07","08","MedComm (Beijing)","MedComm",NA,"Deng","Wenjun","Department of Neurology Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA",NA
"2845","34230922","10.1002/mco2.52","Risk factors associated with deep vein thrombosis in COVID-19 patients."," .","2021","07","08","MedComm (Beijing)","MedComm",NA,"Xie","Mingxing","Department of Ultrasound Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China",NA
"2846","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Wang","Jing-Jing","Center of Liver Diseases, Beijing Ditan Hospital Capital Medical University Beijing China",NA
"2847","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Su","Yun-Juan","Department of Cardiology, Beijing Ditan Hospital Capital Medical University Beijing China",NA
"2848","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Wang","Qi","Center of Liver Diseases, Beijing Ditan Hospital Capital Medical University Beijing China",NA
"2849","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Cao","Ying","Center of Liver Diseases, Beijing Ditan Hospital Capital Medical University Beijing China",NA
"2850","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Wang","Ai-Bin","Infectious Diseases Diagnostic, Therapeutic and Research Centre, Beijing Ditan Hospital Capital Medical University Beijing China",NA
"2851","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Ding","Rui","Center of Liver Diseases, Beijing Ditan Hospital Capital Medical University Beijing China",NA
"2852","34230921","10.1002/mco2.66","Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19.","Recent studies reported sex differences in patients with coronavirus disease-2019 (COVID-19). We aim to analyze sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. All adults (185 cases) diagnosed with COVID-19 and admitted to Beijing Ditan Hospital, Capital Medical University were included in samples. The median age of all patients was 41 years. The mean body mass index (BMI) of males was relatively higher compared","2021","07","08","MedComm (Beijing)","MedComm","COVID-19; SARS-CoV-2; disease severity; risk factors; sex differences","Xie","Wen","Center of Liver Diseases, Beijing Ditan Hospital Capital Medical University Beijing China",NA
